The alphaviruses: gene expression, replication, and evolution by Strauss, James H. & Strauss, Ellen G.
MICROBIOLOGICAL REVIEWS, Sept. 1994, p. 491-562 Vol. 58, No. 3
0146-0749/94/$04.00+0
Copyright C) 1994, American Society for Microbiology
The Alphaviruses: Gene Expression, Replication, and Evolution
JAMES H. STRAUSS* AND ELLEN G. STRAUSS
Division of Biology, Califomia Institute of Technology, Pasadena, Califomia 91125
INTRODUCTION................................................... 492
The Cast of Characters ................................................... 492
Dispersal of Alphaviruses................................................... 494
Full-Length Clones of Alphaviruses ................................................... 494
STRUCTURE OF ALPHAVIRUSES ................................................... 495
Structure of the Virion................................................... 495
Nucleocapsid................................................... 495
Virion envelope................................................... 496
Organization of the Alphavirus Genome................................................... 498
REPLICATION OF ALPHAVIRUSES................................................... 499
Overview of the Alphavirus Life Cycle................................................... 499
Structural Proteins ................................................... 499
Capsid protein................................................... 499
Synthesis of glycoproteins................................................... 500
Addition of carbohydrate and lipids ................................................... 502
Folding and transport of glycoproteins ................................................... 502
Cleavage of PE2 during transport................................................... 503
Reorientation of the E2 C-terminal domain ................................................... 504
Virus Assembly................................................... 505
Assembly of nucleocapsids................................................... 505
Capsid-spike interaction during budding................................................... 506
Domains involved in the E2-nucleocapsid interaction ................................................... 506
Lateral interactions between glycoproteins ................................................... 508
The 6K protein and ion gradients in assembly ................................................... 509
Nonstructural Proteins ................................................... 509
Translation..........................509
Functions ofnsPi....................................................510
Functions of nsP2 ................................................... 510
Functions of nsP3 ................................................... 511
Functions of nsP4 ................................................... 511
Nonstructural Proteinase................................................... 512
Active site of the enzyme................................................... 512
Nature of cleavage sites recognized by the enzyme................................................... 512
Cleavage site preferences of the enzyme................................................... 513
Synthesis of Viral RNAs ................................................... 514
RNA replicase................................................... 514
Control of minus-strand RNA synthesis ................................................... 514
Role of the opal termination codon................................................... 517
cis-ACTING SEQUENCE ELEMENTS IN ALPHAVIRUS RNAS ................................................... 518
Conserved Nucleotide Sequence Elements ................................................... 518
Identification of CSEs ................................................... 518
Mutagenesis of CSEs................................................... 519
CSEs can be tissue specific ................................................... 519
Cellular proteins bind to CSEs................................................... 519
Promoter for subgenomic RNA synthesis................................................... 520
Repeated Sequence Elements in the 3' NTR ................................................... 521
Sequences in DI RNAs Define Essential cis-Acting Elements ................................................... 522
Packaging Signal in Alphavirus RNAs ................................................... 524
Chimeric Alphaviruses ................................................... 525
Alphaviruses as Vectors ................................................... 525
VIRUS-HOST INTERACTIONS................................................... 526
Host Cell Receptors for Alphaviruses ................................................... 526
Early studies of alphavirus receptors ................................................... 527
Anti-idiotypic antibodies as antireceptor antibodies ................................................... 527
* Corresponding author. Phone: (818) 395-4903. Fax: (818) 449-
0756. Electronic mail address: StraussJ@Starbasel.Caltech.edu.
491
492 STRAUSS AND STRAUSS
Laminin receptor as a mammalian receptor
Mosquito receptor for VEE .................... .
Virus receptor-binding domain.......................
Virus Entry............................................................
Early events in virus penetration...................
Entry into endosomes.......................................
Conformational changes in El and E2..........
Cholesterol requirement for entry by SF.......
Early Events in Establishment of Infection......
..528
..529
cln.
*.................................................................................... hY!
..530
..530
Nucleocansdl dlsassembIv.3s
.................*.................................................................................531
..532
..533
..533
Superinfection exclusion....................................
Inhibition of host protein synthesis.................
Formation of replication factories....................
Pathogenesis and Immunity..................................
Neutralization epitopes in E2...........................
Neutralization epitopes in El...........................
Conformational dependence of epitopes..........
Protection from disease......................................
Virus neurovirulence...............................
Clearance of virus from persistently infected
Induction of apoptosis........................................
Replication in the Mosquito Vector.....................
EVOLUTION OF ALPHAVIRUSES........................
Divergence of Alphaviruses ...................................
Rates of divergence.............................................
Divergence of EEE and VEE.............................
Divergence of Sindbis viruses...........................
Alphavirus evolutionary trees...........................
Recombination among Alphaviruses...................
Recombination in the laboratory.....................
Recombination to form WEE...........................
The Family Togaviridae..........................................
The Sindbis-Like Supergroup of Viruses.
CONCLUDING REMARKS.
ACKNOWVLEDGMENTS ......................................
REFERENCES ...................................... .
neurons.... .
INTRODUCTION
The Cast of Characters
The alphaviruses have 26 currently recognized members
(55). Each virus in turn consists of numerous geographical
variants or strains. Inclusion in the genus Alphavirus has been
based on serological cross-reaction with one or more of the
existing members of the group (55, 409). Complete or partial
sequences of the RNA genomes of more than 10 alphaviruses
have now been reported, and these alphaviruses all share a
minimum amino acid sequence identity of about 45% in the
more divergent structural proteins and about 60% in the
nonstructural proteins. Table 1 lists the currently recognized
alphaviruses, as well as a number of strains that are referred to
in this review, together with the geographic distribution of the
viruses, their evolutionary relationships, and the-abbreviations
for the virus names that will be used throughout this review.
The literature review for this paper was completed in May
1994.
As a group the alphaviruses have a very wide geographic
distribution, isolates having been reported from all continents
except Antarctica and from many islands (55), although each
individual virus has a more limited distribution. The type virus,
SIN, has a very wide distribution, strains of virus referred to as
SIN having been isolated from throughout the Old World
including Europe, Asia (including India and the Philippines),
Australia, and many parts of Africa (both northern Africa and
southern Africa). Viruses related to SIN have also been
isolated from New Zealand (WHA) (484) and from South
American (AURA) (434). The relationship of OCK to SIN
deserves special mention. OCK has often been described as a
distinct species because it causes a human disease different
from that caused by SIN and it is serologically distinguishable
from SIN. However, OCK is much more closely related to SIN
AR339 and to South African strains of SIN than are strains
called SIN that have been isolated from India, the Philippines,
or Australia. In this review we will refer to OCK as a strain of
SIN, on the basis of close sequence relationships, and use the
term SIN-like viruses to include WHA and AURA.
Other Old World alphaviruses have more restricted distri-
butions. RR, for example, is primarily an Australian virus.
ONN virus caused a localized epidemic in Africa of about two
million cases of human disease and has not been identified
outside of this area. SF virus has been isolated from Africa, the
USSR, and India.
Many of the New World viruses are widely distributed
throughout the Americas. WEE is found from Canada to
Argentina, and EEE and VEE occur in both North America
and South America. Other New World viruses such as MAY or
AURA have a more restricted distribution.
The alphaviruses can be grouped into seven complexes on
the basis of serological cross-reactivity (55), and at least one
member of six of these complexes has been sequenced in whole
or in part. On the basis of these sequence data, the members of
these six complexes fall naturally into three larger groups: the
VEE/EEE group, the SF group, and the SIN group (10, 292,
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TABLE 1. The alphaviruses
Complex Abbreviationa Virus nameb Strains Distribution Sequencereference(s)
VEE/EEE group EEE EASTERN EQUINE North American North America 68, 569, 592
ENCEPHALMS South American South America
VEE VENEZUELAN EQUINE Trinidad donkey South America 258
ENCEPHALITIS TC-83 Central America
EVE Everglades Florida 589
MUC Mucambo Brazil, Peru 589
PIX Pixuna Brazil 589
SF group SF SEMLIKI FOREST Africa, Eurasia 137, 138, 540
MID Middelburg Africa 516
CHIK Chikungunya Africa 85
ONN O'NYONG-NYONG Africa 292
RR ROSS RIVER Nelson Bay, T48 Australia, Oceania 116
BF Barmah Forest Australia 10
GET Getah Australia, Asia
SAG Sagiyama Japan
BEB Bebaru Malaysia
MAY Mayaro South America 85
UNA Una South America
SIN group SIN SINDBIS AR86, AR339, Girdwood, Africa, Asia, 517
Karelian fever Europe, Australia
OCKELBO (OCK) Scandinavia 485
AURA AURA Brazil, Argentina 434
WHA VVHATAROA New Zealand 484
BAB Babanki West Africa
KYZ Kyzylagach USSR
Recombinant or WEE Western equine encephalitis North America, 177, 592
uncertain South America
HJ Highlands J Eastern U.S.A. 484, 587
FM Fort Morgan Western U.S.A.
Ungrouped NDU Ndumu Africa
?? Buggy Creek Western U.S.A.
a Standard abbreviations of the virus names which are used throughout the text.
b Complete nucleotide sequences have been reported for the viruses shown in boldface capitals, and partial sequences have been reported for viruses in boldface,
lowercase type. References to the sequences are given in the last column.
592). The VEE/EEE group is exclusively New World in its
distribution. The SF group is mostly Old World in its distribu-
tion, but one representative, MAY, is found in South America
(85). The SIN group, as noted above, is primarily Old World in
its distribution, but AURA is a New World virus related to
SIN. As their names suggest, many members of the VEE/EEE
group, as well as WEE, cause encephalitis in humans or
domestic animals, whereas viruses in the other groups cause
diseases characterized primarily by fever, rash, and arthralgia.
WEE is a New World virus that has been classified as a
member of the SIN group because of serological cross-reac-
tions with SIN (56). However, WEE is in fact a recombinant
virus whose glycoproteins were derived from a SIN-like virus
but the rest of the genome was derived from EEE (177), and,
in common with EEE, WEE can cause encephalitis in humans,
although the incidence and severity of encephalitis are usually
lower than those of EEE encephalitis. WEE is thus more
properly classified in a recombinant subgroup or as a derivative
of the EEE subgroup. It is unclear at present how many of the
New World viruses that are serologically related to SIN are
recombinants like WEE and how many, like AURA, are New
World representatives of the SIN group. Trent and Grant
(549) found that 15 isolates of WEE from different regions of
the United States, Canada, Mexico, Brazil, and Argentina had
very similar oligonucleotide fingerprints, indicating that these
viruses are all very closely related and thus recombinants.
However, they found that isolates of HJ virus from the eastern
United States, which are serologically closely related to WEE,
had oligonucleotide fingerprints that were unrelated to those
of WEE. Recent sequence data have shown that HJ is in fact
a recombinant like WEE and thus belongs to the WEE
recombinant group (587). Studies of other viruses in this group
are in progress.
The alphaviruses are a serious or potential threat to human
health in many areas (166, 402, 405, 414). EEE and WEE
regularly cause fatal encephalitis in humans in both North
America and South America, although the number of cases is
small. VEE also causes human illness. CHIK and its close
relative ONN have caused millions of cases of serious, but not
life-threatening, illness characterized by fever, rash, and a
painful arthralgia. RR, BF, and the OCK strain of SIN cause
epidemic polyarthritis in humans; the symptoms of this disease
can persist for months or years. Two viruses regularly studied
in the laboratory, SIN and SF, are usually considered avirulent
for humans, and the laboratory strains have not been reported
to cause disease following laboratory infection (184), with the
notable exception of one fatal case of SF encephalitis in a
laboratory worker (619). However, natural variants of these
viruses have been found to cause painful human disease. SIN
strains in northern Europe cause polyarthritis (373), and
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strains in South Africa cause a disease characterized by fever
and rash (372). SF strains in the Central African Republic
cause a disease characterized by exceptionally severe head-
ache, fever, myalgia, and arthralgia (337).
Dispersal of Alphaviruses
From a consideration of the sequence relationships among
alphaviruses and their distributions, Levinson et al. (292)
proposed that alphaviruses originated in the New World and
were spread to the Old World twice, once to found the SIN
group and once to found the SF group. Weaver et al. (592)
presented a modified hypothesis in which the alphaviruses
originated in either the New World or the Old World and were
transmitted to the other hemisphere 2,000 to 3,000 years ago.
This hypothesis requires that MAY and AURA must have
been separately introduced (or reintroduced) into the New
World after the divergence of the SF and SIN groups in the
Old World. In either scenario, migratory birds are postulated
to have distributed the viruses, although humans may have
contributed to their spread.
The alphaviruses are arthropod borne, with mosquitoes
being the usual vector. However, Fort Morgan virus and the
Bijou Bridge strain of VEE have swallow bugs as their vector
and alphaviruses have been isolated from other hematopha-
gous arthropods. For example, SIN, whose primary or exclu-
sive vectors are mosquitoes, has also been isolated from mites
and ticks (55, 372, 481) and EEE has been isolated from
chicken mites and lice that had been naturally infected (479);
the chicken mites could transmit EEE but only very ineffi-
ciently. The distribution of the viruses thus reflects in part the
distribution of their mosquito vectors, and the viruses are more
abundant in tropical regions. Many of these viruses have birds
as their primary vertebrate hosts, and bird-associated viruses
such as SIN, WEE, and EEE tend to have the widest distribu-
tions. Many studies have been conducted in an effort to
determine the importance of bird migration or dispersion in
the spread of alphaviruses and other arboviruses (57, 95, 313,
331, 333, 334, 364, 499). These studies have shown that a large
fraction of migratory birds may demonstrate evidence of past
infection by alphaviruses and that alphaviruses can be isolated
from the blood of migrating birds. Furthermore, it is clear that
migrating birds are capable of transporting viruses long dis-
tances; South American strains of EEE have been isolated
from the blood of migrating birds in the Mississippi delta (57),
showing that these birds were infected in South America and
arrived in the United States while still viremic.
The importance of birds in the dissemination of at least
some alphaviruses is also suggested by comparisons of the
genetic heterogeneity of RR, SIN, and the flaviviruses Murray
Valley encephalitis virus and Kunjin virus in Australia. SIN
and the flaviviruses are thought to have migratory waterfowl as
major hosts in Australia, and minor variants of a single virus
type are found throughout Australia. In contrast, the major
vertebrate reservoirs of RR are small nonmigratory marsupi-
als, and this virus has evolved into distinct strains in different
parts of Australia (115a, 305, 309a, 310a).
Although avian hosts may be responsible for the global
spread of alphaviruses, once introduced into an area most
viruses evolve into an endemic strain that persists in a localized
area, and continual mixing does not occur. As one example,
EEE isolated in North America is distinguishable from virus
isolated in South America (57, 62), even though, as described
above, migrating birds are capable in principle of mixing these
virus strains. Studies of other alphaviruses, including RR (332)
and VEE (589), have similarly shown that strains isolated from
one geographic area are distinguishable from strains isolated
from other areas. Strains of SIN-like viruses, which are almost
worldwide in distribution, are for the most part related by
location rather than by year of isolation (484, 485).
Humans are also capable of disseminating alphaviruses (as is
the case for many other virus groups), particularly since the
introduction of jet travel. RR is primarily an Australian virus
which causes periodic outbreaks of polyarthritis in humans in
many regions of Australia. RR recently caused an explosive
epidemic of polyarthritis throughout the South Pacific (332),
maintained probably by a human-mosquito-human transmis-
sion cycle. After infecting most of the human populations of a
number of island groups, the virus died out, apparently failing
to establish an endemic cycle in other animals. Because the
first cases of disease occurred near the Nadi airport in Fiji,
which has direct air connections with Australia, and then
spread to other island groups having air connections with Nadi,
and because all virus isolated during the epidemic appeared to
be closely related if not identical (53, 115a), it seems very likely
that a single infected air traveler introduced the virus to Fiji
and that the spread was very rapid because the human
populations on these islands had not been previously exposed
to the virus.
Full-Length Clones of Alphaviruses
Much sequence information has been reported for different
alphavirus RNAs. Complete sequences have been determined
for two strains of SIN (485, 517), for two strains of RR (116),
for four strains of VEE and a vaccine derivative of one of these
strains (258, 260, 261), for SF (137, 138, 540), for ONN (292),
for EEE (68, 569, 592), for AURA (434), and for WHA (484);
partial sequences have been determined for WEE (177, 592),
MID (516), CHIK (85), MAY (85), BF (10), and HJ (484,587).
In addition, the results of extensive studies of the replication of
these viruses in cultured cells have been reported, as have the
results of many studies of temperature-sensitive (ts) mutants
and of variants that differ in their neurovirulence or in their
reactivity with monoclonal antibodies; many of these studies
are reviewed below. An important development in these
studies has been the construction of full-length cDNA clones
corresponding to either a defective interfering (DI) RNA or
the entire genome of an alphavirus, in which the viral se-
quences are positioned downstream of a promoter for an RNA
polymerase, usually T7 or SP6 RNA polymerase. RNA tran-
scribed in vitro from such clones can be transfected into
susceptible cells. In the case of DI RNA, the cells are also
infected with helper virus and DI particles can be rescued after
several passages (295, 465, 467). In the case of full-length viral
RNA, transfection leads to virus replication and production of
infectious virions. Full-length clones have been reported for
SIN (418), VEE (90) and a vaccine derivative of VEE (257),
SF (303), and RR (273). Studies with these clones have allowed
the identification of domains essential for the replication and
packaging of the RNA, the mapping of genetic markers such as
ts mutations or attenuating mutations in the genome, the
construction of new mutations in regions of interest using site
directed mutagenesis, the construction of chimeric viruses to
study the interactions of different domains of viral genomes
with one another, and the use of alphaviruses as expression
vectors to express genes of interest in the cytoplasm of an
infected cell. These studies have required appropriate controls
because it has been found that the RNA polymerases can make
consistent mistakes and introduce errors into the transcribed
RNA (272, 370, 371) and that suppressor mutations may arise
rapidly, obscuring the effects of the mutation introduced into
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FIG. 1. Stereoviews of the three-dimensional structure of RR virus. Surface-shaded representations of the three-dimensional structure of RR
viewed along the icosahedral threefold axis are shown. The image was computed from 76 independent particle images obtained by cryoelectron
microscopy (70). Bar, 200 A (20 nm). Figure courtesy of R. J. Kuhn.
the genome (162, 312). It is possible to control for all these
effects, however, and the results from many studies that rely on
construction of mutants or of chimeric viruses are reported in
detail in the various sections of this review. The alphaviruses
now represent one of the best-studied of the animal virus
groups, and new information is continually being reported on
their evolution, the molecular biology of their replication, and
their virulence. Within recent years, it has also become clear
that the viruses interact with their hosts in a more intimate
fashion than was previously suspected, and the necessity for
the viruses to alternate between the mosquito vector and a
vertebrate host has constrained their evolution in interesting
ways. Studies of the interactions of the viruses with the host
cell are leading alphavirologists into more detailed studies of
cell biology, which are also important for our understanding of
viral pathogenesis.
STRUCTJRE OF ALPHAVIRUSES
Structre of the Vmion
Alphaviruses contain an icosahedral nucleocapsid that is
enveloped in a tight-fitting envelope whose glycoprotein com-
ponents are present in an icosahedral lattice. The virion has a
very regular structure, and crystals of SIN or SF have been
obtained that diffract to about 3 nm, which implies a variability
of no more than 0.5 to 0.8 nm in any part of the particle (191),
and alphavirions have been described as icosahedral protein
lattices with an associated membrane bilayer (391). The struc-
tures of SIN, SF, and RR have been solved to a resolution of
±3 nm by cryoelectron microscopy (70, 130, 391, 568). A
reconstruction of the surface features of the RR virion is
shown in Fig. 1 as a stereo pair. In Fig. 2 a reconstruction
showing a cutaway view of the particle illustrates the surface
lattice, the lipid bilayer, and the nucleocapsid within. Finally,
the radial density distribution of the RR virion is shown in Fig.
3 at 14-A (1.4-nm) intervals. The features illustrated by these
three figures are described in detail below.
Nucleocapsid. The alphavirus nucleocapsid contains the
single-stranded plus-sense RNA genome of approximately 11.7
kb complexed with multiple copies of a single species of capsid
protein of about 30 kDa. It possesses icosahedral symmetry
and a fenestrated structure such that the RNA within the
capsid is sensitive to RNase degradation. Early electron mi-
croscopy of isolated capsids suggested triangulation numbers
(7) for the symmetry of the particle of 3, 4, or 9 (reviewed in
references 189 and 529). Reconstruction of cryoelectron mi-
croscopic images of whole SIN virions by Fuller (130) sug-
gested that T = 3. Subsequent work has clearly shown by
several different methods that T = 4. First, the three-dimen-
sional structure of the capsid protein of SIN has been solved to
a resolution of 0.3 mu by X-ray diffraction (71, 546), and the
dimensions of the folded capsid protein and of the nucleocap-
sid are compatible with a T = 4 particle containing 240 copies
of the capsid protein but incompatible with a T = 3 structure
made up of 180 copies of capsid protein. Second, electron
microscopy of SIN capsids that were carefully prepared so as to
prevent RNase degradation of the encapsidated RNA also led
to the interpretation that T = 4 (77). Third, the mass of the
SIN nucleocapsid was recently determined to be 10.9 MDa by
scanning transmission electron microscopy, which predicts that
240 copies of capsid protein are present and therefore that T =
4 (392). Finally, recent reconstructions of SIN and RR virions
from cryoelectron-microscopic images have clearly shown that
for the nucleocapsid, T = 4 (70, 391) (Fig. 2 and 3). T = 4
means that there is a one-to-one relationship between capsid
protein and envelope glycoproteins, which simplifies the inter-
pretation of interactions that occur during virus assembly.
The reconstructions of RR in Fig. 2 and 3 clearly demon-
strate the presence of five- and sixfold-coordinated subunits in
the nucleocapsid arranged in a T = 4 icosahedral array. In
these images the individual capsid protein subunits are visible
and their interactions to form pentamers or hexamers can be
seen. It is notable that these images give no sign of the
presence of dimers of the nucleocapsid protein in the capsid,
and the dimers observed in the crystal structure of the SIN
capsid protein (71, 546) are thought not to be present in the
capsid (70).
The diameter of the SIN nucleocapsid is 41 nm as deter-
mined by X-ray scattering by intact virus particles (189, 533),
40.4 mu as determined by X-ray diffraction of nucleocapsid
crystals (191), or 34 to 38 am as seen in the electron micro-
scope after isolation from virions (77). Isolated nucleocapsids
are stable and have a sedimentation coefficient of 140S.
Electrostatic interactions are important for the stability of the
VOiL 58, 1994
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FIG. 2. Cutaway surface representation of RR revealing the multilayered structure of the virion. The envelope glycoproteins appear in the
outer layer as thumb-like projections displayed in grey, while the inner layer of nucleocapsid protein is shown in blue. The inner and outer borders
of the lipid bilayer membrane are displayed in orange and probably represent the polar head groups of the bilayer membrane. Interactions of the
lipid bilayer membrane and the nucleocapsid are clearly visible. Figure courtesy of R. J. Kuhn.
capsid, and presumably for its assembly as well, because high
salt concentrations (.1 M) cause the capsid to disassemble
(79), suggesting that the highly basic N-terminal domain of the
capsid protein binds the viral RNA.
Virion envelope. The virion envelope consists of a lipid
bilayer in which are embedded multiple copies of two virus-
encoded glycoproteins (reviewed in references 189 and 529).
The lipid bilayer is composed of lipids derived from the plasma
membrane of the host cell, and its composition closely approx-
imates that of the host plasma membrane. It has a thickness of
4.8 nm and is centered at a radius of 23.2 nm in SIN. Because
of the high curvature of the bilayer, the outer leaflet has an
area 40% larger than the inner leaflet.
The two glycoproteins, El and E2, each have a molecular
mass of about 50 kDa and are anchored in the membrane by
conventional membrane-spanning anchors in the C-terminal
regions (135, 141, 189, 416, 459). E2 is 423 amino acids long in
SIN and has a 33-residue cytoplasmic domain following the
anchor. El is 439 residues long in SIN and has a cytoplasmic
domain of only 2 residues. Both El and E2 are glycosylated,
MICROBIOL. REV.
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FIG. 3. Projections of RR electron density at different radii. The RR image reconstruction is presented as projected views of the electron
density truncated progressively toward lower radii starting from the outer surface of the envelope glycoproteins (345 A) down to the capsomer
region of the nucleocapsid (205 through 191 A). The density shells move toward lower radii in increments of 14 A. All representations are viewed
along a radial direction midway between the axes of the pentavalent (toward the top) and hexavalent (toward the bottom) capsomer axes. Highest
density is indicated by yellow, and low density is indicated by red. Figure courtesy of R. J. Kuhn.
but the number and position of the attached chains are not
absolutely conserved among alphaviruses. El usually carries
one or two chains, whereas E2 usually carries two or three
chains. Both El and E2 of SIN and of SF also have covalently
attached palmitic acids in or near the membrane-spanning
anchors (474, 475; reviewed in reference 459), one attached to
El and four to six attached to E2. Palmitoylation of the
glycoproteins of other alphaviruses has not been studied.
E2 and El form a stable heterodimer that remains intact
upon dissociation of the virus with mild detergents, and three
E2-El heterodimers interact to form the spike that is found on
the virus surface (420, 627; reviewed in reference 189). Cross-
linking studies suggest that the trimers are maintained by
El-El interactions (7), a result consistent with the finding that
upon fusion of the viral envelope with a cell membrane during
viral infection, the El-E2 heterodimer disassembles to give rise
to E2 monomers and El homotrimers (575). In the spike the
three heterodimers twist around one another in an anticlock-
wise direction to form the stalk of the spike and then separate
to form a tripartite head (Fig. 1). At the tip of each het-
erodimer, El and E2 appear to separate (Fig. 1) (269). A
model for the relative locations of El and E2 in the spike that
was based on differential cryoelectron-microscopic reconstruc-
tions of untreated and detergent treated particles has been
presented (567). The glycoprotein spikes extend to a radius of
about 34.5 nm, so that the total diameter of the virion is 69 nm
(190, 391). The glycoproteins of the virus form an icosahedral
lattice with T = 4 (130, 391, 568, 570), and there are 240
heterodimers on the surface of the virus, assembled into 80
spikes.
The trimeric nature of the spikes is clearly seen in the radial
density distribution maps in Fig. 3, as are capsid-glycoprotein
interactions that are believed to result in the precise 1:1 ratio
of capsid protein to envelope protein. Proceeding from the
inside out, the sections at 191 and 205 A show the capsid
protein capsomers. The next three sections are in the region of
the lipid bilayer, in which only light density can be seen where
the membrane-spanning domains of the glycoproteins traverse
it. The glycoproteins emerge from the lipid bilayer precisely
over the capsid protein subunits, consistent with a one-to-one
interaction between a glycoprotein heterodimer and a capsid
protein subunit. These interactions are described in more
detail below. At this point the glycoproteins exhibit the same
icosahedral lattice as the capsid and the trimeric structure is
not evident (sections at 261 and 275 A). As they extend
upward, the glycoproteins take a sharp bend, seen in the
section at 289 A, and form trimeric assemblies that are
positioned between capsid subunits rather than over them
(sections beyond 303 A). The heterodimers twist around one
another as the stalk elongates and then separate.
E2 is formed as a precursor called PE2 or p62 that is cleaved
into E2 and a small glycoprotein called E3. E3 remains
associated with the virion in some cases (e.g., SF) but not in
others (e.g., SIN). There is also a small hydrophobic peptide
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region. Readthrough of the opal stop codon produces P1234, which can form an active replicase. The 26S subgenomic mRNA is expanded below
to show the structural ORF and its translation products. Polypeptides present in the virion are shaded. vcRNA is the minus-strand complement
of the genomic RNA.
that is produced as a linker between E2 and El, called the 6K
protein, that has been found to be associated with the virus in
submolar quantities (7 to 30 molecules per virion) (133, 317).
From its composition (reviewed in reference 529), the SIN
virion has a molecular mass of 52 MDa and is composed of
29% lipid, 57% protein, 6% carbohydrate, and 7% RNA. It has
a sedimentation coefficient of 280S and a density of 1.22 g/ml
in sucrose-D20 solutions.
There are conflicting reports of whether the envelope of the
virus is permeable to hydrogen ions. Isolated nucleocapsids of
SF have been found to undergo a marked contraction on
treatment at low pH (497); treatment of intact SF virions at low
pH also led to the contraction of the nucleocapsid, as deter-
mined by examination of nucleocapsids isolated from treated
virions (458). It was suggested that the viral envelope proteins
function as ion channels that allow penetration of H+ ions. In
contrast, treatment of intact SIN virions at pH 5 was found not
to affect the diameter of the capsid, as determined by X-ray
solution scattering by the intact particles, although the glyco-
protein spikes did undergo a conformational rearrangement
such that their length increased by 40 A (4 nm) and they now
extended to a radius of 390 A (39 nm) (533).
Organtion of the Alphavinis Genome
The organization and expression of the genome of the type
alphavirus SIN are illustrated in Fig. 4, and comparisons of the
different regions of the SIN genome with those of other
alphaviruses are shown in Table 2. The SIN genomic RNA is
11,703 nucleotides (nt) in length exclusive of the 5'-terminal
cap and a 3'-terminal poly(A) tract (reviewed in reference
524). It is divided into two major regions: a nonstructural
domain encoding the nonstructural or replicase proteins,
which forms the 5'-terminal two-thirds of the RNA, and a
structural domain encoding the three structural proteins of the
virus, which forms the 3'-terminal one-third. The nonstructural
proteins are translated as one or two polyproteins from the
genomic RNA itself. These polyproteins are cleaved to pro-
duce nsPl, nsP2, nsP3, and nsP4, as weli as a number of
cleavage intermediates that possess important functions dis-
tinct from the final products. In most sequenced alphaviruses a
termination codon (UGA) is present following nsP3 and two
polyproteins (P123 and P1234) are produced, whereas in some
alphaviruses this codon has been replaced by a sense codon
and only P1234 is produced. The structural domain is trans-
lated as a polyprotein from a subgenomic mRNA, the 26S
mRNA (4,103 nt in SIN). 26S RNA is also capped and
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TABLE 2. Genome organization and translation products of alphaviruses
Nonstructural region (aa) Structural region (aa)
Virus (total nt) 5'NT nsP3 Junca 3'(nt) nsPl nsP2 Cons./ nsP4 (nt) C E3 E2 6K El (nt)
noncons.
SIN (11,703) 59 540 807 325/231 556 610 48 264 64 423 55 439 322
AURA (11,813) 66 539 806 325/219 544 610 53 267 61 424 54 438 465
WHA (11,586) 60 540 807 325/189 514 610 52 266 63 423 55 439 323
EEE (11,675) 46 532 794 324/235 559 608 66 260 63 420 57 441 361
VEE (11,444) 44 535 794 329/228 557 607 38 275 59 423 55 442 121
ONN (11,835) 79 535 798 324/246 570 611 48 260 64 423 61 439 425
SF (11,442) 85 537 798 324/158 482 614 41 267 66 422 60 438 264
RR (11,851) 78 533 798 324/214 538 611 47 270 64 422 60 438 524
a Defined as nontranslated nucleotides only; the termination codons of both the nonstructural and structural ORFs are considered to be nontranslated.
b Cons./noncons., conserved/nonconserved.
c Length of nsP3 to the nsP3/nsP4 cleavage site, not to the stop codon; nsP3 terminating at the stop codon will be 7 amino acids (aa) shorter.
polyadenylated. The structural polyprotein is processed to
produce the envelope proteins, the capsid protein, and the two
small polypeptides E3 and 6K.
The junction region between the nonstructural and struc-
tural domains of the genome contains the nucleotides encod-
ing the C terminus of the nonstructural polyprotein, a pro-
moter for transcription of the subgenomic mRNA, and the
start site and 5' nontranslated leader sequence of 26S mRNA.
In addition there are 59 nt that are nontranslated in SIN at the
5' terminus of the genome (5' NTR) and 322 nt in the 3' NTR.
Both NTRs contain signals important for replication of the
RNA.
During RNA replication, a minus-strand copy of the genome
RNA is produced that is an exact complement except for the
presence of an unpaired G at the 3' end (610, 611). This
full-length minus strand serves as a template not only for the
production of additional genomic RNA but also for transcrip-
tion of the subgenomic RNA (reviewed in reference 524).
REPLICATION OF ALPHAVIRUSES
Overview of the Alphavirus Life Cycle
Alphaviruses replicate in both arthropod hosts and verte-
brate hosts, producing a persistent lifelong infection in arthro-
pods while leading to an acute, usually short-duration infection
in vertebrates. This situation is mirrored in cell culture, where
alphaviruses produce a persistent infection in mosquito cells,
in which the cells survive and continue to produce virus at low
levels, but produce a cytolytic infection in vertebrate cells. The
persistent infection in mosquito cells has been the more
difficult to study because the virus fails to inhibit host macro-
molecular synthesis and low levels of viral products are pro-
duced. In alphavirus-infected vertebrate cells, host macromo-
lecular synthesis is inhibited and viral products are made in
large amounts that are readily visualized.
Replication of alphaviruses in mosquito cells is sensitive to
inhibitors such as dactinomycin (49), and very little replication
occurs in enucleated cells (113), indicating that a functional
nucleus is required for the infection. In contrast, in vertebrate
cells normal yields can be obtained even in the presence of
dactinomycin or at-amanitin and virus replication occurs al-
most normally in enucleated vertebrate cells (it is thus of
interest that about half of nsP2 produced after infection is
transported to the nucleus [398]). Although there is no evi-
dence for the requirement for a nucleus during the infection
process, vertebrate cells treated for long periods with dactino-
mycin or ot-amanitin produce lower yields of virus, providing
evidence that nucleus-encoded functions are also required for
virus replication in these cells (reviewed in reference 524). In
addition, many mutations in the viral genome have been found
to affect virus replication differently in different cell lines,
suggesting an interaction with host proteins (271, 272, 370,
371).
A growth curve for SIN in chicken cells at 30°C is shown in
Fig. SA. In this differential growth curve, the medium over the
cells was changed every hour and the virus released into the
medium during each hour was assayed and plotted as a
function of the time after infection (since virus maturation
occurs by budding through the cell plasma membrane, the virus
is released into the cell culture fluid and does not accumulate
in intracellular pools). Virus output increases rapidly between
4 and 6 h after infection and then becomes almost constant,
being released at a rate of about 2,000 PFU per cell per h. As
might be predicted by the fact that the virus grows both in
mosquitoes, whose body temperature is often quite low, and in
birds, whose body temperature can approach or exceed 40°C,
the virus grows well over a wide range of temperatures. In
chicken cells in culture, SIN produces high yields over a
temperature range from 25°C (lower temperatures have not
been tested) to about 41°C.
Figure SB illustrates that in vertebrate cells, minus-strand
RNA is made only early after infection. Minus-strand RNA is
synthesized until about 6 h after infection at 30°C or about 4 h
at 40°C, and its synthesis then ceases abruptly; after this time,
only plus-strand RNAs are produced (453).
Structural Proteins
Capsid protein. The alphavirus structural proteins are trans-
lated from a subgenomic 26S mRNA as a polyprotein that is
processed both cotranslationally and posttranslationally (re-
viewed in reference 466). The nucleocapsid protein is N-
terminal in the polyprotein, and it possesses a serine protease
activity that acts in cis to release itself from the nascent
polypeptide chain (reviewed in reference 531). The protein is
believed to fold with the bond to be cleaved lying in the active
site of the enzyme so that proteolysis is very rapid. Capsid
protein is produced when 26S RNA, whether isolated from
infected cells or produced by transcription of cDNA clones in
vitro, is translated in vitro (6, 38, 180, 489), and it has been
shown recently that a construct that terminates 2 residues
downstream of the C terminus of the capsid protein is cleaved
normally to produce authentic capsid protein (269). Numerous
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FIG. 5. Growth curve of SIN in chicken embryo fibroblasts at 30°C.
(A) Release of infectious virus into the culture fluid. At the times
shown, the medium was harvested and replaced with fresh medium,
and the titer was determined by plaque assay on monolayers of chicken
cells. (B) Cells infected as in panel A were pulsed with radioactive
uridine for 1 h at the times specified. Symbols: 0, total radioactivity
incorporated into acid-insoluble form; 0, incorporation into minus-
strand RNA (note that the scale is 10-fold less than that for total
RNA). Adapted from reference 524 with the permission of the
publisher.
studies have shown that the catalytic triad forming the active
site of the SIN capsid proteinase consists of H-141, D-163, and
S-215 (reviewed in reference 531). Boege et al. (31) first
suggested that S-215 formed part of the active site of a serine
proteinase because of the context surrounding this residue.
Mapping of mutations that rendered the proteinase tempera-
ture sensitive led to the hypothesis that S-215, H-141, and
either D-147 or D-163 formed the catalytic triad (179, 532).
Site-specific mutagenesis experiments confirmed the impor-
tance of S-215 (180, 345) and H-141 (180) but were unable to
identify an active-site aspartic acid. It is of interest that
enzymes with C-215 or T-215 retained partial activity, whereas
enzymes with A-215 or I-215 were inactive (180). It was
hypothesized that the very rapid kinetics of this autoproteolytic
event led to residual activity with these particular amino acids
in the active site of the enzyme.
Protein-modeling studies suggested that D-163 formed the
third component of the SIN catalytic triad (156). This was
confirmed from the three-dimensional structure of the capsid
protein (71, 546) which revealed that the SIN capsid protein
C-terminal to residue 114 has a fold homologous to that of
chymotrypsin, with S-215, H-141, and D-163 forming the
catalytic triad and W-264, the C-terminal residue, present
within the active site (Fig. 6). Thus, once the capsid protein has
cleaved itself, the proteinase is no longer active because the
active site is occupied.
The capsid protein has an overall size that varies from 258
residues in MAY to 275 residues in VEE and is divided into
two distinct domains. The amino-terminal 96 residues (SIN
numbering) are not conserved as to sequence among alphavi-
ruses (84, 419) and are not ordered in crystals (71). This
domain is rich in lysine and arginine and probably binds
electrostatically to the RNA. There are 30 positively charged
residues (K or R) and only one negatively charged residue (E)
in the first 108 amino acids of the SIN capsid; 240 capsid
monomers in the nucleocapsid contain a net positive charge in
this N-terminal region sufficient to neutralize about 60% of the
negative charges on the viral RNA. The presence of 20 proline
residues in the first 100 amino acids, together with the large
positive charge, suggests that this domain has little structure
and protrudes into the interior of the nucleocapsid, where it
interacts electrostatically with the RNA.
In contrast, the domain from residue 97 to the C terminus is
highly conserved in sequence among alphaviruses and residues
C-terminal to residue 114 are ordered in crystals (Fig. 6). In
addition to its function as a proteinase, this domain probably
contains regions that promote capsid protein-capsid protein
interactions during nucleocapsid assembly and regions that
lead to interaction with the cytoplasmic domains of the glyco-
proteins during budding.
There are regions in the capsid protein that bind specifically
to RNAs. Newly synthesized capsid protein is bound by the
large ribosomal subunit, and this binding reaction could be
active in disassembling nucleocapsids upon entry into the cell
(reviewed in reference 490). Wengler et al. (612) have pre-
sented evidence that the sequence KPGKRQRMALKLEAD
(positions 99 to 113) in the SIN capsid protein binds to
ribosomes. This element is conserved in alphavirus capsid
proteins (7 of 15 residues are invariant in 10 sequenced
alphaviruses) and is predicted to be present on the surface of
the capsid (71), where it acts as a linker to join the basic N
terminus in the interior of the capsid with the conserved and
ordered C terminus.
Capsid protein also binds specifically to the viral genomic
RNA, and this binding is believed to be important for the
initiation of nucleocapsid formation and possibly for the
stimulation of RNA synthesis (599). Deletion analysis of the
capsid protein identified a region of 32 amino acids (residues
76 to 107) that was essential for specific binding and a region
of 68 amino acids (residues 1 to 10 and 75 to 132) that
possessed almost full binding activity (148). Thus, the genomic
RNA-binding region overlaps the region required for binding
to the large ribosomal subunit.
Synthesis of glycoproteins. A schematic overview of the
synthesis and processing of the glycoproteins is shown in Fig. 7.
Once the nucleocapsid protein is released from the nascent
polypeptide chain, an N-terminal signal sequence functions in
a conventional manner and leads to the insertion of glycopro-
tein PE2 into the endoplasmic reticulum (ER). Translation in
cell-free systems has shown that microsomal membranes are
required for insertion and processing of the envelope proteins
(38, 142), that signal recognition particles are required for this
process (39), and that the signal sequence is not removed (37).
The signal sequence has not been mapped precisely, but the
N-terminal 40 residues of PE2 have been shown to act as a
signal for translocation of two different reporter molecules
(139), and the signal is thought to be contained within the first
19 residues. The signal sequence has a carbohydrate attach-
ment site at an asparagine residue between residues I1 and 14
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FIG. 6. Three-dimensional structure of the SIN capsid protein (residues 114 to 264). The ribbon structure of the SIN capsid protein as
determined by Choi et al. (71) is shown with ,3-strands represented by the large arrows. The fold of the protein is similar to that of chymotrypsin.
R-1 14 is the N terminus of the ordered region of the capsid protein, and W-264 is the C terminus of the capsid protein; these residues are boxed.
The residues that form the catalytic triad of the serine proteinase (S-215, H-141, and D-163) are shown in underlined italics, and the positions in
the structure are indicated by the open diamonds; note that W-264 is present within the active site. The seven residues that have changed from
the EEE sequence to the SIN sequence in WEE (M-137, N-172, G-201, L-231, A-234, T-238, and 1-254) are also indicated by solid circles. These
seven residues form a roughly linear trace across the capsid protein and are proposed to interact with the C-terminal cytoplasmic domain of
glycoprotein E2 during virus assembly. Figure courtesy of R. J. Kuhn.
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in all alphaviruses examined, and it has been hypothesized that
addition of carbohydrate to this site may be responsible for the
retention of the signal sequence in PE2. The carbohydrate
chain is added early, while the polypeptide is nascent, suggest-
ing that the N terminus of PE2 is released from the ER
membrane into the lumen very soon after translation and thus
that the signal sequence plays no role in further translocation
of the protein (139, 480).
Near the C terminus of PE2 is a hydrophobic stretch that
functions as a stop transfer signal and membrane anchor for
E2 (Fig. 8). In common with other such signals, the luminal
and cytoplasmic boundaries are marked by charged residues in
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FIG. 7. Model for the production of glycoproteins PE2 and El.
Stop-transfer signals are indicated by cylinders, and signal sequences
are indicated by rectangular blocks. Stalked symbols show the locations
of carbohydrate chains, and the proteolytic cleavage sites are indicated
by arrows ( , signalase cleavage site; 4~, furin cleavage site). The
model is not drawn to scale, in order to emphasize certain features.
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FIG. 8. The hydrophobic membrane anchor of alphavirus E2 gly-
coproteins. The 26 residues which constitute the anchor domain are
shown, numbered from the N terminus of E2. Charged residues are
shaded: gray, basic amino acids; diagonal lines, acidic amino acids.
Note that the cytoplasmic face is positively charged with respect to the
luminal face of the anchor. Boxed residues in WEE and EEE are those
in which the WEE amino acid differs from the SIN residue but is
identical to the EEE residue (see text).
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which the cytoplasmic charge cluster is positive with respect to
the luminal boundary (25). Site-specific mutagenesis of the
charge cluster at the cytoplasmic boundary of SF PE2 showed
that changing the charge from +2 to 0 or to -1 did not change
the topology of PE2 in the membrane or inhibit the subsequent
transport of the protein to the plasma membrane (82, 83).
These changes did lower the stability of the anchoring of the
protein in cellular membranes, however, as the mutant pro-
teins were more readily released from cell membranes upon
washing with alkaline sodium carbonate.
Following the anchor sequence, PE2 contains 33 residues (in
SIN) which act as a signal for insertion of the following
peptide, referred to as 6K (Fig. 7). The central part of this
sequence is uncharged and traverses the membrane such that
the N terminus of 6K is external. Liljestrom and Garoff (301)
have shown that if 6K is deleted, the signal at the end of E2
leads to the translocation of El, and thus that this signal
sequence can act independently of the 6K sequence. The
cleavage between PE2 and 6K is almost certainly effected by
signalase in the lumen of the ER since the site cleaved is
characteristic of signalase sites, cleavage does not require
expression of nonstructural proteins or of the capsid protein,
and mutations that alter the C-terminal alanine of PE2 abolish
cleavage in a fashion consistent with signalase recognition of
the site (301, 345, 524). Cleavage by signalase signifies that the
C terminus of PE2 is present at least transiently in the lumen
of the ER.
The C-terminal domain of the 6K polypeptide acts as a
signal sequence for the translocation of El. Translocation of
PE2 is not required for this sequence to function as an internal
signal for the translocation of El, and this sequence will also
function as an N-terminal signal for the translocation of El or
of a recorder gene (193, 301, 344, 355). Cleavage between 6K
and El is, again, almost certainly effected by signalase (301,
345, 524). Insertion of 15 amino acids into the SIN 6K protein
following F-29 was found to interfere with proteolytic process-
ing of the glycoprotein precursor and, as a result, with trans-
port of the glycoproteins, leading to decreased amounts of
mature E2 and El in the cell (462).
Synthesis of glycoprotein El continues until a stop codon is
reached (Fig. 7). Just upstream of the stop codon is a stop-
transfer sequence that acts as an anchor for El. This stop-
transfer signal also follows the rule that the cytoplasmic
boundary is more positively charged than the luminal bound-
ary, and in most alphaviruses, the cytoplasmic domain of El
consists of only two arginine residues. Deletion of the cyto-
plasmic domain or substitution of the arginine residues by
neutral amino acids did not affect the topology of El or the
subsequent transport of the protein to the cell surface (21).
Thus, both PE2 and El are type I integral membrane proteins
that have a membrane-spanning anchor at or near the C
terminus (135, 141, 189, 416, 459).
Addition of carbohydrate and lipids. The addition of carbo-
hydrate chains to alphavirus PE2 and El has been extensively
studied; high-mannose chains are added en bloc to the nascent
proteins in the lumen of the ER, and the carbohydrate chains
are subsequently modified during transit through the Golgi
apparatus (reviewed in reference 459). It appears that all
potential sites in the ectodomains of alphavirus glycoproteins
are glycosylated and carry either complex or simple oligosac-
charide chains. It has been postulated that if a simple oligo-
saccharide chain is accessible to cellular processing enzymes
during transport through the Golgi apparatus, the chain is
modified to the complex type, whereas if the folding of the
protein renders the chain inaccessible, it remains simple (215).
Both PE2 and El are glycosylated in all alphaviruses stud-
ied, but the number, position, and type of the attached chains
are not absolutely conserved among different alphaviruses. In
most strains of SIN, for example, both El (N-139 and N-245)
and E2 (N-196 and N-318) have two N-linked carbohydrate
chains, whereas SF El carries one chain (N141) and SF E2
carries two (N200 and N262). For SIN, the N-terminal chains
of both El and E2 are complex whereas the C-terminal chain
of El can be either complex or simple depending upon the host
cell (214, 340) and the C-terminal chain of E2 is simple. A SIN
strain that has three chains in E2 and that appears to grow
normally in cultured cells has been isolated (59); from this
variant, another variant that had four E2 chains was selected by
passage in mosquito cells (105, 107). The variant with four E2
chains grew well in mosquito cells but was temperature sensi-
tive in vertebrate cells. As another example of variability, a
variant of SIN selected to be resistant to a particular mono-
clonal antibody was found to have acquired resistance by
addition of a new carbohydrate chain on E2 (520).
Palmitoylation of the glycoproteins of SIN and of SF (459,
474, 475) occurs in a compartment reached approximately 15
min after completion of the polypeptide chain and is catalyzed
by a protein acyltransferase that uses palmitoyl coenzyme A as
a donor (27, 476). It has been shown that palmitoylation of
PE2 in vertebrate cells occurs after exit from the ER but
probably before arrival in the cis Golgi (40). However, palmi-
toylation in mosquito cells was found to occur primarily on E2
rather than on PE2 (454). This difference probably results
because the cleavage of PE2 occurs in an early compartment in
mosquito cells but in a late compartment in vertebrate cells.
The one palmitic acid in SF El was shown by direct
biochemical analysis to be attached to C-433 which is present
in the transmembrane segment at a location corresponding to
the middle of the inner leaflet of the bilayer (473). The one
palmitic acid chain attached to SIN El is presumed to be
attached to C-430 (the only cysteine in the region). Interest-
ingly, two alphaviruses, EEE and VEE, have no cysteine
residue in this region of El and are presumably not palmitoy-
lated, although this has not been examined directly.
E2 carries four to six palmitic acid chains in SIN and
probably the same number in SF. Site-specific mutagenesis has
shown that C-396, C-416, and C-417 are palmitoylated in SIN
E2 (134, 221). All three sites are in the cytoplasmic domain of
E2 (see below), and these three cysteines are conserved in all
alphaviruses sequenced to date. In addition, there is at least
one palmitic acid residue attached to the membrane anchor of
E2, possibly in a location similar to the El site, as shown by the
fact that E2 is palmitoylated even when the cytoplasmic tail is
deleted (432).
The 6K protein is also palmitoylated. The SIN 6K protein is
55 residues in length, and site-specific mutagenesis has shown
that C-35, C-36, C-39, and probably one other cysteine are
palmitoylated (132, 133). Mutagenesis to reduce the amount of
palmitoylation did not interfere with the transport of the
glycoproteins to the cell surface, but virus budding was affected
(132).
Folding and transport of glycoproteins. The folding and
oligomerization of viral glycoproteins have been studied in a
number of virus systems (reviewed in reference 99), and the
available data for alphaviruses suggest that the details of
folding and oligomerization are similar to those for other
viruses (325, 365). Folding of viral glycoproteins normally
begins immediately upon entry into the ER, while the protein
is nascent, and requires molecular chaperones, folding en-
zymes, energy, and the formation of disulfide bonds (44).
Furthermore, the addition of carbohydrate chains is usually
required for proper folding; it is believed that the function of
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the carbohydrates at this stage is to increase the solubility of
the protein and prevent aggregation or side reactions from
occurring. It has been shown that inhibitors of glycosylation
interfere with the transport and function of the proteins in SIN
(341, 464), presumably because they fail to fold properly. Once
folded, the proteins oligomerize in a specific fashion. Proteins
that fail to fold properly are not transported out of the ER,
usually aggregate into nonspecific complexes, and are slowly
degraded. While in the ER, misfolded proteins may be rescued
and induced to fold properly as a result of the activities of
folding enzymes and chaperones; such rescue may be dramatic
when conditions are changed, such as a shift from a nonper-
missive to a permissive condition for a ts mutant (442).
Both PE2-E1 heterodimers and E2-E1 heterodimers have
been demonstrated in the cell (235, 420, 628). Heterodimers
can form in trans from proteins translated from two different
mRNAs (309), consistent with early observations that ts defects
in El and E2 are complementable (reviewed in reference 521)
and with our general understanding that folding of protein
monomers into their proper conformation must occur before
oligomerization can occur (99). PE2-E1 heterodimers are
much more stable than E2-E1 heterodimers. Wahlberg et al.
(574) found that PE2-E1 heterodimers remain associated after
exposure to pH 5.8, whereas the E2-E1 heterodimers are
dissociated by exposure to pH 6.4. Related studies have shown
that alterations in the conformation of El and E2 in the dimers
that occur upon exposure to acidic pH require much lower pH
for PE2-El dimers than for E2-El dimers; these changes in
conformation are manifested by the exposure of new antigenic
epitopes, by an alteration in the susceptibility of the glycopro-
teins to proteases, or by the activation of the fusion activity
presumed to be present in El (224, 252, 308). Furthermore,
Lobigs et al. (309) found that E2-El dimers did not form, or
were of such low stability they could not be demonstrated,
when E2 was produced as E2 rather than as PE2 (in this
experiment a synthetic signal peptide replaced E3 and was
removed by signalase after insertion). Thus, dimerization is a
process that normally requires interaction of PE2 and El.
After formation, the PE2-El dimer is transported to the
Golgi apparatus and ultimately to the cell surface. It is
unknown whether the unit transported is a single PE2-El
heterodimer or a trimerized spike unit. The structure and
function of the Golgi apparatus and the transport of proteins
through it have been intensively studied (reviewed in reference
346). Where studied, the transport of alphavirus glycoproteins
is similar in detail to that of other glycoproteins, and the
alphavirus glycoproteins have been used as probes for Golgi
function (91, 274, 442, 443).
Efficient transport of alphavirus glycoproteins beyond the
ER normally requires dimerization (and possibly higher-order
oligomerization) of the glycoproteins but does not require
expression of capsid protein or of nonstructural proteins (140,
220, 264, 265, 309, 417, 423, 432, 603). Monomeric E2 of SF
was transported inefficiently but detectably to the cell surface,
whereas monomeric El was not detectably transported beyond
the ER. In contrast, SIN El was found to be efficiently
transported to the cell surface in the absence of PE2 or E2
(355), and the necessity for oligomerization may depend upon
the virus.
Removal or alteration of the cytoplasmic domain of SF PE2
or of the intramembrane region was found not to prevent the
transport of the protein to the cell surface (140, 423) or its
polar localition at the basolateral surface of polarized cells
(432), indicating that whatever signals exist for transport do
not lie in the C-terminal region of the protein. Similarly,
removal or replacement of the two Arg residues that constitute
the cytoplasmic domain of El had only a minor effect on
transport of the complex (21). Deletion of the 6K protein,
which is normally transported in association with the glyco-
protein complex (317), also did not interfere with the transport
of the glycoprotein complex to the cell surface (303).
A number of ts mutations of both SF (444) and SIN (9),
which interfere with the transport of the glycoproteins, have
been described. These mutations lead to reversible defects in
which transport of the proteins is inhibited at the nonpermis-
sive temperature, and the proteins accumulate in the ER or in
the Golgi apparatus. Upon shift to the permissive temperature,
transport of the previously formed proteins occurs. SIN muta-
tions causing such a phenotype were mapped to changes at El
residues 106, 176, and 267 in the ectodomain of the protein. It
is assumed that the protein fails to fold properly at the
nonpermissive temperature and that this leads to the failure to
transport the protein complex; the misfolded protein is present
in large aggregates (420).
Following transport through the Golgi complex, the glyco-
proteins are transported from the trans Golgi network to the
cell plasma membrane, where they are used to assemble
viruses. In polarized cells, sorting of proteins to the apical or
basolateral surface occurs at this stage (91, 131, 338, 339, 346),
and the transport of alphavirus glycoproteins to the cell surface
is polarized. During SIN or SF infection of the FRT line of
thyroid epithelial cells, the glycoproteins accumulate at the
apical surface (and virus budding occurs only at the apical
surface in such cells) (374, 629). However, following SF
infection of Madin-Darby canine kidney cells (432) or SIN or
SF infection of CaCo-2 cells (629), the glycoproteins are
transported to the basolateral surface (and budding occurs
from this surface). It has also been found that in SF-infected
hippocampal cells in culture the viral glycoproteins were
present exclusively in dendrites and cell body but not in axons
(100). Differences in the surface used for virus budding in
different tissues could be of importance in the spread of the
virus in the organism.
Cleavage of PE2 during transport During transport of the
PE2-E1 complex, PE2 is cleaved to form E2 and E3. Cleavage
occurs after the consensus sequence R-X-(KJR)-R I, where X
is any amino acid and cleavage occurs at the arrow (reviewed
in reference 523). Cleavage of PE2 is effected by a host cell
proteinase and is a late event in vertebrate cells, occurring
after the proteins reach the trans Golgi network but before
arrival at the cell surface (91), but has been reported to be an
early and continuous event in mosquito cells (366, 454). There
is now known to exist a family of cellular proteinases that
cleave after basic residues and process a large number of
cellular proproteins including, among others, insulin, pro-
opiomelanocortin, and the insulin receptor precursor. These
enzymes, which are Ca2"-dependent serine proteinases related
to bacterial subtilisin, include furin (also called PACE), PC2,
PC3-PC1, and PACE 4 in mammals and kex2 protease in
Saccharomyces cerevisiae (reviewed in references 19, 129, 492,
and 506). PC2 and PC3 are restricted to neuroendocrine cells,
lack a membrane anchor, and process insulin and pro-opi-
omelanocortin, among others, only after packaging of the
proproteins into secretory vesicles (16, 383, 493, 547). They
prefer to cleave following the sequence (K/R)-R I (see, for
example, reference 97). In contrast, furin has a wide tissue
distribution, has a membrane anchor, is localized in the Golgi
apparatus, and has a cleavage site preference for the sequence
R-X-(K/R)-R J . This enzyme is thought to cleave a number of
proproteins as they traverse the Golgi apparatus, such as the
insulin receptor precursor, which is cleaved following the
sequence RKRR; mutation to RKRS leads to failure to cleave
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the receptor precursor and to insulin-resistant diabetes in
humans (624). Because of its properties, furin is believed to be
the enzyme that cleaves alphavirus PE2 as well as glycoprotein
precursors of several other virus families.
Although the cleavage of PE2 is normally extremely efficient
and only E2 is found in virus particles, uncleaved PE2 can be
efficiently incorporated into virus particles, at least when virus
is grown in vertebrate cells, showing that cleavage of PE2 is not
required for transport of the glycoprotein dimer to the cell
surface or for virus assembly. Several approaches have been
devised in which cleavage of PE2 was blocked, and such
experiments routinely produced yields of PE2-containing par-
ticles that were similar to the yields of E2-containing particles
in control experiments, although the specific infectivity of the
PE2-containing particles was usually low. Russell et al. (437)
isolated a mutant of strain AR89 of SIN in which no cleavage
of PE2 occurred. PE2-containing particles were produced in
high yield when the virus was grown in vertebrate cells but not
when it was grown in mosquito cells. In the case of SIN AR339,
treatments were devised that resulted in the partial incorpora-
tion of PE2 into virus (410), but with this approach it was not
possible to completely replace E2 with PE2. Watson et al.
(585) isolated a strain of CHO cells that was resistant to
Pseudomonas exotoxin A, which requires cleavage after basic
residues for activation. This cell line was defective in the
proteinase that cleaves alphavirus PE2; SIN infection of these
cells led to the production of high yields of virus particles that
contained only uncleaved PE2. Dubuisson and Rice (102)
studied SIN variants containing random insertions in PE2 or
El and identified variants in which an insertion near the PE2
cleavage site led to a failure to cleave PE2; uncleaved PE2 was
efficiently incorporated in virions. Finally, in the case of SF,
cleavage defective mutants of PE2 were constructed by chang-
ing the conserved arginine in the P1 position to lysine, leucine,
or glutamic acid (308) or to phenylalanine (224). Uncleaved
PE2 was efficiently transported and incorporated into virus
particles (440).
Cleavage of PE2, which changes the stability of the glyco-
protein dimer, is normally required to activate the virus for
infection of a cell, and in almost all cases cited above in which
PE2 completely replaced E2 in virus particles, the specific
infectivity of the particles was quite low. When the cleavage-
defective SF E2 glycoproteins were expressed by using vaccinia
virus or simian virus 40 vectors, uncleaved PE2 was expressed
at the cell surface in PE2-E1 dimers. No fusion of cells (by El)
occurred in cells transfected with cleavage defective PE2 after
exposure to pH 5.5, the optimal pH of fusion for the wild-type
virus; instead, exposure to pH c 5.0 was required for fusion,
and exposure to this low pH led to dissociation of PE2-El
dimers and alteration in trypsin sensitivity of the glycoproteins
(310). SF virions containing PE2 (produced by introducing a
cleavage mutation into the virus genome) were essentially
noninfectious (440). SF virus with uncleaved PE2 bound to
cells at pH 7.3 only one-fourth as well as did E2-containing
virus, virus once bound was internalized only one-fifth as well,
and internalized virus did not undergo the pH-dependent
changes in El associated with fusion. Infectivity of the PE2-
containing virions could be activated by trypsin treatment,
which led to the cleavage of PE2 to E2, or by exposure of cells
with bound virus to a pH of 4.5. Similarly, SIN containing
uncleaved PE2 because it was grown in the mutant CHO cells
(585) or because the virus contained an insertion preventing
PE2 cleavage (102) was essentially noninfectious and was
defective in binding to vertebrate cells; infectivity could be
rescued by treating the virus with trypsin. The ability of
uncleaved PE2 at the cell surface or in virus to be cleaved by
exogeneously added proteinases to produce a protein very
similar in size to E2, as well as the fact that this cleavage
activates the heterodimer for fusion and infectivity, suggests
that the sequence near the E3-E2 junction must be exposed in
a form that makes it readily susceptible to proteolytic attack.
Thus, the precise cleavage at this junction by furin must result
not only from the specificity of the enzyme for its cleavage site
but also from the exposure of this region to attack.
Although cleavage of PE2 is normally required to activate
the infectivity of alphaviruses, it is possible to obtain virus with
suppressor mutations in E3 or E2 that allow PE2-containing
virus to retain infectivity. SIN AR86 and SIN AR339 that
contain only PE2 are not infectious, but suppressor mutations
that render PE2-containing virus infectious arise readily; all
such suppressor mutations mapped to date lie in E3 or E2
(194, 437). It is probable that the compensating mutations
allow PE2-containing virus to be infectious by destabilizing the
PE2-E1 heterodimer. In addition, SIN AR339 in which PE2
partially replaced E2 in the virion was fully infectious (410),
although in this case the remaining E2 in the virus could have
activated the virus infectivity.
During transport to the cell surface, alphavirus glycoproteins
are potentially exposed to slightly acidic pH which could
trigger the low-pH-induced changes in the E2-E1 heterodimer,
thereby inactivating it. The greater stability of the PE2-E1
heterodimer supports a model in which the stable PE2-E1
heterodimers are transported through the cell and the cleavage
of PE2 just before arrival at the cell surface activates virus
infectivity.
Although different in detail, the PE2 cleavage activation
event is formally similar to those that occur in a number of
other enveloped viruses in which glycoprotein precursors must
be cleaved to activate virus infectivity. For flaviviruses, retro-
viruses, myxoviruses, and paramyxoviruses, cleavage occurs
after a canonical sequence that is similar or identical to the
cleavage sequence in alphavirus PE2, suggesting that these
cleavages are all effected by the same cellular enzyme (re-
viewed in references 210, 523, and 618).
Reorientation of the E2 C-terminal domain. The C terminus
of PE2 is thought to lie in the lumen of the ER when first
synthesized (Fig. 7), with subsequent reorientation of the
C-terminal region into the cytoplasm being required for virus
budding (141, 221, 301, 419). A schematic of this reorientation
is shown in Fig. 9. Liu and Brown (306) have recently
presented evidence that the reorientation takes place during
transport of the protein complex. A mutant was constructed
with Y-420 in place of S-420 in E2, just upstream of the
C-terminal A-423. Cells were infected with the mutant, and
membrane vesicles were prepared by homogenization; such
vesicles have the cytoplasmic side as the outside of the vesicle
and the luminal side inside. The authors found that Y-420
could not be iodinated when PE2 was first synthesized and
concluded that at this time it was protected because it was
within the lipid bilayer. At some point during transport of the
complex, after it had left the ER, this tyrosine became suscep-
tible to iodination, showing that the E2 tail had reoriented to
the cytoplasm.
In a second set of experiments, Liu and Brown (307)
presented evidence that reorientation of the PE2 tail was
associated with phosphorylation. In the presence of inhibitors
of phosphorylation, when no phosphorylation of PE2 or of E2
was detectable, glycoproteins were synthesized and trans-
ported to the plasma membrane and PE2 was cleaved to E2.
However, nucleocapsids were randomly distributed in the
cytoplasm, and under these conditions there was no specific
interaction between nucleocapsids and glycoproteins in the cell
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FIG. 9. Schematic model of the configuration of glycoprotein PE2
(E3 + E2) in membranes. The upper panel shows the configuration of
PE2 immediately after signalase cleavage from 6K, with the C terminus
in the lumen. Open circles are potential sites for acylation. The lower
panel shows the configuration after acylation and phosphorylation-
dephosphorylation, with the C terminus in the cytoplasm. In this model
the side chains of the fatty acids are shown penetrating into the
membrane, resulting in the alignment of the C-terminal domain along
the membrane. The model is not to scale.
surface. In contrast, in the presence of inhibitors of dephos-
phorylation, PE2 was also synthesized, transported, and
cleaved to PE2, but in this case PE2 and/or E2 was detectably
phosphorylated and nucleocapsids were aligned along mem-
branes in the cell. Thus, in this case there was an interaction
between nucleocapsids and glycoproteins in the cell surface,
although no budding was seen. The authors hypothesized that
the withdrawal of the E2 tail into the cytoplasm requires
phosphorylation within the region; once in the cytoplasm, the
E2 tail can interact with the nucleocapsid but cannot support
budding until it is dephosphorylated.
The three conserved cysteine residues that are fatty acylated
in SIN, and presumably in all alphaviruses, are present in the
cytoplasm after reorientation (Fig. 9). It seems certain that the
palmitic acid residues will be present within the lipid bilayer,
rather than in the cytosol, and thus might serve to orient the E2
tail along the bilayer. It is possible that addition of palmitic
acid is associated with the reorientation process.
Virus Assembly
Assembly of nucleocapsids. Viral nucleocapsids assemble as
distinct entities in the cytoplasm of an infected cell. These
nucleocapsids are easily visible in electron-microscopic images
of infected cells and can be readily isolated from infected cells
as stable structures (see, for example, references 52 and 511).
Capsid assembly is specific in that only genomic RNA is
normally packaged into capsids and a packaging signal has
been identified in SIN viral RNA that is required for efficient
encapsidation (599). Capsids always have RNA associated with
them, and there are no reports of the assembly of RNA-free
subviral structures. These observations lead to the following
model for nucleocapsid assembly. Assembly begins with a
specific nucleation event in which a capsid protein molecule or
an assemblage of molecules binds to the packaging signal.
After initiation, additional capsid proteins are recruited into
the structure in a reaction that probably involves both lateral
interactions with proteins already in the partially assembled
shell and electrostatic interactions between the highly charged
N-terminal domain of the capsid protein and the viral RNA.
The electrostatic binding of the N-terminal domain to the
RNA is probably nonspecific and requires no specific protein
structure. The very high charge density in this region could be
responsible for the failure of empty capsids to assemble,
because assembly may require neutralization of these charges.
The lateral interactions with other capsid proteins, in contrast,
are presumably specific and mediated by sequences in the
conserved C-terminal part of the protein. These interactions
determine the structure of the icosahedral shell, which closes
on itself to produce a T = 4 particle.
Although in most alphaviruses only the genomic RNA is
packaged, in AURA virus the subgenomic 26S RNA is also
packaged (436), suggesting that in this virus a packaging signal
is found within the region of the genome transcribed into the
subgenomic RNA. The genomic RNA is found only in T = 4
particles, but the subgenomic RNA is packaged into both T =
4 particles and a smaller particle believed to have T = 3
symmetry (435). Smaller particles have also been found in SF
(20) or SIN (233) preparations containing DI particles and in
SIN virus preparations produced in mosquito cells (51), and
thus the ability to form T = 3 particles seems to be universal
among alphaviruses. The results are consistent with a model in
which the structure formed by the capsid protein is not
predetermined. Genomic RNA is of a size that it can be
encapsidated only in a T = 4 (or larger) particle, and assembly
is forced into a mode that results in a T = 4 particle. Smaller
RNAs that possess a packaging signal can be packaged into
smaller particles, and assembly may proceed in such a way as to
produce either a T = 3 structure or a T = 4 structure, perhaps
depending on whether more than one RNA is recruited into
the structure. Evidence exists that T = 1 particles may also be
formed under some conditions (51), and Lee and Brown (280)
have recently found that a larger particle, probably T = 7, is
formed in high yield by a mutant of SIN having two amino acid
changes in the capsid protein. Thus, it appears that particles
with triangulation numbers of 1, 3, 4, and 7 can be formed by
alphaviruses under different conditions.
During budding of the nucleocapsid to produce virions, the
nucleocapsid appears to undergo a maturation event in which
it contracts, or is triggered to contract upon isolation from the
virus, and sediments more rapidly. Nucleocapsids isolated
from mature SIN virus sediment more rapidly than and are
more sensitive to RNase than nucleocapsids isolated from
infected cells (76). This observation is corroborated by studies
of a mutant of SIN (E2 A-344 -> V) that is defective in
envelopment and forms multicored particles (178, 511). Nu-
cleocapsids isolated from multicored particles, which have
failed to mature properly, sediment more slowly than do
nucleocapsids isolated from wild-type virions or from mutant
virions that sediment identically to wild-type virions and that
therefore appear to be standard mature virions (511). We
hypothesize that the signaling event for contraction is the
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interaction of the capsid with E2 during maturation; the results
with the envelopment-defective mutant suggest that envelop-
ment must be complete or nearly complete before contraction
occurs.
Capsid-spike interaction during budding. Nucleocapsids
assembled in the cell cytoplasm are thought to diffuse freely to
the plasma membrane, where they are bound by the viral
glycoproteins present at the cell surface. It has long been
proposed that the nucleocapsid binds specifically to the C-
terminal cytoplasmic domains of the glycoprotein spikes (of
which only the cytoplasmic domain of E2 is significant) and
that this binding provides the free energy to propel the capsid
through the plasma membrane, during which process it ac-
quires a complete complement of glycoprotein spikes (141).
Lateral interactions between the glycoproteins are also impor-
tant for virus assembly (571).
Early studies demonstrated that the interactions of alphavi-
rus capsids and glycoprotein were specific (reviewed in refer-
ence 523). Phenotypic mixing did not occur between alphavi-
ruses and viruses belonging to different families (625), and no
host protein was incorporated into the alphavirus virion (510).
Expression and transport of the glycoproteins to the cell
surface were found to be necessary for binding of nucleocap-
sids to the plasma membrane. In a study of ts mutants of SIN,
Brown and Smith (52) found that for mutant ts23, which has
two mutations in the ectodomain of El (A-106 -> T and R-267
-- Q) (9) that lead to a failure to transport the glycoproteins to
the cell surface at the nonpermissive temperature, nucleocap-
sids were found distributed uniformly throughout the cyto-
plasm. In contrast, for SIN ts20, which has a single mutation in
the ectodomain of E2 (H-291 -> L) (304) but whose glyco-
proteins are transported to the cell surface at the nonpermis-
sive temperature (although PE2 is not cleaved), the nucleo-
capsids were found to be aligned along the plasma membrane,
apparently bound by the glycoprotein spikes, although no
budding occurred at the nonpermissive temperature. Other
studies showed that the location of the glycoproteins in the cell
determined the site of virus budding, indicating a need for
interaction between capsid and glycoproteins during budding.
Saraste et al. (444) found that in a ts mutant of SF with a
transport defect in the glycoproteins, no budding occurred at
the nonpermissive temperature; shift down led to functional
glycoprotein and virus budding into the Golgi apparatus where
the glycoprotein spikes had accumulated, whereas normally
the virus buds only from the plasma membrane. In related
findings it was reported that treatment of cells with a manno-
sidase inhibitor (341) or with monensin (170, 229) could lead
to limited budding at intracellular membranes. It has also been
shown that transport of alphavirus glycoproteins to the cell
surface is polarized in polarized cells and that virus budding
occurs only at the surface containing the glycoproteins,
whether it be basolateral or apical (374, 629). Finally, it has
been shown recently that no virus assembly occurs in the
absence of nucleocapsid formation or of glycoprotein expres-
sion (536), formally demonstrating the necessity for capsid-
glycoprotein interactions for virus formation.
Several independent studies have led to the conclusion that
most of the viral glycoprotein present at the cell surface is
bound to nucleocapsids after the first few hours of infection.
Johnson et al. (230) used fluorescent photobleaching to study
the mobility of SIN glycoproteins on the cell surface and
concluded that these proteins were mobile early after infection
but not later in infection, suggesting that most of the SIN
glycoproteins at the cell surface are immobilized later in
infection by interactions with nucleocapsids. This finding con-
trasted with results obtained with vesicular stomatitis virus
glycoproteins in the same experiments, which were mobile
both early and late after infection. The distribution of SIN
glycoproteins on the surface of cells has also been studied by
electron microscopy with freeze-fracture or surface replica
techniques, and conclusions similar to those from the fluores-
cent-photobleaching experiments were drawn. Birdwell et al.
(29) found that SIN glycoproteins could first be detected at the
cell surface at 1.5 h after infection in a distributed pattern, with
budding virus containing high concentrations of glycoproteins
evident by 3 h after infection. Pavan et al. (394, 395) used both
surface replica and freeze-fracture techniques together with
gold labeling to detect virus glycoproteins. They found that
after virus budding was first detected, almost all of the virus
glycoprotein was associated with budding figures and there was
no pool of free glycoprotein. Further, they found that budding
virus figures excluded cell proteins. In related studies, Torrisi
and Bonatti (548) used freeze-fracture to show that the viral
glycoproteins partitioned differently in the plasma membrane
from in internal membranes, suggesting that the glycoproteins
in the plasma membrane, but not in intracellular membranes,
are attached to nucleocapsids. In a different approach, Zhao
and Garoff (626) reported that the SF glycoproteins are
unstable at the cell surface in the absence of expression of the
capsid protein and turn over rapidly. Degradation of El results
in release of an El fragment into the culture fluid. The
instability of the glycoproteins when expressed alone is consis-
tent with the hypothesis that the viral membrane proteins are
normally captured efficiently by budding nucleocapsids and
that no large pool of free glycoprotein spikes exists at the
plasma membrane.
Binding to the nucleocapsid by the glycoproteins has been
directly demonstrated in studies in which SF virions were
treated with octylglucoside. This treatment removed the lipid
bilayer but left most of the glycoproteins attached to the
nucleocapsid, suggesting that there is a noncovalent binding of
the glycoprotein spikes by the capsid (196).
Domains involved in the E2-nucleocapsid interaction. Both
the nucleocapsid and the glycoproteins are organized into a T
= 4 lattice (70, 71, 391) such that there is a 1:1 molar ratio
between nucleocapsid and glycoproteins, and the current
model for virus budding is that there is a binding site on each
nucleocapsid protein for part of or all of the cytoplasmic
domain of E2 (Fig. 2 and 3). Metsikko and Garoff (348) found
that a synthetic peptide of 31 residues corresponding to the SF
E2 tail would in fact bind to SF capsids, either in solution or
after coupling the peptides to a solid matrix. The peptide was
found to oligomerize, and it was the oligomers that interacted
with the capsid.
Hahn et al. (177) sequenced the structural-protein region of
the WEE genome and found that it is a recombinant virus in
which the nucleocapsid protein was derived from EEE whereas
the glycoproteins were derived from a SIN-like parent. The
EEE capsid protein and the SIN glycoproteins in WEE
appeared to have undergone selection after the recombination
event that adapted these two proteins to one another (Fig. 10).
Seven amino acids in the WEE nucleocapsid protein have
changed from the EEE sequence to the SIN sequence, and
Hahn et al. (177) suggested that these seven changes adapted
the EEE nucleocapsid to the SIN glycoproteins. These amino
acids, M-137, N-172, G-201, L-231, A-234, T-238, and 1-254
(SIN numbering and residues), form a roughly linear trace in
the capsid protein about 45 A (4.5 nm) long (Fig. 6), and the
cytoplasmic tail of E2 may lie along this trace (71). Conversely,
four amino acids in the cytoplasmic domain of the SIN-like E2
ofWEE have switched to the EEE amino acids, presumably to
better adapt the glycoproteins to the EEE nucleocapsid. The
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FIG. 10. Evolution of the WEE capsid protein and glycoprotein E2
after formation of WEE by recombination. At the top of the figure is
a schematic representation of the structural protein domain ofWEE in
which the capsid protein was donated by EEE and the glycoproteins
were donated by a SIN-like virus. In the WEE capsid protein the seven
amino acids (aa) whose positions are indicated by the tick marks have
changed from the EEE residue to the SIN residue as shown below;
these residues are marked on the structure of the capsid protein in Fig.
6. In addition, the four amino acids in the C-terminal domain of E2
whose locations are shown by the tick marks have changed from the
SIN residue to the EEE residue as shown. Adapted from reference 527
with permission of the publisher.
SIN E2 cytoplasmic domain extends from K-391 to A-423, and
these changes in WEE E2 at 1-408, V-418, S-420, and A-421
(SIN numbering and residues) suggested that the C-terminal
half of the tail, at a minimum, is important for the specificity of
the capsid-E2 interaction.
Lopez et al. (312) extended this line of reasoning by
constructing a chimeric virus in which the entire genome was
derived from RR except for the capsid protein, which was
derived from SIN. In this chimera, SIN nucleocapsid protein
must interact with RR envelope proteins during virus assem-
bly. The chimera was almost nonviable, producing 5 orders of
magnitude less virus than the parental RR, as determined
either by infectivity assays of released virus or by the release of
radiolabeled virus particles into the culture medium. The
number of nucleocapsids formed in cells transfected with RNA
from the chimeric virus and from RR was the same, however,
demonstrating that the defect in viral assembly was not in the
formation of nucleocapsids. Other studies have shown that
alphavirus glycoproteins are transported to the cell surface
independently of the expression of other viral genes (626), and
thus the very limited production of the chimeric virus must
result from defective capsid-glycoprotein interactions that do
not permit budding.
There are 11 amino acid differences between RR and SIN in
the 33-amino-acid E2 tail (Fig. 11). Changing two of these
residues in the chimera from the RR sequence to the SIN
sequence, A-403 and N-405 (SIN numbering and residues),
gave rise to a variant that produced >100-fold more virus than
did the parental chimera. Changing nine of these residues to
the SIN sequence, A-403, N-405, 1-408, T-410, S-411, A-413,
V-418, R-419, and S-420, resulted in a virus that grew 104-fold
better (Fig. 11). These results show that it is possible to adapt
the RR E2 tail to the SIN nucleocapsid and directly demon-
strate the importance of the E2 tail-capsid interaction for virus
assembly, as distinct from possible effects of amino acid
substitutions on glycoprotein transport or glycoprotein-glyco-
protein interactions; they also show that the entire domain
from residues 403 to 420 is important for the specificity of the
interaction. Although the amino acid changes could affect the
binding reaction by alterations in the conformation of the E2
tail at regions away from the actual site of change, the simplest
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FIG. 11. Mutational analysis of the chimeric virus RR(SINc). A
schematic of the genome of RR(SINc) is shown, indicating that the
entire genome is derived from RR with the exception of the capsid
protein, which is derived from SIN. The E2 cytoplasmic domain is
expanded below, with the residues numbered from the beginning of
E2. The sequences of the two parental viruses and those of the
mutated chimeras are shown. Single plaques from transfection with
RNA were picked and used to infect one well of a six-well plate of
BHK cells under liquid medium; the titer shown is the average of
duplicate stocks produced in this way. Reprinted from reference 312
with permission of the publisher.
hypothesis is that the entire C-terminal region of the E2 tail is
involved in binding to the nucleocapsid. Of interest was the
finding that change of a 10th residue to the SIN sequence,
K-394 (RR) -- E-395 (SIN), was deleterious for the growth of
the chimera (Fig. 11), suggesting that the N-terminal region of
the tail might be involved in glycoprotein-glycoprotein inter-
actions expressed in the membrane-spanning region or in the
ectodomains of the proteins. The importance of the 11th
difference, K-391 in SIN, was not tested.
Gaedigk-Nitschko and Schlesinger (134) and Ivanova and
Schlesinger (221) also studied the effects of site-specific muta-
tions in the E2 tail of SIN upon assembly. Changes at E-395,
P-399, A-401, P-404, L-415, C-416, or C-417 were found to be
deleterious for virus assembly, and for some mutants tested the
extent of inhibition was found to depend on whether the virus
was grown in mosquito cells or in vertebrate cells. Many of
these mutations led to the formation of multicored particles,
showing that the interactions among viral components re-
quired for virus assembly were defective. These results dem-
onstrate the importance of the E2 cytoplasmic domain for
efficient virus assembly, but because the effect of the mutation
is to inhibit virus assembly, it cannot be determined from these
results alone whether the inhibition results from interference
with nucleocapsid-E2 tail interactions or with glycoprotein-
glycoprotein interactions. From other results, however, it
seems likely that interference is at the nucleocapsid-E2 binding
step in assembly.
A different approach was used by Schlesinger and colleagues
(73, 460) and by Kail et al. (239), who used short synthetic
peptides as inhibitors of virus assembly. Schlesinger and col-
leagues used peptides 6 to 25 residues in length that were
derived from the E2 tail. These were simply introduced into
the culture fluid over cells infected with SIN, and a number of
these peptides were found to inhibit virus assembly by up to
90%. The inhibitory peptides all contained sequence from the
N-terminal part of the E2 tail, but because of the requirement
that the peptides be taken up by the cells in an unknown
fashion, it was not clear whether the peptides that failed to
n
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inhibit were not involved in assembly or were simply taken up
less efficiently. The peptides that interfered with virus assembly
may have done so by disrupting nucleocapsid-glycoprotein E2
interactions or by disrupting glycoprotein-glycoprotein inter-
actions or both.
Kail et al. (239) injected peptides 8 to 31 residues in length
into cells infected with SF, which allowed them to study a
variety of peptides without concern for the efficiency of uptake.
They found that many of these peptides were extremely
efficient inhibitors of virus production (inhibition, '95%),
including an 8-mer representing the C-terminal 8 residues of
the SF E2 tail. They also found that a 15-mer consisting of 14
residues derived from SIN E2 with an N-terminal lysine would
inhibit assembly of SF.
Taken together, these various results suggest that all regions
of the cytoplasmic tail of E2 are involved in the assembly
process. The N-terminal region of the E2 tail may be involved
in glycoprotein-glycoprotein interactions, whereas the entire
C-terminal two-thirds appears to be involved in the binding of
the spikes by the nucleocapsid.
Vaux et al. (566) and Kail et al. (239) used yet another
approach to study nucleocapsid-E2 tail interactions. Antipep-
tide antibodies were made to a synthetic peptide representing
the 31-residue SF E2 tail and were used to produce an
anti-idiotypic antibody called F13. The anti-idiotypic antibody
was reported to bind to the capsid and thus to reproduce the
E2 tail-capsid interaction. Anti-anti-idiotypic antibodies (anti-
F13) were then prepared; the anti-F13 antibodies recognized
the 8 C-terminal residues of the E2 cytoplasmic domain, and
the authors concluded that these 8 residues constitute a linear
recognition signal for the binding of nucleocapsid. The signif-
icance of these observations has been called into question by a
recent report that the anti-idiotypic antibody F13 does not in
fact react with the nucleocapsid but instead reacts with some
component of the RNA replication machinery (535), and if
F13 does not in fact bind the capsid, it cannot be used to
identify nucleocapsid-binding sites. Interaction of F13 with the
RNA replication machinery rather than with the capsid might
explain the finding that the F13 antibody did not display a
specificity for a particular alphavirus and would, surprisingly,
also interact with the very different flaviviruses.
It is clear from these results that the E2 cytoplasmic domain
interacts with the nucleocapsid in a sequence-specific but
cross-reactive fashion. The E2 tails of 10 sequenced alphavi-
ruses are compared in Fig. 12, and conservation of sequence is
evident. Of the 33 residues, 12 are invariant in the 10 viruses;
these include 3 cysteines, 3 prolines, 2 alanines, 1 arginine, 1
leucine, and 1 each of threonine and tyrosine in the invariant
tripeptide TPY. The three invariant cysteines have been found
to be palmitoylated in SIN (134, 221) and are presumably
palmitoylated in all alphaviruses. The conservation of the
tripeptide TPY suggests that the phosphorylation of E2 that is
believed to occur in this region (307) might be on the T or the
Y residue of this tripeptide. The conservation of cysteines and
prolines suggests that the E2 tail has a conserved structure that
is important for binding to the capsid, and the presence of this
conserved structure may explain the cross-reactivity observed.
The results with RR-SIN chimeras then suggest that the
precise interactions with the capsid are modified by the
changes that have occurred in the changeable residues.
It is intriguing that in addition to the cluster of four changes
in the WEE E2 tail from the SIN sequence to the EEE
sequence, there are clusters of changes in the membrane-
spanning domains of both WEE E2 and WEE El from the SIN
sequence to the EEE sequence, six in E2 and four in El. The
sequences of the membrane-spanning anchors of 10 sequenced
SIN KA R L i P S q II TSLAL SAN COH
AURA .. . . . . FLVT. QRTS .COOH
WHA . . . . . . . . . . . V . . . lI .PT . co
WEE . . . . v.A .. V. lI .PT. -CH
EEE RT L I I L. .... IKPTR zom
VEE RS . . . FC. .V. .T.R CZH
ONN C . . I E r.FL . GC. l.T . KCOOH
SF A. . . GI. R .H coo
RR T . v .|. a.VLT . G .. PR. . -cH
MAY V . T Ii. GVVTGV. wK. cH
FIG. 12. Alignment of amino acid sequences of the cytoplasmic
tails of 10 alphavirus E2 glycoproteins. The sequences shown are from
the references cited in Table 1; amino acid numbering is that for SIN
and begins with the N terminus of E2. The cytoplasmic tail of SIN E2
is 33 residues in length, and for convenience the last 33 amino acids of
all E2s are shown. Invariant amino acid residues are shaded. The three
invariant cysteine residues have been shown to be palmitoylated in SIN
and are presumably palmitoylated in all alphaviruses. The invariant
TPY is a possible site of phosphorylation.
alphaviruses were compared in Fig. 8, and in contrast to the E2
tail region, these anchors exhibit very little conservation in
sequence. Since this region exhibits so little conservation
among alphaviruses, the presence of six changes from the SIN
to the EEE sequence (boxed in Fig. 8) suggests that these
changes might also have been important for adapting the SIN
glycoproteins to EEE, although it remains possible that they
represent random fluctuations in a nonconserved domain.
Mutagenesis of the transmembrane regions to test their im-
portance in virus replication would be of interest.
Lateral interactions between glycoproteins. Lateral interac-
tions between the glycoproteins are also important in virus
assembly. von Bonsdorff and Harrison (571) found that SIN
glycoproteins would form regular hexagonal arrays that were
isomorphous in local packing to the viral surface lattice,
showing that the T = 4 surface lattice on the virus arises not
just from interactions with a T = 4 nucleocapsid but also from
highly specific lateral interactions between the glycoproteins
(Fig. 1 and 2). The importance of the lateral interactions
derives further support from studies of mutations in the
ectodomain of SIN E2. In one mutant, H-291 -* L, glycopro-
teins are transported to the plasma membrane at the nonper-
missive temperature, where they bind the nucleocapsid, but no
budding occurs (52, 304). A second mutation in the ectodo-
main of E2, A-344 -> V, results in budding to form multicored
particles (178, 511). The effect of this mutation can be partially
suppressed by a compensating change in El, K-227 -> M.
These results suggest that altered conformations of E2 can
lead to a failure of correct glycoprotein-glycoprotein interac-
tions during virus budding. A third mutation, 1-277 -T,
results in the formation of a new glycosylation site at N-275;
the SIN strain in which this mutant was isolated had three
glycosylation sites in E2, and the new site resulted in a total of
four polysaccharide chains being attached to E2 (105, 107). In
this mutant, glycoproteins were transported to the cell surface,
where they interacted with the capsid, but no virus budding
occurred in vertebrate cells at 34.5°C, although normal virus
production occurred in mosquito cells at this temperature. In
this mutant the extra bulk or charge contributed by the fourth
carbohydrate chain at position 275 appears to block the lateral
interactions between the glycoproteins required for virus as-
sembly in vertebrate cells; in mosquito cells the carbohydrate
chain added by position 275 does not interfere with virus
budding, perhaps because it is less bulky or because it is
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nsP4 >
-10 -1 +1
R R T E Y OD L T G V G G
AR339 AoGGAGGACU GAAUAC CUA ACC GGG (1jA GCU OGG
SIN A
CUA ACC COG GUA CGJ COGG
Y I F S T D T G
UAC AUAUUUUCGACG GAM ACA OGC
Y I F S T D T G
UACAUAUUUUCGACGGAC ACA CGC
AUA G N R Q Y OD L T G V G G Y I F S S D T GAURA GA MC AGA CUAUIMCUAACCGGGGUAGGUGG UAC AUAUC UCUUCUGAU ACA GC
RWQ H S N ODR Y E A G AWEE CGU CCAUUCO AAC GCG UAUGAA OGCGG GCG
EEE R R H S N R Y E A G ACOGGAGG CAC UCGMUBECGG UAC GAA CG GCC GCG
V IEVVA Q Q Q On R F D A G AVE1 CGA GCAA CM CAA CAA LQAIrG WUUGAU COG GaJ OCA
MID R L T S A X L D R A G AOGUWUA ACG UCA GCA LLQUA GAC CGG CG GGG OCC
D F D Q F OP L G R A G A
GAUUUUGAC CAA uuCOUR CUA CGGACA GCOG GCG CCG
SF
Y I F S S E T G
UAUAUUWUC UCAUCGGM ACA CGC
Y I F S S E T G
UAC AUUUUC UCAUCC GAG ACG UGA
Y I F S S D T G
UAC AUC UUUUCC UCC GAC ACC CGU
Y I F S S D T G
UAC AUAUUC UCAUCG GAU ACA CGC
Y I F S S D T G
UAC AUIC UWC UCGUCUGAU ACC UGA
F D D V L R L G R A G A Y I F S S D T G
UC GAC GAC GLU CUG CGA CJA CGC CGC COG GGUGCA UAUAUUUC UCC UCG GAC ACU OGC
T D E E L R L D R A G G Y I F S S D T GONN ACA GAC GAA GAG UUA CGA CUA GAC AGA QCA CGCGGU UACUAUCWC UCUGMX ACAC xGU
FIG. 13. Translated sequences of 10 alphaviruses around the termination codon (boxed) between nsP3 and nsP4. The top two lines are two
strains of SIN which differ by only 2 nt (shaded) in this region. One of these changes alters the opal codon (UGA) to one encoding Cys (UGU).
In the bottom two lines the opal codons have been replaced with CGA, encoding Arg, in SF and ONN. In every case the nucleotide following the
opal codon (or its replacement) is C (underlined), which has been shown to be necessary for readthrough. This figure also illustrates that there
is little sequence conservation upstream of the opal codon and that even where amino acid identity is high, such as the N-terminal region of nsP4,
multiple codons are used such that the nucleotide sequences have diverged almost to the full extent allowed by the degeneracy of the code.
Sequences for this figure are found in the references cited in Table 1, except for the SIN AR86 sequence, which is from reference 484.
uncharged (mosquito cells do not add sialic acid to oligosac-
charide chains).
The 6K protein and ion gradients in assembly. The 6K
polypeptide has been found to be important for virus assembly
and to be incorporated into virions in small amounts (7 to 30
copies) relative to the glycoproteins (133, 317). Several alter-
ations introduced into the 6K region, including mutations that
reduced palmitoylation of 6K (132, 134) or deletion of the
sequence encoding this peptide (303), resulted in greatly
reduced virus yield. Many of the site-specific mutations tested
resulted in multicored particles, demonstrating the failure of
normal budding when mutant 6K is present. However, virus
particles formed that were totally devoid of 6K appeared to be
indistinguishable from wild-type particles, showing that al-
though the 6K protein facilitates virus assembly, it is not
essential for virus assembly, and that the incorporation of a few
molecules of it into the virus is not required for infectivity. The
mechanism by which the 6K protein affects transport and
assembly is thus obscure.
It is also known that ion gradients are important in some way
for virus assembly. SIN assembly has long been known to be
sensitive to the ionic strength of the medium, and final
maturation of the particles is very inefficient at low ionic
strength (513, 577, 578). Shifting from low ionic strength to
isotonic medium results in the rapid release of virus, but this
release can be inhibited by furosemide, an inhibitor of the
K+/Na+/Cl- cotransporter. These results suggest that efficient
virus maturation requires a high intracellular concentration of
Na+ ions (560) and that the alterations in ion transport
induced by virus infection (144, 561) may facilitate the efficient
release of progeny virus particles. In like vein, verapamil and
chloropromaxine, which affect calcium levels in cells, were
found to block virus formation at the final stages of assembly
(461). It has also been shown that SF-infected cells become
depolarized (24). The precise mechanism by which these ionic
changes promote virus assembly is not known (but see refer-
ence 287).
Nonstructural Proteins
Translation. The alphavirus nonstructural proteins are
translated from the genomic RNA as one or two polyproteins,
depending on the virus. For SIN AR339 and derivatives of it,
translation begins at an AUG codon at nt 60 to 62 (386, 516,
517). Polyprotein P123, containing the sequences of nsPl,
nsP2, and nsP3, is produced when translation terminates at an
opal codon at codon 1897 of the nonstructural open reading
frame (ORF), between nsP3 and nsP4. Polyprotein P1234,
containing in addition the sequence of nsP4, is produced upon
readthrough of this opal codon (Fig. 4). Readthrough of UGA
codons in mammalian cells has been found to result from the
incorporation of arginine, cysteine, or tryptophan in the posi-
tion of the UGA codon (120). Readthrough of the opal codon
in SIN occurs 10 to 20% of the time during translation in
cell-free systems at 30°C and <5% of the time at 40°C (92, 300,
487) and presumably at about the same frequency in infected
cells. Six other alphaviruses, MID (516), RR (515), VEE (258),
AURA (434), WEE (587), and EEE (587), also have an opal
codo'n positioned between nsP3 and nsP4 (Fig. 13). Polypro-
tein synthesis and processing in cells infected with these viruses
is not as well understood as in the case of SIN, but the opal
codon is assumed to function in the same way in each virus. In
two alphaviruses, SF and ONN, the opal codon has been
replaced by an arginine codon (CGA) such that there is no
termination at this position and only polyprotein P1234 is
produced (292,540); in addition, in the AR86 strain of SIN the
UGA codon is replaced by a cysteine codon (UGU) (484). The
subsequent processing of the viral nonstructural proteins in
viruses with or without a stop codon interrupting the ORF
appears to be similar, although this should be examined in
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greater detail. SIN (92) and SF (541) have been found to
produce P123 and nsP4 early in infection and P12 and P34
later in infection, which are then further processed. The major
differences seem to be that SF produces nsP4 and nsP4-
containing polyproteins in greater amounts than does SIN, that
P34 has a half-life of 30 min in SF-infected cells but is relatively
stable in SIN-infected cells late in infection, and that relatively
greater amounts of nsP4 are present in SF-infected cells than
in SIN-infected cells.
The signal for translational readthrough of the UGA codon
has been found to consist of a single C residue downstream of
the UGA (283, 300). UGAC is leaky, whereas UGA followed
by any other nucleotide terminates efficiently; no other up-
stream or downstream SIN nucleotides were required for the
UGA to be leaky.
In every alphavirus sequence, C follows the opal codon or its
replacement (Fig. 13). In the three sequenced alphaviruses in
which the opal termination codon has been replaced by a sense
codon, therefore, there is only a single nucleotide change from
the tetranucleotide UGAC. Because alphavirus sequences drift
rapidly in the absence of selection, we suggest that the selective
advantage of a sense codon in these viruses may be transient
and that sense codons may be in equilibrium with opal. Note
from Fig. 13 that the N-terminal sequence of nsP4 is almost
invariant among alphaviruses (and thus the amino acid se-
quence must be crucial for function) but the amino acids are
encoded by different codons in the different viruses (and thus
the exact nucleotide sequence is not crucial). For example,
both possible codons are used for the N-terminal tyrosine and
all three possible codons are used for the following isoleucine,
and so forth. Figure 13 also shows that upstream of the opal
codon there is little or no conservation of sequence at the
amino acid or nucleotide level but the downstream sequence is
conserved. Thus, the fact that the three viruses with sense
codons differ by only one nucleotide from UGAC is striking.
Conservation of the C is particularly notable given that both
arginine and leucine, both of which can be encoded by six
different codons, occur as the following amino acid and that
the leucine in this position in the three viruses with sense
codons could be encoded by UUA or UUG. The fact that one
SIN isolate contains a sense codon but other closely related
strains contain an opal codon also suggests that the advantage
of a sense codon is transient.
Functions of nsPl. The four different nonstructural proteins
function during infection as polyproteins as well as cleaved
final products, and in any event the replicase activity is believed
to reside in a complex of nonstructural proteins and host
proteins. Functions of the individual protein components have
been explored by examining the protein sequence for the
presence of sequence motifs found in biochemically character-
ized enzymes, by performing biochemical assays with the
different nonstructural proteins or polyproteins, and by study-
ing the phenotypes of ts mutants or of mutants exhibiting other
properties such as change in host range, RNA synthesis
pattern, or protein processing, whose lesions have been deter-
mined to arise from specific changes in one of the nonstruc-
tural proteins. The mutants examined include site-specifically
constructed mutants as well as mutants isolated on the basis of
a selectable phenotype.
nsPl appears to be specifically required for initiation of (or
continuation of) synthesis of minus-strand RNA. The change
A-348 - T gives rise to a mutant (ts 1) that upon shift from
permissive to nonpermissive temperatures stops making mi-
nus-strand RNA, whereas plus-strand synthesis continues (183,
450, 584). nsPl is also thought to be the enzyme, or a
component of the enzyme, that caps the genomic and sub-
genomic RNAs during transcription. A new methyltransferase
is produced in virus-infected cells (80) that is thought to be
responsible for the methylation of the caps of both genomic
and subgenomic RNAs (81). Stollar and colleagues have shown
that the methyltransferase activity resides in nsPl. They iso-
lated variants of SIN that, unlike the parental virus, were able
to replicate in mosquito cells in the absence of methionine in
the medium (106). In one variant examined in detail, resistance
to low methionine levels was due to two changes in nsPl, R-87
-> L and S-88 -* C (350), both of which were required for
expression of the phenotype (351). These mutations decreased
the Km for S-adenosylmethionine, the methyl donor for the
transferase, by 10-fold (456). Thus, the mutant nsPl is able to
function efficiently as a methyltransferase at the much lower
S-adenosylmethionine concentrations present in cells grown in
methionine-free medium. The mutant was also more sensitive
to the effects of S-adenosylhomocysteine hydrolase inhibitors
such as neplanocin A (104), which lead to an increase in the
concentration of S-adenosylhomocysteine, an inhibitor of
methyltransferase enzymes. The results are consistent with the
hypothesis that the mutations alter the binding pocket for
S-adenosylmethionine. Subsequently it was shown that SIN
nsPl expressed alone in Escherichia coli has methyltransferase
activity (352).
A second activity required to cap RNA is guanyltransferase.
Scheidel et al. (455) isolated mutants of SIN that were resistant
to mycophenolic acid and ribavirin. These drugs inhibit wild-
type SIN replication by reducing the cellular GTP levels (322).
One such mutant was studied in detail and found to contain
three changes in nsPl, all of which are probably required for
full expression of the resistance phenotype: Q-21 -> K, S-23
N, and V-302 -> M. These results are consistent with the
hypothesis that nsPl is a guanyltransferase and these muta-
tions produce a mutant enzyme that is active at the reduced
levels of GTP present in cells treated with mycophenolic acid.
A third activity of nsPl is its modulation of the activity of the
proteinase activity of nsP2. Polyproteins containing nsPl
cleave the bond between nsP2 and nsP3 very poorly (92).
Functions of nsP2. The N-terminal domain of nsP2 (residues
1 to 459 in SIN) is believed to be an RNA helicase. SIN nsP2
belongs to a superfamily of proteins containing nucleoside
triphosphate (NTP)-binding domains that are characterized by
two motifs, one represented by the sequence GSGKS (starting
at residue 189) and the second represented by DEAF (starting
at residue 252) (157, 161, 209). Gorbalenya et al. (155, 158)
have argued that this protein superfamily, with representatives
from bacteria, eukaryotes, and many viruses, is monophyletic,
suggesting that the core domain of the helicase is a very ancient
one. A number of proteins belonging to this superfamily,
including the E. coli RecBCD helicase and certain proteins
belonging to the so-called DEAD box subset (159), have been
shown biochemically to possess helicase activity. Because of its
homology to these NTP-binding proteins, the N-terminal
domain of nsP2 is thought to be a helicase involved in duplex
unwinding during RNA replication and transcription.
The C-terminal domain of nsP2 (residues 460 to 807 in SIN)
functions as the nonstructural proteinase and will be discussed
in more detail below.
nsP2 has also been found to be specifically required for the
synthesis of the 26S subgenomic mRNA, presumably for the
initiation of its transcription. A number of mutations in the
proteinase domain of nsP2 have been found to render the
synthesis of 26S RNA temperature sensitive (183, 448, 449). It
is not known at present whether the temperature sensitivity of
subgenomic RNA synthesis is due to an altered proteinase
activity at the nonpermissive temperature or whether nsP2 has
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a function in 26S RNA synthesis distinct from its proteolytic
role. Since nsP2 is known to have at least two distinct functions
(helicase and proteinase), it is possible that it has additional
functional domains whose signature amino acid motifs have
not been identified.
In SF-infected cells, about 50% of nsP2 is found in the
nucleus, principally in the nucleolus (398). Nuclear localization
signals have been found in both the N-terminal and C-terminal
regions of the protein, and a nucleolus-targeting signal is
centered near residue 500 (424). The function served by nsP2
in the nucleus is unknown, but it is presumably distinct from its
involvement in viral RNA replication.
Functions of nsP3. The functions of nsP3 in viral replication
are not well understood. The protein has two distinct domains
(258, 515) (Table 2). The N-terminal domain varies from 322
to 329 residues in length in sequenced alphaviruses and is
conserved in sequence, exhibiting a minimum of 51% amino
acid sequence identity between any two alphaviruses se-
quenced to date. In contrast, the C-terminal domain is not
conserved in length or sequence. This domain varies in length
from 134 residues in MID to 246 residues in ONN (Table 2),
and no detectable sequence similarity has been identified
between different alphaviruses. nsP3 is heavily phosphorylated
on serine and threonine residues in SIN, probably by a cellular
enzyme (297), and less heavily phosphorylated in SF (399), and
it is suspected that much or all of the phosphorylation occurs
within the nonconserved domain. Presumably these two do-
mains play different roles in virus replication. It has been
shown that SF nsP3 produced alone in COS cells is phosphor-
ylated and localized to vesicular structures, demonstrating that
phosphorylation does not require association with other viral
proteins (397). The function of phosphorylation in the activity
of nsP3 is not known, and studies in this area are needed.
Barton et al. (23) found that replication complexes isolated
from infected cells 6 h after infection contained nsP3 that was
heavily phosphorylated, suggesting that the highly phosphory-
lated forms play an active role in RNA synthesis.
It has been found that large deletions within the noncon-
served C-terminal domain of nsP3 are well tolerated in the
case of SIN (quoted in reference 297) and VEE (90). In the
case of VEE, a deletion of 34 amino acids in this domain gave
rise to a virus that was indistinguishable from wild-type VEE in
its growth properties in several cultured cell lines. The fact that
large deletions in this domain may be tolerated is consistent
with the lack of conservation in length or sequence of this
domain. It is also of note that two forms of nsP3 are produced
by viruses that contain an opal codon between nsP3 and nsP4,
one upon termination at the opal codon and the second, 7
residues longer, from cleavage of the readthrough polyprotein.
A ts mutation has been mapped to nsP3, F-312 -> S, that
renders the virus RNA negative; that is, no RNA is synthesized
upon infection of cells at 40°C (183). Thus, it is clear that nsP3
is required in some capacity for RNA synthesis, as is also
shown by the requirement for the presence of the nsP3
sequence in polyprotein P123 for minus-strand RNA synthesis
(285, 286, 487). The presence of nsP3 in polyproteins also
affects the cleavage specificity of the nsP2 proteinase; nsP2 and
P12 cleave the site between nsP3 and nsP4 very poorly,
whereas both P123 and P1234 cleave this site efficiently (92).
Functions of nsP4. nsP4 is thought to be the RNA poly-
merase of the virus. It contains the GDD motif characteristic
of viral RNA polymerases (241), and three ts mutations in nsP4
(G-153 -- E, G-324 -> E, Q-93 -* A) that render the virus
RNA negative are known (181). The first of these leads to total
cessation of RNA synthesis upon shift to the nonpermissive
temperature (22, 246, 450), consistent with the hypothesis that
nsP4 is the RNA polymerase. Other mutations in nsP4 (L-48
-- V, D-142 -- G, and P-187 -- R) result in ts virus that is
more restricted for growth in mosquito cells than in chicken
cells (283). Finally, a mutation in nsP4 (Q-191 -* K) renders
the mutant unable to shut off the synthesis of minus strands at
the nonpermissive temperature (446).
The concentration of nsP4 is tightly regulated in infected
cells. In most alphaviruses, translation of nsP4 requires
readthrough of a UGA stop codon, leading to its underpro-
duction relative to other nonstructural proteins (516); in
addition, excess nsP4 is rapidly degraded by an N-end rule
pathway (93). Replacement of the opal codon in SIN with a
sense codon gives rise to a virus that overproduces nsP4, but
nsP4 does not accumulate, being rapidly degraded (299).
However, increase of the termination efficiency of this codon,
either by replacing it with an amber or ochre codon (299) or by
changing the context around the opal codon (UGAC ->
UGAU) to decrease readthrough (283), gives rise to a virus
that is impaired in its replication. In these cases the amount of
nsP4 produced appears to be insufficient to support efficient
RNA replication. In the last case the virus was also found to be
ts and relatively more impaired for growth in mosquito cells
than in chicken cells.
nsP4 is not only metabolically unstable in infected cells (186,
187, 247, 299) but also short-lived in rabbit reticulocyte lysates
(92, 188, 486). Wellink and van Kammen (602) first pointed
out that the amino terminus of nsP4 of all alphaviruses was
tyrosine and that these proteins might therefore be degraded
by the N-end rule pathway. The N-end rule pathway relates the
half-life of a protein to the identity of its N-terminal residue
(14, 154). As currently understood, the degradation signal,
referred to as the N-degron, comprises at least two distinct
determinants, a destabilizing N-terminal residue (14, 154) and
one or more specific internal lysine residues that serve as
multiubiquitination sites (15, 69, 231). After conjugation to
ubiquitin, the protein is rapidly degraded by a large ATP-
dependent proteinase complex. Amino termini can be divided
into stabilizing (e.g., methionine and alanine) and destabilizing
(e.g., tyrosine, phenylalanine, leucine, arginine, lysine, aspartic
acid, and glutamic acid), depending on whether they confer a
short half-life on a protein that contains the second (lysine)
determinant. This pathway has been reviewed recently by
Varshavsky (565).
deGroot et al. (93) studied the degradation of Sindbis nsP4
following translation in reticulocyte lysates and showed that
nsP4 was in fact degraded by an N-end rule pathway. The
formal proof involved the demonstration that (i) the metabolic
stability of nsP4 in reticulocyte lysates was a function of its
N-terminal residue, the half-life of nsP4 bearing different N
termini decreasing in the order Met > Ala > Tyr 2 Phe > Arg
(this was the precise order determined by Gonda et al. [154]
for a chimeric polypeptide that has been widely used in the
characterization of the N-end rule pathway), and (ii) addition
of the dipeptides Tyr-Ala, Trp-Ala, or Phe-Ala inhibited
degradation of Tyr-nsP4 and Phe-nsP4 but not of Arg-nsP4,
whereas addition of His-Ala, Arg-Ala, or Lys-Ala inhibited
degradation of Arg-nsP4 but not of Tyr-nsP4 or Phe-nsP4. This
was the predicted result for degradation by the N-end rule
pathway (15, 154).
Although it is clear that nsP4 is degraded by an N-end rule
pathway, de Groot et al. (93) were not able to identify a lysine
residue required for degradation, and no attempt was made to
demonstrate ubiquitin dependence. nsP4 was the first natural
substrate shown to follow the N-end rule, and further study of
the degradation of this protein in infected cells to examine the
ubiquitin dependence of degradation and a requirement for a
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lysine residue will be of interest. The recent discovery of an
N-end rule degradation pathway in bacteria which is indepen-
dent of ubiquitin suggests that the pathway in mammals should
be reexamined with natural substrates (545).
Although the bulk of nsP4 is unstable and degraded rapidly,
there is a resistant fraction that is stable. The fraction of nsP4
synthesized in a short pulse that is resistant to degradation is
larger early in infection than late in infection in SIN (92, 186,
187) but does not appear to be as dependent upon the stage of
the infection cycle in SF (541). We have suggested that nsP4
associated with the RNA replicase complex is protected from
degradation, whereas free nsP4 is rapidly degraded (93). Such
a model is consistent with the fact that replication complexes
are formed early and are then stable, which would lead to
protection of a higher proportion of SIN nsP4 synthesized
early than synthesized late. Barton et al. (23) labeled SIN-
infected cells with radioactive amino acids from 2 to 4 h after
infection and then isolated replication complexes at 6 h after
infection. These replication complexes contained significant
levels of labeled nsP4, demonstrating that nsP4 in these
complexes was stable during the 2-h chase period.
Nonstructural Proteinase
Active site of the enzyme. Many animal viruses encode
proteinases required for processing of viral polyproteins in the
cytosol of the cell (526). In the case of alphaviruses, processing
of the envelope glycoproteins is effected by cellular enzymes
resident in the subcellular organelles, but removal of the capsid
protein from the structural protein precursor and processing of
the nonstructural polyproteins proceed in the cytosol and
require viral enzymes (531). The capsid proteinase was de-
scribed above. Here we describe what is known about the
nonstructural proteinase.
Hahn et al. (183) mapped the causal mutations of four SIN
ts mutants that were deficient in proteinase activity at the
nonpermissive temperature. All such mutations were found to
reside in the C-terminal half of nsP2 (F-509 -> L, A-517 -T,
D-522 -> N, G-736 S-> ), and the authors concluded that this
domain functioned as the nonstructural proteinase. To define
the proteinase domain and the activities of the enzyme more
precisely, the activity of the proteinase was studied after its
translation in a cell-free system. RNA isolated from virions or
RNA transcribed in vitro from cDNA constructs can be
translated in rabbit reticulocyte lysates, and the resulting
polyproteins are processed by the nonstructural proteinase to
produce cleaved products that appear to be identical to the
products produced in infected cells. In the first studies, the
effects of truncations (96) or deletions (188) on the activity of
the SIN enzyme were determined. The results clearly defined
the C-terminal half of nsP2 as necessary and sufficient for
proteolytic processing of the alphavirus nonstructural polypro-
tein. Deletion of virtually all of nsPl, nsP3, or nsP4 led to
effectively normal processing of the deleted constructs. Dele-
tions in the N-terminal half of nsP2 led to an active protease
but altered processing pathways, presumably because of mis-
folding of the protein product. Deletions in the C-terminal half
of nsP2 abolished processing, however; more precisely, resi-
dues 475 to 728 of nsP2 were required for proteolytic activity.
As a control, it was shown that in cases when processing was
abolished, cleavage would occur in trans when an active
proteinase translated from wild-type viral RNA was supplied,
demonstrating that the failure to cleave did not result from
misfolding of the protein induced by the deletions such that the
cleavage sites could not be recognized by the proteinase.
From an analysis of the amino acid sequences of the
C-terminal domains of alphavirus nsP2s, Hardy and Strauss
(188) postulated that nsP2 is a thiol protease that resembles
papain in which C-481 and one of five conserved histidine
residues in the region defined by the deletion mapping form
the catalytic dyad. This hypothesis has been tested by site-
specifically changing this cysteine and all five histidines, as well
as a number of other residues in the protease domain, and
testing the mutagenized construct for activity (512). The
change of C-481 -> G, S, or R abolished all protease activity,
consistent with the hypothesis that this is the active-site
cysteine, whereas changes in C-525 or S-535, both of which are
conserved, were tolerated. Of the five conserved histidines in
this domain, substitution of A, Q, or Y for H-558 abolished all
activity of the enzyme, whereas changes in the other four
histidines were tolerated. The results are consistent with the
hypothesis that nsP2 is a papain-like proteinase in which C-481
and H-558 form the catalytic dyad. A schematic diagram of
SIN nsP2 that illustrates the different amino acid substitutions
tested and their effects on the activity of the enzyme is shown
in Fig. 14.
The possible importance of an asparagine residue for the
activity of the enzyme was also examined (136, 202). All four
conserved asparagine residues were changed to aspartic acid
and to serine, and the effects on the proteinase activity were
examined (512). No asparagine was absolutely required for
activity, but the changes in N-609 markedly reduced the activity
of the enzyme, and, remarkably, N-614 -> D led to enhanced
cleavage. This last change was lethal for the virus at 37°C,
suggesting that the extent of cleavage is regulated and that
polyprotein P123 has a specific function in virus replication.
It was also found that W-559, following the active-site
H-558, was essential for proteolysis (512). A model was
presented that W-559 might interact with W-482, following the
active-site C-481, to maintain the two components of the
catalytic dyad in the proper conformation for proteolysis.
The alphavirus proteinase is papain-like in that it has a
catalytic cysteine upstream of a catalytic histidine, but no
sequence identity with papain is discernible other than a few
residues around the active site. It would be of considerable
interest to determine if the protein has a fold similar to that of
papain, indicating that the virus had in the past acquired a
cellular proteinase for its own use, or if convergence of
function led to the similarities observed. A statistically signif-
icant alignment of the (putative) papain-like proteinase of
rubella virus with cellular papain-like proteinases has been
reported (160), suggesting that the viral enzymes may have
derived from cellular enzymes. Koonin and Dolja (267) have
presented an alignment for the papain-like proteinases en-
coded by several families of RNA viruses that suggests that all
of these proteinases may be related to one another.
Nature of cleavage sites recognized by the enzyme. There are
three sites in the nonstructural polyproteins of alphaviruses
that are cleaved. The sequences flanking these three sites in 10
alphaviruses are aligned in Fig. 15. The sites all share common
features, consistent with the hypothesis that all three cleavages
are effected by the same enzyme.
In all 10 viruses sequenced to date, the residue in the P2
position is invariably glycine in all three sites. The importance
of glycine in the P2 position was examined by Shirako and
Strauss (486) for SIN. Substitution of the P2 glycine in the
nsP1/nsP2 site or the nsP2/nsP3 site with alanine led to slower
cleavage, and substitution in any of the three sites with valine
or glutamic acid made the site completely refractory to cleav-
age.
The residue in the P1 position of the cleavage sites is an
amino acid with a small side chain, i.e., alanine, cysteine, or
MICROBIOL. REV.
THE ALPHAVIRUSES 513
nsP2
.L... P.TJT.A .Q.
200
+< PROTEASE->
T + .
400 .
R Tt'-
G.,' L T R
41 *
475
T
D S
-A
D
S
600 I' -Q0 Amino acids
Original Protoolysis
Amino Acid /ts +
Cys * 0
His * 0
Asn A A
Other
G
-%
%% _
a
. S0D
SDA
S
690
, >^~%. R 750
A ftS bl ri
D AA A
S Y
FIG. 14. Map of SIN nonstructural protein nsP2, showing the location of the proteinase catalytic residues and of various mutations introduced
into the proteinase. Both site-specific mutations (512) and mutations that were selected because they render the proteinase ts (183) are shown.
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Reprinted from reference 512 with permission of the publisher.
glycine, with only two exceptions (the P1 residue is Arg in the
WEE and EEE nsP2/nsP3 site). The importance of alanine or
glycine in the P1 position was examined in SIN by substituting
the P1 glycine in the nsP3/nsP4 site with valine; the modified
site was no longer cleavable (92). Thus, it is clear that efficient
cleavage in SIN requires GA 4 or GG 4 (GC 4 has not been
tested) and that substitution of either of these amino acids with
bulky residues abolishes cleavage at the modified site.
The residue in the P3 position of all cleavage sites is alanine
in all viruses examined except SIN and WHA, in which it is
isoleucine or valine, and AURA, in which it is alanine, serine,
or valine (Fig. 15). This suggests that the P3 position is also
important for cleavage site recognition, although this has not
been directly tested. The P4 residue exhibits only limited
conservation, and the major recognition signal for cleavage
may be contained, therefore, in residues P3-P2-P1.
The residue in the P1' position is always alanine or glycine in
nsPl/nsP2
Po PP PI +P'P'P3'PP'
SIN DlfGA A LV E
AURA D GA ALVE
WHA DIGA ALVE
VEE E GA GSVE
EEE E GA GSVE
WEE EAGA GSVE
ONN RAGA GIVE
SF HAGA GVVE
RR RAGA GVVE
MD RAGA GV N
nsP2/nsP3
P PS Pi PSP P
GVGA APSY
GS GA APSY
GVGA APSY
E AGC APSY
E AGR AP A Y
E AGR AP AY
R AGC AP SY
T AGC APSY
T AGC APSY
T _ C APSY
nsP3/nsP4
P4 PS Pi Pi"SPMPd
*LTGVGG Y I F S
*LTGV GG YI FS
*LTGVGG YI FS
*RFD AGA YI FS
*RYE AGA Y I F S
*RYE AGA YI FS
RIR AGG YIFS
RLGR A G A Y I F S
LGR AG A YI FS
*IDR _A Y I F S
FIG. 15. Cleavage sites in the nonstructural proteins. Amino acid
sequences at the sites of proteolytic cleavage in the nonstructural
polyproteins of 10 alphaviruses are shown. Boxed residues are those
for which at least 7 out of the 10 viruses have the same amino acids.
The glycine residue in the P2 position is shown in boldface type to
emphasize that it is invariant in all three cleavage sites. The asterisks
indicate opal codons upstream of the nsP3/nsP4 cleavage site. Se-
quences are from the references cited in Table 1.
the nsP1/nsP2 and nsP2/nsP3 sites but is invariably tyrosine in
the nsP3/nsP4 site. This suggests that the enzyme is relatively
insensitive to the P1' position or to other residues C-terminal
to the cleavage site and that the identity of the residues in these
positions is determined by their function in the protein rather
than by a requirement for cleavage site recognition. Consistent
with this, de Groot et al. (93) used P34 constructs as a substrate
for trans cleavage by the SIN nsP2 proteinase in which the
N-terminal residue of nsP4 was tyrosine (the wild-type resi-
due), phenylalanine, methionine, alanine, or arginine and
found that all of these P34 polyproteins were cleaved with
kinetics that differed by less than a factor of 3.
The mutagenesis studies described above, together with the
mutagenesis studies of the active site of the nsP2 proteinase
described in the previous section, the cleavage site preference
studies described in the following section, and studies on the
ability of the nsP2 proteinase to cleave in cis or in trans (188),
make it clear that the nsP2 proteinase is the only proteinase
involved in cleaving the nonstructural polyprotein of SIN
(reviewed in reference 512). In contrast, polyprotein P34 of SF
was reported to self-cleave by using a proteinase within nsP4
(541, 542). Comparable studies with SIN P34 have shown that
this polyprotein is stable when translated as such in reticulo-
cyte lysates but can be cleaved in trans by nsP2-containing
polypeptides (93). Furthermore, in a reconstituted in vivo
system that examined SIN RNA replication, a requirement for
active nsP2 proteinase was found if the nsP4 required for RNA
synthesis was to be produced from polyprotein P34 but the
proteinase was not required if nsP4 itself was supplied (286),
demonstrating that SIN nsP4 is produced by cleavage by the
nsP2 proteinase. It is possible that SIN and SF differ in this
regard, given the differences in producing nsP4 used by the two
viruses, but it seems more likely that the nsP4 found in the SF
experiments resulted from internal initiation within the con-
structs used.
Cleavage site preferences of the enzyme. Many experiments
have shown that the SIN nonstructural proteinase cleaves
primarily in trans in a bimolecular reaction, but certain bonds
I
--------------------
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can be cleaved in cis in an autocatalytic reaction (92, 188, 486).
The major points that have been elucidated are as follows: (i)
P1234 can cleave autoproteolytically to produce P123 and
nsP4; (ii) P123 cannot cleave in cis but can be cleaved only
in a bimolecular reaction; (iii) P12 can cleave autoproteo-
lytically in a slow reaction (t12 9 min at 37°C) to produce
nsPl and nsP2; and (iv) all three sites can be cleaved in
trans.
Both nsP2 and polyproteins containing nsP2 have been
found to be active enzymes in trans, but the cleavage site
preferences of different polyproteins are different. Shirako and
Strauss (486) found that P123 would cleave in trans the
nsPl/nsP2 bond of another P123 but not the nsP2/nsP3 bond.
This observation was extended by de Groot et al. (92), who
produced a nested set of nsP2-containing polyproteins whose
own cleavage sites were blocked by substitutions at P1 or P2.
These polypeptides were tested in an in vitro system for their
ability to cleave in trans the three bonds of a labeled substrate
P1234 whose own protease activity had been abolished by
mutagenesis of the active-site cysteine (nsP2 C-481 -> G). A
clear set of rules emerged that described the trans-cleavage
preferences of different polyprotein enzymes: (i) polyproteins
containing the sequence of nsPl, that is, P12, P123, or P1234,
were unable to cleave the nsP2/nsP3 site but cleaved the
nsP3/nsP4 site fairly efficiently and the nsPl/nsP2 site ineffi-
ciently; (ii) only polyproteins containing the sequence of nsP3,
that is, P123, P1234, P23, and P234, were able to cleave the
nsP3/nsP4 site; (iii) polyproteins lacking nsPl, that is, P23 and
P234, as well as nsP2 under certain circumstances, cleaved the
nsP2/nsP3 bond very efficiently; and (iv) the presence or
absence of nsP4 in the polyprotein did not affect cleavage
specificity.
For SIN, these cleavage site preferences have been shown to
result in different processing pathways for the virus nonstruc-
tural proteins early and late after infection (92). Very early in
infection, P123 and P1234 are produced on translation of the
genomic RNA. Cleavage of the nsP3/nsP4 bond in cis, coupled
with the inability of P123 to autoproteolyze, results in the
presence of P123 and nsP4. As infection proceeds and the
concentration of P123 increases, cleavage in trans of the
nsPl/nsP2 bond in P123 produces enzymes that are very active
in cleaving the nsP2/nsP3 bond. By 3 to 4 h after infection,
cleavage of the nsP2/nsP3 site is so rapid that it probably
occurs in the nascent polyprotein. This has the effect that the
major protein products produced after this point in the infec-
tion cycle are P12 and P34. P12 can be cleaved in cis or in trans
to produce nsPl and nsP2, although autoproteolysis appears to
be kinetically favored. P34, however, is stable because there
are no longer any enzymes in the cell that can cleave the
nsP3/nsP4 site efficiently (i.e., no polyproteins containing both
nsP2 and nsP3). Thus after 4 h postinfection, the major
proteins found in the infected cell are nsPl, nsP2, nsP3
(produced by termination at the opal termination codon), and
P34.
In SF virus, which lacks an opal termination codon between
nsP3 and nsP4, nsP3 is produced throughout the infection
cycle, implying that cleavage at the nsP3/nsP4 site continues,
either in P34 or in P1234. Thus, there may be some differences
in the processing pathways of the nonstructural polyproteins of
SIN and SF. However, Takkinen et al. (541) have shown that
during SF infection P123 is produced only early in infection
and that later the predominant pathway is cleavage to produce
P12 and P34, similar to the case for SIN.
Synthesis of Viral RNAs
RNA replicase. After infection by alphaviruses, RNA repli-
case complexes are assembled on modified endosomal and
lysosomal membranes (127). Attempts to purify the replicase
complexes have met with only limited success: these partially
purified complexes are membrane associated (72, 153, 335,
354, 412, 498); contain viral nonstructural proteins nsPl, nsP2,
nsP3, and nsP4, as well as a cellular 120-kDa protein and other
cellular proteins (22, 23); and are capable of limited RNA
synthesis. These complexes are formed early in infection and
are stable throughout the infection cycle. It has been shown
that active complexes will form when the SIN nonstructural
proteins are produced by vaccinia virus expression systems
(298) or by baculovirus expression systems (54) and will
function to replicate viral RNAs containing appropriate pro-
moter elements, making possible the study of RNA replication
following expression of engineered nonstructural proteins.
Cellular proteins are also thought to be required for RNA
synthesis, possibly as components of the replicase complexes.
A role for host proteins in viral RNA replication is suggested
by studies of host range mutants of SIN (268) or of the effects
of inhibitors of cellular RNA synthesis (17; reviewed in refer-
ence 524), by the finding that mutations in viral RNA promoter
elements affect RNA replication differently in different cells
(272, 370, 371), and by the finding that cellular proteins bind to
the 3' end of the minus strand (389, 390). The structural
proteins also appear to be important in some way for alphavi-
rus RNA synthesis. Kuhn et al. (270, 273) found that for
chimeric SIN-RR alphaviruses in which the structural proteins
were derived from one of the viruses and the replicase was
derived from the second virus, RNA synthesis following infec-
tion was less efficient than RNA synthesis following infection
by viruses whose nonstructural and structural proteins were
derived from the same virus. The simplest hypothesis to
explain this is that one or more of the structural proteins
interacts in some way with the RNA replication machinery to
regulate RNA synthesis. It is known that the capsid protein of
SIN binds specifically to the viral RNA and that deletion of the
RNA sequence to which the capsid binds results in less efficient
RNA synthesis (599), so that capsid protein binding might
promote RNA synthesis. It has also been found that for RR
and for SIN a deletion of 7 amino acids in the ectodomain of
E2 centered on residue 55 affects RNA synthesis following
infection of some, but not all, cells (572, 598) and that
substitutions at position 55 of SIN can affect RNA synthesis in
mouse cells depending on the major histocompatibility com-
plex (MHC) antigens expressed by the cell (175), suggesting
that E2 may regulate RNA synthesis in some unknown way. It
is of interest that Suomalainen and Garoff (535) postulated
that the anti-idiotypic antibody F13, made to an antibody
against the E2 cytoplasmic domain, bound to some component
of the replication complex, which might imply that this domain
of E2 is involved in some way with the replicase complex.
Control of minus-strand RNA synthesis. Alphaviruses reg-
ulate minus-strand RNA synthesis (447, 450, 453). Early in
infection there is an exponential increase in the rate of RNA
synthesis, with both plus-strand and minus-strand RNA being
synthesized. At about 3 h after infection at 37 to 40°C or 6 h at
30°C (Fig. 5B), synthesis of minus-strand RNA ceases, after
which plus-strand RNA synthesis continues at a constant rate
throughout the remainder of the infection cycle (Fig. 5).
Studies primarily by Sawicki and colleagues (23, 446, 449, 451,
452) have shown that replication complexes are formed early
after infection and that these complexes are then stable. There
appears to be a limit on the number of replicase complexes that
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FIG. 16. Characteristics of SIN mutants unable to cleave nonstructural polyproteins. Results for wild-type virus and three mutants are shown.
In 12V the penultimate Gly in the cleavage site between nsPl and nsP2 and that in the site between nsP2 and nsP3 have been changed to Val.
In 2V only the Gly in the nsP2/nsP3 site has been changed to Val. In 3V the Gly in the nsP3/nsP4 site has been changed to Val. These changes
abolish processing at the mutated site, and the nonstructural proteins produced by the mutants or the wild type are shown schematically at the top
of the figure. The lower panels show the growth characteristics of these viruses following RNA transfection at either 30 or 40°C. Total incorporation
of nucleic acid precursors was used to measure plus-strand synthesis, whereas minus-strand synthesis was measured by quantitative reverse
transcriptase PCR. The plaque size produced by the mutants is also indicated, as is the titer of stocks produced upon infection of cells with each
virus. Data from reference 487.
can be formed, possibly imposed by a limited number of
cellular accessory proteins, because overexpression of minus-
strand RNAs or of replicase proteins does not lead to an
increase in the rate of RNA synthesis late in infection. The
mechanism by which minus-strand RNA synthesis is controlled
has been elucidated recently as the result of work in several
laboratories.
As described above, P123 can be cleaved only in trans, and
early after infection the predominant nonstructural proteins in
the infected cell are P123 and nsP4. Later in infection when the
concentration of P123 in the cell is high enough to support an
efficient bimolecular reaction, P123 is further processed to
nsPl, nsP2, and nsP3. This observation led Hardy and Strauss
(188) to propose that P123 was active in the synthesis of
minus-strand RNA. Further support for a role for P123 in
RNA synthesis came from studies of Strauss et al. (512), who
found that a mutation in nsP2 (N-614 -* D) resulted in more
efficient cleavage of P123, such that no uncleaved P123 was
present during translation in vitro. This mutation was lethal for
the virus at 37°C, leading the authors to propose that P123 (or
an intermediate polyprotein) has a required role in RNA
replication.
Shirako and Strauss (486, 487) examined the role of P123 in
RNA synthesis by constructing mutants that were unable to
cleave either the nsP1/nsP2 site or the nsP2/nsP3 site (mutant
12V), such that only P123 and nsP4 were produced in the
infected cell. Using a quantitative PCR assay to examine
minus-strand RNA synthesis after infection by this mutant,
they found that early minus-strand RNA synthesis proceeded
normally but that subsequent production of plus strands was
greatly impaired and temperature sensitive (Fig. 16). At 30°C
small amounts of plus-strand RNA were produced (about 6%
as much plus-strand RNA as produced by wild-type virus was
present at 12 h after infection), allowing limited amplification
of RNA (plus and minus strand) and production of tiny
plaques. At 40°C no detectable plus-strand RNA was made
and the minus-strand RNA produced early after infection was
slowly degraded over the next 12 h. They also found an
absolute requirement for nsP4; mutations introduced into the
nsP3/nsP4 cleavage site that prevented cleavage to release
nsP4 (e.g., mutant 3V) were lethal. These authors concluded
that P123 and nsP4 functioned in minus-strand RNA synthesis
but that cleaved products from P123 were required for efficient
plus-strand RNA synthesis. Mutant 12V, in which cleavage of
the nsP1/nsP2 and nsP2/nsP3 sites was blocked, could comple-
ment mutant 3V, in which cleavage of the nsP3/nsP4 site was
blocked, leading to the synthesis of plus-strand RNA and
production of large amounts of late-gene products.
Lemm et al. (284-286) used a reconstituted system to study
the polypeptide requirements for SIN RNA replication. These
researchers studied the ability of various SIN nonstructural
proteins expressed transiently by a vaccinia virus system to
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replicate a synthetic RNA template containing a reporter gene.
P123 and nsP4 would support minus-strand RNA synthesis
from a plus-strand template, but the four individual nonstruc-
tural proteins or combinations of polyproteins that did not
include P123 would not support minus-strand RNA synthesis.
It is possible that the extra N-terminal methionine present on
nsP2 or nsP3, required for their expression as individual
polypeptides, causes these proteins to be inactive, but further
support for a required role for P123 came from constructs
containing the nsP2 N-614 -- D mutation. P123 containing
D-614 was inactive in RNA synthesis unless the nsPl/nsP2 and
nsP2/nsP3 cleavage sites were blocked, consistent with the
hypothesis that the accelerated cleavage of these sites by the
mutant proteinase is responsible for the failure of the mutant
to make RNA and that uncleaved P123 is required for
minus-strand RNA synthesis.
Lemm et al. (284-286) also found that nsP4 was required for
synthesis of minus-strand RNA. nsP4 could be supplied by
cleavage of P34 or truncated forms of P34 or could be supplied
as a ubiquitin-nsP4 fusion product that is rapidly cleaved in the
cell to produce authentic nsP4. Interestingly, nsP4 produced
from a construct in which an N-terminal methionine was
present was almost inactive in this system, leading to the
synthesis of only small amounts of minus-strand RNA and no
plus-strand RNA. The sensitivity of nsP4 to the identity of its
N-terminal residue was also demonstrated by examining vi-
ruses in which the N-terminal tyrosine of nsP4 was replaced by
phenylalanine, tryptophan, leucine, alanine, arginine, or me-
thionine (434, 484). Viruses producing nsP4s containing an
N-terminal aromatic residue (tyrosine, phenylalanine, or tryp-
tophan) grew well; those producing nsP4 with N-terminal
methionine grew poorly and formed small plaques (but dem-
onstrating therefore at least some plus-strand RNA synthesis);
and viruses producing nsP4 with N-terminal leucine, alanine,
or arginine were not viable. The effect of the alanine substitu-
tion at the N terminus of nsP4 could be partially suppressed by
a compensating change in nsPl (484), suggesting that there is
an interaction between nsPl and the N terminus of nsP4
required for (minus-strand) RNA synthesis. This compensat-
ing mutation (T-349 -- K) is immediately adjacent to the
mutation in tsll (A-348 -- T) that renders the virus unable to
make minus-strand RNA at 40°C (although it can make
plus-strand RNA at 40°C), suggesting that this domain is
involved specifically in minus-strand RNA synthesis. It is of
interest that from a study of mutations that render the
synthesis of RNA temperature sensitive, Hahn et al. (181) had
also suggested that nsP2 and nsP4 interact during RNA
synthesis and that the RNA replicase presumably functions as
a complex in which the individual components bind to one
another and interact.
One major difference between the results of Shirako and
Strauss (487) and those of Lemm et al. (284-286) was in the
importance of cleaved products from P123 for plus-strand
RNA synthesis. Shirako and Strauss found that uncleaved P123
was very inefficient for plus-strand RNA synthesis at 30°C and
totally lacked activity for plus-strand synthesis at 40°C, whereas
Lemm et al. found that uncleaved P123, although preferring to
synthesize minus strands, could synthesize plus-strand RNA
fairly efficiently at 37°C in their system. The difference may
arise from mass action considerations. The system used by
Lemm et al. produced large numbers of replicase molecules
and of RNA templates continuously, whereas Shirako and
Strauss required amplification of the minus-strand RNA tran-
scribed from the incoming RNA by the replicase translated
from it for buildup of RNA. Under the latter conditions, the
inefficient production of plus-strand RNA by uncleaved P123
becomes apparent.
The model for RNA synthesis supported by these studies is
diagramed in Fig. 17. Upon entry of the genomic RNA, it is
translated into the nonstructural proteins. P123 and nsP4 are
produced upon readthrough of the opal termination codon and
self-cleavage of P1234 and form a replicase complex, probably
in association with cellular proteins, that can use the genomic
RNA as a template to synthesize minus strands. As the
concentration of nonstructural proteins builds up, P123 be-
comes vulnerable to processing, which converts the replicase
complex into one which is capable of synthesizing plus strands
with high efficiency but can no longer synthesize minus strands.
At 3 to 4 h after infection at 37°C, the concentration of
proteinases in the infected cell becomes high enough that P123
cannot exist or be synthesized because it is cleaved while
nascent. Once this stage is reached, only plus-strand RNAs can
be synthesized.
In the simplest form of the model, P123 and nsP4 function to
initiate minus strands and a different complex containing nsPl,
nsP2, nsP3, and nsP4 functions to initiate plus strands. How-
ever, the possibility that a complex composed of nsP1, P23, and
nsP4 also functions as a minus-strand replicase has not been
ruled out. Complexes containing nsPl and P23 are more
efficient in plus-strand synthesis than P123-containing com-
plexes but not as efficient as the complex containing the fully
processed nonstructural proteins (Fig. 16), and it is possible
that they represent an intermediate state for the replicase in
which both plus and minus strands can be made. The first
cleavage of P123 produces nsPl plus P23 (486), and complexes
containing these products would be expected to exist, at least
transiently. It is also of note that, although the replicase
complexes are formed early and appear to be stable, the ability
of ts mutants containing lesions in different nonstructural
proteins to complement one another (181, 183, 514) suggests
that the cleaved components are capable of exchange.
The model in which cleavage of P123 results in shutdown of
minus-strand RNA synthesis is supported by earlier results of
Sawicki et al. (447, 450), who studied the sensitivity of RNA
synthesis to protein synthesis inhibitors. During the early phase
of the infection cycle, when minus-strand RNA is synthesized,
continuing protein synthesis was found to be required for
continuing synthesis of minus-strand RNA but not for continu-
ing synthesis of plus-strand RNA. The vulnerability of P123 to
processing, which converts the replicase complex to a complex
capable of synthesizing only plus-strand RNAs, means that
continuing synthesis of P1234 and formation of new minus-
strand replicase complexes is required for continued synthesis
of minus-strand RNA.
Two mechanisms are possible by which the cleavage of P123
could convert the replication complex from one that synthe-
sizes minus strands to one that synthesizes plus strands. One
possibility is that cleavage leads to the loss of a component
which is required for minus-strand synthesis but not for
plus-strand synthesis. A second possibility is that cleavage
leads to changes in conformation such that the ability to
initiate minus strands is lost. This second possibility is favored
in studies by Sawicki et al. (446, 448, 449, 451, 453), in which
mutations in nsP2 (A-517 -* S and N-700 -- K) or in nsP4
(Q-191 -* K; not Q-195 -> K as reported in reference 446)
were found to result in temperature-sensitive shutdown of
minus-strand RNA synthesis. The nsP2 mutations also inacti-
vated the nonstructural proteinase (183, 186, 449), but the
nsP4 mutation had no observable phenotype other than its
effect on minus-strand RNA synthesis. Upon incubation at the
nonpermissive temperature, minus-strand synthesis is not shut
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FIG. 17. Schematic representation of the formation of replicase complexes specific for the synthesis of SIN minus-strand and plus-strand RNA.
(A) The uncleaved nonstructural polyprotein is shown, with different types of shading for the nsPl, nsP2, nsP3, and nsP4 domains. (B and C)
Cleavage of the nsP3/nsP4 bond (and perhaps addition of host factor) leads to the formation of the active minus-strand replicase. (D and E)
Cleavage of nsPl/nsP2 and nsP2/nsP3 bonds with a concomitant change in conformation leads to the formation of the plus-strand replicase and
synthesis of plus strands. This model is based on the results of Shirako and Strauss (487) and of Lemm et al. (286).
off by these mutants, or if minus-strand synthesis has shut
down, shift to a nonpermissive temperature leads to resump-
tion. In these mutants, continuing protein synthesis is not
required for minus-strand synthesis, in contrast to the situation
for wild-type virus, and thus it appears that in these mutants
cleaved P123 can make minus strands. It appears likely,
therefore, that the cleavage of P123 alters its conformation in
such a way as to render it incapable of initiating minus-strand
synthesis and that conformational changes induced in nsP2 or
nsP4 by these mutations allow the cleaved replication complex
to mimic the conformation of the uncleaved complex and thus
to synthesize minus strands as well as plus strands.
The cleavage site preferences exhibited by the SIN nonstruc-
tural proteinase lead not only to the disappearance of P123 at
3 to 4 h after infection but also to the appearance of a large,
fairly stable pool of P34 at the same time. de Groot et al. (92)
hypothesized that the changes effected by the cleavage site
preferences found by them were responsible for the shutoff of
minus-strand RNA synthesis and suggested that P34 might
play an active role in RNA replication. It now seems probable
that P34 arises simply as a by-product of the cleavage pathway
and plays no direct role in RNA replication.
The work of Lemm and Rice (284, 285), as well as earlier
studies of DI RNAs (see especially references 293 and 295),
makes clear that a plus-strand RNA template can be supplied
to a replicase in trans. On the other hand, attempts to supply
minus-strand templates in trans have all failed (284, 463) for
reasons that are not clear. It is possible that a minus-strand
RNA is normally used only in cis by the replicase that
transcribes it from a plus-strand template or that assembly of
active replicase complexes occurs only on plus-strand tem-
plates, although the results of Sawicki and Sawicki (449)
suggest that exchange of templates is possible, at least with
certain mutant replicases. As a practical matter, the inability to
supply minus-strand templates to a preformed replicase com-
plex means that synthesis of plus-strand RNA cannot be
studied independently of minus-strand synthesis and that the
minimal requirements for synthesis of 26S subgenomic RNA
versus 49S genomic RNA are not well understood. The 26S
promoter differs from the 49S promoter, but it is not known
whether the 26S transcription complex contains a different
constellation of nonstructural proteins (and host compo-
nents?) from the 49S replicase. A number of SIN mutations in
nsP2 (C-304 -- Y, F-509 -* L, A-517 -> T, N-700 -1 K G-736
-> S) result in the synthesis of reduced quantities of 26S RNA
relative to 49S RNA following a shift to the nonpermissive
temperature, suggesting that nsP2 could have a distinct role in
the specific initiation of 26S subgenomic RNA transcription.
Role of the opal termination codon. The model for control of
minus-strand RNA synthesis described above suggests a model
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FIG. 18. Schematic map of the alphavirus genome showing the locations of four CSEs. The four CSEs are shown as black boxes in the genome
organization. Below are shown the structures for CSE 1 and CSE 2, for which it is believed that the structure is as important as or more important
than the linear sequence. In the case of CSE 3 (the subgenomic promoter) and CSE 4 [the last 19 nt adjacent to the 3' poly(A) tract], consensus
sequences are shown.
for the function of the opal termination codon that is present
between nsP3 and nsP4 in most alphaviruses. The readthrough
rate of the SIN opal codon during cell-free translation has
been found to be 10 to 20% at 30°C and <5% at 40°C (92, 300,
487). Assuming that the readthrough rate is comparable in
infected cells, for alphaviruses having the opal codon there will
be 5- to 20-fold more proteinase molecules present early in
infection than there are nsP4-containing replicase complexes.
This suggests that the function of the termination codon is to
produce P123 proteinases that will act in trans to accelerate the
processing of minus-strand replication complexes containing
P123 and nsP4 into plus-strand replicases containing cleaved
products from P123. It is intriguing that such acceleration
appears to be particularly important at 40°C, a temperature at
which the SIN P123-containing replication complex is totally
unable to synthesize plus-strand RNA and at which read-
through is particularly inefficient, leading to a higher ratio of
proteinase to replicase.
This model for the function of the opal termination codon is
supported by results of Li and Rice (299), who studied the
effect of replacing the opal codon in SIN with a sense codon.
The sense codon-containing virus was found to grow well but
to be delayed in total-RNA synthesis if the multiplicity of
infection was moderate (z20 PFU per cell), and under these
conditions the wild-type virus containing an opal codon had a
selective advantage. At high multiplicities (100 PFU/cell), the
replication of the sense mutant was essentially indistinguish-
able from that of the wild type. These results are consistent
with the hypothesis that at low multiplicities the conversion of
P123-containing complexes into plus-strand replicases is de-
layed in the mutant but at high multiplicities many extra viral
RNAs are translated, giving rise to proteinases active in
cleaving P123. It seems probable from other studies that the
total number of replicases inside the cell is limited, possibly
because a host component is limiting, and that at multiplicities
of 100 many of the translation products will not be able to form
functional replicase complexes but could provide proteinases
to cleave the functional complexes.
As described above, there is reason to postulate that sense
and opal codons are in flux in any virus, and it would appear
that regulation by the UGA codon is a subtle fine tuning of the
virus replication cycle. The selective advantage of opal over a
sense codon could depend on the nature of the hosts and
geographical constraints. It is intriguing that all three viruses
containing a sense codon were isolated from the Ethiopian
region and the conditions that give a selective advantage to a
sense codon could be more prevalent in this region. It would be
of interest to examine other alphavirus isolates for the pres-
ence or absence of the opal codon. It would also be of interest
to determine whether P123-containing complexes from viruses
that have a sense codon are able to synthesize plus-strand
RNA more efficiently than P123-containing complexes from
SIN containing an opal codon, thus compensating for the delay
in cleavage of P123.
cis-ACTING SEQUENCE ELEMENTS IN ALPHAVIRUS
RNAs
Conserved Nucleotide Sequence Elements
Identification of CSEs. One of the most active areas of
alphavirus research over the last decade has been attempts to
identify and characterize cis-acting nucleotide sequence ele-
ments in alphavirus RNAs required for replication of the
genomic RNA, for transcription of the subgenomic RNA, and
for RNA encapsidation. One of the earliest efforts to identify
such elements utilized comparative nucleotide sequence anal-
yses of alphavirus RNAs. In general, even regions of alphavirus
genomes encoding conserved amino acid sequences have di-
verged significantly during evolution because codons encoding
conserved residues have been randomized among those per-
mitted by the degeneracy of the genetic code (524) (see, for
example, Fig. 13). Thus, regions of nucleotide sequence con-
served among alphaviruses must be of special significance. It
seems clear that sequence elements that specifically interact
with proteins will evolve slowly because any change in the
sequence element would require compensating changes in the
binding protein to maintain function. In the case of viral
proteins that specifically recognize such viral nucleotide se-
quences, coevolution of the interacting components is possible
but requires simultaneous changes in the element and the
protein. In cases when cellular proteins recognize a viral
sequence element, the amount of variation tolerated within the
element may be severely restricted. In either case, these
1 2
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interacting sequence elements should evolve more slowly than
other viral sequences.
Four conserved sequence elements (CSEs) have been iden-
tified in the alphavirus genome (384-387), and their locations
are illustrated schematically in Fig. 18. From their conservation
and location, these elements were hypothesized to perform
specific functions during viral RNA replication (reviewed in
reference 524). A conserved stem-loop structure is found at the
5' end of alphavirus RNAs, formed by the first 44 nt in the case
of SIN. The complement of this sequence was hypothesized to
serve as a promoter, at the 3' end of the minus strand, for
initiation of plus-strand RNAs from a minus-strand template.
A 51-nt CSE found in the coding sequence for nsPl is also
capable of forming stem-loop structures. Although the func-
tion of this element is not clear, it has been suggested that it
might serve as a copromoter for initiation of minus-strand
synthesis on a genomic RNA template. The rationale for this
hypothesis is that subgenomic 26S mRNA is not transcribed
into minus strands in infected cells, suggesting that there is a
sequence element not present in 26S RNA that is required for
minus-strand synthesis. A 24-nt CSE found within the junction
region was postulated to be the promoter for transcription of
the subgenomic mRNA. The 19-nt CSE at the 3' end of the
RNA was hypothesized to serve as a promoter for initiation of
minus-strand RNA synthesis on the plus-strand template.
Mutagenesis of CSEs. Mutational and mapping studies have
been performed on the four CSEs described above. Here we
consider mutational analyses of three of the conserved CSEs.
The analyses of the promoter for the subgenomic RNA, which
has progressed along different lines, will be considered sepa-
rately below.
For the analysis of the 5' and 3' elements and the 51-nt
element, many defined mutations, either point mutations or
deletions, were introduced into the elements and the mutant
viruses were examined for phenotypic defects. It was found
that a simple examination of the plaque morphology of a
mutant was not sufficient to determine if the mutation was
deleterious. Although virus production by mutants which pro-
duced minute plaques or whose plaques took longer to develop
was invariably impaired, many mutants were found that grew 3
or 4 orders of magnitude less well than the parental virus but
formed plaques that were virtually indistinguishable from
wild-type plaques (272, 370, 371). Thus, careful growth curves
were required to determine if any given mutation was delete-
rious.
An analysis of the 5' NTR in which the effects of 24 different
deletions and substitutions were examined (370) revealed that
the virus was very sensitive to changes in the first 44 nt, which
are capable of forming a stem-loop structure, whereas the
downstream nucleotides in the NTR could be deleted without
effect. Deletion of nt 1, of nt 2 to 4, or of nt 5 was lethal;
deletion of nt 8 or 36 resulted in ts virus; and numerous other
deletions tested in the first 44 nt resulted in virus that grew
poorly compared with the wild-type virus. These results sug-
gested that it was the 3'-terminal structure in the minus strand
that was important for promotion of plus-strand synthesis, as
originally suggested by Ou et al. (386) and consistent with DI
RNA findings described below. In a mutational analysis of the
51-nt CSE, 25 substitution mutants were examined, of which 21
did not involve a change in amino acid coding (371). Of the 21
silent changes, 19 were extremely deleterious for virus replica-
tion, resulting in a decrease in virus growth of 2 to 4 orders of
magnitude. The 51-nt sequence is capable of forming two
stem-loop structures that may be the functional elements;
however, even changes that should not disrupt the structures
were deleterious, and thus the linear nucleotide sequence is
(also?) important. Finally, a study of the 3' NTR in which 42
different substitutions and deletions were examined (272)
showed that the virus was particularly sensitive to changes in
the 19-nt CSE and that substitutions or deletions in this
element often decreased the ability of the virus to replicate by
2 orders of magnitude or more. The entire 3' NTR was
important for virus RNA replication, however, because dele-
tion of large areas upstream of the 3'-terminal CSE was
deleterious (but not lethal); such deletions were more delete-
rious in mosquito cells than in chicken cells.
From these three studies, certain common themes emerged.
One was that most of the nucleotide substitutions attempted
led to viable virus. Thus, although these sequence elements are
highly conserved among alphaviruses, many changes are toler-
ated, although in virtually all cases the virus grew less well than
the parental virus and would be selected against during passage
in nature. Second, many mutants were affected differently in
their growth in chicken cells and in their growth in mosquito
cells (or in their growth in mouse cells [271]). As one example,
deletion of nt 16 to 19 of the 3' NTR resulted in a mutant
which replicated to threefold-higher titer in mosquito cells
than did the parental virus but which grew less well in chicken
cells. In nature, SIN alternates between mosquito vectors and
higher vertebrates, and birds serve as an important vertebrate
reservoir. The virus has evolved to replicate efficiently in both
invertebrate hosts and a range of vertebrate hosts, and it seems
clear that the CSEs are a compromise between the sequences
that best adapt it for growth in the different types of hosts. The
fact that these mutations affect growth in these cell lines so
differently suggests that host cell factors, presumably proteins,
bind to these three sequence elements, and since these se-
quence elements are all quite disparate, it is likely that
different cellular proteins interact with the three different
elements.
CSEs can be tissue specific. The finding that mutations in
CSEs had different effects on virus growth in chicken and
mosquito cells was followed up with detailed studies on four
mutants with changes in the 5' NTR and four mutants with
changes in the 3' NTR (271). These mutants were tested for
rates of RNA synthesis and virus production in cultured mouse
cells, mosquito cells, and chicken cells and were examined for
virulence and for virus production in different tissues in mice.
All of the mutants had defects in RNA synthesis, and virus
production was host cell dependent. Mouse, chicken, and
mosquito cells responded differently to each change from the
wild-type sequence, indicating that the wild-type sequence
elements have been adapted to interact with all of the natural
hosts for the virus but are not necessarily optimal for a
particular host. Growth in cultured mouse cells was found to
be a better predictor for the virulence of any particular variant
in newborn mice than was growth in chicken or mosquito cells;
viruses that grew poorly in mouse cells were usually attenuated
in their neurovirulence. Of particular interest was the finding
that a mutant in which nt 18 to 25 of the 3' NTR (numbered 3'
to 5') were deleted demonstrated tissue-specific differences.
This mutant grew slightly less well than the parental virus did
in cultured mouse cells but grew to ninefold higher titer than
the parental virus did in mouse brain (and was correspondingly
quite virulent for newborn mice). Thus, the host proteins that
interact with these CSEs appear to be tissue specific as well as
species specific, and this may serve to modulate the tissue
tropism of the virus.
Cellular proteins bind to CSEs. Studies described above
suggested that cellular factors, presumably proteins, bind to
alphavirus CSEs, presumably to promote RNA replication. To
test this, minus-sense riboprobes of 60 or 120 nt corresponding
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to the 3' end of the minus strand of SIN genomic RNA were
mixed with extracts from uninfected or infected chicken cells.
Cellular proteins were found to bind to these probes, resulting
in a shift in the electrophoretic mobility of the probe (390).
The affinity constants for the binding (Ks 108) were similar to
those found for the binding of sea urchin proteins to (DNA)
sequence elements that lead to altered transcriptional states
and result in embryonic development (58), and thus the
binding reaction is potentially significant for virus RNA repli-
cation. One riboprobe with a single nucleotide deletion bound
more tightly to the cellular proteins than did the wild-type
probe, resulting in a threefold-longer half-life for the complex,
indicating that the interaction is sequence specific.
Chicken cellular proteins binding to the RNA probes were
labeled by being cross-linked to the bound 32P-labeled ribo-
probe by irradiation of the complexes with UV light, followed
by RNase treatment. The labeled proteins were then displayed
on acrylamide gels. The major labeled products were proteins
of 42 and 44 kDa, which could be two forms of the same
protein.
Pardigon et al. (389) also identified proteins of 50 and 52
kDa from mosquito cells that bound specifically to the SIN
probes described above with an affinity approximately equal to
that of the chicken 42- and 44-kDa proteins. Using a number of
different probes, these authors found that within the first 250
nt at the 3' end of SIN minus-strand RNA there were three
high-affinity binding sites and one low-affinity site for the
mosquito proteins, which may interact cooperatively. High-
affinity binding to the 3'-most binding site required the first 15
nt of the SIN sequence, suggesting that binding of these
cellular proteins represents an important step in the initiation
of RNA replication. The same mosquito proteins were also
found to bind specifically to riboprobes from SF and RR,
demonstrating that binding of this protein is a general phe-
nomenon in alphavirus infection.
The binding protein from mosquito cells has been purified
and partially characterized by amino acid sequence analysis
(388). The sequence obtained to date suggests that this protein
is the mosquito homolog of the La protein. This finding should
make it possible to determine whether the mammalian or avian
proteins are in fact La.
In parallel studies, Nakhasi et al. (367) found that a 3'-
terminal minus-strand riboprobe from SIN was bound by
proteins of 79 and 56 kDa in extracts of uninfected Vero cells
and by these same two proteins plus a protein of 97 kDa in
extracts of rubella virus-infected Vero cells. Similar results
were obtained with riboprobes representing the 3' minus
strand of rubella virus. Competition experiments indicated that
the probes competed for the same proteins, indicating that
they probably serve a similar function in the replication of the
two viruses. Why different proteins were found by Nakhasi et
al. (367) and by Pardigon and Strauss (390) is not clear and
requires further investigation; it may be that a number of
cellular proteins are bound in the formation of the initiation
complex and that differences in the method of preparing the
extracts result in different amounts of these binding proteins.
Nakhasi et al. (368) had previously reported that cellular
proteins also bind to the 3' end of the rubella virus plus strand,
where they could play a role in the initiation of minus-strand
transcription; one of these proteins appears to be the same as
the 56-kDa protein identified as binding to the 3' end of the
minus strand (367).
Promoter for subgenomic RNA synthesis. The promoter for
subgenomic RNA synthesis, originally postulated to be a 21-nt
CSE found in the junction region of the RNA (384), has now
been precisely defined in an elegant series of experiments.
SIN
AURA
WHA
WEE
EEE
VEE
ONN
SF
SF-1
RR
MID
MAY
-10
-1
AUCUCUACGGUGGUCCUAA
L Y G G P K
C----
-- c-- --
§C - -- -- - -- CI- A -- -- -
PC - -- -- - -- C R- A -- -- -
OC - -- -- - -- COAA--- ---
OCU -G -- - -- C - -A -- -- -
-C - -C -
-C -
-C-- V
-C -c-
C C--
----G -----C--------
26S RNA
+1
AUAGU
*
_--A
- ---G
- - -- G
- -
G
- -
- - - -
G
-
-v<.- G
,J- - G
- - -- A
- - - - G
RUB CC- -G- - - -UG- -G--- UU -AUC-
Relative
Promoter
Strength in SIN
1.00
nd
nd
nd
0.63
0.53
0.75
0.75
0.13
2.13
0.88
nd
0.05
FIG. 19. Aligned nucleotide sequences of the subgenomic promot-
ers of 10 alphaviruses and of rubella virus. The SIN sequence is shown
in the first line. Nucleotides that are the same as SIN are indicated
below with a dash. Changed nucleotides that result in coding changes
are shaded. Two different sequences have been reported for the SF
promoter; they are labeled SF (384) and SF-1 (540) in this figure. The
other alphavirus sequences are from the references cited in Table 1.
The RUB sequence is from Frey (123). The right-hand column shows
the relative strength of several of these promoters in a SIN construct
containing two subgenomic promoters. The second promoter, whether
the same (SIN) or heterologous, drove the synthesis ofmRNA for the
CAT reporter gene. The activity of this second promoter relative to the
SIN promoter that drove expression of the SIN structural proteins in
the same construct was measured either as the ratio of CAT mRNA to
26S RNA or as the ratio of CAT activity to the amount of structural
proteins synthesized (201). nd, not determined.
Alphavirus DI RNAs are not translated into protein, and the
promoter for transcription of the subgenomic mRNA is not
present in DI RNAs (reviewed in reference 467). A 227-nt
sequence bracketing the junction region, extending from 98 nt
upstream of the start of the subgenomic RNA to 117 nt
downstream of the start, was transferred into a SIN DI RNA
and shown to function for transcription of a subgenomic RNA
in the presence of helper virus. Deletion mapping of this
construct showed that precisely 24 nt, including 19 nt 5' of the
start site and 5 nt downstream of the start site, were necessary
and sufficient to promote transcription of a subgenomic RNA
(294).
Subsequent studies have defined the strength of various
subgenomic promoters more precisely. SIN RNA genomes
that transcribe two different subgenomic RNAs by using two
independent promoters were constructed, and the use of such
double subgenomic RNA genomes makes it possible to com-
pare directly the relative efficiencies of different promoters
(411). These studies showed that although the minimal 24-nt
promoter is sufficient for the transcription of the subgenomic
RNA, the presence of upstream sequences increases the
promoter activity sixfold. Further, two mutant promoters were
tested; one, a 3-nt insertion originally described by Grakoui et
al. (162), led to a 100-fold decrease in the activity of the
promoter, and the second, a 4-nt deletion, had the surprising
effect of increasing the efficiency of promotion twofold. In a
related series of experiments, the efficiencies with which the
subgenomic promoters of other alphaviruses could be used by
SIN were assayed (201). The promoter sequence for produc-
tion of the subgenomic mRNA is highly conserved among the
different alphaviruses, but some differences are present (Fig.
19). Site-specific mutagenesis was used to change the minimal
24-nt promoter to that of several other alphaviruses or of
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FIG. 20. Schematic representation of repeated sequences in the 3' NTRs of alphaviruses. For SIN, the repeated element shown is
approximately 40 nt long and contains two motifs (shaded differently). This repeated element also appears in AURA, WHA, and WEE, and the
individual motifs are found in EEE as separate elements. Among the remaining alphaviruses, the repeated units share no sequence similarity from
virus to virus, as indicated by different types of shading. Both the lengths of the repeats and the overall lengths of the 3' NTRs have been drawn
to scale. The downward-pointing arrow indicates the termination codon at the end of the structural protein ORF. Sequence data for the
construction of this figure are found in the references cited in Table 1.
rubella virus, and the relative efficiencies of the promoters
were tested with the double subgenomic system. Almost all
alphavirus promoters tested were recognized by the SIN RNA
polymerase with various degrees of efficiency (Fig. 19). Inter-
estingly, the promoter for RR was used more efficiently than
that for SIN when the assays were performed in infected
hamster (BHK-21) cells. One possible interpretation of the
results is that the promoter strength is regulated by the virus
because of the need to balance the production of genomic
RNA and subgenomic RNA following infection and that an
overly strong promoter is selected against. A second possible
interpretation is that the optimal promoter sequence might
depend on the normal host cell of the virus (RR is primarily a
virus of mammals, whereas SIN has birds as its primary
vertebrate reservoir), possibly because a host protein is in-
volved in promoter recognition. It will be necessary to test the
strengths of the promoters in cells derived from different
tissues or from different animals to examine this hypothesis.
Involvement of host proteins in the recognition of the
subgenomic promoter was suggested in studies by Durbin et al.
(103). These authors found that a mutant of SIN with a
nucleotide substitution in the subgenomic promoter led to
decreased synthesis of 26S RNA in mosquito cells but not in
chicken cells (the mutation is in the region encoding the C
terminus of nsP4 but does not lead to an amino acid substitu-
tion). Interestingly, the decreased synthesis of 26S RNA in
mosquito cells led to increased cytopathology and to the
formation on mosquito cells of plaques that were clearer and
better defined.
There is also evidence that viral proteins are required for the
recognition of the subgenomic promoter. Grakoui et al. (162)
inserted 3 nt into the wild-type SIN subgenomic promoter and
found that transcription of subgenomic RNAs was dramatically
reduced to the extent that the resulting virus was barely viable.
The authors found that second-site revertants which grew well
although retaining the 3-nt insertion were easily obtained. At
least two of these revertants recognized the mutant promoter
more efficiently than they recognized the wild-type promoter,
suggesting that the revertants contain suppressor mutations in
viral proteins that promote subgenomic RNA synthesis by
binding to the subgenomic promoter and that these suppressor
mutations have adapted the viral protein to the mutant pro-
moter. The finding that SIN recognizes the different promoters
with differing efficiencies (note especially that SIN recognizes
one of the two SF promoters very poorly) also indicates that a
SIN protein is involved in promoter recognition (Fig. 19).
Repeated Sequence Elements in the 3' NTR
There are repeated sequence elements 40 to 60 nt in length
in the 3' NTRs of almost all alphaviruses. These elements are
not conserved among alphaviruses: although almost all alpha-
viruses have repeated sequences, their sequence and length are
different in different viruses (387), as illustrated schematically
in Fig. 20. These elements may be useful in virus classification.
In the 3' NTR of SIN there are three copies of a 40-nt
repeated element (387). Sequence analyses of a number of
strains of SIN isolated from widely separated geographic areas
showed that all isolates examined had three copies of the
repeated element, whose sequences were much more highly
conserved than the sequence in other regions of the 3' NTR
(with the notable exception of the 19-nt 3'-terminal sequence)
(485). As an example, an Australian strain and an Egyptian
strain of Sindbis virus diverged by 18% in the 3' NTR
sequence, but this overall divergence resulted from 6% diver-
gence within the repeated elements and 24% divergence
elsewhere. Furthermore, the SIN-related viruses WHA and
AURA also have three copies of the same element, confirming
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FIG. 21. Comparison of the repeated sequence elements in the 3'
NTRs of SIN and AURA. The sequence of the 5'-most repeated
sequence element in the SIN 3' NTR is shown in the top line, and the
second and third SIN copies of this element, as well as all three copies
from AURA, are compared below. A dash indicates that the residue is
the same as that in the top line; gaps have been introduced for
alignment. Nucleotides are numbered beginning with the termination
codon for the structural ORF at the 5' end of the 3' NTR; ticks are
every 10 nt. The sequence of SIN is from reference 517; that of AURA
is from reference 434.
that they are SIN-like viruses (Fig. 21). In the case of SIN,
therefore, it appears that precisely three copies of this se-
quence are optimal for persistence of the virus in nature.
Kuhn et al. (272) studied the effect of deleting these
repeated elements from the SIN genome. They found that a
virus missing all three copies (nt 53 to 318, numbered 3' to 5',
of the 3' NTR had been deleted) was viable. In cultured
chicken cells the deletion variant yielded about half as much
virus as did the parental virus, whereas in cultured mosquito
cells virus growth was delayed by 2 h and virus release from the
cells was depressed by 30-fold. This difference -in effect in the
two cell lines suggests that this region binds a cellular protein
whose function in virus replication is more important in
mosquito cells than in avian cells. The fact that the RR and
SIN 3' NTRs, whose repeated sequences are unrelated, can be
exchanged without apparent effect on viral replication is
consistent with the hypothesis that the primary function of
these repeated elements is to bind a cellular protein rather
than a viral protein (273).
In contrast to SIN, different strains of RR do not all contain
the same number of copies of the RR repeat element. There
are four copies of a repeated sequence in the prototypic T48
strain that vary from 49 to 58 nt in length and differ slightly in
sequence (84) (Fig. 20). Five other isolates of RR from
different geographic locations were found to have at least one
copy of this sequence, corresponding to the 3'-terminal ele-
ment in T48, which was precisely conserved in sequence and in
location relative to the poly(A) tract. The different isolates had
different numbers of repeats upstream of this, however (115).
Further, Getah virus, a close relative of RR, had three copies
of the same element although overall the 3' NTRs of RR and
Getah have diverged markedly, confirming that Getah is an
RR-like virus. These results suggest that at least one copy of
the repeat element is necessary for persistence of RR in nature
but that multiple copies of it are not (always?) necessary.
The repeated elements in the 3' NTR could regulate RNA
translation. Such a role is suggested by the fact that these
elements have been deleted in at least some SIN DI RNAs,
which are not translated but which do replicate vigorously
(360, 362), and is consistent with observations that RNAs of at
least some other virus families have (unrelated) sequence
elements in the 3' NTRs that bind cellular proteins and
regulate translation of the RNA (279).
Sequences in DI RNAs Define Essential cis-Acting Elements
DI RNAs replicate and are packaged in the presence of
helper virus and thus retain all cis-acting elements required for
this. One DI RNA of SIN and two DI RNAs of SF have been
sequenced in their entirety, and partial sequences or sequence
analyses by other techniques have also been reported, in
attempts to define the cis-acting elements required for repli-
cation and packaging. The sequences found in these DI RNAs
are illustrated schematically in Fig. 22 in comparison with the
sequences present in the viral genomes.
All naturally occurring SIN and SF DI RNAs contain a
minimum of 50 nt from the extreme 3' end of the genome (5,
362). This sequence contains the 3' CSE that is hypothesized to
be required for initiation of minus-strand copies on the
plus-strand RNA template. Deletion analysis of a SIN DI RNA
showed a precise requirement for the 3'-terminal 19 nt of the
genome; deletion of the entire sequence derived from the 3'
NTR except for the 3'-terminal 19 nt resulted in active DI
RNA in these experiments, but deletion of 2 additional bases
(leaving a 17-nt element) or of the entire element resulted in
an inactive RNA (295).
Unlike the 3' ends, the 5' ends of SIN DI RNAs are not
homogeneous and three unrelated 5' termini have been found,
all of which support DI RNA replication. Not surprisingly, the
first of these is the normal 5' end of virion RNA (550), such
that the DI RNA contains the 5' and 3' ends of the genome
with deletions and rearrangements in the middle. Deletion of
nt 16 to 26 in the 5' NTR abolished function (551), and by
analogy with results with complete virus (370), it seems likely
that the 5'-terminal 44-nt structure is required for DI RNA
replication. A second 5' sequence element found in SIN DI
RNA consisted of nt 10 to 75 of a cellular tRNAAP sequence
(361) (Fig. 22). This sequence must have originated by recom-
bination with host cell RNA, and this sequence element must
fulfill the functions of the 5' element required for RNA
replication that is normally present in virion RNA. The fact
that this element was found in more than one independent DI
RNA isolate suggests that it supports RNA replication more
efficiently than the normal 5' end of the RNA does. It is
intriguing that tRNAs have a defined structure and that a
structure at the 5' end of the genomic RNA, rather than a
linear sequence, is thought to be important for function. The
third 5' element found on SIN DI RNA was a sequence
derived from the first 142 nt at the 5' end of the 26S
subgenomic RNA (550); the 26S sequence had a deletion of nt
25 to 66, and this deletion was found to be necessary for
amplification of the DI RNA (551). It appears that the 5' end
of SIN RNA is not optimized for RNA replication, perhaps
because of the requirement that the 5' end also function as a
leader for translation. SIN DI RNAs are not translated and
thus have the luxury of substituting the 5' end with one that is
more efficient for replication but which may not support
translation. It is also possible that the alternation of the virus
in vertebrate and invertebrate cells constrains the type of 5'
end of the viral RNA; DI RNAs sequenced to date have arisen
in vertebrate cells, and studies of their replication in mosquito
cells are limited.
The 5' ends of SF DI RNAs have not been as well
characterized as those of SIN DI RNAs. The 5' ends of SF DI
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FIG. 22. Diagram of the locations in the alphavirus genome of sequences found in DI RNAs. Maps are shown for SF and two SF DI RNAs
(281, 282) and for SIN and its best-characterized DI (360, 362). (A) The SF genome is shown to scale; the two long ORFs are indicated by boxes,
and the boundaries between the proteins are shown by vertical lines. Sequences found in two DI RNAs are mapped on the genome and illustrated
above and below expanded fourfold. The maps of the DI RNAs are also expanded fourfold relative to the SF map. Some sequence elements are
repeated three or four times; the exact 5' sequence of the SF DI RNAs has not been reported. (B) A similar analysis of a SIN DI RNA. In this
case, the 5' end of the DI consists of a 66-nt sequence derived from a cellular tRNAAP. Other conventions are as in panel A.
RNAs were found to be heterogeneous and different from the
5' end of the genomic RNA (403), suggesting that the situation
may be analogous to that for SIN DI RNAs.
In the middle of the DI genome are sequences derived from
internal regions of the virus genome, mostly from the 5' region,
and there is little or no sequence present in DI RNA that is not
derived from the virus. Early sequence studies revealed that DI
RNAs of either SIN (360, 362) or SF (281, 282) contained
repeated and rearranged genomic sequences of a complexity
much lower than that of the parental virus; repeated elements
are of particular interest and are presumably selected because
they enhance the replication and packaging of the DI RNA.
The sequences present in one SIN DI RNA sequenced in its
entirety (Fig. 22) consisted of 5' tRNAAP followed by SIN nt
29 to 546 (which contain the 51-nt CSE at nt 154 to 205), an
internal region containing SIN nt 647 to 1226 and 10239 to
10668, and the 3'-terminal sequence (nt 11655 to 11703). The
internal region had two copies each of nt 350 to 490 and 746 to
1226. Deletion experiments suggested that the sequence from
nt 746 to 1226 contains signals for both RNA replication and
packaging (295, 599). At least one copy of the 5' part of this
element (nt 746 to 947) was required for efficient replication of
the DI RNA, and one copy of the 3' 279 nt (nt 948 to 1226) was
required to allow packaging of DI RNA. This region was also
shown to bind capsid protein in in vitro binding assays, and the
two cis-acting functions of this 481-nt domain, encapsidation of
the genomic RNA and promotion of RNA replication, could
both require binding of capsid protein (599).
The 51-nt CSE was also found to be necessary for efficient
DI RNA function. Deletion of this element gave rise to a viable
DI RNA that was amplified and packaged (295) but which
replicated more slowly and competed less efficiently than the
parental DI RNA did (465).
Finally, deletion analysis showed that nt 647 to 745 and
10292 to 10668 were dispensible for DI RNA function and may
simply represent sequence that has failed to be deleted or filler
that increases the size of a minimal DI RNA (295).
Two SF DI RNAs have been sequenced in their entirety
except for the extreme 5' end (Fig. 22). One (DIa) had a
complexity of only 680 nt (total length, 1,652 nt): only SF RNA
residues 11 to 317 and 2728 to 2994 and the 3' 106 bases were
present (281). nt 37 to 317, 2729 to 2857 and 2918 to 2993 were
present in three copies in the DI RNA. The second DI RNA
(DIb) had a complexity of 1,169 nt (total length, 2,286 nt) and
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contained residues 79 to 137, 164 to 684, 2628 to 3063, and
11216 to 11276 and the 3' 103 bases; there were four copies of
the sequence from 2737 to 3009 (282). Three additional SF DI
RNAs have been examined by electron-microscopic heterodu-
plex analysis (5). Although this method is less precise than
sequencing, the conclusion was reached that these three DI
RNAs had three regions in common with one another and with
the two sequenced DI RNAs. These were the 3'-terminal 80 nt,
a sequence of 100 nt located around nt 200, and 90 nt near
position 2740. The SF 51-nt CSE comprises residues 176 to
230. It is thus present in both sequenced DI RNAs (in three
copies in DIa) and appears to be present in the three addi-
tional DI RNAs examined. The presence of this element in all
SF and SIN DI RNAs examined suggests that this element is
important for DI RNA function. The residues near nt 2740
may be required for packaging, and the importance of the
3'-terminal sequence has been commented upon above. It is of
considerable interest that the only sequences in common
between the SF and SIN DI RNAs are the 51-nt CSE and
surrounding sequence and the 3' end of the RNAs. Other
signals for RNA replication and packaging in these two viruses
(other than the 5'-end signals which differ in different DI
RNAs) must therefore reside in nonidentical positions in the
viral RNAs. It is of note that SIN DI RNAs have been found
to cross-interfere with the replication of SF and that SF DI
RNAs have been found to interfere with the replication of SIN,
but interference was less efficient with the heterologous virus
than with the homologous virus (600). Thus, some of the
cis-acting signals are shared between the two viruses, consis-
tent with the hypothesis that CSEs form such signals.
It is of interest to compare the sequence requirements for
DI RNAs with those for the viral RNA (272, 370, 371). It
seems surprising that deletion of the 51-nt CSE had such a
limited effect on DI RNA function when single-nucleotide
substitutions in this element had a profound effect upon virus
replication, reducing the growth rate by 4 orders of magnitude.
In like vein, certain deletions in the 3' NTR reduced the virus
growth rate by an order of magnitude or more but had no
apparent effect on DI RNAs. Conversely, deletion of nt 16 to
26 in the 5' sequence was lethal for DI RNA but had a less
profound effect on the virus than did other substitutions or
deletions which were dispensable for DI RNA function. It
seems apparent that the functions required for DI RNA
replication and packaging must be related to and overlap those
for replication and packaging of virion RNA. However, it also
seems clear that the replication of the viral RNA is more
complicated and involved than is apparent from results with DI
RNA replication.
Packaging Signal in Alphavirus RNAs
Wengler et al. (606, 609) found that the SIN virus capsid
protein would assemble into corelike particles in vitro in the
presence of any RNA, including SIN 49S genomic RNA or 26S
subgenomic RNA, tRNA, or even polyanionic polymers. This
result was unexpected because SIN packages only the genomic
RNA into virions, and other RNAs found in the cell, most
notably 26S RNA, are not encapsidated. Recent results now
suggest that the exclusivity of RNA packaging results from the
presence of a specific encapsidation signal required for effi-
cient formation of nucleocapsids in infected cells.
In vitro binding assays developed by Weiss et al. (599)
showed that the RNA region between nt 746 and 1226 is
specifically bound by the nucleocapsid protein of SIN, suggest-
ing that this region contains a signal for encapsidation. One or
more copies of this element have been found in all SIN DI
RNAs examined (360, 362). Weiss et al. (599) found that
deletion of nt 948 to 1226 prevented packaging of DI RNA,
and thus this region is functionally a packaging signal.
Although the sequence from nt 948 to 1226 was required for
packaging of a DI RNA, alphavirus packaging appears to be
more complicated than simply having or not having this
packaging signal. Bredenbeek et al. (45) studied the packaging
of a number of constructs with deletions between nt 746 and
1226 and that had either the SIN 5' end or the tRNAAP
sequence found in a number of SIN DI RNAs. They found that
the deleted constructs were packaged but that they were
packaged less efficiently than constructs containing the region
from nt 746 to 1226 and that the efficiency of packaging
depended upon the particular deletion in the genome. Con-
structs with 5' tRNA"P were packaged more efficiently than
were constructs having the 5' SIN sequence, which may reflect
differences in replication efficiency of the RNA. It appears that
possession of the signal from nt 948 to 1226 is required for
packaging of the RNA with the highest efficiency but that other
sequences may influence packaging, that the size of the RNA
is important, and that RNA lacking a signal can be packaged
but with lowered efficiency.
It is of interest that the domain in SIN RNA that is required
for efficient packaging of DI RNA is not present in the
sequenced SF DI RNAs. The presence of a packaging signal in
SF RNA has not been explicitly demonstrated, but expression
of DI sequences in an SF-infected cell was shown to inhibit
capsid assembly (226), and, as is the case for SIN, only the
genomic RNA of SF is packaged in infected cells. Further-
more, SF DI RNAs that differ in their efficiency of packaging
have been described, suggesting that these different DI RNAs
contain packaging signals of different strengths, possibly as a
result of differences in the number of copies of the packaging
signal in the DI RNAs (237). It therefore seems most probable
that the SF DI RNA does contain a packaging signal but that
it is found in a different region of the SF genome from the
packaging signal in the Sindbis genome. The sequences present
in SF DI RNAs, described above, suggest that the SF packag-
ing signal lies between nt 2737 and 2993.
As noted above, the putative packaging signals are present
in multiple copies in DI RNAs. Smaller RNAs appear to be at
a selective disadvantage during capsid assembly in vivo (237),
and possession of multiple encapsidation binding sites might
enable a DI RNA to be packaged more efficiently or at least to
compete more effectively with genomic RNA during encapsi-
dation.
In the case of AURA, a South American alphavirus that is
serologically related to Sindbis virus, a packaging signal appar-
ently resides in the 26S region of the genome (436) because
26S RNA is packaged into capsids and is found in virions.
Packaging is fairly efficient, but, analogous to the case for
packaging of DI RNAs, 26S RNA is packaged less efficiently
than genomic RNA, possibly because of the size differences.
Thus, it appears that for three different alphaviruses, SIN, SF,
and AURA, the primary packaging signal is found in different
positions in the RNA genome.
Although the primary encapsidation signals in different
alphaviruses appear to be present in different position in the
genome, these signals appear to be related to one another. A
chimeric alphavirus genome consisting of the RR genome in
which the capsid protein gene has been replaced with that for
the SIN capsid protein gene is efficiently encapsidated by the
encoded SIN capsid protein, showing that the capsid protein of
SIN can encapsidate the RNA of RR (270, 312).
It seems clear from these results that a packaging signal in
alphavirus RNA is required for efficient packaging of RNA
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into capsids in infected cells. In support of this, Suomalainen et
al. (536) found that only very small numbers of virus-like
particles were assembled in the absence of SF genomic RNA
when SF capsid protein and glycoproteins were produced in
large amounts in cells by using the vaccinia virus-T7 expression
system. The fact that some particles were assembled, however,
together with the results of Breedenbeck et al. (45) that SIN
RNA lacking the putative packaging signal was packaged but
with lowered efficiency, suggests that in the absence of a
packaging signal, capsids will assemble with low efficiency,
consistent with the results of Wengler et al. (606, 609).
Chimeric Alphaviruses
Interactions between different domains of the alphavirus
genome have been studied by constructing chimeric viruses in
which part of the genome is derived from SIN and the
remainder of the genome is derived from RR. In these
chimeras, proteins encoded by one virus must interact with
proteins or sequence elements encoded by the other virus. If
these interactions are faulty, the virus will be attenuated and
the nature of interacting components can be identified. Studies
with chimeric viruses that probed the interactions between
nucleocapsids and glycoproteins, between capsid protein and
RNA, and between structural proteins and the RNA synthesis
machinery were described above. Here we describe chimeras
that probe interactions between the 5' and 3' NTRs and the
rest of the genome.
Chimeric RR-SIN viruses in which the entire sequence was
from one virus except for replacement of either the 5' or 3'
NTR with that of the other virus were constructed (273).
Replacement of the 3' NTR of SIN with that of RR resulted in
a chimeric virus whose growth was essentially indistinguishable
from that of SIN in either mammalian cells or mosquito cells.
The reciprocal chimera, RR having the SIN 3' NTR, was
indistinguishable from RR. Thus, although individual substitu-
tions within the 3' NTR of SIN led to virus that grew poorly
(272), replacement of the whole unit resulted in virus that was
essentially wild type. This finding is consistent with the hypoth-
esis that a major function of this NTR, other than the
3'-terminal CSE, is to interact with cellular proteins to pro-
mote viral RNA replication or translation. Although the
essential features of the 3'-terminal CSE may be conserved
between SIN and RR to the extent that interaction with viral
proteins might be normal, the remainder of the 3' NTR is very
different between the two viruses.
The converse chimeras in which the 5' NTRs were ex-
changed were not wild type, however. Replacement of the
entire 5' NTR with that of the other virus gave rise to viruses
that were viable but that grew less well, suggesting that there is
an interaction between the 5' NTR (or its complement in the
minus strand) and a virus-encoded protein. Chimeras within
the 5' NTR such that part of the NTR was derived from SIN and
part was derived from RR were not viable, suggesting that these
chimeras might disrupt secondary features required for function.
Alphaviruses as Vectors
The identification of cis-acting elements required for RNA
replication and packaging makes it possible to design alphavi-
rus expression vectors that can express any gene of interest in
the cytoplasm of any cell permissive for virus replication (28,
45, 46, 217, 302, 623). Because of the toxicity of the virus for
cells, these vectors will be useful primarily for transient expres-
sion, but an alphavirus expression system has several advan-
tages. First, the high level of alphavirus replication and the
interference of the viruses with host functions lead to the
production of very large amounts of expressed product. Sec-
ond, full-length clones of alphavirus cDNAs can be easily
manipulated and infectious RNA can be produced by in vitro
transcription, and the cloning steps required to produce the
RNA vectors are straightforward. Third, alphaviruses replicate
exclusively in the cytoplasm, and there is no possibility of
adventitious splicing.
Several approaches have been explored to date. In the
approaches illustrated schematically in Fig. 23, the gene to be
expressed is placed downstream of the viral subgenomic pro-
moter such that a subgenomic mRNA is transcribed and
translated into the protein of interest. The RNA vector
replicates to high copy number inside the cell, and large
quantities of the mRNA are produced, leading to production
of large amounts of the protein of interest. The factors to be
considered in the design of the vector system are the method
used to introduce the RNA into a susceptible cell, the nature
of the vector carrying the gene to be expressed, and the design
of a packaging system if it is desired to package the vector for
high-efficiency infection.
The most effective system for expressing a foreign protein is
one in which the structural protein genes of the virus (4.1 kb)
have been deleted and replaced with the gene to be expressed
(Fig. 23B); such systems have been described for both SIN (45,
623) and SF (28, 302). The RNA transcribed in vitro from the
resulting construct can be introduced into a cell by lipofectin
treatment (623) or electroporation (45, 302). This RNA is
self-replicating since it encodes the viral replicase, and the
vector leads to high rates of production of subgenomic mRNA
encoding the protein to be expressed (reviewed in reference
46). In experiments with the SF vector, protein production
continued for up to 75 h and resulted in the expressed protein
constituting as much as 25% of total cell protein (302).
To package the RNA so as to enable it to be delivered with
high efficiency to any cell sensitive to virus infection, cells can
be coinfected with helper virus or cotransfected with a defec-
tive RNA that leads to production of the virus structural
proteins. Xiong et al. (623) used coinfection of helper virus and
a DI construct containing the heterologous gene to be ex-
pressed (Fig. 23A); the virus resulting from the mixed infection
consisted of a mixture of wild-type virus and virions containing
the vector RNA. In contrast, Liljestrom and Garoff (302) and
Berglund et al. (28) used a deleted form of the SF genome or
of the SIN genome, respectively, as a helper (Fig. 23B). In this
helper, the packaging signal for the RNA had been deleted
such that only the vector RNA could be efficiently packaged,
and the virions from the mixed infection contained almost
exclusively vector RNA. Because infection of a large fraction
of the cells is possible by using electroporation, coinfection
with the two RNAs can be efficient and high yields of the
packaged vector can be obtained. Bredenbeek et al. (45)
developed a number of deleted helpers for packaging of SIN
that were packaged or not packaged, depending on the dele-
tion, allowing the investigator to choose a packaged or non-
packaged helper (Fig. 23B).
DI RNAs have also been used as packaging helpers. DI
RNAs contain all of the cis-acting elements required for RNA
replication and packaging. Engineering of a DI RNA to
contain the structural protein-coding region downstream of the
subgenomic promoter led to an efficient helper RNA. The
virus population produced in this case consisted of packaged
vector and packaged DI helper, and many virus particles
contained both RNAs in the same particle, enabling them to
form a plaque (149).
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FIG. 23. Alphavirus expression vectors. (A) In one form of expression system, the heterologous gene is inserted into a packaged DI RNA under
the control of an alphavirus subgenomic promoter. Cells are infected with wild-type helper virus and transfected with the DI RNA. The yield from
such an infection is a mixture of wild-type virus and packaged DI RNAs. (B) The foreign gene replaces the genes for the structural proteins in
a full-length alphavirus RNA construct. Transfection of this RNA leads to replication of the genome and transient expression of the foreign gene
upon transcription of subgenomic RNA. The replicon can be packaged by cotransfection with a DI RNA construct that expresses the structural
genes. DI RNA will also be packaged if it contains the packaging signal (construct 1) but not otherwise (construct 2). (C) The foreign gene can
be inserted into a full-length nondefective construct under the control of a second subgenomic promoter. Because of size limitations on packaging,
such constructs are unstable if the foreign gene is much larger than 2 kb. In these diagrams neither the SIN genomes nor the foreign inserts are
drawn to scale.
Another approach was used by Hahn et al. (176, 182) (Fig.
23C). These investigators used infectious SIN as a vector to
express small peptides derived from heterologous viruses, in
order to map antigenic determinants of the second virus. For
this, a second subgenomic RNA promoter was inserted into
the 3' NTR of the virus, positioned upstream of the gene for
the peptide to be expressed. The resulting virus RNA was
infectious and was packaged efficiently. During infection, two
subgenomic RNAs were produced, the smaller of which was
translated into the heterologous peptides to be studied. Al-
though large inserts (4 kb) can be placed in the 3' NTR and the
resulting viral genome can be packaged, large inserts are
unstable, and this system is effectively limited to expression of
small inserts (<2 kb) (46). Raju and Huang (411) have also shown
that this vector system can be used to express the CAT gene.
In a different approach to the use of SIN as a vector, London
et al. (311) inserted a neutralization epitope from Rift Valley
fever (RVF) virus randomly into the sequence for SIN glyco-
protein PE2. They recovered infectious chimeras in which the
RVF epitope had been inserted into E3 or into one of two
positions in E2. The E2 chimeras stimulated a weak protective
response in mice to RVF virus. Thus, the SIN glycoproteins
can be used to express heterologous epitopes, but the potential
of the system has yet to be explored in detail.
An interesting use of the SIN subgenomic promoter to
express a foreign gene was described by Olivo et al. (377). The
SIN subgenomic promoter was placed upstream of the lucif-
erase gene and downstream of a Rous sarcoma virus promoter,
and this construct was used to stably transform cells. Upon
infection of the transformed cells with SIN or defective SIN
variants that expressed a functional RNA replicase, high levels
of luciferase were produced. Thus, such transformed cells
produce significant amounts of the product under the control
of the SIN promoter only upon infection with SIN. In addition
to the potential value of such cells for the detection of SIN,
such an approach could be useful in cases when expression of
a gene product was desirable only after virus infection.
VIRUS-HOST INTERACTIONS
Host Cell Receptors for Alphaviruses
The alphaviruses have an enormous host range that com-
prises both invertebrate hosts (mosquitoes or other hemato-
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phagous insects that serve as vectors) and vertebrate hosts
(many species of birds and mammals [and some alphaviruses
have also been isolated from amphibians or reptiles]) (66, 166,
372, 402). Within their hosts they replicate in a wide variety of
cells including neurons and glial cells, striate and smooth
muscle cells, cells of lymphoid origin, synovial cells, and brown
fat cells. The question then arises whether the viruses are using
the same receptor throughout this wide host range; if so, the
same receptor must be expressed on the surface of many
different mosquito, avian, and mammalian cells. Studies to
address this issue (described below) have suggested that alpha-
viruses use protein receptors; that different alphaviruses may
use the same receptor or different receptors; that more than
one receptor can be used by one virus, leading to cases in which
the major receptors used by one virus to enter different cells
are different; that the nature of the receptors used determines
in part the virulence of the virus; and that one or a few amino
acid changes in the envelope glycoproteins can lead to utiliza-
tion of different sets of receptors.
Early studies of alphavirus receptors. The number of recep-
tors on the surface of a cell to which an alphavirus can bind has
been examined by electron microscopy (30) and by quantita-
tion of labeled virus bound to cells (125, 494). The number of
receptors depended on the virus, the cell line, and even the
individual cell, with values from 4 x 104 to 4 x 106 per cell
being found. The apparent binding constant for SF was found
to be 1010 to 1011 M-1.
An early study that examined the nature of the receptors for
alphaviruses reached the conclusion that the receptors for SIN
were proteinaceous, at least in part, because treatment of cells
with proteases, but not with phospholipases or neuraminidases,
greatly reduced or abolished virus binding (494). Two strains of
SIN were used, a neurovirulent strain, AR86, isolated from
South Africa and a nonvirulent strain, AR339, isolated from
Egypt. These two strains did not compete with one another for
binding, and it was concluded that these viruses used com-
pletely different receptors. Two different neuronal cell lines
were found to possess many more receptors for the neuroviru-
lent strain than for the avirulent strain and in fact possessed
more receptors for the neurovirulent strain than did nonneu-
ronal cells for either strain. Thus, the nature of the receptors
used appeared to determine at least in part the virulence of the
virus. Finally, SIN AR86 and EEE partially competed with one
another for binding, suggesting that these two neurovirulent
alphaviruses shared some of their receptors; the fact that the
competition was only partial suggested that each virus can use
more than one receptor.
Maassen and Terhorst (319) attempted to identify receptors
for SIN on lymphoblastoid cell lines, using two of the same
lines utilized by Helenius et al. (200) in their studies of SF (see
below). They showed that the SIN glycoproteins could be
cross-linked to a cell surface protein of 90 kDa and concluded
that this protein must be a SIN receptor or be found near the
SIN-binding site.
Using a different approach, Sanders et al. (441) found that
chicken fetal antigen determinant 9 served as a receptor for the
binding of Sindbis virus to avian erythrocytes and is the
receptor required for hemagglutination by the virus. Whether
this receptor for hemagglutination is related to receptors used
by the virus for entry into susceptible cells is not known.
Although these studies and other studies described below
have suggested that SIN uses protein receptors, studies by
Symington and Schlesinger (537, 538) suggested that charge is
also important for binding to cells. They isolated a SIN variant
that was more negatively charged and was able to bind to and
infect mouse plasmacytoma cells 10-fold better than the wild-
type virus. The increased binding appeared to be due to the
increased charge of the virus because pretreatment of the
plasmacytoma cells with heparin enabled the wild-type virus to
bind almost as well as the variant. One interpretation of these
results is that a charge repulsion must be overcome for the
virus to bind tightly to a protein receptor.
Helenius et al. (200) suggested that antigens of the MHC,
HLA-A and HLA-B in humans or H-2K and H-2D in mice,
served as receptors for SF on the basis of their findings that
these MHC antigens bound to SF glycoproteins. This binding
was demonstrated in several different ways, including the
isolation of specific complexes between the spike glycoproteins
and MHC antigens. It is important to note, however, that
MHC antigens are expressed in large amounts by the cells used
by Helenius et al. (200) but that these cells do not serve as
efficient host cells. Subsequently it was found that murine F9
and PCC4 teratoma cells, which do not express H-2 MHC
antigens, as well as H-2-negative murine lymphoblastoid cells,
are nonetheless sensitive to infection by SF, demonstrating
that H-2 antigen expression is not required for SF infection
(376). Daudi cells, which lack HLA antigens, were found to be
resistant to SF not because of failure of the virus to bind to and
enter cells but because of a subsequent block to replication.
Thus, it is unclear whether the binding of SF to MHC is
functional for virus entry. The many indications that alphavi-
ruses can use more than one receptor make it possible that
MHC antigens serve as only one of multiple receptors used by
SF.
Anti-idiotypic antibodies as antireceptor antibodies. Anti-
idiotypic antibodies can sometimes be used to identify recep-
tors that bind to ligands, as reviewed by Gaulton and Greene
(147). Two alphavirus studies used neutralizing monoclonal
antibodies (MAbs) reactive with E2 of SIN to generate poly-
clonal anti-idiotypic antibodies in rabbits, and the anti-idio-
typic antibodies obtained functioned as antireceptor antibodies
(555, 582). Wang et al. (582) found that three such anti-
idiotypic antibodies bound to chicken cells, as shown by
fluorescence-activated cell-sorting assays, and blocked virus
binding by about 50%. One of the antibodies, anti-Id 49 made
to MAb 49, bound with much higher affinity than the other
two. The finding that an anti-idiotypic antibody made to a
purified MAb selected to be reactive with SIN E2 would bind
to chicken cells and block virus binding is very suggestive
evidence that it is functioning as an antireceptor antibody.
Anti-Id 49 also immunoprecipitated a protein of about 63 kDa
from chicken plasma membrane preparations, which is a
putative receptor molecule. The results with the anti-idiotypic
antibodies suggested that there are at least two receptors in
chicken cells and that the anti-idiotypic antibody recognizes
only one of these because (i) the antibody blocked virus
binding by only 50% and (ii) a variant of SIN called v49,
selected to be resistant to neutralization by MAb 49, was not
blocked in its binding by anti-Id 49. This variant has a change
in E2 (R-214 -> P) that renders it unable to bind MAb 49; it
presumably is unable to bind to the receptor recognized by
anti-Id 49 and instead enters cells by the second receptor
recognized by wild-type virus.
It was also found by Wang et al. (582) that anti-Id 49 did not
bind to BHK cells and had no effect on virus binding to BHK
cells. Evidently, BHK cells do not express a homolog of the
chicken 63-kDa protein on their surface that reacts with the
anti-idiotypic antibody, and the receptors used by the virus to
enter hamster cells appear to be different from those used to
enter chicken cells.
Related results were reported by Ubol and Griffin (555).
These authors found that an anti-Id 209 bound to murine N18
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neuroblastoma cells and blocked virus binding by 50%. This
antibody immunoprecipitated proteins of 110 and 74 kDa from
N18 cells; these proteins may therefore function as receptors
for SIN. These proteins were present on mouse brain cells at
birth, as shown by the binding of anti-Id 209 to these cells, but
by 4 days after birth half of the cells had ceased expression of
proteins reactive with the anti-idiotypic antibody. It was sug-
gested that the age-dependent expression of this protein could
be responsible in part for the age-dependent susceptibility of
mice to fatal encephalitis caused by SIN (but see also the
discussion of apoptosis below).
Laminin receptor as a mammalian receptor. Wang et al.,
observing that their antireceptor antibody was effective for
chicken cells but not for BHK cells, set out to obtain an
antireceptor MAb that would block SIN binding to BHK cells
(580). Mice were immunized with whole BHK cells, hybridoma
supernatants were screened for virus-blocking activity, and a
MAb that blocked SIN binding to BHK cells by up to 80% was
isolated. This MAb, called 1C3, bound to BHK cells, as
expected, and immunoprecipitated a protein of apparent mo-
lecular size 67 kDa from membrane fractions of BHK cells.
Screening of Agtll libraries with MAb 1C3 revealed that it
bound to the C-terminal domain of a cell surface protein
referred to the high-affinity laminin receptor. The nature of
this protein is controversial. It was originally isolated as a
67-kDa protein that was able to bind to laminin with high
affinity. Screening of cDNA libraries by Wang et al. (580) and
by others (174, 613) identified an ORF encoding a protein of
only 295 amino acids. There is no evidence for an mRNA
encoding a longer ORF (413, 434, 613), and considerable
evidence has been presented that the 67-kDa protein and the
295-amino-acid ORF possess amino acid sequence in common
(64, 65, 581, 613, 614). It has been proposed that the 295-
residue protein is a precursor to the 67-kDa form (reviewed in
reference 65). Glycosylation is not involved in the modification
(64, 174), and Castronovo et al. (64, 65) have proposed that the
295-residue protein is covalently linked to another protein to
produce the 67-kDa form. Grosso et al. (174), in contrast, have
proposed that the 295-amino-acid protein is unrelated to the
laminin receptor and that the mRNA for the 67-kDa protein is
yet to be identified.
Castronovo et al. (65) found that antibodies made to syn-
thetic peptides derived from the C-terminal part of the 295-
residue ORF (specifically, residues C-terminal to position 107)
would bind to intact cells, whereas antibodies to synthetic
peptides from the region from positions 1 to 103 reacted only
with permeabilized cells. This, together with a computer
analysis (413), supported a model in which the N terminus of
the 295-residue protein is intracellular, residues 86 to 101 form
a membrane-spanning domain, and the N terminus is extracel-
lular. This orientation is illustrated schematically in Fig. 24.
Castronovo et al. (65) also found that a synthetic peptide
comprising residues 161 to 180 bound to laminin and hypoth-
esized that this sequence constituted the laminin-binding do-
main of the receptor. MAb 1C3 used by Wang et al. (580)
reacted with Xgtll clones containing residues 248 to 295,
suggesting that SIN binds to this C-terminal region of the
protein.
Transformation of hamster cells with vectors that overex-
pressed the 295-amino-acid ORF gave rise to cells that bound
up to 4.5 times as much radiolabeled virus, and the efficiency
with which the virus formed plaques on such cells was in-
creased by up to sevenfold (580). Binding was saturable for
both the parental cells and the cells overexpressing the 295-
residue ORF (Fig. 25). Expression of antisense RNA led to
decreased sensitivity to the virus. Cells transformed with the
MAb 1C3
* binding -*
plasmalemma
FIG. 24. Schematic model for the orientation in the cell surface of
the 295-residue protein that is believed to form part of the high-affinity
laminin receptor. The amino terminus of the molecule is thought to be
in the cytoplasm, and amino acids (aa) 86 to 110 are believed to
constitute a transmembrane domain (65). The laminin-binding domain
(65) and the MAb 1C3-binding domain (580) are indicated.
plus-sense or antisense constructs were shown to bind more or
less MAb 1C3, respectively. The amount of laminin receptor
on the cell surface was assayed by the binding of 1C3, by the
binding of radioactive virus, and by the sensitivity of the cell to
virus infection as measured by a plaque assay. This quantita-
tion showed that binding of the virus varied linearly with the
concentration of laminin receptor on the cell surface whereas
the sensitivity to the virus measured by a plaque assay varied
300
/ ~~~CHO-LR
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FIG. 25. Overexpression of the 295-residue laminin receptor ORF
results in increased binding of SIN to the surface of hamster cells.
CHO cells were transformed with the 295-residue laminin receptor
ORF in a high-efficiency mammalian expression vector (CHO-LR) or
transformed with the vector only (CHO). Monolayers of each resulting
cell line were tested for their ability to bind purified 35S-labeled SIN in
a saturation binding assay. After 1.5 h of incubation at 8°C, the
monolayers were washed to remove unbound virus, dissolved in 0.5%
sodium dodecyl sulfate, and assayed for radioactivity. Reprinted from
reference 580 with permission of the publisher.
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with the 1.4 power of the receptor concentration, suggesting
that interaction with more than one receptor aids virus pene-
tration. Thus, the high-affinity laminar receptor is functionally
a receptor for SIN in BHK cells.
MAb 1C3 was found to block SIN binding to a number of
other cultured mammalian cells tested, including murine,
monkey, and human cells. It thus appears that the high-affinity
laminar receptor is a major receptor for SIN virus in all
mammalian cells. This receptor, or at least the 295-residue
ORF studied to date, is highly conserved among mammals.
There are only two amino acid differences between the ham-
ster sequence and a human sequence or between the hamster
sequence and a bovine sequence, and the hamster sequence is
identical to a sequence obtained from mice (580). Because the
laminin receptor is highly conserved in amino acid sequence
among mammals and is widely expressed, it appears that the
ability of the virus to infect many different mammals and to
infect many different tissues within those mammals results at
least in part from utilization by the virus of a highly conserved
protein receptor.
Although the antibody blocked virus binding to many differ-
ent mammalian cells, it had only slight effects (<10%) on the
binding of SIN to chicken cells. These results complement
those found by Wang et al. (582) with anti-Id 49, and the major
receptor used by the virus to enter chicken cells must be
different from that used to enter mammalian cells. The 63-kDa
chicken protein precipitated by anti-Id 49 is different from the
chicken laminin receptor, because MAb 1C3 was found to
precipitate a protein of 71 kDa, presumably the chicken
laminin receptor, from chicken membranes. The sequence of
the chicken laminin receptor (i.e., the 296-residue ORF cor-
responding to the mammalian 295-residue ORF) is now known
(434), and it is -98% identical to the mammalian gene. Thus,
there is reason to believe that the chicken laminin receptor
could be used by the virus as a receptor, but apparently there
is a higher-affinity virus receptor, possibly present in greater
amounts, in chicken cells that is preferred by the virus. These
results suggest that the very broad host range of the virus is
achieved in part by utilizing more than one protein receptor.
The extreme conservation of the laminin receptor between
birds and mammals, which diverged >200 million years ago,
suggests that the laminin receptor is conserved in all multicel-
lular animals. Wang et al. (580) found that MAb 1C3 partially
blocked binding of SIN to mosquito cells as well as to
mammalian cells, suggesting that the sequence of the laminin
receptor is conserved in mosquito cells and that the receptor
serves as a virus receptor in these cells.
Thus, the results from several lines of study suggest that the
very wide host range of the alphaviruses results in part from
the ability of the virus to use a receptor that is highly conserved
and in part from the ability of the virus to use more than one
receptor on the surface of the cell. The relationships between
the different proteins studied in the different laboratories are
unknown. In most cases only the protein molecular weights
estimated from acrylamide gel electrophoresis were deter-
mined, and side-by-side comparisons of these proteins are
necessary to determine if they are all different.
Mosquito receptor for VEE. Ludwig and Smith (314) have
recently developed a direct binding assay to search for cellular
receptors in mosquito cells. Proteins from plasma membrane
preparations were separated on acrylamide gels and trans-
ferred to nitrocellulose, and the blot was probed with radiola-
beled VEE. The virus bound to a protein of 32 kDa, which was
expressed on the surface of mosquito cells. This protein bound
laminin and cross-reacted immunologically with the high-
affinity laminin receptor, consistent with the results of Wang et
al. (580) that a protein in mosquito cells reactive with MAb
1C3 acts as a receptor for some alphaviruses. The exact
correspondence between the 32-kDa protein expressed in
mosquito cells, the product expressed from the 295-residue
ORF, and the 67-kDa high-affinity laminin receptor remains to
be determined. Ludwig and Smith (314) found that VEE and
SIN competed for binding, that higher-molecular-weight pro-
teins from mosquito cells cross-reacted immunologically with
the 32-kDa protein and bound VEE and laminin, and that
VEE bound to 32- and 67-kDa proteins from BHK cells,
consistent with the hypothesis that the 32- and 67-kDa proteins
share sequence identity.
Virus receptor-binding domain. Evidence is developing that
the set of cellular receptors that an alphavirus can use can be
altered by relatively minor changes in El and E2. In one study
with SIN, two strains of SIN that were identical except for a
single amino acid difference in E2 (G-172 -* R) were exam-
ined for their ability to bind to cells of neuronal origin in
culture; it was found that the more neurovirulent of the two
strains, possessing G-172, bound more readily to neuronal cells
than did the less virulent strain, although the two strains bound
identically to BHK cells (552). In another study, variants of
SIN that differed in their neurovirulence for mice were se-
quenced and used to construct recombinant viruses; it was
shown that amino acid substitutions in El and E2 affected the
neurovirulence of the virus (318). For at least some of these
mutants it was shown that the virus replicated less well in the
brain if it was less virulent. Other studies, by Johnston and
colleagues (described in a later section), have also demon-
strated that changes in El and E2 can alter the neurovirulence
of SIN for mice. Although these studies do not directly
demonstrate a difference in binding to cells, it is suspected that
at least some of these changes affect the ability of the virus to
bind to receptors expressed on neurons.
Changes in E2 of RR have also been shown to affect the
ability of the virus to bind to and infect different cells. RR, in
contrast to SIN, is maintained in nature in small mammals,
primarily marsupials, and the virus infects chicken cells in
culture very poorly. In one study, variants of the Nelson Bay
strain of RR were selected by passaging in chicken cells (249).
The passaged virus had single changes in E2: in two of three
independent variants sequenced the change was N-218 -> K,
and in the third variant the change was E-4 -> K. Weir and
Kuhn (598) examined the effect of changing E2 N-218 to T, K,
or R by site-specific mutagenesis of a full-length cDNA clone
of the T48 strain of RR, from which virus can be recovered
(273). The parental T48 was found to infect only -2% of
chicken cells in culture, by using an immunofluorescence assay
with anti-RR antibodies to determine which cells were in-
fected. Virus with T-218 or K-218 infected -6% of chicken
cells, but virus with R-218 infected -40% of chicken cells.
Thus, the single change N-218 -> R in E2 led to a 20-fold
increase in the ability of RR T48 to infect chicken cells. Serial
passage of the R-218 virus in chicken cells led to selection of a
strain of RR that retained R-218 but also had two other
changes, C-153 -> R in E2 and D-323 -> Y in El. This strain
infects almost all chicken cells in culture and will form plaques
on chicken monolayers.
The importance of the domain of RR E2 near residue 218
for the host range of the virus is also suggested by studies of
RR isolated during the epidemic of polyarthritis in the Pacific
region described above. Although the virus is maintained in
small mammals in Australia, it is believed to have been
maintained by direct human-mosquito-human transmission
during this epidemic. A single amino acid change occurred in
E2 during the epidemic, T-219 -- A, and it was suggested that
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FIG. 26. Domain of glycoprotein E2 containing important neutralization epitopes. The amino acid sequence of residues 170 to 220 of E2 of
SIN AR339 is shown. Residues that have been found to vary in different SIN strains are boxed. This domain is very hydrophilic and contains an
N-linked carbohydrate chain indicated by the circled CHO. Above the sequence are indicated the locations of changes in MAb-resistant variants
(519) and of changes in other SIN strains (italics) (304, 485). Below the line, the arrow indicates the domain that is reactive with MAb 23 when
expressed in a Xgtll library (583).
this change may have been selected because it adapted the
virus to humans (53).
It seems clear that the alphaviruses are a fairly plastic system
in terms of host range and potential virulence. Limited
changes, primarily in E2 but also in El, allow the virus to
recognize new sets of receptors, which can lead to an altered
host range or altered potential to cause disease. The results
with RR in chicken cells are particularly dramatic because
three changes in the glycoproteins result in a virus that can
infect all chicken cells in culture, whereas the parental virus
infects only 2% of these cells. Although El and E2 form a
heterodimer that functions as a unit, the E2 domain from
about residue 170 to 220 (SIN numbering) appears to be
particularly important in binding to cells. Other studies also
indicate the importance of this region for cell binding. The
anti-idiotypic antibodies that function as antireceptor antibod-
ies in chicken cells were made to neutralizing anti-E2 antibod-
ies that bind to this domain, as shown by two different
methods. First, variants resistant to these antibodies possessed
changes at E2 residue 214 (MAb 49), at residue 216 (MAb 23),
or at residues 181, 190, and 205 (MAb 50) (520). Second, MAb
23 was shown to bind to Agtll clones expressing fusion
proteins containing the E2 region between residues 173 and
220 (583). Thus, there is the presumption that this domain
directly interacts with the cellular receptor (at least in chicken
cells). This domain is illustrated schematically in Fig. 26. It is
hydrophilic, and in SIN a polysaccharide chain is attached at
N-196; thus, this domain would be predicted to be exposed on
the surface of the particle.
Although the studies of mutants and anti-idiotypic antibod-
ies show that E2 is important for binding to cells, El is also
involved in binding and penetration. Omar and Koblet (381)
prepared SF lacking E2 by treating the virus with trypsin in the
presence of detergent. The resulting virus was infectious,
showing that El alone can induce virus binding and penetra-
tion. The detergent treatment led to the loss of 90% of the viral
infectivity, however, indicating that the structure of the virion
had changed, and the relationship between binding and entry
of detergent-treated virus and of untreated virus remains to be
determined.
Virus Entry
Early events in virus penetration. After binding to a recep-
tor on the cell surface, the alphavirus envelope must at some
point fuse with a cellular membrane for the nucleocapsid to be
deposited in the cytoplasm. The fusion activity is postulated to
reside in a highly conserved hydrophobic stretch of 17 amino
acids in El that starts at residue 80 (138, 419). Consistent with
this hypothesis, it has been shown that cells that express
alphavirus El-E2 heterodimers but not E2 alone at their
surface can be induced to fuse by exposure to low pH, showing
that El is required for fusion (264, 265). This El putative
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FIG. 27. Putative fusion domain in glycoprotein El of alphaviruses.
(A) The aligned sequences of El between residues 78 and 98 of El
(SIN numbering). Residues identical to the SIN sequence in the top
line are indicated by dashes. The hydrophobic domain between
residues 80 and 96 is postulated to form the fusion domain. Data are
taken from references cited in Table 1. (B) Comparison of the
alphavirus fusion sequence with those of other enveloped viruses. In
influenza virus the fusion sequence is found at the amino terminus of
the HA2 protein (41), and in the paramyxoviruses it is at the N
terminus of the F2 protein (363). PIV-3 is human parainfluenza virus
type 3. Although the alphavirus sequence ends with a conserved acidic
residue (boxed D) like the paramyxovirus sequences shown (boxed E)
and the influenza virus sequence (boxed E), other paramyxovirus
fusion sequences end with K or Q.
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fusion domain is illustrated and compared with the fusion
domains of a paramyxovirus and an influenza virus in Fig. 27.
Disassembly of the alphavirus virion appears to begin at the
surface of the cell, presumably induced by binding to a
receptor and interactions with cell surface components. Flynn
et al. (121) found that previously hidden epitopes in both E2
and El, referred to as transitional epitopes, became exposed
upon binding of SIN to a cell. These conformational alter-
ations could be mimicked, albeit not precisely, by treatment of
the virus with heat, reducing agents, or low pH (349). Heat-
treated virus can be neutralized by MAbs reactive with transi-
tional epitopes, and selection for resistance to neutralization
by these MAbs gave viruses with changes at E2 position 200 or
202 (anti-E2 MAbs) or at El position 300 (anti-El MAbs). It
is intriguing that the E2 domain centered near position 200 has
been proposed to be important for receptor binding. Transi-
tional epitopes have also been reported for SF, in which a MAb
was isolated that reacted only with acid-treated SF El and
inhibited virus penetration and fusion (576).
It is known that disulfide bonds play an important role in the
stability of the virus (8, 240, 365, 382). Moreover, studies of
certain toxins that require reduction of disulfide bonds for
entry and toxicity have shown that reduction of disulfide bonds
can occur at the cell surface and in endosomes, presumably
catalyzed by cellular proteins (118, 438, 620). Abell and Brown
(1) have presented evidence that destabilization of the virus
structure by reduction or rearrangement of disulfide bonds is
important for infection by SIN. These authors found that
infection of cells by SIN was inhibited by the presence of the
thiol-alkylating agent 5,5'-dithiobis(2-nitrobenzoic acid) dur-
ing uptake. Because other studies had indicated that this
reagent is active only at the cell surface, they concluded that
these changes in disulfide bonds in the SIN glycoproteins must
occur at the cell surface. These disulfide changes are assumed
to be associated with the conformational changes that result in
exposure of transitional epitopes, which could be the result of
reduction of disulfide bonds or could result from interaction
with a receptor and help to induce the reduction or rearrange-
ment of disulfide bonds within the viral glycoproteins (50).
Entry into endosomes. Fan and Sefton (114) first presented
evidence that alphaviruses might enter by an endocytic path-
way when they showed that the viral glycoproteins do not
remain on the cell surface following infection. In contrast, the
glycoproteins of Sendai virus, which is known to fuse at the cell
surface, did remain on the cell surface after infection. Helenius
and colleagues have presented extensive data indicating that
the normal pathway of entry for alphaviruses is endocytosis in
clathrin-coated vesicles followed by transfer to endosomes,
where the low pH leads to a conformational reorganization of
the El-E2 heterodimer such that the fusion domain in El is
exposed and the virus envelope fuses with the endosomal
membrane. This topic has been reviewed several times in the
last few years (210, 250, 251, 326, 329, 504, 618).
Helenius and colleagues (101, 195, 197, 199, 327, 328, 330)
used radiolabeled virus or electron microscopy to show that the
bulk of SF bound to cells was endocytosed quickly and that
virus could be seen to fuse to endosomal membranes but not to
the cell surface. Anti-clathrin antibodies introduced into the
cell inhibited endocytosis of SF. Lysosomotropic weak bases,
which raise the pH of endosomes and lysosomes, blocked
infection by SF if added before virus addition. However,
addition of the bases even 5 min after virus led to detectable
infection as assayed by the release of infectious virus 4.5 h after
infection (197) or by the incorporation of [3H]uridine into
virus nucleic acid from 2.5 to 5 h after infection (199), and
addition 1 h after the virus had little effect on the establishment
of virus infection. The inhibition by the bases could be
bypassed by briefly exposing cells with bound virus to low pH,
which leads to fusion of the virus with the plasma membrane;
establishment of infection after acid treatment was demon-
strated by the increased incorporation of [3H]uridine into viral
RNA at 1.5 to 4.5 h (616), by the finding that at 4.5 h after
treatment 63% of acid-treated cells could be stained with
fluorescent antibodies to the viral structural proteins versus
<3% for the cells treated at pH 7 (197), and by a 10-fold
increase in release of infectious virus (197). Thus, these agents
block a very early stage of infection. These studies concluded
that low pH in the endosome is essential for infection to occur;
Helenius et al. (198) also found that the Na+ concentration in
the medium was important for virus entry and proposed that
fusion depends not only on acidic pH but also on the mainte-
nance of a voltage potential.
The essential details of these experiments have been con-
firmed in other laboratories. Garoff and colleagues (440, 576)
used a fluorescent-antibody assay to show that cells treated
with lysosomotropic weak bases failed to synthesize viral
structural proteins following attempts to infect them with SF
and that the inhibition of infection could be bypassed by
exposing cells with bound virus to low pH. Wengler and
Wengler (608) found that treatment with chloroquine, a lyso-
somotropic weak base, prevented the transfer of SIN capsid
protein to the large ribosomal subunit, one of the earliest steps
to occur after nucleocapsid penetration into the cytoplasm.
Stegmann et al. (505) used a fluorescence-dequenching
assay and a pyrene excimer assay to study the effects of
lysosomotropic weak bases on fusion of SF with BHK cells. In
these assays, fusion of the virus envelope with a cell membrane
results in a dilution of a fluorescent probe incorporated into
the viral membrane and this leads in turn to a detectable
change in the fluorescence of the probe. Results with a
fluorescence-dequenching assay, in which octadecylrhodamine
(R18), which has been widely used to study fusion events, was
incorporated into SF virions by addition as an ethanolic
solution to a virus-containing solution, were ambiguous. The
authors concluded that transfer of the added R18 probe did
not depend on fusion under some circumstances and that the
probe may have been associated with the exterior of the
particle rather than incorporated into the lipid bilayer. How-
ever, the pyrene excimer assay gave the unambiguous result
that fusion did not occur in the presence of 20 mM NH4Cl,
supporting the Helenius model of entry. In this assay, pyrene-
phospholipids are metabolically incorporated into the virus
and do not appear to undergo spontaneous exchange.
Support for the importance of low pH in the endosome for
fusion of the viral membrane with that of the endosome has
also come from the study of mutants that require lower pH to
fuse with liposomal membranes (255, 256). Infection by such
mutants was inhibited by lower concentrations of lysosomo-
tropic weak bases, consistent with the hypothesis that these
mutants require a lower endosomal pH for entry than does
wild-type SF. These mutants were also delayed in their pene-
tration of cells, suggesting that they required a longer period to
reach endosomes of sufficiently low pH for fusion. Mutations
that appear to be similar to these have been described for SIN
and mapped to two locations in El (position 72, close to the
putative fusion peptide in El at amino acids 80 to 96, and
position 313); these two mutations, either separately or to-
gether, led to a requirement for a lower pH to fuse cells
infected by the virus and expressing viral glycoproteins at their
surface (so-called fusion from within) (36) and altered the
neurovirulence of the virus for mice (318).
Mutants with site-specific mutations in SF El have been
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constructed that led in some cases to a requirement for
exposure to lowered pH for fusion of cells expressing the
altered proteins at their surface (296). These site-specific SF
mutations were constructed in or near the putative fusion
domain of El, and changes at residues 75, 83, and 91 led to a
requirement for lowered pH for fusion; the effects of the
mutations on the infectivity or entry of the virus have not been
tested. Thus, changes in El near or within the fusion domain
often lead to changes in pH required for fusion, but changes
far from this domain (at least in the linear amino acid
sequence) can also change the pH required. It is of interest
that all of the changes described to date represent changes that
appear to stabilize El at lowered pH, resulting in a require-
ment for lower pH for fusion.
Edwards and Brown (108) found that for cultured mosquito
cells, the pH of fusion from without was determined by the
medium in which the cells were grown. The specific infectivity
of SIN in mosquito cells that required a lower pH for fusion
was only one-third that in mosquito cells that were fused at
higher pH, consistent with the hypothesis that in the cells
requiring lower pH for fusion, virus would not reach endo-
somes of sufficiently low pH for fusion as efficiently.
Endosomes can be physically separated into two subpopu-
lations that differ in their protein composition and that are
kinetically related to one another such that an incoming ligand
first encounters an early endosome and is then transferred to a
late endosome (472). The early endosomes recycle receptors,
whereas the late endosomes deliver the ligand to lysosomes.
Schmid et al. (471) used wild-type SF and the mutant SF
requiring a pH of <5.3 for fusion and for the accompanying
changes in glycoprotein conformation described below in order
to measure the kinetics of delivery of SF to these different
endosome populations and to ascertain the pH encountered by
the virus in these endosomes. These experiments were carried
out with both wild-type CHO cells and ts mutant CHO cells
defective in acidification of endosomes at a restrictive temper-
ature. SF was found to first reside briefly in vesicles of neutral
pH, but with a half time of 5 min it encountered a pH of <6.2
in early endosomes. A fraction of virus reached a pH of <5.3
in early endosomes, but most virus did not reach this pH until
transfer to late endosomes, which occurred with a half time of
8 to 10 min from the time entry was initiated by warming the
cells. The authors concluded that acidification of both endo-
somal populations was heterogeneous but that SF always
passed through a less acidic early endosome before encoun-
tering a more acidic late endosome. CHO cells temperature
sensitive in acidification of endosomes were found to be
defective in acidification of both endosomal populations at the
restrictive temperature.
Fusion of alphaviruses with artificial membranes (457, 615)
or with the plasma membrane of cells (440, 576, 616), as well
as fusion of cells expressing alphavirus glycoproteins on their
surface to form heterokaryons, whether vertebrate cells (36,
242, 264, 323, 617) or mosquito cells (108, 262), can be
accomplished by treatment with low pH. As described above,
the pH required for these fusion reactions is correlated with
the sensitivity of the virus to lysosomotropic agents when
studied, and it is assumed that these assays measure the same
phenomena that are involved in virus fusion with cellular
membranes during entry. Although it seems certain that these
phenomena are related, there are obvious differences between
heterokaryon formation and initiation of a normal infection.
For one, we know that virus bound to receptors at the cell
surface undergoes conformational changes. Furthermore, cell-
cell fusion induced by exposure of infected cells to low pH is a
multiphasic phenomenon. Very soon after exposure to low pH,
infected mosquito cells demonstrate the presence of ion chan-
nels that have a pore size of about 1 nm, which are believed to
be formed by the viral glycoproteins (277). During cell-cell
fusion from without, similar-size pores form between two cells
within about 1 min and then slowly expand in size (275, 276).
Kempf et al. (243) found that the initial fusion of cells occurred
very quickly and did not require energy, whereas the expansion
of the initial pores to form heterokaryons required energy and
considerable time. In the case of infected BHK cells, ATP was
rapidly depleted upon exposure to low pH, which prevented
heterokaryon formation until the cells were returned to neu-
trality and the ATP pools were reestablished (244). Abell and
Brown (1) found that return to neutral pH was not required for
heterokaryon formation if mercaptoethanol was present in the
medium, suggesting that the energy requirement is related to
shuffling of disulfide bonds. In addition, it has been shown that
SF-induced cell-cell fusion will occur at neutral extracellular
pH if the cytoplasmic pH is lowered (245).
The data supporting the model that alphavirus entry occurs
by endocytosis followed by fusion with an endosomal mem-
brane triggered by low pH are extensive, internally consistent,
and convincing. Nevertheless, Brown and colleagues have
proposed that alphaviruses infect cells by direct fusion to the
cell surface, or at least that the low pH of the endosome is
irrelevant to virus infection, and that the major effect of
lysosomotropic weak bases is upon viral replication rather than
upon endosomal pH (references 63, 78, and 109; reviewed in
reference 50). They argue that their finding that infection of
BHK cells in the presence of chloroquine or ammonium
chloride allowed the establishment of superinfection exclusion
(described in more detail below) when one virus was first
added and then followed by the second must mean that
infection had been established in the presence of the bases,
because the establishment of exclusion requires the establish-
ment of the infection process. They have reported that they
have preliminary data suggesting that SIN nonstructural pro-
teins are translated in the presence of lysosomotropic weak
bases (48). They also found that a mutant CHO cell that is
resistant to diphtheria toxin because of defects in the
acidification of endosomes was completely sensitive to SIN
and suggested that this indicated that low endosomal pH is
not required for virus entry (109). However, Robbins et al.
(425) found that two other such cell lines were in fact
partially resistant to SIN and that the resistance could be
overcome by exposing the cells to acidic pH, consistent with
the model for endosome-mediated entry and pH-dependent
fusion.
Conformational changes in El and E2. Several studies have
shown that El and E2 undergo irreversible conformational
changes when exposed to the fusion pH, and these changes are
proposed to activate the fusion activity. In SF the change in El
is accompanied by acquisition of resistance to digestion by
trypsin (254) and changes in the reactivity of El with certain
MAbs (252, 574, 576). These properties have been used to
monitor the exposure of El to low pH during transit through
the endosomal pathway (198, 256, 440, 471). The acid-induced
change in SF El also increases the hydrophobicity of the virus
(381) and exposes disulfide bonds that were otherwise not
accessible (382). In the case of SIN, exposure of the virus to
low pH was shown to cause an irreversible alteration in the
density and sedimentation characteristics accompanied by con-
formational changes in the envelope proteins and inactivation
of the virus (110).
Wahlberg et al. (575, 576) found that during infection by SF,
the E2-E1 heterodimer dissociates on exposure to the acidic
pH of the endosomes. E2 is then present as a monomer. El
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forms a trypsin-resistant homotrimer that may be derived from
the trimeric spike, or that may form by interactions similar to
the El-El interactions that have been proposed to hold the
spike together (7).
The kinetics of changes in El and E2 have been studied
during acid-induced fusion of the virus with either liposomes
(47) or with BHK plasma membranes (236). In the former
system, binding to liposomes occurs only after exposure to low
pH, whereas in the latter system, the virus is prebound to the
membranes through receptor-mediated binding. The kinetics
were found to be sensitive to pH and to temperature, and by
working at a pH above the optimal fusion pH and at temper-
atures below 37°C, the different steps in the fusion process
could be separated. Dissociation of the El-E2 heterodimer
occurred early, as did the acquisition of trypsin resistance and
exposure of conformation-specific epitopes in El and the
formation of El homotrimers. Justman et al. (236) reported
that in their system the dissociation of El-E2 heterodimers
occurred first, followed by the conformational changes in El
and then by trimerization of El. Bron et al. (47) found that
binding to liposomes occurred only after trimerization of El
had occurred. Fusion occurs only after homotrimerization of
El (and binding to liposomes in the liposome model system).
Because there was a distinct lag between formation of homotri-
mers and fusion, it was suggested that multimers of El
homotrimers are involved in fusion.
The changes in El are proposed to expose the fusion domain
and allow fusion to occur by an unknown mechanism. In the
case of influenza virus, the HA2 subunit, which contains the
fusion domain at its N terminus, has been shown to insert into
the target membrane prior to fusion (503). The presumption is
that the fusion domain of El, which is very hydrophobic,
inserts into the target membrane and induces fusion of the two
bilayers in some way.
Cholesterol requirement for entry by SF. In the case of SF,
fusion to liposomes triggered by low pH has been found to
require cholesterol (47, 615); other sterols that contain a
3-,B-hydroxyl group can substitute for cholesterol, but sterols
lacking this group cannot do so (253). The pH-dependent
conformational changes observed in El also require choles-
terol (252). Furthermore, cholesterol-depleted cells are less
susceptible to infection by the virus, and the resistance to
infection is reversed by addition of cholesterol (404). In
addition to the requirement for cholesterol during entry,
cholesterol is required for the assembly of SF; in cholesterol-
depleted mosquito cells, production and transport of viral
glycoproteins proceeded normally but production of progeny
virions was severely depressed (324). It appears that the
stability or conformation of SF glycoproteins is affected by
binding to cholesterol. This dependence is curious because in
nature alphaviruses replicate in mosquitoes that are unable to
synthesize cholesterol, although a blood meal will contain it.
Cholesterol-independent mutants of SF have now been iso-
lated (324), which suggests that the requirement for it may
come and go in nature depending on the host in which the virus
replicates or that it may be a laboratory phenomenon that
arose during passage of the virus in cells containing large
amounts of cholesterol. Other alphaviruses have not been
tested directly for a similar requirement, but it is known that
mosquitoes that have never been exposed to cholesterol can be
infected with SIN per os or by intrathoracic inoculation, and a
complete infection cycle occurs with transfer of the virus to the
brain and to the salivary glands (50).
Early Events in Establishment of Infection
Nucleocapsid disassembly. The mechanism by which the
nucleocapsid disassembles when it reaches the cell cytoplasm
has been a topic of interest (reviewed in reference 490). How
is it that a nucleocapsid is unstable when it first enters a
previously uninfected cell but newly assembled nucleocapsids
are stable later in the infection process?
Newly synthesized SF capsid protein was found many years
ago to bind to the large ribosomal subunit when synthesized in
vitro (151, 609) or in vivo (557, 558). Wengler and Wengler
(608) reported that capsid protein from infecting SIN virus was
also associated with ribosomes and suggested that this binding
to ribosomes resulted in nucleocapsid disassembly. In this
model the ribosome competes with the viral RNA for capsid
protein, and upon infection of the cell the large excess of
unoccupied ribosome-binding sites leads to disassembly of the
nucleocapsid. Wengler et al. further hypothesized that during
virus replication, saturation of ribosomes with newly synthe-
sized capsid protein leads to a switch from disassembly to
assembly of nucleocapsids (605, 608, 609). Wengler et al. (612)
and Singh and Helenius (491) have confirmed several aspects
of this model. Both groups found that disassembly took place
in cell-free lysates in a reaction requiring ribosomes. The
capsid protein was transferred to the large ribosomal subunit
in this in vitro reaction, and each ribosome could bind three to
six capsid protein molecules. Wengler et al. (612) showed that
pretreatment with capsid protein to saturate the binding sites
resulted in a failure of the treated ribosomes to uncoat
nucleocapsids, and they mapped the ribosome-binding site to
residues 94 to 105 of the SIN capsid protein by examination of
the binding of fragments of the capsid protein to ribosomes.
However, Singh and Helenius (491) found that ribosomes in
infected cells were not saturated with capsid protein and were
still capable of disassembling capsids in an in vitro reaction,
consistent with a previous report that well into infection only
20% of ribosomes were saturated with capsid protein (558).
Thus, the shift from disassembly of capsids to assembly of
capsids during infection does not appear to be due simply to
saturation of ribosomes with capsid protein, and although
ribosomes may uncoat the nucleocapsid there must be other
factors at work that lead to the shift from instability to stability
of the nucleocapsids.
As described above, one possibility arises from the observa-
tion that newly synthesized alphavirus nucleocapsids present in
the infected cell appear to differ in size from mature capsids
found in virions; this maturation event could trigger the capsid
for disassembly in the cytoplasm. A second possibility is that
the changes in Na+ and K+ concentrations inside the cell that
occur about 3 h after infection (144) stabilize the capsids. A
third possibility was proposed by Lanzrein et al. (277), who
suggested that exposure of the virus to low pH in the endosome
led to the formation of ion channels in the virus that allowed
the entry of protons into the interior of the virus; they
proposed that this facilitated the uncoating process.
Superinfection exclusion. Upon infecting a cell, many vi-
ruses establish a state such that the infected cell is resistant to
superinfection by the same or closely related viruses. This
phenomenon, called superinfection exclusion or homologous
interference, can arise by a number of different mechanisms.
Early studies on SIN by Johnston et al. (234) showed that
superinfection exclusion could be established within 15 min
after infection at moderate multiplicity (10 to 25 PFU/cell),
could be established within 1 h after infection at very low
multiplicity, and required the functioning of the incoming
genome, as shown by the failure of UV-irradiated virus to
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establish exclusion or by the failure of a ts mutant, ts24, to
establish exclusion at the nonpermissive temperature. Estab-
lishment of exclusion was less sensitive to UV irradiation by a
factor of 5 than was the ability to form a plaque, suggesting that
expression of only 20% of the genome is required to establish
exclusion. These authors also found that another RNA-nega-
tive mutant, ts6, could establish superinfection exclusion at the
nonpermissive temperature under conditions where no detect-
able RNA was being synthesized, suggesting that a limited
number of RNA genomes was sufficient to establish exclusion.
It appears that exclusion requires translation and function of
nonstructural proteins but can be established very early, before
extensive replication of the RNA or production of the struc-
tural proteins.
Atkins (12) confirmed that superinfection by Sindbis virus
can be established very early and that it can be established by
RNA-negative mutants. Adams and Brown (3) also confirmed
that RNA-negative mutants were capable of establishing su-
perinfection exclusion and that the phenomenon occurred
within 30 min of infection. These authors used ts mutants to
establish exclusion at the nonpermissive temperature and
superinfected the cells 30 min later with wild-type virus. They
found that although the superinfecting wild-type virus did not
replicate, it was able to complement the ts mutant, leading to
increased production of ts virus. The simplest interpretation of
these results is that under these conditions the superinfecting
genome is uncoated and translated but the RNA does not
replicate.
One model to explain this early superinfection exclusion is
that a host protein or other cell component required for
replication of the virus is present in limiting amounts and that
once the excluding virus begins to replicate, it titrates out this
factor. A second model is that the buildup of nonstructural
proteinase limits production of minus-strand RNA by the
superinfecting virus; as described above, P123 is required for
minus-strand synthesis and accumulation of the viral nonstruc-
tural proteinase eventually prevents synthesis of minus-strand
RNA. The conceptual problem with either of these models is
that the first virus continues to synthesize minus-strand RNA
for 3 h after infection, presumably forming new replication
complexes in the process, and yet the second virus appears to
be prevented from forming replication complexes after 0.5 to 1
h. It may be simply a kinetic phenomenon in which the second
virus does replicate but is unable to overcome the advantage
resulting from the exponential rise in minus-strand RNA
synthesized by the first virus during the time that exclusion is
being established, so that most of the yield is that of the first
virus. The number of minus strands present in cells infected by
SIN or SF has been found to be 4,000 to 7,000 (553a, 584).
Starting from a multiplicity of 1, a doubling time of about 15
min would be required to produce this number of minus
strands in 3 h. Thus, the advantage of a 1-h head start would be
about 16-fold if replication were uniform. Exclusion has been
found to lead to a more than 16-fold advantage in most cases,
but nonuniform replication in which minus-strand RNAs are
formed faster early in infection (which is quite reasonable)
might lead to the observed exclusion without invoking anything
other than the head start for the first virus and shutoff of
minus-strand synthesis as the concentration of viral proteinase
rises. It is also possible that there are factories established by
the first virus into which cellular factors are recruited, making
them unavailable to the superinfecting virus for establishment
of a new factory.
Inhibition of host protein synthesis. Upon infection of
vertebrate cells by alphaviruses, host macromolecular synthesis
is inhibited (reviewed in references 238, 488a, 521, and 604).
The viral inhibition of host protein synthesis has been the most
extensively studied. Inhibition sets in abruptly at about 3 h
after infection, and after this time most protein synthesis is
virus specific. Four mechanisms for inhibition of host protein
synthesis by alphaviruses have been proposed which are not
mutually exclusive and which could be synergistic in effect.
These are (i) competition for translational machinery by viral
mRNA, (ii) an altered intracellular environment that favors
viral mRNA translation, (iii) direct inhibition by the viral
capsid protein, and (iv) interference with initiation factors
caused in some way by the nonstructural proteins.
Early studies led to the suggestion that inhibition of host
protein synthesis resulted from competition with viral mRNAs
for the translational machinery (607). This hypothesis received
support from studies by Atkins (11), who used ts mutants to
show that the inhibition of host protein synthesis was propor-
tional to viral RNA synthesis. Because a number of the
mutants used did not process the structural polyprotein at the
nonpermissive temperature but nonetheless inhibited host
protein synthesis but not host DNA synthesis, the conclusion
was reached that viral structural proteins were not required for
inhibition of host protein synthesis but were required for
inhibition of host DNA synthesis. It seems unlikely that simple
competition is the primary mechanism of inhibition, however,
because total protein synthesis declines markedly in infected
cells (528), and thus the decline in host protein synthesis does
not seem to arise from a limitation in the capacity of the
system.
A second model for inhibition of host protein synthesis was
proposed by Carrasco (60) and by Garry et al. (144), who
suggested that changes in the ionic environment within the
infected cell favored translation of viral mRNA. Garry et al.
(144) examined the concentrations of monovalent ions in cells
infected with SIN and found that the intracellular K+ concen-
tration decreased from 150 to about 50 mM and the Na+
concentration increased concomitantly from 20 to 50 mM at
the same time after infection of chicken cells by SIN that host
protein synthesis was inhibited. They proposed that the change
in cation concentration resulted in inhibition of the initiation
of host cell mRNA translation, consistent with known ionic
requirements for initiation of translation (375, 439), and that
viral RNAs were resistant to these altered ionic conditions.
Garry et al. (146) found that treatment of cells with ouabain,
which interferes with the Na+/K+ pump, also raised the
intracellular Na+ concentration and reduced the K+ concen-
tration and that this led to inhibition of host protein synthesis
but not viral protein synthesis. They hypothesized that a viral
component interferes with the Na+/K+ pump, leading to the
observed alteration in cation concentration in the infected cells
and resulting in inhibition of host protein synthesis. It is of
interest that Garry and Bostick reported that heat shock also
led to inhibition of the Na+/K+ pump (145).
Ulug et al. (561) measured the uptake of 6Rb+, a tracer for
K+, and found that the Na+/K+ pump was, in fact, inhibited 40
to 50% as a consequence of SIN infection but that the
furosemide-sensitive Na+/K+/Cl- cotransport system was not
affected by virus infection. Binding studies revealed that there
was no difference in the number of pump sites and no change
in the Km of the pump for K+ but that the Vm. of the pump
was lowered. In a follow-up paper, Ulug and Bose (559)
reported that treatment of infected cells with tunicamycin, an
inhibitor of glycosylation, prevented the inhibition of the
Na+/K+ pump that would otherwise occur and also prevented
the development of the obvious cytopathic effects that nor-
mally occur at this stage of the infection cycle. In the presence
of tunicamycin the transport of viral proteins to the plasma
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membrane was reduced and the transported proteins were not
glycosylated. They concluded that insertion of glycosylated
viral proteins into the plasma membrane was probably re-
quired for inhibition of the pump. Studies with ts mutants of
SIN in which the glycoproteins are transported to the cell
surface but no budding occurs showed that the pump was
inhibited under these conditions and that virus maturation is
therefore not required for inhibition (560).
Ulug and Bose (559) found that although tunicamycin
prevented the virus-induced inhibition of the Na+/K+ pump, it
did not prevent the virus-induced inhibition of host protein
synthesis. Inhibition of host protein synthesis was not as
efficient in tunicamycin-treated cells, however, suggesting that
the altered ionic conditions induced by the virus are partly
responsible for inhibition of host protein synthesis but that
other mechanisms must also be involved. Further support for
this modified hypothesis came from Garry (143), who found
that addition of K+ to the medium over SIN-infected cells
resulted in a rise in the intercellular K+ concentration; this
resulted in an increase in the overall rate of protein synthesis
and a partial reversal of the virus-induced termination of host
protein synthesis.
Gray et al. (163-165) confirmed that there are alterations in
the concentration of monovalent cations in cells infected by
SF. From studies with drugs, including the monovalent cation
ionophore nigericin, they concluded that these changes could
not account for the extent of inhibition of protein synthesis
seen in infected cells, although they could contribute to
inhibition, consistent with the results for SIN. Carrasco et al.
(61) have reviewed the evidence that permeability changes
occur following infection by many viruses, including alphavi-
ruses, and that these changes may be responsible at least in
part for inhibition of protein synthesis by altering the ionic
conditions in the cell.
A third mechanism for inhibition of host protein synthesis
was proposed by Van Steeg et al. (563), who found that SF
capsid protein inhibited translation of cellular mRNA or of SF
genomic RNA, but not of subgenomic 26S mRNA, when tested
in a cell-free translation system. Inhibition appeared to be at
the level of formation of 80S initiation complexes. They also
confirmed that capsid protein was bound to ribosomes isolated
from infected cells and could be removed in high-salt washes.
They hypothesized that the inhibition of host protein synthesis
following viral infection was the direct result of capsid protein
interfering with initiation of translation of host mRNAs. In
more extensive studies, Elgizoli et al. (112) reported that
protein synthesis was markedly stimulated upon introduction
of low concentrations of SF capsid protein (103 to 104 mole-
cules per cell) into several mammalian cell lines, whereas
protein synthesis was significantly inhibited (up to 60%) upon
introduction of large amounts of capsid protein (105 to 106
molecules per cell). It was not determined whether the inhibi-
tion resulted from a direct interference with translation or
whether it resulted from an indirect action, such as interfer-
ence with transcription. The introduced capsid protein was
found to be transported efficiently to the nucleus and to
concentrate in the nucleolus (353), in agreement with earlier
studies in which capsid protein was expressed from recombi-
nant simian virus 40 (225). The inhibition of protein synthesis
caused by capsid protein was transitory (353), and it seems
unlikely that inhibition of host protein synthesis by the virus
capsid protein is significant in infected cells. Schlesinger et al.(462), in fact, reported that a mutant of SIN in which capsid
protein was synthesized in the same amounts as in wild-type-
infected cells did not inhibit host protein synthesis and con-
cluded that capsid protein was not responsible for the observed
inhibition of protein synthesis in infected cells.
The fourth model for inhibition of host protein synthesis is
interference with initiation factors required for protein synthe-
sis, as has been found for other virus systems (111). In recent
studies, Frolov and Schlesinger (126) found that SIN replicons
that were unable to synthesize structural proteins or that
synthesized only small amounts of subgenomic mRNA were
able to inhibit host protein synthesis with the same kinetics as
SIN virus, and they concluded that early steps in viral gene
expression resulted in inhibition. In agreement with the results
of Ulug and Bose, they found that replicons that did not
express the glycoproteins did not induce cytopathologic
changes. The initiation of alphavirus RNA translation differs
from that of host mRNAs, and the initiation factors used could
differ. van Steeg et al. (564) found that cell-free translation
systems isolated from infected cells translated host mRNA or
SF 49S RNA poorly while translating 26S RNA efficiently and
that addition of cap-binding protein or of eIF-4B overcame the
inhibition. 26S RNA requires lower concentrations of these
initiation factors and binds these factors more tightly (26). It is
also worth noting that the structure of the 5' NTR is thought
to control the efficiency with which an mRNA interacts with
initiation factors, but alphavirus RNAs contain hypermethyl-
ated caps (m22'7G and m32'2'7G) as well as m7G caps (216),
which could affect initiation of translation. It is known that SIN
or SF 26S RNA requires a cap to be translated, as tested in
cell-free systems, but translation of the RNA is insensitive to
the presence of cap analogs that inhibit translation of host
mRNAs (26, 539, 564). Tahara et al. (539) found that m2'7G
caps were bound more tightly than m G caps and supported
translation of model mRNAs more efficiently in cell-free
systems, whereas m2'2'7G caps are bound poorly and mRNAs
with these caps are translated poorly. Nevertheless, SIN 26S
RNA containing the authentic 5' NTR was translated equally
well whether it carried an m7G cap or an m2'7G cap but was
translated poorly if it carried an m2'2'7G cap. van Duijn et al.
(562) found that in SF-infected cells, polysomal 26S mRNA
RNA disproportionately possessed monomethylated caps and
few had trimethylated caps.
In summary, the subject of inhibition of host protein synthe-
sis has proven to be complex. It seems most likely that early
viral gene functions are involved by mechanisms that have as
yet to be determined but that inhibition of the host is aug-
mented by the alteration in intracellular [K+] induced by the
virus. Inhibition could result in a lowered capacity of the
system, with viral mRNAs being preferentially translated be-
cause they bind initiation factors more tightly. In addition to
the alteration in intracellular ionic conditions, the onset of
inhibition of host protein synthesis is accompanied by in-
creased phospholipase activity that results in the release of
choline and of arachidonic acid into the medium (401) and by
the depolarization of the cell (24), and it is conceivable that
these changes might (also?) contribute to inhibition of host
protein synthesis.
Formation of replication factories. After infection of verte-
brate cells, cytopathic vacuoles (CPVs) that serve as sites of
RNA replication and perhaps as sites of RNA translation and
nucleocapsid assembly are formed. CPVs are 0.6 to 2 ,um in
diameter and have 50-nm membrane spherules lining the
vacuole membrane at regular intervals. They were long ago
shown to be associated with RNA replication (2, 124, 171, 172).
They form early (detectable after 1 h) following infection at a
multiplicity of 200 but are not detectable until 5 h postinfection
following infection at a multiplicity of 20. A recent immuno-
electron-microscopic study by Froshauer et al. (127) has shown
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that the CPVs are derived from endosomes and lysosomes and
that the viral nonstructural proteins, presumably replicases
active in RNA replication, are associated with the cytoplasmic
face of the CPVs. Moreover, fibrous ribonucleoprotein struc-
tures extend from the base of the spherules on the cytoplasmic
face of the CPVs and form connections with the rough ER.
The association with the rough ER suggested that the CPVs
are replication factories that constitute sites for RNA replica-
tion as well as containing sites for translation of structural
proteins and assembly of nucleocapsids.
Pathogenesis and Immunity
Neutralization epitopes in E2. The epitopes on the surface
of a virus that interact with antibodies, especially neutralizing
antibodies, have attracted attention over the years because of
their obvious importance in protection from viral disease.
Studies with neutralizing MAbs have been reported for several
alphaviruses including SIN, VEE, RR, SF, EEE, and WEE
(reviewed in reference 426).
In general, antibodies directed against glycoprotein E2 are
more often neutralizing than are antibodies reactive with El.
In the case of SIN, at least two apparently nonoverlapping
domains in glycoprotein E2 have been found to contain
epitopes that lead to neutralization by one or more MAbs. One
of the E2 domains consists of a linear sequence in the
ectodomain of the protein between amino acids 170 and 220,
which is illustrated in Fig. 26. This domain is highly charged, is
variable in sequence among strains of SIN, contains a bound
oligosaccharide chain, and is almost certainly exposed on the
surface of the virion. The importance of this region for virus
neutralization has been shown in several ways. Strauss et al.
(518, 520) found that variants resistant to neutralization by six
different MAbs reactive with E2 (502) had amino acid substi-
tutions within this domain (Fig. 26). Competition-binding
studies showed that all six MAbs interfered with one another
for binding to the virus; i.e., they reacted with overlapping
epitopes, but the resistant variants could be divided into two
groups by their pattern of cross-resistance to the six MAbs
(502, 520). MAbs 49 and 50 define antigenic site A, and MAbs
23, 18, 30, and 51 define site B. It is clear from the location of
amino acid changes in resistant variants (Fig. 26), as well as
from the cross-competition experiments, that these sites are
overlapping. Davis et al. (88) also mapped other variants
resistant to MAb 23 and to two additional MAbs to substitu-
tions at residue 216. Intriguingly, the last two MAbs, R8 and
R10, require E-216, a negatively charged residue, for full
reactivity, whereas MAbs 23, 18, and 51 require K-216, a
positively charged residue. Almost all of the amino acid
changes in the MAb-resistant variants resulted in a change in
charge. Two exceptions to this general rule were resistant
variants which had acquired a new site for N-linked glycosyla-
tion, K-216 -> N (520) and T-213 -+ N (88). It is assumed that
the presence of the new carbohydrate chain prevents binding
of the antibody.
Residues that are changed in resistant variants have been
shown in at least some cases to form part of the epitope bound
by the MAb (278), and it is assumed that this is usually the
case, although cases have been described in which single amino
acid substitutions away from the antibody-binding domain
result in a change in conformation such that the MAb no
longer binds (94, 393). Most neutralizing antibodies recognize
conformational or discontinuous epitopes, and, without per-
forming structural analysis of the complex, it is difficult to
ascertain where in a protein an antibody binds. However, SIN
anti-E2 MAb 23 will bind to Xgtll phage that express residues
173 to 220 of E2 (583), and it is clear that for this antibody, at
least, the domain illustrated in Fig. 26 contains all or substan-
tially all of the antigenic epitope. It seems likely from the
changes seen in the antibody-resistant variants that all of the
E2 epitopes in sites A and B are contained largely within this
domain.
A second neutralizing domain in SIN E2, called antigenic
site C, is defined by reactivity with MAbs R6 and R13 and has
been studied by Pence et al. (396). MAbs R6 and R13 were
found to bind to but not to neutralize wild-type virus contain-
ing S-114 in E2 (379) but to neutralize an attenuated strain of
SIN that contains R-114 (87, 378, 379). Variants resistant to
MAbs R6 and R13 were found to have changes in E2 at
position 62, 96, or 159. This epitope thus appears to be
discontinuous and dispersed over E2.
Studies with VEE identified the E2 domain between resi-
dues 182 and 207 as important in virus neutralization. MAbs
directed against VEE E2 have been grouped into eight anti-
genic sites, which have been shown by competitive-binding
assays to fall into four overlapping domains (427, 431). Six of
these sites led to neutralization of virus, but the antibodies
differed in their ability to neutralize different strains of VEE.
Five of these sites cluster into what the authors refer to as a
critical neutralization domain of E2, and variants resistant to
MAbs defining four of these have been isolated and se-
quenced. Changes found were S-182 -> R, G-183 ->V,
E-199 -> K, and 1-207 -+ F (227). Thus, this critical neutraliza-
tion domain appears to be essentially the same as the SIN E2
domain illustrated in Fig. 26.
Three neutralization epitopes in RR E2 that overlap in
competitive-binding assays have been studied by isolation of
antibody escape variants (573). One neutralizing antibody
selected variants changed at T-216 and thus this epitope
appears to be related to those in the major SIN and VEE
domain described above. Two other MAbs selected changes at
residues K-234 or H-232 or at D-246, T-248, or R-251.
Anti-E2 MAbs have also been described for SF and grouped
into five antigenic determinants by competitive-binding assays
(32, 35). Two determinants were associated with neutraliza-
tion, but no information on antibody escape variants has been
reported.
Neutralization epitopes in El. El-reactive MAbs have been
studied for several alphaviruses including SIN (67, 428, 470,
500), VEE (427), SF (35), and WEE (219); for SIN, VEE, and
SF some of the MAbs were neutralizing, but in only one case
have resistant variants been obtained and sequenced. MAb 33
neutralizes the infectivity of SIN and is directed against El.
Two independent resistant variants were found to have substi-
tutions at G-132 of El, to R in one case and to E in the second
(520). It is of considerable interest that this El-specific MAb
and the E2-specific MAbs belonging to sites A and B described
above competed with one another in binding studies with intact
virus, suggesting that the El domain reactive with MAb 33 and
the E2 domain in Fig. 26 are spatially close in the virion. A
related finding has been reported for VEE, in that a neutral-
izing anti-El MAb was found to compete with neutralizing
anti-E2 MAbs reactive with the critical neutralization domain
defined by Roehrig and collaborators (427). As described
above, the domain of the El-E2 heterodimer defined by these
neutralizing antibodies may form, in whole or in part, the virus
receptor-binding domain.
Conformational dependence of epitopes. Most epitopes that
bind MAbs depend to a greater or lesser extent on the native
conformation of the glycoprotein (or of the virus) for reactiv-
ity. In general it has been found that antibodies reactive with
El are very sensitive to conformation, whereas those reactive
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with E2 are less so and many of the MAbs studied will react
with denatured E2 or with peptide fragments derived from E2
(219, 428, 431, 470). Some peptides derived from E2 of VEE
(218), RR (248), or SF (173) reacted with polyclonal antisera
produced against the respective virus; in the case of VEE and
SF certain antipeptide antisera bound to the intact virus but
did not neutralize virus infectivity, and immunization of mice
with certain of these peptides protected against viral disease.
Cryptic epitopes that are nonreactive with antibody in the
native protein but which become exposed after conformational
changes in the proteins have been described for both El and
E2 of alphaviruses. In an early study of SIN, certain anti-El
MAbs were found that were nonneutralizing and that did not
bind to the intact virus but became reactive after detergent
treatment or treatment at low pH (470). These MAbs were
capable of mediating complement-dependent lysis of infected
cells, showing that these cryptic epitopes were expressed on the
cell surface, possibly in immature forms of the glycoproteins.
Cryptic epitopes called transitional epitopes that become
exposed upon binding of SIN to a receptor on the surface of a
cell or after exposure to heat, thiol-reducing agents, or low pH
were described above. Cryptic epitopes have also been found
in WEE El (219).
Stanley et al. (500) found that two SIN viruses that differed
at positions 55 and 209 of E2 and at positions 72 and 313 of El
(318) were differently neutralized by 3 of 11 MAbs directed
against El and 8 of 12 MAbs directed against E2. Resistant
variants have not been selected and mapped, and the relation-
ship of these residues to the epitopes defined by resistant
variants is unclear, but because differences in neutralization by
so many different antibodies were observed it was suggested
that the El and E2 changes led to conformational changes in
the glycoprotein spikes.
Protection from disease. The most important mechanisms by
which the immune system protects an animal from viral disease
are usually considered to be neutralization of virus infectivity
by humoral neutralizing antibodies, which prevents the spread
of the virus, and lysis of infected cells by cytotoxic T cells,
which prevents further production of the virus. The alphavirus
epitopes defined by the various catalogs of MAbs appear to
define the major neutralizing epitopes seen by the immune
system. In the case of SIN, epitopes E2 A, E2 B, and the El
epitope defined by the anti-El MAb 33 figure prominently in
the antibody response of an infected mouse. Schmaljohn et al.
(468, 470) found that serum from a mouse infected with
wild-type virus neutralized wild-type virus 10-fold better than it
neutralized a variant multiply resistant to MAbs 33, 50, and 23.
Conversely, serum from a mouse infected with the triple
variant neutralized the variant 10-fold more efficiently than it
neutralized the wild type. This suggests that 90% of the
neutralizing immune response in a mouse is directed against
these three antigenic sites. Using a similar approach, Kerr and
Weir (quoted in reference 573) found that a triply resistant
variant of RR E2 was neutralized one-fourth as well as the wild
type by an anti-RR polyclonal antiserum.
The mechanisms of neutralization vary. In some cases
binding of the antibody has been shown to interfere with virus
binding to a potential host cell, whereas in other cases virus
with attached antibody could attach to cells but could not
penetrate (430). In the case of the anti-SIN E2 A and E2 B
sites, it has been suggested that the antibodies bind to the
receptor-binding domain of the virus and block attachment to
cells (582), and variants selected to be resistant to these
antibodies have usually been found to lose the ability to bind
the antibody (502). However, Flynn et al. (122) reported that
MAb 49, which reacts with site A, would bind to many strains
of SIN and activate the infectivity of the virus for BHK cells.
Antibodies that bind to the E2 C site bind to a number of SIN
strains but neutralize only some of them (379).
Although neutralizing antibodies are clearly of major impor-
tance in protection from viral infection, studies of alphaviruses
have repeatedly shown that nonneutralizing antibodies can be
protective (35, 219, 336, 347, 431, 469, 470, 501, 621, 622). The
mechanism(s) of protection is not known, but possible mech-
anisms include binding of antibody to epitopes expressed only
in immature forms of the glycoprotein leading to inhibition of
virus maturation, complement-mediated lysis of infected cells
(34, 469), and curing of viral infection by a nonlytic mechanism
(33, 290).
Stanley et al. (501) reported protection studies in which a
distinction was made between prophylaxis (antibody passively
administered before infection) and cure (antibody adminis-
tered after establishment of an acute encephalitis that will
result in death of the animal in the absence of an immune
response). Most MAbs were protective when administered
either prophylactically or after infection was established, but
two MAbs were found that could cure an established infection
but were not effective when administered prophylactically, and
two MAbs were found that were effective prophylactically but
not when administered after infection. These authors sug-
gested that the mechanisms of prophylaxis and recovery might
differ.
Rather than protecting animals from disease, the immune
response sometimes leads to exacerbation of disease. Mokhtar-
ian et al. (358, 359) found that alphaviruses can induce a
paralytic disease resembling experimental autoimmune en-
cephalomyelitis in certain strains of mice.
The complement system has also been shown to be impor-
tant in host defense against alphaviruses. SIN has been shown
to activate both the alternative and classical complement
pathways, and depletion of complement results in prolonged
viremia and a more severe central nervous system infection
(203-205, 208). The relative ability of the virus to activate
complement and to be cleared by an animal is inversely related
to its sialic acid content (206). Thus, the natural immunity to
SIN is higher in strains of mice that have less sialic acid in their
tissues (207).
Virus neurovirulence. Many of the New World alphaviruses
are capable of causing a serious encephalitis in humans or
other animals; the Old World viruses are less neurovirulent
and, in humans, lead to disease characterized by headache,
fever, rash, and arthralgia (166, 402, 488). Old World viruses
are often neurotropic in mice, however, and three of these,
SIN, RR, and SF, have been used as models to investigate the
molecular basis of neurovirulence.
The severity of encephalitis caused by alphaviruses is often
age dependent. In humans, WEE and EEE lead to a more
serious encephalitis in infants and young children than in
adults (reviewed in reference 414). Similarily, SIN causes a
more acute encephalitis in young mice than in adults. After
infection with most strains of SIN, neonatal mice die of
encephalitis whether the virus is administered peripherally or
intracranially, whereas older mice survive and clear the infec-
tion. Two different approaches have been used to study SIN
neurovirulence; in one approach, variants virulent for adult
mice have been characterized, and in the other, variants
attenuated for newborn mice have been examined (reviewed in
references 167 and 168). Both virulent and attenuated strains
replicate in neurons of the brain and spinal cord, and the
pattern of virus replication is similar in fatal and nonfatal
infections (222, 223, 483). However, neurovirulent strains of
virus replicate to higher titers in brains of neonates of in brains
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of adult mice and cause fatal infection; they are designated
neurovirulent for neonates or adults, respectively. Further-
more, it appears that neurovirulent strains induce apoptosis
and subsequent neuronal death; if apoptosis is not induced, the
animal survives (556).
A neuroadapted strain of SIN referred to as NSV causes a
fatal encephalitis in adult mice as well as in neonatal mice after
ic inoculation. NSV was isolated after alternating passage in
adult and suckling mice (169). It was shown by Lustig et al.
(318) that alterations in the glycoproteins of the virus were
largely responsible for the increased neurovirulence, although
change(s) outside this region also contributed; changes in both
El and E2 were required. Key changes associated with the
increased virulence identified in this and in follow-up studies
were Q-55 -- H and R-172 -> G in E2 and V-72 -- A and
G-313 -> D in El (318, 552, 553). H-55 was particularly
important for virulence, because five other amino acids tested
in this position led to attenuation in 2-week-old mice. Studies
of viral replication in mouse brain and in cultured cells led to
the conclusion that virus with H-55 replicated more efficiently
in both neuronal and nonneuronal cells (553). The identities of
the residues at positions 55 and 172 in E2 and at positions 72
and 313 in El, as well as other changes in both El and E2, were
also important for the virulence of the virus in newborn mice.
The importance of H-55 in E2 for growth in neurons and for
neurovirulence was also shown in a study in which scid mice
were infected with AR339 SIN (288). Weanling scidlCB17
mice are persistently infected by SIN. The infection can be
abrogated by treatment with antibodies, but in about half the
mice the infection reactivates after 30 to 90 days (289, 290).
Virus was isolated from the brains of mice that had been
persistently infected for 39 days without treatment with anti-
body or from mice that had been treated with antibody and in
which the infection had reactivated after 37 to 52 days. Of nine
virus isolates, four had the change Q-55 -> H in E2 and all four
were virulent for weanling BALB/cJ mice. The remaining five
isolates retained Q-55 and were avirulent for weanling
BALB/cJ mice. Thus, extended growth in mouse brain selected
for a virus containing H-55, and this virus was neurovirulent.
Interestingly, the H-55-containing virus did not result in the
death of the scid mice, suggesting that a host immunopatho-
logic response may be involved in the severity of the enceph-
alitis.
Johnston and collaborators have studied attenuation of SIN
infection in neonatal mice. They selected variants that were
able to penetrate cultured BHK cells rapidly and found that
these variants were also attenuated in mice and altered in their
reactivity with certain MAbs (18, 378, 379). The substitution
responsible for all three changes in virus phenotype was
S-114 -> R in E2 (87, 406), and this substitution was found to
reduce the stability of the virus on exposure to a number of
inactivating agents, suggesting that the conformation of the
glycoprotein spikes is altered (150). Although these three
phenotypes covaried in selection procedures, it was later found
that the attentuated phenotype could be separated from the
rapid penetration phenotype (408) and from the MAb reactiv-
ity phenotype (396). In the course of these studies, other
attenuating mutations in both El and E2 were characterized
(406, 407).
Schoepp and Johnston (477, 478) examined mutants with
site-specific mutations at E2 positions 62, 96, and 159, which
form part of antigenic site E2c, and found many changes that
reduced virulence and reduced binding of MAbs specific for
site E2c. In general, binding of antibody was correlated with
virulence, and the authors concluded that residues 62, 96, 114,
and 159 -are probably close together in the protein structure
and define an epitope that is important in some way for
pathogenesis. They also found that changes at position 62 or
159 could render the virus virulent regardless of the residue at
position 114.
Russell et al. (437) studied attenuation of the AR86 strain of
SIN. This strain, unlike the AR339 strain used for most studies,
is virulent for adult mice when inoculated intracranially.
Rapid-penetration mutants were isolated and found to be
attenuated. Two different changes were found to attenuate the
virus. In one, S-114 -- R in E2, the same change found to
attenuate AR339 for neonatal mice, led to attenuation of
AR86. In the second, S-1-> N in E2 gave rise to a new
glycosylation site that resulted in failure of PE2 to be cleaved
and in attenuation of virus virulence.
These various studies make clear the importance of the
glycoproteins for SIN neurovirulence. Using a different ap-
proach, Kuhn et al. (271) examined the effect of deletions in
the 5' and 3' NTRs of the SIN genome RNA. They found that
the effect of any particular deletion was host cell specific.
Several deletions that resulted in lowered RNA synthesis in
infected cells and attenuated the neurovirulence of the virus in
mice were found, and attenuation was correlated imperfectly
with the replication efficiency of the virus in cultured mouse
NIH 3T3 cells. In one case the virus grew better in the brain
than did the parental virus and was increased in its neuroviru-
lence but grew like the parental virus in cultured cells. Thus, as
has been found for other viruses such as poliovirus (263),
changes in nontranslated regions can be attenuating.
Variants of RR that are either enhanced or reduced in their
virulence for mice have also been characterized. Passage of a
strain of RR of low virulence for neonatal mice 10 times in
mice resulted in a marked increase in virulence (342). It was
concluded that early in passage, unmapped changes in the
nonstructural proteins occurred that resulted in increased
replication efficiency and increased virulence. Later during
passage, changes in the E2 protein occurred that led to a still
more efficient replication of the virus. Changes at nine differ-
ent E2 residues were observed in the various variants se-
quenced. In another study, Vrati et al. (572) found that
deletion of residues 55 to 61 of E2 in a virulent RR strain
resulted in attenuation of the virulence of the virus for mice.
Attenuated variants of SF have been isolated, and the
pathology of virus infection has been studied (13, 320, 321).
Although no details of the molecular changes involved are
known, several interesting studies on the pathologic changes
caused by an attenuated variant of SF, called A7(74), have
been reported. Growth of this mutant is restricted in the mouse
brain; although the virus replicates in mouse neurons, little
virus budding is observed (117). Infection of mice with the
virus causes an acute inflammatory reaction in the central
nervous system, which leads to demyelination; demyelination
can be prevented by depletion of CD8+ T cells (534). Treat-
ment of mice with gold sodium thiomalate results in the
proliferation of membranes in the mouse central nervous
system and leads to increased growth and increased virulence
of A7(74), suggesting that the restriction in A7(74) growth in
the brain is due at least in part to an inability of the virus to
induce sufficient proliferation of membranes required for virus
growth (343). Perhaps related to the hypothesis that mem-
brane proliferation is required for SF growth in neurons is the
report that synthesis of SF RNA requires continuous lipid
synthesis (400).
The neurovirulence of VEE, a New World virus, has also
been studied. VEE is neurovirulent for mice and can cause
encephalitis in horses and humans. An attenuated strain that is
avirulent for mice and has been used as a vaccine in horses and
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in humans was isolated by passage in guinea pig heart cells.
The complete sequence of this attenuated TC-83 strain has
been obtained and compared with the sequence of the parental
Trinidad donkey strain (228, 257-259). There are only 12
nucleotide changes between the two viruses, of which 5 lead to
amino acid changes in E2 and 1 results in a change in El,
illustrating that passage in cultured cells often selects prefer-
entially for changes in the envelope glycoproteins and that such
changes are often attenuating. Mapping of the attenuating
mutations in TC-83 by making recombinant viruses between
the parental TRD strain and TC-83 and testing the virulence of
the resulting viruses in mice showed that attenuation in mice
resulted primarily from two changes. The amino acid change
T-120 -> R in E2 was the most important attenuating muta-
tion, followed by the nucleotide substitution G-3 -> A in the 5'
NTR of the virus; in combination, these two changes alone
resulted in a completely attenuated virus (257).
Variants of VEE that are attenuated in their virulence for
mice have also been isolated by selection for rapid penetration
of cells in culture (232). Attenuation was due to amino acid
changes in E2 at positions 3+4, 76, 120, or 209 (89). Combin-
ing these mutations gave rise to further attenuation of virus
virulence. It is interesting that changes in the envelope of
alphaviruses that allow them to penetrate BHK cells in culture
more rapidly result in less efficient growth in mice.
Clearance of virus from persistently infected neurons. Most
nucleated cells in the body produce class I MHC, and infected
cells can be killed by cytotoxic T lymphocytes reactive with viral
epitopes presented in the context of class I MHC. Neurons are
terminally differentiated cells that do not express class I MHC
and are therefore not a target for cytotoxic T cells. How can
viral infections of neurons be cleared? Levine et al. (290)
investigated the clearance of SIN infection from mouse brain
and found that humoral antibody could inhibit virus replication
in neurons by a noncytolytic mechanism. SIN infection of adult
scid mice, which are unable to mount either a humoral or a
T-cell immune response, led to persistent infection of brain
and spinal cord neurons that could be cured by passive transfer
of humoral antibody but not by passive transfer of T cells.
Using MAbs, the authors found that three neutralizing MAbs
directed against E2 were able to clear the infection but that
other anti-E2 MAbs (including other neutralizing MAbs) and
anti-El MAbs were not effective. There was no defined
relationship between neutralizing activity, protective capacity
upon prophylactic treatment, and ability to mediate comple-
ment-dependent lysis; this suggested that viral clearance from
neurons involves a different humoral effector mechanism.
These results could be reproduced in an in vitro system in
which dorsal root ganglia were explanted and cultured. Infec-
tion of these neurons with SIN led to a persistent infection that
could be cured by treatment with the same three MAbs that
cured the infection in vivo, and the antibody treatment inter-
fered with virus RNA transcription or translation (Fig. 28).
Remarkably, continued presence of the MAb in the medium
was not required; a 48-h treatment of the infected cells
followed by removal of the MAb resulted in clearing of the
infection over the next 5 days. The mechanism by which
humoral antibodies clear SIN infection of neurons is unknown
but is clearly of great interest.
Levine and Griffin (289) used a sensitive PCR assay to
examine mice that had recovered from acute encephalitis
caused by SIN for the persistence of viral RNA in brain cells;
they found that viral RNA was still present in the brain up to
17 months after recovery from disease. In immunocompetent
mice, no evidence for reactivation of viral infection was
observed; however, in scid mice that had recovered following
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FIG. 28. Effect of MAb therapy on SIN replication in primary rat
neuron cultures. Dorsal root ganglions were dissected from embryonic
rats and maintained in culture (290). Six-week-old cultures were
infected with SIN at a multiplicity of 0.1. Two days later, cultures were
treated with different neutralizing MAbs for 2 days (shaded area), after
which the MAbs were washed from the cultures and medium without
MAb was added. At 48-h intervals, aliquots of the supernatants were
removed and assayed for virus by plaque assay on BHK monolayers.
MAbs 209 (A) and R6 (0) are reactive with glycoprotein E2 epitope
C, MAb 50 (0) reacts with E2 epitope A, MAb 202 (A) reacts with E2
epitope AB, and MAb 106 (A) reacts with glycoprotein El epitope C.
A, no MAb. Adapted from reference 290.
passive transfer of antibody, viral reactivation was seen in some
of the mice treated with a low dose of antibody (Fig. 29).
Reactivation was correlated with waning antibody titer in the
animal, and the revived infection could be abrogated by fresh
treatment with antibody. These authors concluded that SIN
can persist for extended periods in a nonreplicating form in
mouse brain and that the humoral response to virus infection
plays an important role in preventing viral reactivation. The
finding that a lytic RNA virus is able to persist in a latent state
within neurons for long periods and that its replication is
repressed by the continuing presence of humoral antibody was
unexpected.
Induction of apoptosis. Alphavirus infection of vertebrate
cells usually results in the death of the cell, with the notable
exception of neuronal cells in which a persistent infection may
be established (289, 290). Recent studies have suggested that
alphaviruses kill the cell by inducing apoptosis, a cell suicide
pathway characterized by DNA fragmentation and morpholog-
ical changes (291). BHK cells, N18 mouse neuroblastoma cells,
and AT-3 rat prostatic adenocarcinoma cells were found to
exhibit symptoms characteristic of apoptosis following infec-
tion by SIN, including membrane blebbing, nuclear condensa-
tion, and fragmentation of DNA into nucleosome-sized pieces.
Thus, there is the presumption that the virus induces apoptosis
in some way and that this results in the death of the cell.
Production of the cellular oncogene bcl-2 protects cells, in
some unknown way, from apoptosis. One of the steps involved
in the maturation of neurons is acquisition of the ability to
express bcl-2, and this suggests that the age-dependent neuro-
virulence of alphaviruses may arise because mature neurons
are protected from apoptosis. A number of treatments, such as
withdrawal of nerve growth factor, induce apoptosis in imma-
ture neurons, which do not express bcl-2, but these treatments
do not affect mature neurons, which do produce bcl-2. In
immature neurons infection by wild-type SIN results in cell
death, presumably by apoptosis, whereas in mature neurons a
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FIG. 29. Reactivation of SIN in the central nervous system of scid mice after antibody treatment. scid mice were inoculated intracranially with
1,000 PFU of SIN on day 0 and treated with 200 ,ug of MAb 209 (open circles) or anti-SIN hyperimmune serum (solid circles) on day 7; normal
mice were also inoculated with 1,000 PFU on day 0 but had no antibody treatment (solid squares). At various times after infection, mice were
sacrificed and assayed by plaque assay for infectious virus in the brain (A) and by enzyme-linked immunosorbent assay for the titer of anti-SIN
antibody in the serum (B). Adapted from reference 289 with permission of the author and the publisher.
persistent infection is established, presumably because the cells
are protected. Support for this model has come from studies in
which immature rat dorsal root ganglia were explanted and
grown in culture. These neurons do not express bcl-2 when first
explanted, and infection by SIN results in the death of the cell.
After 6 weeks in culture, bcl-2 is produced by the neurons, and
they are no longer killed by the virus (291).
The importance of bcl-2 in protecting cells from virus-
induced apoptosis has been shown by studies with nonneuronal
cells. Infection by SIN of rat AT-3 cells leads to the induction
of apoptosis and death of the cell. Transformation of AT-3
cells with the bcl-2 led to a cell line in which wild-type SIN no
longer induces apoptosis and instead establishes a persistent
infection (291), as illustrated in Fig. 30.
Strains of SIN that have histidine at position 55 of E2 can
overcome the effects of bcl-2 expression (556). Strains with
H-55 are not affected in their growth rate by the presence of
the bcl-2 gene product in AT-3 cells that express bcl-2, and they
induce apoptosis, whereas virus strains with Q-55 grow only
about 10% as well in AT-3 cells expressing bcl-2 and do not
induce apoptosis. The mechanism by which bcl-2 inhibits the
replication of virus containing Q-55 is unknown. SIN strains
containing H-55 are more neurovirulent in adult mice, consis-
tent with the model that bcl-2 expression protects neurons
against less neurovirulent strains of the virus.
Replication in the Mosquito Vector
In nature, alphaviruses alternate between growth in arthro-
pod hosts, almost always mosquitoes, and vertebrate hosts.
Some arboviruses (arthropod-borne animal viruses) can be
maintained by transovarial transmission in arthropods. For
alphaviruses, transovarial transmission has been difficult to
demonstrate and has been assumed to be rare (reviewed in
reference 554). Natural vertical transmission has been demon-
strated recently for WEE, however, leading to the suggestion
that this is an important mechanism for the maintenance of the
virus in nature (128). The possible importance of vertical
transmission for other alphaviruses remains to be determined.
For horizontal transmission of an alphavirus, the vertebrate
infection must produce a viremia of sufficient intensity and
duration that the mosquito vector is infected when taking a
blood meal, and the infection of the mosquito must lead to
virus replication in the salivary glands of sufficient intensity
that enough virus to infect a vertebrate is transmitted with the
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FIG. 30. Replication of SIN in rat prostatic adenocarcinoma
(AT-3) cells which express the cellular oncogene bcl-2. AT-3 cells were
transfected with an expression vector that expresses the human bcl-2
gene (AT3Bcl2) or with the vector alone (AT3Neo). (A) Percentage of
cells viable as a function of time after infection by SIN. Open symbols,
mock-infected cells; solid symbols, cells infected with SIN at a multi-
plicity of 1 on day 0. Cells expressing bcl-2 remain viable after infection
by SIN, whereas cells not expressing bcl-2 are killed by the virus. (B)
Virus titer produced by these cells. Cells expressing bcl-2 (AT3Bcl2
cells) are persistently infected and continue to release virus, whereas
control cells are acutely infected and die (AT3Neo cells). Adapted
from reference 291 with permission of the authors and the publisher.
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salivary fluid when the mosquito next feeds. These require-
ments have shaped the evolution of these viruses in interesting
ways, and studies of the molecular biology of virus replication
must take them into account. As one example, it has been
found repeatedly that passage of alphaviruses in mosquitoes or
in mosquito cells selects for variants that grow better in
mosquito cells but less well in vertebrate cells (86, 482, 509,
544).
In vertebrate hosts alphaviruses often cause a serious illness,
but the infection of the arthropod host is relatively benign.
Early studies suggested that viral infection had no effect on the
mosquito host, but reports of salivary gland abnormalities in
Aedes aegypti following infection by SF suggested otherwise
(reviewed in reference 185). Pathologic changes in the salivary
glands ofAedes albopictus after infection by SIN have also been
reported (42, 43), and recent experiments have demonstrated
transient abnormalities in the midgut of the vector mosquito
after infection by EEE (595) or WEE (593). More-detailed
study of the effects of virus infection on the mosquito are
needed, especially studies involving the normal vector for the
virus in question.
Following ingestion of a blood meal, cells of the midgut
epithelium of the mosquito are infected (reviewed in reference
185) and virus is released into the hemocele when virus buds
from the basolateral surface of the midgut epithelial cells. In a
small fraction of mosquitoes, the midgut appears to be "leaky,"
such that virus has direct access to the hemocele (596). Once
released into the hemocele, the virus eventually finds its way to
the salivary glands, where a persistent infection is established.
After an extrinsic incubation period of 3 days to more that 2
weeks, depending on the virus, the vector, and the environ-
mental conditions, the mosquito is capable of transmitting the
virus with any future blood meals. Strains of Culex tarsalis, a
natural vector for WEE, have been identified in which WEE
fails to replicate in the midgut (185), perhaps as a result of a
lack of receptors for the virus (213). Other strains of WEE
have been identified in which midgut infection occurs but
infection of the salivary glands does not (185). In the case of
VEE, mosquitoes that are very sensitive to infection by one
strain of virus may fail to replicate closely related strains of
VEE (reviewed in reference 479). Thus, the competence of any
mosquito to serve as a vector for a particular alphavirus is
affected by many factors.
Replication of alphaviruses in cultured mosquito cells has
been studied as a proxy for the effects of virus replication in
mosquitoes (reviewed in references 49, 356, 357,509, and 543).
A persistent infection is established in cultured mosquito cells,
whereas a cytolytic infection occurs in most vertebrate cells.
Although all mosquito cell lines examined can be persistently
infected by alphaviruses, the mechanisms by which persistence
is established appear to differ. In most cases virus is produced
during the first 24 to 48 h at levels similar to those in cultured
vertebrate cells. This is followed by a decline in virus produc-
tion to low levels that are maintained indefinitely. In some cell
lines and under certain conditions no cytopathologic changes
are noted, whereas in other lines or under different conditions
there is extensive cell damage followed by establishment of a
persistent infection (356, 445, 543). Increased RNA production
has been found to be correlated with increased cytopathologic
changes, although the yield of virus was unchanged (509).
Similarly, virus maturation has been reported to differ in
different cell lines; in some lines maturation at the cell plasma
membrane appears to be a major method of virus production,
whereas in other lines virus appears to mature within intracel-
lular vesicles (reviewed in reference 356). Maturation of virus
in intracellular vesicles has not been found in whole mosqui-
toes, and the role of vesicles in pathologic changes is unclear.
Following infection of cultured A. albopictus cells by SIN
(422) or SF (369), a polypeptide factor is released that
downregulates the production of virus. The factor is cell
specific in that it affects only mosquito cells and virus specific
in that the anti-SIN and anti-SF factors are distinct and
relatively ineffective against the other virus. Only certain lines
of cultured A. albopictus cells infected by SIN release this
factor and are sensitive to its effects (74, 75). Treatment with
the factor interferes with RNA synthesis following infection by
SIN, and cells that produce the factor become resistant to
superinfection by SIN. Full expression of the antiviral state
requires 48 h of treatment with the factor. The anti-SIN factor
has now been purified and found to be a hydrophobic polypep-
tide of 3,200 Da (315). Treatment of noninfected cells with the
factor first leads to arrest of cell division, followed by recovery
accompanied by acquisition of resistance to SIN and the
constitutive expression of the factor (i.e., the factor induces its
own synthesis). Also induced is the synthesis of a 55-kDa
membrane protein that is associated with lysosomes which
might be involved in the resistance to virus infection exhibited
by these cells (316). Further characterization of this 55-kDa
protein and comparison of the SIN antiviral factor with the
anti-SF factor will clearly be of great interest for our under-
standing of the interactions of viruses and mosquitoes that lead
to persistent infection and for our understanding of mosquito
physiology and development. It is known, for example, that
infection in mosquitoes is downregulated after about 7 days
(reviewed in references 185 and 479); the mechanisms by
which this occurs are unknown but could be related to the
production of this antiviral factor.
EVOLUTION OF ALPHAVIRUSES
Divergence of Alphaviruses
Rates of divergence. RNA viruses are capable of very rapid
divergence because mutation rates are high (211, 212, 508,
530). Proofreading does not seem to occur during RNA
replication (507), resulting in a high misincorporation rate.
The free energy of base pair formation allows a discrimination
of only i0-' to 10-5 during RNA (or DNA) synthesis, and
experimentally measured rates of misincorporation by DNA or
RNA polymerases in the absence of proofreading are of this
order (reviewed in reference 212).
Although the average rate of mutation is 10-4 to 10-', there
appear to be well-established examples in which the rate is
higher (on the order of 10-') or lower (on the order of 10' to
10-8) at specific nucleotides in alphavirus fenomes. In the case
of SIN, apparent reversion rates of 10- to 10-' have been
found for most sequenced ts mutants that have been carefully
examined (178, 181, 183). However, reversion rates of -108
have been found in three well-studied cases. Kuhn et al. (272)
found that a SIN mutant having a C as residue 7 upstream of
the poly(A) tract in the 3' NTR was ts. Change of this residue
to U, A, or G (or even deletion of the C residue) resulted in a
temperature-insensitive virus. The ts virus reverted to temper-
ature insensitivity at a frequency of <10-8, however. Similarly,
Hahn et al. (183) found that ts24 was ts because of a single
nucleotide transition (G -> A, leading to the amino acid
substitution G-736 -- S in nsP2); reversion of the virus to
temperature insensitivity was <10-8, even when sequenced
constructs were used to rule out the presence of other muta-
tions that might contribute to temperature sensitivity. Finally,
Durbin and Stollar (107) studied a mutant that was ts because
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it had an extra glycosylation site in E2. They found that
revertants arose by U-9455 -> A, A-9454 -- U, or C-9460 -> U
changes, but the reversion frequency was estimated to be <5 x
i0'7. In each of these cases, contribution of a second mutation
to temperature sensitivity seems to have been ruled out. It
appears either that misincorporation occurs very infrequently
at certain positions in the viral RNA for reasons that are not
understood at present or that limited proofreading does occur.
Although alphaviruses have the potential for rapid diver-
gence, the actual rates of divergence measured are very low in
comparison with those of other RNA viruses for which good
data exist (reviewed in reference 594). RR virus isolated at the
beginning and end of an 11-month epidemic that swept
through the Pacific region differed at only 1 nt in 1,600
sequenced (1,200 sequenced in the E2 region and 400 se-
quenced in the 3' NTR), and the measured rate of change
during the epidemic was thus 6 x 10-4/nt/year (53). The rate
of divergence over larger regions of the genome might be even
lower, because it was hypothesized that the one change ob-
served might have been selected by the change in vertebrate
hosts that occurred during the epidemic. Sequencing of EEE
isolated over a period of many years from different locations in
North America gave an estimate of 1.4 x 10-4/nt/year for the
rate of divergence (597). From oligonucleotide fingerprinting
studies, the rates of divergence of VEE (421) and WEE (549)
were estimated to be <5 x 10-4 and 3 x 10-4/nt/year,
respectively. Thus, all studies of alphavirus divergence give
values of 1 x 10-' to 6 x 10- /nt/year for the rate of
divergence, contrasting with rates of divergence of -10-2/nt/
year found for a number of other RNA viruses (495, 508, 530).
Weaver et al. (588) examined unpassaged EEE isolates from
a single host and found that the diversity between different
isolates appeared to be similar to those reported for other
RNA viruses. They concluded that the low rate of virus
evolution was not due to a decreased rate of generation of
variants.
It seems probable that the low rate of divergence of alpha-
viruses results in large part from the requirement for alterna-
tion of growth in an arthropod host (at relatively low temper-
ature) and in higher vertebrates (at .370C). The virus must be
highly adapted to persist in these alternating hosts, and
changes that better adapt the virus to one host, which are
readily selected upon passage in culture, or that might be
neutral in one host may well be deleterious in the alternate
host. In addition, infection of a mosquito when it takes a blood
meal or of a vertebrate when an infected mosquito feeds is
initiated by doses estimated to be >102 infectious viruses, and
initiation of infection with such relatively large multiplicities
minimizes founder effects.
Divergence of EEE and VEE. The molecular evolution of
EEE and of VEE has been studied by partial or complete
sequencing of many strains of virus isolated over periods of
many years from the same or different locations, and the
results for the two viruses differ in interesting and informative
ways. In a study of 10 strains of EEE isolated in North America
between 1933 and 1985, the virus was found to constitute a
single lineage (429, 590, 597) in which all viruses were very
closely related and in which the rate of divergence was 1.4 x
10-4 substitution per site per year. The fact that viruses
isolated over a period of 55 years from locations as far apart as
Massachusetts, Wisconsin, Florida, and the Dominican Repub-
lic constituted a single, slowly changing lineage implies that
regular EEE dispersal and gene mixing occurs. The mecha-
nisms for this have not been proven, but it is suspected that
dissemination by infected birds is responsible. EEE is main-
tained in North America by transmission among passerine
birds in freshwater swamps by the mosquito Culiseta melanura
(479). Epizootics of disease are thought to arise when other
mosquito species that feed on both birds and mammals be-
come infected and spread the virus outside this narrow focus.
The low rate of change in the virus may result in part from this
narrow host range, and it is possible that infected birds
regularly introduce or reintroduce the virus into temperate
areas from overwintering areas in the subtropics, maintaining
continual gene mixing. A more comprehensive study of EEE
divergence in North America involving 24 additional isolates
found that there are presently two closely related but distin-
guishable cocirculating lineages of EEE in North America
(586, 591). The divergence of the North American group into
two lineages probably occurred in the early 1970s. Prior to
1970, the rate of divergence of EEE was found to be only about
2 x 10-5. However, after 1970 the rate of divergence increased
over 10-fold, to about 4 x 10-'.
Although the overall rate of EEE divergence in North
America is low and gene mixing appears to occur, Weaver et al.
(588) also found that within a given year genetic diversity was
generally greater among geographically distant isolates than
among those from the same transmission focus. These several
studies suggest that gene mixing of EEE in North America
requires several years to complete, during which time the virus
diverges into multiple geographically separated lineages, ac-
quiring base substitutions at a rate of about 4 x 10-4 per
nucleotide per year. Over a long time period, however, fre-
quent extinctions of lineages and reintroductions of virus by
migratory birds maintain EEE as a single gene pool, and this
gene pool evolves more slowly, with approximately 2 x 10-5
substitutions per site per year.
EEE in South America is distinct from the North American
virus and has evolved into at least two subtypes that are
geographically separated (586, 591). In South America the
virus is probably maintained in enzootic foci and continual
mixing of the viruses does not occur, in contrast to the situation
for North American EEE. The rate of divergence in the South
American strains was found to be about 4 x 10-4, comparable
to rates for other alphaviruses and to the post-1970 rate for
North American EEE. It was estimated that the North Amer-
ican and South American strains diverged about 1,000 years
ago and that the two South American lineages diverged about
450 years ago.
The VEE complex, which is estimated to have diverged from
EEE about 1,400 years ago, has evolved into a number of
geographically isolated subtypes, thus resembling the case for
South American EEE rather than North American EEE (421,
589). The virus is maintained in enzootic foci by transmission
by a number of mosquito species to small mammals, and the
relative lack of mobility of these mammals may be responsible
for the geographic isolation and independent evolution of the
many subtypes. The virus has erupted a number of times into
epizootics that resulted in the infection of large numbers of
horses and people and that subsequently died out. It is believed
that variants of enzootic strains are the usual source of the
epizootic viruses. However, the epizootic of 1969 to 1972,
which spread from Ecuador through Central America and into
Texas, almost certainly arose from an insufficiently inactivated
vaccine in use throughout Central America. Virus isolated in
Texas in 1972 was almost identical to the Trinidad Donkey
strain of virus isolated during an epizootic in Trinidad in 1943
that was used as the source of virus for formalin-inactivated
vaccines, whereas it was quite different in sequence from that
of other VEE isolates (260, 261, 496).
VEE has been introduced into new areas on occasion,
perhaps by infected birds. Of particular interest was the
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TABLE 3. Percent amino acid identity among alphaviruseSa
% Identity' with:
Virus
SIN WHA AURA WEE EEE VEE ONN SF RR MAY
SIN M79.7 50.1 47.4 44.6 47.7 48.9 45.5
WHA - 1 3.0 51.7 48.8 44.8 46.1 47.6 45.3
AURA 7 - 49.0 46.8 44.7 45.7 46.4 44.1
WEE NAC NA NA 56.4 50.6 43.4 45.3 46.2 44.1
EEE 60.4 60.8 59.6 NA - 57.6 49.2 50.6 49.4 49.1
VEE 60.8 61.3 59.5 NA 72.8 46.8 47.7 47.5
ONN 62.5 62.6 61.3 NA 62.9 62.6 6 61.5 61.0
SF 63.9 62.7 62.2 NA 63.3 61.8 7 7. 68.7
RR 62.2 NA 6 73.6 7.5
a For each pairwise combination of viruses, the percent identical amino acids are shown for the structural region (C, E3, E2, 6K, and El) (upper right half) and for
the nonstructural domain (nsPl, nsP2, nsP3, and nsP4) (lower left). Sequences used for these comparisons are found in the references cited in Table 1. Pairs with .60%
identity are boxed.
b Within the structural protein domain, the N-terminal one-third of the capsid protein is not conserved and was not used in these comparisons. Within the
nonstructural protein domain (nsPl to nsP4) the C-terminal half of nsP3 is not conserved (see Table 2) and was not used in these comparisons.
c NA, sequence not available.
introduction, probably about 40 years ago, of the Bijou Bridge
strain into western North America, where it is vectored by a
swallow bug; the progenitor is believed to be a Tonate-like
virus in the Caribbean or South America, which is vectored by
mosquitoes (579, 589).
Divergence of Sindbis viruses. SIN is the most cosmopolitan
of the alphaviruses. Strains of virus called Sindbis have been
isolated from Europe, Africa, Asia (including India and the
Philippines), and Australia, and closely related viruses have
been isolated from New Zealand (WHA) and South America
(AURA). Early studies indicated that the SIN viruses fell into
two major groupings, a Paleoarctic-Ethiopian group and an
Oriental-Australian group (380, 415). More-recent analyses of
the relationships among different strains of SIN and SIN-like
viruses have been based on nucleotide sequencing of part or all
of the genomes of about 10 different viruses (434, 484, 485).
Shirako et al. (485) reported an analysis of seven strains
isolated between 1952 and 1983 from Africa, Northern Eu-
rope, India, and Australia. Although all of these strains were
identified as SIN on the basis of serologic testing and are
closely related in terms of the amino acid sequence of their
proteins, they exhibit a wide degree of sequence variation. The
Australian and Indian strains of SIN diverged from the other
strains examined by 17% in the 3' NTR. This study also
revealed that the Ockelbo strain of SIN isolated in Northern
Europe in 1982 or 1983, which causes epidemic polyarthritis in
these areas, is more closely related to a strain of SIN isolated
from South Africa in 1963 than it is to the other strains of SIN.
This led to the hypothesis that the South African strain of SIN
was introduced into Sweden in the 1960s and spread to Finland
and the Karelian region of the Soviet Union by the early 1980s.
Sequences of WHA (484) and AURA (434) have now been
obtained, and these viruses are clearly SIN-like. Although they
diverge by about 20% in sequence from other SIN strains, they
have the characteristic 3' NTR of SIN which contains three
copies of a 40-nt element that is conserved among all of the
SIN-like viruses (Fig. 21).
Alphavirus evolutionary trees. Complete sequences have
been obtained for eight alphaviruses, and partial sequences
have been obtained for several others. The close relationships
among all these viruses is illustrated in Table 3, in which the
translated amino acid sequences of all of the sequenced
alphaviruses are compared. On average these viruses share
about 45% amino acid identity in the structural protein domain
and on the order of 70% sequence similarity in the nonstruc-
tural domain.
Phylogenetic trees drawn by using the amino acid sequences
of the nonstructural proteins are shown in Fig. 31, and trees
drawn by using the sequences of the structural proteins are
shown in Fig. 32. Several interesting points can be made from
examination of these trees. First, RR, SF, and ONN cluster
closely, suggesting a comparatively recent dispersal event.
MID belongs to this cluster but is more distantly related.
Recent sequence information (85) for the New World repre-
sentative of this group, MAY, suggests that it is also closely
related to these viruses. The New World encephalitic groups of
VEE and EEE also form a cluster. SIN represents a third
grouping. WEE represents a special case, and the fact that it is
a recombinant is easily seen from Fig. 32.
nsPl
nsP3
RR
- SF
- ONN
MID
- SIN
- VEE
- EEE
- WEE
nsP2
nsP4
,RR
-MID
* ONN
SIN
VEE
IEEE
FIG. 31. Alphavirus phylogenetic trees based on nonstructural
proteins. Unrooted phylogenetic trees obtained from aligned amino
acid sequences for nonstructural proteins nsPl to nsP4 of alphaviruses
were constructed by using the PAPA3 program (119). Branch lengths
reflect evolutionary distance scores separating viruses from hypothet-
ical ancestors. Reprinted from reference 592 with permission of the
authors and the publisher.
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FIG. 32. Alphavirus phylogenetic trees based on the structural
proteins. Unrooted trees based upon the sequences of the capsid
protein and of glycoprotein E2 are shown. Note that WEE clusters
with EEE in the capsid protein tree but with SIN in the E2 tree.
Adapted from reference 292.
Recombination among Alphaviruses
Recombination in the laboratory. Recombination in alpha-
viruses occurs infrequently, so that it has been difficult to study
or to quantitate this phenomenon. It has taken the develop-
ment of full-length clones that can be manipulated in order to
demonstrate recombination in the laboratory. Geigenmuller-
Gnirke et al. (149) developed a SIN derivative with a bipartite
genome. The nonstructural proteins were encoded in a SIN
genomic RNA in which the structural proteins had been
replaced by the CAT gene, and the structural proteins were
encoded in a DI RNA under control of a subgenomic pro-
moter (Fig. 23B). When transfected into the same cell, these
two RNAs complemented one another and infectious virions
that contained copies of both RNAs were produced. Weiss and
Schlesinger (601) found that these two RNAs underwent
recombination at an easily detectable frequency to produce a
nondefective RNA capable of a complete replication cycle.
Recombination was not precise but took place anywhere within
the overlap zone to give recombinant RNAs of different sizes.
Some had two copies of the junction region between the
nonstructural and structural domains and two subgenomic
promoters, both of which were active. With continued passage,
recombinants continued to evolve toward the wild-type config-
uration with a single junction sequence. These studies clearly
demonstrate the inherent flexibility ofRNA virus genomes and
imply that recombination can and does play a role in the
evolution of alphavirus genomes.
Recombination to form WEE. Recombination has been
shown to have occurred between alphaviruses in nature, pro-
ducing a new virus (177, 592). WEE is a recombinant between
EEE and a virus related to SIN in which most of the genome
is derived from the EEE parent but the genes for glycoproteins
E2 and El are derived from the SIN-like parent (Fig. 32 and
33). Two crossovers were required to produce WEE. The
upstream crossover appears to have occurred within E3 be-
tween amino acid residues 5 and 24 of the SIN sequence. The
downstream crossover appears to have occurred within the 3'
NTR (nt 11381 to 11703 in SIN), after nt -11440 of the SIN
genome. There follow 160 nt in the WEE 3' NTR that are not
homologous to either parental sequence and whose origin is
not known, and the last 80 nt of the 3' NTR were then derived
from EEE. The two crossovers required may not have occurred
5' nsPl nsP2 nsP3 nsP4 C E E2 6K El 3'
_7_ | v ~~An
l T ::]=-n=l An
-I__ _ _ _ | I A3__ n
Replicae P-
SIN
WEE
PERCENT SEQUENCE ]IDENTITY
PROTEIN
VIRUS nsP2 nsP3 nsP4 Capsid Envelope
(1-324) (321-610) (106.end)
WEE 181 80 8 1 50
WEE 54 54 77 67 E
EEE 55 53 78 61 46SIN I
FIG. 33. WEE is a recombinant virus. Genome organizations of SIN (shaded boxes) and of EEE (open boxes) are shown together with a
schematic of the genome ofWEE in which the genes derived from EEE are shown as open boxes and those from a SIN-like progenitor are shown
shaded. Sequences are found in the references cited in Table 1; the areas with dotted outlines are the portions of WEE for which no sequence
has been published. Below, the amino acid identities shared by WEE, EEE, and SIN in the various regions are tabulated. Modified from reference
527 with permission of the publisher.
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RUBELLA
FIG. 34. Genome organization of rubella (RUB) compared with that of SIN. The genomes of SIN and RUB are drawn to scale, and several
functional domains are labeled according to the terminology of Koonin and Dolja (267). In the complete sequence of RUB (98, 123), a number
of domains with sequence homology to SIN have been identified; these include the methyltransferase (MTR 1), the helicase (HEL 1), a papain-like
proteinase (P-PRO), the X domain of unknown function, and the polymerase (POL 3). However, in the RUB genome these elements appear in
a different order, suggesting that recombination has occurred during their divergence. The boxed 2 indicates the location of CSE 2 (see Fig. 18).
in one event. The crossover in the 3' NTR could have been a
second event required to produce an efficiently replicating
virus, since the 3' NTR contains promoter elements that
interact with viral (and cellular) proteins to promote replica-
tion of the viral RNA. It seems likely that the recombination
event occurred in mosquitoes in which the virus sets up a
persistent, lifelong infection.
WEE is a widely distributed and successful virus. It is found
from Canada discontinuously to Argentina and can be isolated
every year over this very wide geographic range. The time that
the recombination event occurred to give rise to WEE is not
known. From a phylogenetic analysis of the alphavirus group,
Weaver et al. (592) concluded that the EEE parent of WEE
and the ancestor to the currently circulating EEE strains
diverged more than 1,000 years ago, suggesting that WEE
arose more than 1,000 years ago.
It seems clear that EEE served as one of the parents of
WEE. The SIN-like parent is unknown, however. The New
World SIN-like virus AURA is no more closely related to
WEE than it is to SIN AR339 and could not have served as an
immediate parent (Table 3); in fact, present-day African SIN
and WHA from New Zealand are the most closely related in
their glycoproteins to WEE of the known SIN-like viruses. It is
possible that the SIN-like parent no longer exists, perhaps
being replaced by WEE.
Examination of other alphavirus sequences for evidence of
recombination suggests that recombination to produce new
alphaviruses is rare. Weaver et al. (592) reported that the
positions of ONN and of MID in phylogenetic trees of nsP3
and nsP4 differed, suggesting that one of these may be
recombinant (Fig. 31). In no other case except for WEE,
however, was evidence for recombination found. It appears
that divergence of most alphavirus has resulted from linear
descent from a common ancestor and that recombination
among alphaviruses to produce viruses that persist in nature is
a rare but significant event.
The Family Togaviridae
Alphaviruses are classified as a genus in the family Togaviri-
dae, which contains a second genus with clear genome organi-
zation similarities to the alphaviruses, the genus Rubivirus. The
9,756-nt genome of rubella virus (RUB) has been sequenced in
its entirety, and much is known about the organization and
expression of the genome (reviewed in reference 123). The
genome organization of RUB is very similar to that of alpha-
viruses (Fig. 34). The RUB genome, like alphaviruses, contains
a 5' nonstructural domain translated from the genomic RNA
and a 3' structural domain translated from a subgenomic
RNA. The nonstructural domain is translated into a polypro-
tein that is cleaved by a papain-like proteinase that appears to
be related to the nonstructural proteinase of the alphaviruses.
There are domains in the nonstructural polyprotein of RUB
that share homology with domains in alphavirus nsPl (the
methyltransferase), nsP2 (both the helicase domain and the
proteinase domain), nsP3 (function unknown, referred to as
the X domain), and nsP4 (the RNA polymerase), although
there have been rearrangements in the order of these domains
between the RUB and alphavirus nonstructural polyproteins
(123). The structural proteins of RUB, two glycoproteins and
a capsid protein whose gene order is the same as in the
alphaviruses, are translated from a 24S subgenomic mRNA.
The promoter for the subgenomic RNA is similar to that of the
alphaviruses, and, in fact, the RUB promoter can be used by
the SIN replicase to make a subgenomic RNA, albeit 100-fold
less efficiently than the homologous promoter (Fig. 19). A
sequence element very similar to the 51-nt CSE of alphaviruses
is present in RUB, indicated by the boxed 2 in Fig. 34, and
there is a structural element present at the 5' end of the RUB
genome. We assume that these sequences are regulatory
elements that perform the same function in RUB replication
as do the corresponding sequences in alphavirus replication
and that this function has been conserved during evolution of
the viruses.
Despite the close similarity in the genome organizations of
alphaviruses and RUB, phylo-genetic analysis of the nonstruc-
tural sequences suggests that these viruses are only distantly
related. The helicase proteins and the replicase proteins of
RUB have been found to be closer to those of hepatitis E virus
and of the furoviruses than they are to those of the alphavi-
ruses, which in turn are more closely related to those of a
number of plant viruses including the tobamoviruses, tobravi-
ruses, ilarviruses, bromoviruses, and hordeiviruses than they
are to those ofRUB (266, 592). Recombinational events within
the Sindbis-like superfamily of viruses described below have
led to reorganization and scrambling of the genomes of this
large group of viruses during evolution (267).
The Sindbis-Like Supergroup of Viruses
One of the more interesting results from the complete
sequencing of many viral genomes has been the close relation-
ships that have been found between certain groups of plant and
animal viruses and, more generally, between all positive-strand
RNA viruses. The alphaviruses possess a genome organization
that is similar to the genome organization of a number of plant
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FIG. 35. Comparison of the genome organization of alphaviruses with that of two families of plant viruses. All three genomes have been drawn
to scale, and the shading for the various domains is the same as that used in Fig. 34. The O is the termination codon read-through to produce the
polymerase. "C" is the coat protein, and -k indicates a tRNA-like structure at the 3' terminus of plant virus RNAs. The two plant viruses and SIN
have extensive sequence homology in the MTR 1, HEL 1, and POL 3 regions. However, the plant viruses have no counterpart of the nonstructural
papain-like proteinase of alphaviruses or of the nsP3 domain, and SIN has no counterpart of the domain transcribed into a separate subgenomic
RNA in tobamoviruses or found in RNA 3 of bromoviruses that is thought to encode a protein essential for systemic spread of virus within a plant.
Modified from reference 525.
viruses, most notably tobacco mosaic virus (522). Sequence
comparisons showed that domains of three nonstructural pro-
teins of alphaviruses, the methyltransferase domain of nsPl,
the helicase domain of nsP2, and the core RNA polymerase
domain of nsP4, were clearly homologous to the corresponding
domains of tobacco mosaic virus and certain other plant
viruses (4, 192). The similarities in genome organization and
the locations of these three domains are illustrated in Fig. 35.
The plant members of this group of viruses related to alpha-
viruses include tobamoviruses, tobraviruses, hordeiviruses, fu-
roviruses (soil-borne wheat mosaic virus), cucumoviruses, bro-
moviruses, and alfalfa mosaic viruses (267, 433), and this group
of viruses has been referred to as the Sindbis-like or alpha-like
supergroup of viruses. In addition to the three homologous
domains that are found in the same relative location on the
genome (in nonsegmented viruses), all of these viruses tran-
scribe one or more subgenomic RNAs, including a subgenomic
RNA for the structural protein(s), all are capped, and many of
the viruses require readthrough of a termination codon to
translate the RNA polymerase (reviewed in reference 152).
There are also many differences among the viruses. The
structural proteins have at least three different origins (giving
rise to viruses with different structures), and many of the genes
are not shared among all viruses. The alphaviruses, for exam-
ple, possess a nonstructural papain-like proteinase and a
nonstructural protein nsP3 of unknown function that are not
present in the plant viruses, and the plant viruses possess genes
for movement within the plant that are not present in the
alphavirus genome.
The earliest alignments of the proteins of viruses within the
alphavirus-like group, as well as those within the picornavirus-
like group, aligned proteins that shared 20% or more amino
acid sequence identity, making unambiguous alignment rea-
sonably straightforward. Increasing use of computer-aided
alignment has now made it possible to align more-divergent
proteins by using short motifs that are characteristic of various
viral proteins. The first such motif identified was a 3-residue
GDD motif embedded in a hydrophobic domain that was the
signature of a large number of polymerases of viruses and
bacteria (241). A second motif that was recognized early was
an NTP-binding motif found in helicase molecules, G-X-X-G-
X-GK(T/S). By using such motifs to align proteins from
different viruses, it has now been possible, primarily through
the efforts of Gorbalenya and Koonin but with input from
others as well, to align the RNA polymerases, methyltrans-
ferases, helicases, and proteinases of all plus-strand RNA
viruses into a few groups which, for the most part, are all
related (reviewed in reference 267). These relationships are
illustrated schematically in Fig. 36.
The RNA polymerases of plus-strand RNA viruses have
been found to fall into three or perhaps four supergroups
which, in turn, are all related and probably derived from a
common ancestor (152, 266). The alpha-like viruses all have a
polymerase of group 3 in the nomenclature of Koonin, the
picorna-like viruses have a polymerase of group 1, and the
flaviviruses and their plant relatives (carmoviruses and others)
have a polymerase of group 2. The helicases have also been
found to fall within three lineages. Group 1 helicases are found
in the alpha-like viruses (and in a number of other virus groups
including arteriviruses), group 2 helicases are found in the
flaviviruses, and group 3 helicases are found in the picorna-like
viruses. The methyltransferases have been found to fall in two
groups. Group 1 is characteristic of the alpha-like viruses and
has not been found in any other viruses (433). Group 2 is
present in the flaviviruses.
There is thus a clear clustering of helicases, polymerases,
and methyltransferases into three supergroups of plus-strand
RNA viruses. Koonin and Dolja have proposed a taxonomy for
plus-strand RNA viruses based on these alignments and sug-
gested a possible pathway for the divergence of these RNA
viruses from a common ancestor (267). Of interest is the
suggestion that during the evolution of the alphaviruses, a
recombination event occurred with a tobamo-like virus so that
the methyltransferase and helicase of alphaviruses are more
closely related to those of tobamoviruses than they are to those
of rubiviruses.
CONCLUDING REMARKS
The alphaviruses now represent one of the best-defined
animal virus systems. From extensive sequence analyses of
many alphaviruses, the relationships among members of the
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FIG. 36. Genome organizations of plus-strand RNA viruses. These viruses can be grouped into three supergroups based on sequence
relationships. The RNA polymerases (POL) can be divided into three groups, as shown; the proteinases (PRO) can be divided into three groups;
the methyltransferases (MTR) can be divided into two groups; and the helicases (HEL) can be divided into two groups. Some viruses also have
a VPg (genome-linked virus protein) or a domain labeled X (function unknown) that is shared by more than one virus. From a relatively small
number of building blocks it is possible to arrive at the genomes of all of these viruses by divergence of individual domains and by recombination
to reassemble them into different plans. Data for this figure are from reference 267.
group are known. Sequence elements required for RNA
replication and encapsidation have been identified and char-
acterized, and the function of these elements has been exam-
ined by site-specific mutagenesis and deletion mapping. Se-
quence comparisons have elucidated relationships between
alphaviruses and plant viruses, leading to a better understand-
ing of the evolution of these viruses in nature. Furthermore,
full-length cDNA clones from which infectious RNA can be
transcribed in vitro have been constructed for at least four
alphaviruses, SIN, RR, SF, and VEE viruses, which has made
possible a host of experiments. Such experiments include the
mapping of ts mutants that help define the functions of many
of the virus-encoded proteins, the mapping of mutations that
lead to increased or decreased virulence, and the construction
of site-specific mutants. Possession of clones for more than one
virus also makes it possible to compare the effects of a
mutation in one virus with the result found for the identical
mutation in a second virus and permits the exploration of
hybrid genomes in which the genomes are combined in various
ways to ask which elements are able to interact with elements
of a second virus, either at the protein level or at the RNA
level. We have in our hands an extensively characterized
genetic system for further study, and it is certain that over the
next few years we will learn a great deal more about these
viruses, their evolution, and details of their molecular biology.
ACKNOWLEDGMENTS
We are grateful to our many colleagues who shared ideas with us
and who furnished us with material before publication. We are
particularly grateful to R. H. Cheng, R. J. Kuhn, N. H. Olson, M. G.
Rossmann, H.-K. Choi, and T. S. Baker for furnishing us with figures
of RR virus structure prior to publication.
Our work is supported by grants AI 10793 and Al 20612 from NIH
and grant DMB-9104054 from NSF.
REFERENCES
1. Abell, B. A., and D. T. Brown. 1993. Sindbis virus membrane
fusion is mediated by reduction of glycoprotein disulfide bridges
at the cell surface. J. Virol. 67:5496-5501.
2. Acheson, N. H., and I. Tamm. 1967. Replication of Semliki Forest
virus: an electron microscopic study. Virology 32:128-143.
3. Adams, R. H., and D. T. Brown. 1985. BHK cells expressing
Sindbis virus-induced homologous interference allow the trans-
lation of nonstructural genes of superinfecting virus. J. Virol.
54:351-357.
4. Ahlquist, P., E. G. Strauss, C. M. Rice, J. H. Strauss, J. Haseloff,
and D. Zimmern. 1985. Sindbis virus proteins nsPl and nsP2
contain homology to nonstructural proteins from several RNA
plant viruses. J. Virol. 53:536-542.
5. Alanen, M., J. Wartiovaara, and H. Soderlund. 1987. Sequences
conserved in the defective interfering RNAs of Semliki Forest
virus: an electron microscopic heteroduplex analysis. Hereditas
106:19-29.
Supergroup
110
A ;1. .kw ll.-&%i ito-bo AAJL;OJLJ A.
VOL. 58, 1994
X P-PRO C, PRO
BELl
548 STRAUSS AND STRAUSS
6. Aliperti, G., and M. J. Schlesinger. 1978. Evidence for an
autoprotease activity of Sindbis virus capsid protein. Virology
90:366-369.
7. Anthony, R. P., and D. T. Brown. 1991. Protein-protein interac-
tions in an alphavirus membrane. J. Virol. 65:1187-1194.
8. Anthony, R. P., A. M. Paredes, and D. T. Brown. 1993. Disulfide
bonds are essential for the stability of the Sindbis virus envelope.
Virology 190:330-336.
9. Arias, C., J. R. Bell, E. M. Lenches, E. G. Strauss, and J. H.
Strauss. 1983. Sequence analysis of two mutants of Sindbis virus
defective in the intracellular transport of their glycoproteins. J.
Mol. Biol. 168:87-102.
10. Arthur, C. E., E. Lee, I. D. Marshall, R. C. Weir, and L.
Dalgarno. Unpublished data.
11. Atkins, G. J. 1976. The effect of infection with Sindbis virus and
its temperature-sensitive mutants on cellular protein and DNA
synthesis. Virology 71:593-597.
12. Atkins, G. J. 1979. Establishment of persistent infection in
BHK-21 cells by temperature-sensitive mutants of Sindbis virus.
J. Gen. Virol. 45:201-207.
13. Atkins, G. J., B. J. Sheahan, and N. J. Dimmock. 1985. Semliki
Forest virus infection of mice: a model for genetic and molecular
analysis of viral pathogenicity. J. Gen. Virol. 66:395-408.
14. Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life
of a protein is a function of its amino-terminal residue. Science
234:179-186.
15. Bachmair, A., and A. Varshavsky. 1989. The degradation signal in
a short-lived protein. Cell 56:1019-1032.
16. Bailyes, E. M., K. I. J. Shennan, A. J. Seal, S. P. Smeekens, D. F.
Steiner, J. C. Hutton, and K. Docherty. 1992. A member of the
eukaryotic subtilisin family (PC3) has the enzymatic properties of
the type 1 proinsulin-converting endopeptidase. Biochem. J.
285:391-394.
17. Baric, R. S., L. J. Carlin, and R. E. Johnston. 1983. Requirement
for host transcription in the replication of Sindbis virus. J. Virol.
45:200-205.
18. Baric, R. S., D. W. Trent, and R. E. Johnston. 1981. A Sindbis
virus variant with a cell-determined latent period. Virology
110:237-242.
19. Barr, P. J. 1991. Mammalian subtilisins: the long-sought dibasic
processing endoproteases. Cell 66:1-3.
20. Barrett, A. D. T., W. D. Cubitt, and N. J. Dimmock. 1984.
Defective interfering particles of Semliki Forest virus are smaller
than particles of standard virus. J. Gen. Virol. 65:2265-2268.
21. Barth, B. U., M. Suomalainen, P. Liljestrom, and H. Garoff. 1992.
Alphavirus assembly and entry: role of the cytoplasmic tail of the
El spike subunit. J. Virol. 66:7560-7564.
22. Barton, D. J., S. G. Sawicki, and D. L. Sawicki. 1988. Demon-
stration in vitro of temperature-sensitive elongation of RNA in
Sindbis virus mutant ts6. J. Virol. 62:3597-3602.
23. Barton, D. J., S. G. Sawicki, and D. L. Sawicki. 1991. Solubiliza-
tion and immunoprecipitation of alphavirus replication com-
plexes. J. Virol. 65:1496-1506.
24. Bashford, C. L., G. M. Alder, M. A. Gray, K. J. Micklem, C. C.
Taylor, P. J. Turek, and C. A. Pasternak. 1985. Oxonol dyes as
monitors of membrane potential: the effects of viruses and toxins
on the plasma membrane potential of animal cells in monolayer
culture and in suspension. J. Cell. Physiol. 123:326-336.
25. Beltzer, J. P., K. Fiedler, C. Fuhrer, I. Geffen, C. Handschin,
H. P. Wessels, and M. Spiess. 1991. Charged residues are major
determinants of the transmembrane orientation of a signal-
anchor sequence. J. Biol. Chem. 266:973-978.
26. Berben-Bloemheuvel, G., M. A. M. Kasperaitis, H. van Heugten,
A. A. M. Thomas, H. van Steeg, and H. 0. Voorma. 1992.
Interaction of initiation factors with the cap structure of chimae-
ric mRNA containing the 5'-untranslated regions of Semliki
Forest virus RNA is related to translational efficiency. Eur. J.
Biochem. 208:581-587.
27. Berger, M., and M. F. G. Schmidt. 1984. Identification of acyl
donors and acceptor proteins for fatty acid acylation in BHK cells
infected with Semliki Forest virus. EMBO J. 3:713-719.
28. Berglund, P., M. Sjoberg, G. J. Atkins, B. J. Sheahan, and P.
Liljestrom. 1993. Semliki Forest virus expression system: produc-
tion of conditionally infectious recombinant particles. Bio/Tech-
nology 11:916-920.
29. Birdwell, C. R., E. G. Strauss, and J. H. Strauss. 1973. Replica-
tion of Sindbis virus. III. An electron microscopic study of virus
maturation using the surface replica technique. Virology 56:429-
438.
30. Birdwell, C. R., and J. H. Strauss. 1974. Distribution of the
receptor sites for Sindbis virus on the surface of chicken and
BHK cells. J. Virol. 14:672-678.
31. Boege, U., G. Wengler, G. Wengler, and B. Wittman-Liebold.
1981. Primary structure of the core proteins of the alphaviruses
Semliki Forest virus and Sindbis virus. Virology 113:293-303.
32. Boere, W. A. M., B. J. Benaissa-Trouw, M. Harmsen, C. A.
KraaiJeveld, and H. Snippe. 1983. Neutralizing and non-neutral-
izing monoclonal antibodies to the E2 glycoprotein of Semliki
Forest virus can protect mice from lethal encephalitis. J. Gen.
Virol. 64:1405-1408.
33. Boere, W. A. M., B. J. Benaissa-Trouw, T. Harmsen, T. Erich,
C. A. Kraaijeveld, and H. Snippe. 1985. Mechanisms of mono-
clonal antibody-mediated protection against virulent Semliki
Forest virus. J. Virol. 54:546-551.
34. Boere, W. A. M., B. J. Benaissa-Trouw, T. Harmsen, T. Erich,
C. A. Kraaijeveld, and H. Snippe. 1986. The role of complement
in monoclonal antibody-mediated protection against virulent
Semliki Forest virus. Immunology 58:553-559.
35. Boere, W. A. M., T. Harmsen, J. Vinje, B. J. Benaissa-Trouw,
C. A. KraaiJeveld, and H. Snippe. 1984. Identification of distinct
antigenic determinants on Semliki Forest virus by using mono-
clonal antibodies with different antiviral activities. J. Virol.
52:575-582.
36. Boggs, W. M., C. S. Hahn, E. G. Strauss, J. H. Strauss, and D. E.
Griffin. 1989. Low pH-dependent Sindbis virus-induced fusion of
BHK cells: differences between strains correlated with amino
acid changes in the El glycoprotein. Virology 169:485-488.
37. Bonatti, S., and G. Blobel. 1979. Absence of a cleavable signal
sequence in Sindbis virus glycoprotein PE2. J. Biol. Chem.
254:12261-12264.
38. Bonatti, S., R. Cancedda, and G. Blobel. 1979. Membrane
biogenesis: in vitro cleavage, core glycosylation, and integration
into microsomal membranes of Sindbis virus glycoproteins. J.
Cell Biol. 80:219-224.
39. Bonatti, S., G. Migliaccio, G. Blobel, and P. Walter. 1984. Role of
signal recognition particle in the membrane assembly of Sindbis
viral glycoproteins. Eur. J. Biochem. 140:499-502.
40. Bonatti, S., G. Migliaccio, and K. Simons. 1989. Palmitylation of
viral membrane glycoproteins takes place after exit from the
endoplasmic reticulum. J. Biol. Chem. 264:12590-12595.
41. Both, G. W., and M. J. Sleigh. 1981. Conservation and variation
in the hemagglutininins of Hong Kong subtype influenza viruses
during antigenic drift. J. Virol. 39:663-672.
42. Bowers, D. F., B. A. Abell, and D. T. Brown. Replication of the
alphavirus Sindbis in the mosquito Aedes albopictus. Submitted
for publication.
43. Bowers, D. F., and D. T. Brown. Sindbis virus tropism and
virus-induced cytopathology is tissue specific in Aedes albopictus.
Submitted for publication.
44. Braakman, I., J. Helenius, and A. Helenius. 1992. Role of ATP
and disulphide bonds during protein folding in the endoplasmic
reticulum. Nature (London) 356:260-262.
45. Bredenbeek, P. J., I. Frolov, C. M. Rice, and S. Schlesinger. 1993.
Sindbis virus expression vectors: packaging of RNA replicons by
using defective helper RNAs. J. Virol. 67:6439-6446.
46. Bredenbeek, P. J., and C. M. Rice. 1992. Animal RNA virus
expression systems. Semin. Virol. 3:297-310.
47. Bron, R., J. M. Wahlberg, H. Garoff, and J. Wilschut. 1993.
Membrane fusion of Semliki Forest virus in a model system:
correlation between fusion kinetics and structural changes in the
envelope glycoprotein. EMBO J. 12:693-701.
48. Brown, D. T. 1994. Personal communication.
49. Brown, D. T., and L. D. Condreay. 1986. Replication of alphavi-
ruses in mosquito cells, p. 171-203. In S. Schlesinger and M. J.
Schlesinger (ed.), The Togaviridae and Flaviviridae. Plenum
Publishing Corp., New York.
MICROBIOL. REV.
THE ALPHAVIRUSES 549
50. Brown, D. T., and J. Edwards. 1992. Structural changes in
alphaviruses accompanying the process of membrane penetra-
tion. Semin. Virol. 3:519-527.
51. Brown, D. T., and J. B. Gleidman. 1973. Morphological variants
of Sindbis virus obtained from infected mosquito tissue culture
cells. J. Virol. 12:1535-1539.
52. Brown, D. T., and J. F. Smith. 1975. Morphology of BHK-21 cells
infected with Sindbis virus temperature sensitive mutants in
complementation groups D and E. J. Virol. 15:1262-1266.
53. Burness, A. T., I. Pardoe, S. G. Faragher, S. Vrati, and L.
Dalgarno. 1988. Genetic stability of Ross River virus during
epidemic spread in nonimmune humans. Virology 167:639-643.
54. Buzan, J. M., and S. Schlesinger. 1992. Expression of the
nonstructural proteins of Sindbis virus in insect cells by a
baculovirus vector. Virus Res. 23:209-222.
55. Calisher, C. H., and N. Karabatsos. 1988. Arbovirus serogroups:
definition and geographic distribution, p. 19-57. In T. P. Monath
(ed.), The arboviruses: epidemiology and ecology. CRC Press,
Inc., Baca Raton, Fla.
56. Calisher, C. H., N. Karabatsos, J. S. Lazuick, T. Monath, and
K. L. Wolff. 1988. Reevaluation of the Western equine enceph-
alitis antigenic complex of alphaviruses (family Togaviridae) as
determined by neutralization tests. Am. J. Trop. Med. Hyg.
38:447-452.
57. Calisher, C. H., K. S. C. Maness, R. D. Lord, and P. H. Coleman.
1971. Identification of two South American strains of Eastern
equine encephalomyelitis virus from migrant birds captured on
the Mississippi delta. Am. J. Epidemiol. 94:172-178.
58. Calzone, F. J., N. Theze, P. Thiebaud, R. L. Hill, R J. Britten,
and E. D. Davidson. 1988. Developmental appearance of factors
that bind specifically to cis-regulatory sequences of a gene
expressed in the sea urchin embryo. Genes Dev. 2:1074-1088.
59. Cancedda, R., S. Bonatti, and A. Leone. 1981. One extra oligo-
saccharide chain of the high-mannose class in the E2 protein of
a Sindbis virus isolate. J. Virol. 38:8-14.
60. Carrasco, L. 1977. The inhibition of cell functions after viral
infection: a proposed general mechanism. FEBS Lett. 76:11-15.
61. Carrasco, L., M. J. Otero, and J. L. Castrillo. 1988. Modification
of membrane permeability by animal viruses. Pharmacol. Ther.
40:171-212.
62. Casals, J. 1964. Antigenic variants of Eastern equine encephalitis
virus. J. Exp. Med. 119:547-565.
63. Cassell, S., J. Edwards, and D. T. Brown. 1984. Effects of
lysosomotropic weak bases on the infection of BHK-21 cells by
Sindbis virus. J. Virol. 52:857-864.
64. Castronovo, V., A. P. Claysmith, K. T. Barker, V. Cioce, H. C.
Krutzsch, and M. E. Sobel. 1991. Biosynthesis of the 67 kDa high
affinity laminin receptor. Biochem. Biophys. Res. Commun.
177:177-183.
65. Castronovo, V., G. Taraboletti, and M. E. Sobel. 1991. Functional
domains of the 67-kDa laminin receptor precursor. J. Biol.
Chem. 266:20440-20446.
66. Chamberlain, R W. 1980. Epidemiology of arthropod-borne
togaviruses: the role of arthropods as hosts and vectors and of
vertebrate hosts in natural transmission cycles, p. 175-227. In
R. W. Schlesinger (ed.), The togaviruses: biology, structure,
replication. Academic Press, Inc., New York.
67. Chanas, A. C., E. A. Gould, J. C. A. Clegg, and M. G. R Varma.
1982. Monoclonal antibodies to Sindbis virus glycoprotein El can
neutralize, enhance infectivity, and independently inhibit haem-
agglutination or haemolysis. J. Gen. Virol. 58:37-46.
68. Chang, G.-J. J., and D. W. Trent. 1987. Nucleotide sequence of
the genome region encoding the 26S mRNA of Eastern equine
encephalitis virus and the deduced amino acid sequence of the
viral structural proteins. J. Gen. Virol. 68:2129-2142.
69. Chau, V., J. W. Tobias, A. Bachmair, D. Marriott, D. J. Ecker,
D. K. Gonda, and A. Varshavsky. 1989. A multiubiquitin chain is
confined to specific lysine in a targeted short-lived protein.
Science 243:1576-1583.
70. Cheng, R H., R J. Kuhn, N. H. Olson, M. G. Rossmann, H.-K.
Choi, and T. S. Baker. Three-dimensional structure of an envel-
oped alphavirus with T=4 icosahedral symmetry. Submitted for
publication.
71. Choi, H.-K., L. Tong, W. Minor, P. Dumas, U. Boege, M. G.
Rossmann, and G. Wengler. 1991. Structure of Sindbis virus core
protein reveals a chymotrypsin-like serine proteinase and the
organization of the virion. Nature (London) 354:37-43.
72. Clewley, J. P., and S. L. T. Kennedy. 1976. Purification and
polypeptide composition of Semliki Forest virus RNA poly-
merase. J. Gen. Virol. 32:395-411.
73. Collier, N. C., S. P. Adams, H. Weingarten, and M. J.
Schlesinger. 1992. Inhibition of enveloped RNA virus formation
by peptides corresponding to glycoprotein sequences. Antiviral
Chem. Chemother. 3:31-36.
74. Condreay, L. D., and D. T. Brown. 1986. Exclusion of superin-
fecting homologous virus by Sindbis virus-infected Aedes albop-
ictus (mosquito) cells. J. Virol. 58:81-86.
75. Condreay, L. D., and D. T. Brown. 1988. Suppression of RNA
synthesis by a specific antiviral activity in Sindbis virus-infected
Aedes albopictus cells. J. Virol. 62:346-348.
76. Coombs, K., B. Brown, and D. T. Brown. 1984. Evidence for a
change in capsid morphology during Sindbis virus envelopment.
Virus Res. 1:297-302.
77. Coombs, K., and D. T. Brown. 1987. Topological organization of
Sindbis virus capsid protein in isolated nucleocapsids. Virus Res.
7:131-149.
78. Coombs, K., E. Mann, J. Edwards, and D. T. Brown. 1981. Effects
of chloroquine and cytochalasin B on the infection of cells by
Sindbis virus and vesicular stomatitis virus. J. Virol. 37:1060-
1065.
79. Coombs, K. M., and D. T. Brown. 1989. Form-determining
functions in Sindbis virus nucleocapsids: nucleosomelike organi-
zation of the nucleocapsid. J. Virol. 63:883-891.
80. Cross, R K. 1983. Identification of a unique guanine-7-methyl-
transferase in Semliki Forest virus (SFV) infected cell extracts.
Virology 130:452-463.
81. Cross, R. K., and P. J. Gomatos. 1981. Concomitant methylation
and synthesis in vitro of Semliki Forest virus (SFV) ssRNAs by a
fraction from infected cells. Virology 114:542-554.
82. Cutler, D. F., and H. Garoff. 1986. Mutants of the membrane-
binding region of Semliki Forest virus E2 protein. I. Cell surface
transport and fusogenic activity. J. Cell Biol. 102:889-901.
83. Cutler, D. F., P. Melancon, and H. Garoff. 1986. Mutants of the
membrane-binding region of Semliki Forest virus E2 protein. II.
Topology and membrane binding. J. Cell Biol. 102:902-910.
84. Dalgarno, L., C. M. Rice, and J. H. Strauss. 1983. Ross River
virus 26S RNA: complete nucleotide sequence and deduced
sequence of the encoded structural proteins. Virology 129:170-
187.
85. Dalrymple, J. D. 1992. Personal communication.
86. Davey, M. W., and L. Dalgarno. 1974. Semliki Forest virus
replication in cultured Aedes albopictus cells: studies on the
establishment of persistence. J. Gen. Virol. 24:453-463.
87. Davis, N. L., F. J. Fuller, W. G. Dougherty, R. A. Olmsted, and
R. E. Johnston. 1986. A single nucleotide change in the E2
glycoprotein gene of Sindbis virus affects penetration rate in cell
culture and virulence in neonatal mice. Proc. Natl. Acad. Sci.
USA 83:6771-6775.
88. Davis, N. L., D. F. Pence, W. J. Meyer, A. L. Schmaljohn, and
R. E. Johnston. 1987. Alternative forms of a strain-specific
neutralizing antigenic site on the Sindbis virus E2 glycoprotein.
Virology 161:101-108.
89. Davis, N. L., N. Powell, G. F. Greenwald, L. V. Willis, B. J. B.
Johnson, J. Smith, and R E. Johnston. 1991. Attenuating
mutations in the E2 glycoprotein gene of Venezuelan equine
encephalitis virus: construction of single and multiple mutations
in a full-length cDNA clone. Virology 183:20-31.
90. Davis, N. L., L. V. Willis, J. F. Smith, and R. E. Johnston. 1989.
In vitro synthesis of infectious Venezuelan equine encephalitis
virus RNA from a cDNA clone: analysis of a viable deletion
mutant. Virology 171:189-204.
91. de Curtis, I., and K. Simons. 1988. Dissection of Semliki Forest
virus glycoprotein delivery from the trans-Golgi network to the
cell surface in permeabilized BHK cells. Proc. Natl. Acad. Sci.
USA 85:8052-8056.
92. de Groot, R. J., W. R. Hardy, Y. Shirako, and J. H. Strauss. 1990.
VOL. 58, 1994
550 STRAUSS AND STRAUSS
Cleavage-site preferences of Sindbis virus polyproteins contain-
ing the nonstructural proteinase: evidence for temporal regula-
tion of polyprotein processing in vivo. EMBO J. 9:2631-2638.
93. de Groot, R. J., T. Rumenapf, R. J. Kuhn, E. G. Strauss, and J. H.
Strauss. 1991. Sindbis virus RNA polymerase is degraded by the
N-end rule pathway. Proc. Natl. Acad. Sci. USA 88:8967-8971.
94. Diamond, D. C., B. A. Jameson, J. Bonin, M. Kohara, S. Abe, H.
Itoh, T. Komatsu, M. Arita, S. Kuge, A. Nomoto, A. D. M. E.
Osterhaus, R. Crainic, and E. Wimmer. 1985. Antigenic variation
and resistance to neutralization in poliovirus type 1. Science
229:1090-1093.
95. Dickerman, R. W., M. S. Martin, and E. A. Dipaola. 1980. Studies
of Venezuelan encephalitis in migrating birds in relation to
possible transport of virus from South to Central America. Am.
J. Trop. Med. Hyg. 29:269-276.
96. Ding, M., and M. J. Schlesinger. 1989. Evidence that Sindbis
virus nsP2 is an autoprotease which processes the virus nonstruc-
tural polyprotein. Virology 171:280-284.
97. Docherty, K., C. J. Rhodes, N. A. Taylor, K. I. J. Shennan, and
J. C. Hutton. 1989. Proinsulin endopeptidase substrate specific-
ities defined by site-directed mutagenesis of proinsulin. J. Biol.
Chem. 264:18335-18339.
98. Dominguez, G., C.-Y. Wang, and T. K. Frey. 1990. Sequence of
the genome RNA of rubella virus: evidence for genetic rear-
rangement during togavirus evolution. Virology 177:225-238.
99. Doms, R. W., R. A. Lamb, J. K. Rose, and A. Helenius. 1993.
Folding and assembly of viral membrane glycoproteins. Virology
193:545-562.
100. Dotti, C. G., J. Kartenbeck, and K. Simons. 1993. Polarized
distribution of the viral glycoproteins of vesicular stomatitis, fowl
plague and Semliki Forest viruses in hippocampal neurons in
culture: a light and electron microscopy study. Brain Res. 610:
141-147.
101. Doxsey, S. J., F. M. Brodsky, G. S. Blank, and A. Helenius. 1987.
Inhibition of endocytosis by anti-clathrin antibodies. Cell 50:453-
463.
102. Dubuisson, J., and C. M. Rice. 1993. Sindbis virus attachment:
isolation and characterization of mutants with impaired binding
to vertebrate cells. J. Virol. 67:3363-3374.
103. Durbin, R., A. Kane, and V. Stollar. 1991. A mutant of Sindbis
virus with altered plaque morphology and a decreased ratio of
26S:49S RNA synthesis in mosquito cells. Virology 183:306-312.
104. Durbin, R. K., E. deClercq, and V. Stollar. 1988. SVLM21, a
mutant of Sindbis virus able to grow in Aedes albopictus cells in
the absence of methionine, shows increased sensitivity to S-
adenosylhomocysteine hydrolase inhibitors such as neplanocin.
Virology 163:218-221.
105. Durbin, R. K., and V. Stollar. 1984. A mutant of Sindbis virus
with a host-dependent defect in maturation associated with
hyperglycosylation of E2. Virology 135:331-344.
106. Durbin, R. K., and V. Stollar. 1985. Sindbis virus mutants able to
replicate in methionine-deprived Aedes albopictus cells. Virology
144:529-533.
107. Durbin, R. K., and V. Stollar. 1986. Sequence analysis of the E2
gene of a hyperglycosylated, host restricted mutant of Sindbis
virus and estimation of mutation rate from frequency of rever-
tants. Virology 154:135-143.
108. Edwards, J., and D. T. Brown. 1984. Sindbis virus induced fusion
of tissue cultured Aedes albopictus (mosquito) cells. Virus Res.
1:705-711.
109. Edwards, J., and D. T. Brown. 1991. Sindbis virus infection of a
Chinese hamster ovary cell mutant defective in the acidification
of endosomes. Virology 182:28-33.
110. Edwards, J., E. Mann, and D. T. Brown. 1983. Conformational
changes in Sindbis virus envelope proteins accompanying expo-
sure to low pH. J. Virol. 45:1090-1097.
111. Ehrenfeld, E. (ed.). 1993. Translational regulation in virus in-
fected cells. Semin. Virol. 4:199-268.
112. Elgizoli, M., Y. Dai, C. Kempf, H. Koblet, and M. R. Michel.
1989. Semliki Forest virus capsid protein acts as a pleiotropic
regulator of host cellular protein synthesis. J. Virol. 63:2921-
2928.
113. Erwin, C., and D. T. Brown. 1983. Requirement of cell nucleus
for Sindbis virus replication in cultured Aedes albopictus (mos-
quito) cells. J. Virol. 45:792-799.
114. Fan, D. P., and B. M. Sefton. 1978. The entry into host cells of
Sindbis virus, vesicular stomatitis virus and Sendai virus. Cell
15:985-992.
115. Faragher, S. G., and L. Dalgarno. 1986. Regions of conservation
and divergence in the 3' untranslated sequences of genomic RNA
from Ross River virus isolates. J. Mol. Biol. 190:141-148.
115a.Faragher, S. G., I. D. Marshall, and L. Dalgarno. 1985. Ross
River genetic variants in Australia and the Pacific islands. Aust.
J. Exp. Biol. Med. Sci. 63:473-488.
116. Faragher, S. G., A. D. J. Meek, C. M. Rice, and L. Dalgarno.
1988. Genome sequences of a mouse-avirulent and a mouse-
virulent strain of Ross River virus. Virology 163:509-526.
117. Fazakerley, J. K., S. Pathak, M. Scallan, S. Amor, and H. Dyson.
1993. Replication of the A7(74) strain of Semliki Forest virus is
restricted in neurons. Virology 195:627-637.
118. Feener, E. P., W.-C. Shen, and H. J.-P. Ryser. 1990. Cleavage of
disulfide bonds in endocytosed macromolecules. J. Biol. Chem.
265:18780-18785.
119. Feng, D.-F., and R. F. Doolittle. 1987. Progressive sequence
alignment as a prerequisite to correct phylogenetic trees. J. Mol.
Evol. 25:351-360.
120. Feng, Y.-X., T. D. Copeland, S. Oroszlan, A. Rein, and J. G.
Levin. 1990. Identification of amino acids inserted during sup-
pression of UAA and UGA termination codons at the gag-pol
junction of Moloney murine leukemia virus. Proc. Natl. Acad.
Sci. USA 87:8860-8863.
121. Flynn, D. C., W. J. Meyer, J. M. MacKenzie, and R. C. Johnston.
1990. A conformational change in Sindbis glycoprotein El and
E2 is detected at the plasma membrane as a consequence of early
virus-cell interaction. J. Virol. 64:3643-3653.
122. Flynn, D. C., R. A. Olmsted, J. J. Mackenzie, and R. E. Johnston.
1988. Antibody-mediated activation of Sindbis virus. Virology
166:82-90.
123. Frey, T. K. Molecular biology of rubella virus. Adv. Virus Res., in
press.
124. Friedman, R M., J. G. Levin, P. M. Grimley, and I. K. Berezesky.
1972. Membrane associated replication complex in arbovirus
infection. J. Virol. 10:504-515.
125. Fries, E., and A. Helenius. 1979. Binding of Semliki Forest virus
and its spike glycoprotein to cells. Eur. J. Biochem. 97:213-220.
126. Frolov, I., and S. Schlesinger. 1994. A comparison of the effects
of Sindbis virus and Sindbis virus replicons on host cell protein
synthesis and cytopathogenicity in BHK cells. J. Virol. 68:1721-
1727.
127. Froshauer, S., J. Kartenbeck, and A. Helenius. 1988. Alphavirus
RNA replicase is located on the cytoplasmic surface of endo-
somes and lysosomes. J. Cell Biol. 107:2075-2086.
128. Fulhorst, C. F., J. L. Hardy, B. F. Eldrige, S. B. Presser, and
W. C. Reeves. 1994. Natural vertical transmission of Western
equine encephalomyelitis virus in mosquitoes. Science 263:676-
678.
129. Fuller, R. S., R. E. Sterne, and J. Thorner. 1988. Enzymes
required for yeast prohormone processing. Annu. Rev. Physiol.
50:345-362.
130. Fuller, S. D. 1987. The T=4 envelope of Sindbis virus is orga-
nized by interactions with a complementary T=3 capsid. Cell
48:923-934.
131. Fuller, S. D., R. Bravo, and K. Simons. 1985. An enzymatic assay
reveals that proteins destined for the apical or basolateral
domains of an epithelial cell share the same late Golgi compart-
ment. EMBO J. 4:297-307.
132. Gaedigk-Nitschko, K., M. Ding, and M. J. Schlesinger. 1990.
Site-directed mutations in the Sindbis virus 6K protein reveal
sites for fatty acylation and the underacylated protein affects virus
release and virion structure. Virology 175:282-291.
133. Gaedigk-Nitschko, K., and M. J. Schlesinger. 1990. The Sindbis
virus 6K protein can be detected in virions and is acylated with
fatty acid. Virology 175:274-281.
134. Gaedigk-Nitschko, K., and M. J. Schlesinger. 1991. Site-directed
mutations in Sindbis virus E2 glycoprotein's cytoplasmic domain
and the 6K protein lead to similar defects in virus assembly and
MICROBIOL. REV.
THE ALPHAVIRUSES 551
budding. Virology 183:206-214.
135. Gahmberg, C. G., G. Utermann, and K. Simons. 1972. The
membrane proteins of Semliki Forest virus have a hydrophobic
part attached to the viral membrane. FEBS Lett. 28:179-182.
136. Garavito, R. M., M. G. Rossmann, P. Argos, and W. Eventoff.
1977. Convergence of active site geometries. Biochemistry 16:
5065-5071.
137. Garoff, H., A. M. Frischauf, K. Simons, H. Lehrach, and H.
Delius. 1980. The capsid protein of Semliki Forest virus has
clusters of basic amino acids and prolines in its amino-terminal
region. Proc. Natl. Acad. Sci. USA 77:6376-6380.
138. Garoff, H., A. M. Frischauf, K Simons, H.Lehrach, and H. Delius.
1980. Nucleotide sequence of cDNA coding for Semliki Forest virus
membrane glycoproteins. Nature (London) 288:236-241.
139. Garoff, H., D. Huylebroeck, A. Robinson, U. Tillman, and P.
Liljestrom. 1990. The signal sequence of the p62 protein of
Semliki Forest virus is involved in initiation but not in completing
chain translocation. J. Cell Biol. 111:867-876.
140. Garoff, H., C. Kondor-Koch, R. Petterson, and B. Burke. 1983.
Expression of Semliki Forest virus proteins from cloned comple-
mentary DNA. II. The membrane-spanning glycoprotein E2 is
transported to the cell surface without its normal cytoplasmic
domain. J. Cell Biol. 97:652.
141. Garoff, H., and K. Simons. 1974. Location of the spike glycopro-
teins in the Semliki Forest virus membrane. Proc. Natl. Acad. Sci.
USA 71:3988-3992.
142. Garoff, H., K. Simons, and B. Dobberstein. 1978. Assembly of the
Semliki Forest virus membrane glycoproteins in the membrane of
the endoplasmic reticulum in vitro. J. Mol. Biol. 124:587-600.
143. Garry, R. F. 1994. Sindbis virus-induced inhibition of protein
synthesis is partially reversed by medium containing an elevated
potassium concentration. J. Gen. Virol. 75:411-415.
144. Garry, R. F., J. M. Bishop, S. Parker, K. Westbrook, G. Lewis,
and M. R. F. Waite. 1979. Na+ and K' concentrations and the
regulation of protein synthesis in Sindbis virus-infected chick
cells. Virology 96:108-120.
145. Garry, R. F., and D. A. Bostick. 1987. Induction of the stress
response: alterations in membrane associated transport systems
and protein modification in heat shocked or Sindbis virus-
infected cells. Virus Res. 8:245-259.
146. Garry, R. F., K. Westbrook, and M. R. F. Waite. 1979. Differential
effects of ouabain on host- and Sindbis virus-specific protein
synthesis. Virology 99:179-182.
147. Gaulton, G. N., and M. I. Greene. 1986. Idiotypic mimicry of
biological receptors. Annu. Rev. Immun. 4:253-280.
148. Geigenmuller-Gnirke, U., H. Nitschko, and S. Schlesinger. 1993.
Deletion analysis of the capsid protein of Sindbis virus: identifi-
cation of the RNA binding region. J. Virol. 67:1620-1626.
149. Geigenmuller-Gnirke, U., B. Weiss, R. Wright, and S.
Schlesinger. 1991. Complementation between Sindbis viral
RNAs produces infectious particles with a bipartite genome.
Proc. Natl. Acad. Sci. USA 88:3253-3257.
150. Gidwitz, S., J. M. Polo, N. L. Davis, and R. E. Johnston. 1988.
Differences in virion stability among Sindbis virus pathogenesis
mutants. Virus Res. 10:225-239.
151. Glanville, N., and J. Ulmanen. 1976. Biological activity of in vitro
synthesized protein: binding of Semliki Forest virus capsid pro-
tein to the large ribosomal subunit. Biochem. Biophys. Res.
Commun. 71:393-399.
152. Goldbach, R., 0. Le Gall, and J. Wellink. 1991. Alpha-like viruses
in plants. Semin. Virol. 2:19-25.
153. Gomatos, P. J., L. Kaiariainen, S. Keranen, M. Ranki, and D. L.
Sawicki. 1980. Semliki Forest virus replication complex capable
of synthesizing 42S and 26S nascent RNA chains. J. Gen. Virol.
49:61-69.
154. Gonda, D. K., A. Bachmair, I. Wunning, J. W. Tobias, W. S. Lane,
and A. Varshavsky. 1989. Universality and structure of the N-end
rule. J. Biol. Chem. 264:16700-16712.
155. Gorbalenya, A. E., V. M. Blinov, A. P. Donchenko, and E. V.
Koonin. 1989. An NTP-binding motif is the most conserved
sequence in a highly diverged monophyletic group of proteins
involved in positive strand RNA virus replication. J. Mol. Evol.
28:256-268.
156. Gorbalenya, A. E., A. P. Donchenko, E. V. Koonin, and V. M.
Blinov. 1989. N-terminal domains of putative helicases of flavi-
and pestiviruses may be serine proteases. Nucleic Acids Res.
17:3889-3897.
157. Gorbalenya, A. E., E. V. Koonin, A. P. Donchenko, and V. M.
Blinov. 1988. A conserved NTP-binding motif in putative heli-
cases. Nature (London) 333:22.
158. Gorbalenya, A. E., E. V. Koonin, A. P. Donchenko, and V. M.
Blinov. 1988. A novel superfamily of nucleoside triphosphate-
binding motif containing proteins which are probably involved in
duplex unwinding in DNA and RNA replication and recombina-
tion. FEBS Lett. 235:16-24.
159. Gorbalenya, A. E., E. V. Koonin, A. P. Donchenko, and V. M.
Blinov. 1989. Two related superfamilies of putative helicases
involved in replication, repair, and expression of DNA and RNA
genomes. Nucleic Acids Res. 17:4713-4730.
160. Gorbalenya, A. E., E. V. Koonin, and M. M. C. Lai. 1991. Putative
papain-related thiol proteases of positive-strand RNA viruses.
FEBS Lett. 288:201-205.
161. Gorbalenya, A. E., E. V. Koonin, and Y. I. Wolf. 1990. A new
superfamily of putative NTP-binding domains encoded by ge-
nomes of small DNA and RNA viruses. FEBS Lett. 262:145-148.
162. Grakoui, A., R. Levis, R. Raju, H. V. Huang, and C. M. Rice.
1989. A cis-acting mutation in the Sindbis virus junction region
which affects subgenomic RNA synthesis. J. Virol. 63:5216-5227.
163. Gray, M. A., S. A. Austin, M. J. Clemens, L. Rodrigues, and C. A.
Pasternak. 1983. Protein synthesis in Semliki Forest virus-in-
fected cells is not controlled by permeability changes. J. Gen.
Virol. 64:2361-2640.
164. Gray, M. A., K. J. Micklem, and C. A. Pasternak. 1983. Effect of
vesicular stomatitis virus and Semliki Forest virus on uptake of
nutrients and intracellular cation concentration. J. Gen. Virol.
64:1449-1456.
165. Gray, M. A., K. J. Micklem, and C. A. Pasternak. 1983. Protein
synthesis in cells infected with Semliki Forest virus is not
controlled by intracellular cation changes. Eur. J. Biochem.
135:299-302.
166. Griffin, D. E. 1986. Alphavirus pathogenesis and immunity, p.
209-250. In S. Schlesinger and M. J. Schlesinger (ed.), The
Togaviridae and Flaviviridae. Plenum Publishing Corp., New
York.
167. Griffin, D. E. 1989. Molecular pathogenesis of Sindbis virus
encephalitis in experimental animals. Adv. Virus Res. 36:255-
271.
168. Griffin, D. E., C. S. Hahn, A. C. Jackson, S. Lustig, E. G. Strauss,
and J. H. Strauss. 1989. The basis of Sindbis virus neuroviru-
lence. UCLA Symp. Mol. Cell. Biol. New Ser. 90:387-396.
169. Griffin, D. E., and R. Johnson. 1977. Role of the immune
response in recovery from Sindbis virus encephalitis in mice. J.
Immunol. 118:1070-1075.
170. Grifliths, G., P. Quinn, and G. Warren. 1983. Dissection of the
Golgi complex. I. Monensin inhibits the transport of viral mem-
brane proteins from medial to trans Golgi cisternae in baby
hamster kidney cells infected with Semliki Forest virus. J. Cell
Biol. 96:835-850.
171. Grimley, P. M., L. K. Berezesky, and R. M. Friedman. 1968.
Cytoplasmic structures associated with an arbovirus infection:
loci of viral ribonucleic acid synthesis. J. Virol. 2:1326-1338.
172. Grimley, P. M., J. G. Levin, I. K. Berezesky, and R. M. Friedman.
1972. Specific membranous structures associated with the repli-
cation of group A arboviruses. J. Virol. 10:492-503.
173. Grosfeld, H., B. Velan, M. Leitner, S. Cohen, S. Lustig, B. E.
Lachmi, and A. Shafferman. 1989. Semliki Forest virus E2
envelope epitopes induce a nonneutralizing humoral response
which protects mice against lethal challenge. J. Virol. 63:3416-
3422.
174. Grosso, L. E., P. W. Park, and R. P. Mecham. 1991. Character-
ization of a putative clone for the 67-kilodalton elastin/laminin
receptor suggests that it encodes a cytoplasmic protein rather
than a cell surface receptor. Biochemistry 30:3346-3350.
175. Hahn, C. S. 1993. Personal communication.
176. Hahn, C. S., Y. S. Hahn, T. J. Braciale, and C. M. Rice. 1992.
Infectious Sindbis virus transient expression vectors for studying
VOL. 58, 1994
552 STRAUSS AND STRAUSS
antigen processing and presentation. Proc. Natl. Acad. Sci. USA
89:2679-2683.
177. Hahn, C. S., S. Lustig, E. G. Strauss, and J. H. Strauss. 1988.
Western equine encephalitis virus is a recombinant virus. Proc.
Natl. Acad. Sci. USA 85:5997-6001.
178. Hahn, C. S., C. M. Rice, E. G. Strauss, E. M. Lenches, and J. H.
Strauss. 1989. Sindbis virus tslO3 has a mutation in glycoprotein
E2 that leads to defective assembly of virions. J. Virol. 63:3459-
3465.
179. Hahn, C. S., E. G. Strauss, and J. H. Strauss. 1985. Sequence
analysis of three Sindbis virus mutants temperature-sensitive in
the capsid autoprotease. Proc. Natl. Acad. Sci. USA 82:4648-
4652.
180. Hahn, C. S., and J. H. Strauss. 1990. Site-directed mutagenesis of
the proposed catalytic amino acids of the Sindbis virus capsid
protein autoprotease. J. Virol. 64:3069-3073.
181. Hahn, Y. S., A. Grakoui, C. M. Rice, E. G. Strauss, and J. H.
Strauss. 1989. Mapping of RNA- temperature-sensitive mutants
of Sindbis virus: complementation group F mutants have lesions
in nsP4. J. Virol. 63:1194-1202.
182. Hahn, Y. S., C. S. Hahn, V. L. Braciale, T. J. Braciale, and C. M.
Rice. 1992. CD8+ T cell recognition of an endogenously pro-
cessed epitope is regulated primarily by residues within the
epitope. J. Exp. Med. 176:1335-1341.
183. Hahn, Y. S., E. G. Strauss, and J. H. Strauss. 1989. Mapping of
RNA- temperature-sensitive mutants of Sindbis virus: assign-
ment of complementation groups A, B, and G to nonstructural
proteins. J. Virol. 63:3142-3150.
184. Hanson, R. P., S. E. Sulkin, E. L. Buescher, W. M. Hammon,
R. W. McKinney, and T. H. Work. 1967. Arbovirus infections of
laboratory workers. Science 158:1283-1286.
185. Hardy, J. L. 1988. Susceptibility and resistance of vector mosqui-
toes, p. 87-126. In T. P. Monath (ed.), The arboviruses: epide-
miology and ecology. CRC Press, Inc., Boca Raton, Fla.
186. Hardy, W. R., Y. S. Hahn, R J. de Groot, E. G. Strauss, and J. H.
Strauss. 1990. Synthesis and processing of the nonstructural
polyproteins of several temperature-sensitive mutants of Sindbis
virus. Virology 177:199-208.
187. Hardy, W. R., and J. H. Strauss. 1988. Processing of the
nonstructural polyproteins of Sindbis virus: study of the kinetics
in vivo using monospecific antibodies. J. Virol. 62:998-1007.
188. Hardy, W. R, and J. H. Strauss. 1989. Processing the nonstruc-
tural polyproteins of Sindbis virus: nonstructural proteinase is in
the C-terminal half of nsP2 and functions both in cis and in trans.
J. Virol. 63:4653-4664.
189. Harrison, S. C. 1986. Alphavirus structure, p. 21-34. In S.
Schlesinger and M. J. Schlesinger (ed.), The Togaviridae and
Flaviviridae. Plenum Publishing Corp., New York.
190. Harrison, S. C., A. David, J. Jumblatt, and J. E. Darnell. 1971.
Lipid and protein organization in Sindbis virus. J. Mol. Biol.
60:532.
191. Harrison, S. C., S. Schlesinger, M. J. Schlesinger, and R. K.
Strong. 1992. Crystallization of Sindbis virus and its nucleocap-
sid. J. Mol. Biol. 226:277-280.
192. Haseloff, J., P. Goelet, D. Zimmern, P. Ahiquist, R. Dasgupta,
and P. Kaesberg. 1984. Striking similarities in amino acid se-
quence among nonstructural proteins encoded by RNA viruses
that have dissimilar genomic organization. Proc. Natl. Acad. Sci.
USA 81:4358-4362.
193. Hashimoto, K., S. Erdei, S. Keranen, J. Saraste, and L. Kitaari-
ainen. 1981. Evidence for a separate signal sequence for the
carboxy-terminal envelope glycoprotein El of Semliki Forest
virus. J. Virol. 38:34-40.
194. Heidner, H. W., K. L. McKnight, N. L. Davis, and R. E. Johnston.
1994. Lethality of PE2 incorporation into Sindbis virus can be
suppressed by second-site mutations in E3 and E2. J. Virol.
68:2683-2692.
195. Helenius, A. 1984. Semliki Forest virus penetration from endo-
somes. Biol. Cell. 51:181-186.
196. Helenius, A., and J. Kartenbeck 1980. The effects of octylglu-
coside on the Semliki Forest virus membrane: evidence for a
spike-protein-nucleocapsid interaction. Eur. J. Biochem. 106:
613-618.
197. Helenius, A., J. Kartenbeck, K. Simons, and E. Fries. 1980. On
the entry of Semliki Forest virus into BHK-21 cells. J. Cell Biol.
84:404-420.
198. Helenius, A., M. Kielian, J. Wellsteed, I. Mellman, and G.
Rudnick. 1985. Effects of monovalent cations on Semliki Forest
virus entry into BHK-21 cells. J. Biol. Chem. 260:5691-5697.
199. Helenius, A., M. Marsh, and J. White. 1982. Inhibition of Semliki
Forest virus penetration by lysosomotropic weak bases. J. Gen.
Virol. 58:47-61.
200. Helenius, A., B. Morrein, E. Fries, K. Simons, P. Robinson, V.
Schirrmacher, C. Terhorst, and J. L. Strominger. 1978. Human
(HLA-A and -B) and murine (H2-K and -D) histocompatibility
antigens are cell surface receptors for Semliki Forest virus. Proc.
Natl. Acad. Sci. USA 75:3846-3850.
201. Hertz, J. M., and H. Huang. 1992. Utilization of heterologous
alphavirus junction sequences as promoters by Sindbis virus. J.
Virol. 66:857-864.
202. Higaki, J. N., B. W. Gibson, and C. S. Crailk 1987. Evolution of
catalysis in the serine proteases. Cold Spring Harbor Symp.
Quant. Biol. 52:615-621.
203. Hirsch, R L., D. E. Griflin, and J. A. Winkelstein. 1978. The
effect of complement depletion on the course of Sindbis virus
infection in mice. J. Immunol. 121:1276-1278.
204. Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1980. The role
of complement in viral infections. II. The clearance of Sindbis
virus from the bloodstream and central nervous system of mice
depleted of complement. J. Infect. Dis. 141:212-217.
205. Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1980. Role of
complement in viral infections: participation of terminal comple-
ment components (C5 to C9) in recovery of mice from Sindbis
virus infection. Infect. Immun. 30:899-901.
206. Hirsch, R. L., D. E. Griffin, and J. A. Winkelstein. 1981. Host
modification of Sindbis virus sialic acid content influences alter-
native complement pathway activation and virus clearance. J.
Immunol. 127:1740-1743.
207. Hirsch, R L., D. E. Griffin, and J. A. Winkelstein. 1983. Natural
immunity to Sindbis virus is influenced by host tissue sialic acid
content. Proc. Natl. Acad. Sci. USA 80:548-550.
208. Hirsch, R. L., J. A. Winkelstein, and D. E. Griffin. 1980. The role
of complement in viral infections. III. Activation of the classical
and alternative pathways by Sindbis virus. J. Immunol. 124:2507-
2510.
209. Hodgman, T. C. 1988. A new superfamily of replicative proteins.
Nature (London) 333:22-23.
210. Hoekstra, D., and J. W. Kok. 1989. Entry mechanisms of envel-
oped viruses. Implications for fusion of intracellular membranes.
Biosci. Rep. 9:273-305.
211. Holland, J., K. Spindler, F. Horodyski, E. Grabau, S. Nichol, and
S. VandePol. 1982. Rapid evolution of RNA genomes. Science
215:1577-1585.
212. Holland, J. J., J. C. De La Torre, and D. A. Steinhauer. 1992.
RNA virus populations as quasispecies. Curr. Top. Microbiol.
Immunol. 176:1-20.
213. Houk, E. J., Y. M. Arcus, J. L. Hardy, and L. D. Kramer. 1990.
Binding of Western equine encephalomyelitis virus to brush
border fragments isolated from mesenteronal epithelial cells of
mosquitoes. Virus Res. 17:105-118.
214. Hsieh, P., M. R Rosner, and P. W. Robbins. 1983. Host-
dependent variation of asparagine-linked oligosaccharides at
individual glycosylation sites of Sindbis virion envelope glyco-
proteins. J. Biol. Chem. 258:2548.
215. Hsieh, P., M. R. Rosner, and P. W. Robbins. 1983. Selective
cleavage by endo-,-N-acetylglucosaminidase H at individual
glycosylation sites of Sindbis virion envelope glycoproteins. J.
Biol. Chem. 258:2555.
216. HsuChen, C.-C., and D. T. Dubin. 1976. Di- and trimethylated
cogeners of 7-methylguanine in Sindbis virus mRNA. Nature
(London) 264:190-191.
217. Huang, H. V., C. M. Rice, C. Xiong, and S. Schlesinger. 1989.
RNA viruses as gene expression vectors. Virus Genes 3:85-91.
218. Hunt, A. R, A. J. Johnson, and J. T. Roehrig. 1990. Synthetic
peptides of Venezuelan equine encephalomyelitis virus E2 gly-
coprotein. I. Immunogenic analysis and identification of a pro-
MICROBIOL. REV.
THE ALPHAVIRUSES 553
tective peptide. Virology 179:701-711.
219. Hunt, A. R., and J. T. Roehrig. 1985. Biochemical and biological
characteristics of epitopes on the El glycoprotein of Western
equine encephalitis virus. Virology 142:334-346.
220. Huth, A., T. A. Rapoport, and L. Kaiiriainen. 1984. Envelope
proteins of Semliki Forest virus synthesized in Xenopus oocytes
are transported to the cell surface. EMBO J. 3:767-771.
221. Ivanova, L., and M. J. Schlesinger. 1993. Site-directed mutations
in the Sindbis virus E2 glycoprotein identify palmitoylation sites
and affect virus budding. J. Virol. 67:2546-2551.
222. Jackson, A. C., T. R. Moench, D. E. Griflin, and R. T. Johnson.
1988. The pathogenesis of spinal cord involvement in the enceph-
alomyelitis of mice caused by neuroadapted Sindbis virus infec-
tion. Lab. Invest. 56:418-423.
223. Jackson, A. C., T. R Moench, B. D. Trapp, and D. E. Griffin.
1988. Basis of neurovirulence in Sindbis virus encephalomyelitis
of mice. Lab. Invest. 58:503-509.
224. Jain, S. K., S. DeCandido, and M. Kielian. 1991. Processing of
the p62 envelope precursor protein of Semliki Forest virus. J.
Biol. Chem. 266:5756-5761.
225. Jalanko, A. 1985. Expression of Semliki Forest virus capsid
protein from SV40 recombinant virus. FEBS Lett. 186:59-64.
226. Jalanko, A., and H. Soderlund. 1985. The repeated regions of
Semliki Forest virus defective-interfering RNA interfere with the
encapsidation process of the standard virus. Virology 141:257-
266.
227. Johnson, B. J. B., J. R. Brubaker, J. T. Roehrig, and D. W. Trent.
1990. Variants of Venezuelan equine encephalitis virus that resist
neutralization define a domain of the E2 glycoprotein. Virology
177:676-683.
228. Johnson, B. J. B., R. M. Kinney, C. L. Kost, and D. W. Trent.
1986. Molecular determinants of alphavirus virulence: nucleotide
and deduced protein sequence changes during attenuation of
Venezuelan equine encephalitis virus. J. Gen. Virol. 67:1951-
1960.
229. Johnson, D. C., and M. J. Schlesinger. 1980. Vesicular stomatitis
virus and Sindbis virus glycoprotein transport to the cell surface
is inhibited by ionophores. Virology 103:407-424.
230. Johnson, D. C., M. J. Schlesinger, and E. L. Elson. 1981.
Fluorescence photobleaching recovery measurements reveal dif-
ferences in envelopment of Sindbis and vesicular stomatitis virus.
Cell 23:423-431.
231. Johnson, E. S., D. K. Gonda, and A. Varshavsky. 1990. cis-trans
recognition and subunit-specific degradation of short-lived pro-
teins. Nature (London) 346:287-291.
232. Johnston, R. E., and J. F. Smith. 1988. Selection for accelerated
penetration in cell culture coselects for attenuated mutants of
Venezuelan equine encephalitis virus. Virology 162:437-443.
233. Johnston, R. E., D. R. Tovell, D. T. Brown, and P. Faulkner. 1975.
Interfering passages of Sindbis virus: concomitant appearance of
interference, morphological variants and truncated viral RNA. J.
Virol. 16:951-958.
234. Johnston, R. E., K. Wan, and H. R Bose. 1974. Homologous
interference induced by Sindbis virus. J. Virol. 14:1076-1082.
235. Jones, K. J., R. K Scupham, J. A. Pfeil, K. Wan, B. P. Sagik, and
H. R Bose. 1977. Interaction of Sindbis virus glycoproteins
during morphogenesis. J. Virol. 21:778-787.
236. Justman, J., M. R. Klimjack, and M. Kielian. 1993. Role of spike
protein conformational changes in fusion of Semliki Forest virus.
J. Virol. 67:7597-7607.
237. Kaariainen, L., R. F. Pettersson, S. Keranen, P. Lehtovaara, H.
Soderlund, and P. Ukkonen. 1981. Multiple structurally related
defective-interfering RNAs formed during undiluted passages of
Semliki Forest virus. Virology 113:686-697.
238. Kfaarianen, L., and M. Ranki. 1984. Inhibition of cell functions by
RNA-virus infections. Annu. Rev. Microbiol. 38:91-109.
239. Kail, M., M. Hollinshead, W. Ansorge, R. Pepperkok, R. Frank,
G. Griffiths, and D. Vaux. 1991. The cytoplasmic domain of
alphavirus E2 glycoprotein contains a short linear recognition
signal required for viral budding. EMBO J. 10:2343-2351.
240. Kaluza, G., and G. Pauli. 1980. The influence of intramolecular
disulfide bonds on the structure and function of Semliki Forest
virus membrane glycoproteins. Virology 102:300-309.
241. Kamer, G., and P. Argos. 1984. Primary structural comparison of
RNA-dependent polymerases from plant, animal and bacterial
viruses. Nucleic Acids Res. 12:7269-7282.
242. Kempf, C., U. Kohler, M. R. Michel, and H. Koblet. 1987. Semliki
Forest virus-induced polykaryocyte formation is an ATP-depen-
dent event. Arch. Virol. 95:111-122.
243. Kempf, C., M. R. Michel, U. Kohler, and H. Koblet. 1987. A novel
method for the detection of early events in cell-cell fusion of
Semliki Forest virus infected cells growing in monolayer cultures.
Arch. Virol. 95:283-289.
244. Kempf, C., M. R. Michel, U. Kohler, and H. Koblet. 1988.
Exposure of Semliki Forest virus-infected baby hamster kidney
cells to low pH leads to a proton influx and a rapid depletion of
intracellular ATP which in turn prevents cell-cell fusion. Arch.
Virol. 99:111-115.
245. Kempf, C., M. R. Michel, A. Omar, P. Jentsch, and A. Morell.
1990. Semliki Forest virus induced cell-cell fusion at neutral
extracellular pH. Biosci. Rep. 10:363-374.
246. Keranen, S., and L. Kiiariainen. 1979. Functional defects of
RNA-negative temperature-sensitive mutants of Sindbis and
Semliki Forest viruses. J. Virol. 32:19-29.
247. Keranen, S., and L. Ruohonen. 1983. Nonstructural proteins of
Semliki Forest virus: synthesis, processing, and stability in in-
fected cells. J. Virol. 47:505-515.
248. Kerr, P. J., S. Fitzgerald, G. W. Tregear, L. Dalgarno, and R. C.
Weir. 1992. Characterization of a major neutralization domain of
Ross River virus using anti-viral and anti-peptide antibodies.
Virology 187:338-342.
249. Kerr, P. J., R C. Weir, and L. Dalgarno. 1993. Ross River virus
variants selected during passage in chick embryo fibroblasts:
serological, genetic, and biological changes. Virology 193:446-
449.
250. Kielian, M., and A. Helenius. 1986. Entry of alphaviruses, p.
91-119. In S. Schlesinger and M. J. Schlesinger (ed.), The
Togaviridae and Flaviviridae. Plenum Publishing Corp., New
York.
251. Kielian, M., and S. Jungerwirth. 1990. Mechanism of enveloped
virus entry into cells. Mol. Biol. Med. 7:17-31.
252. Kielian, M., S. Jungerwirth, K. U. Sayad, and S. DeCandido.
1990. Biosynthesis, maturation, and acid activation of the Semliki
Forest virus fusion protein. J. Virol. 64:4614-4624.
253. Kielian, M. C., and A. Helenius. 1984. Role of cholesterol in
fusion of Semliki Forest virus with membranes. J. Virol. 52:281-
283.
254. Kielian, M. C., and A. Helenius. 1985. pH-induced alterations in
the fusogenic spike protein of Semliki Forest virus. J. Cell Biol.
101:2284-2291.
255. Kielian, M. C., S. Keranen, L. Kaariainen, and A. Helenius. 1984.
Membrane fusion mutants of Semliki Forest virus. J. Cell Biol.
98:139-145.
256. Kielian, M. C., M. Marsh, and A. Helenius. 1986. Kinetics of
endosome acidification detected by mutant and wild type Semliki
Forest virus. EMBO J. 5:3103-3109.
257. Kinney, R. M., G.-J. Chang, K. R. Tsuchiya, J. M. Sneider, J. T.
Roehrig, T. M. Woodward, and D. W. Trent. 1993. Attenuation of
Venezuelan equine encephalitis virus strain TC-83 is encoded by
the 5'-noncoding region and the E2 envelope glycoprotein. J.
Virol. 67:1269-1277.
258. Kinney, R. M., B. J. B. Johnson, V. L. Brown, and D. W. Trent.
1986. Nucleotide sequence of the 26S mRNA of the virulent
Trinidad donkey strain of Venezuelan equine encephalitis virus
and deduced sequence of the encoded structural proteins. Virol-
ogy 152:400-413.
259. Kinney, R. M., B. J. B. Johnson, J. B. Welch, K. R Tsuchiya, and
D. W. Trent. 1989. The full-length nucleotide sequences of the
virulent Trinidad donkey strain of Venezuelan equine encepha-
litis virus and its attenuated vaccine derivative, strain TC-83.
Virology 170:19-30.
260. Kinney, R. M., K. R. Tsuchiya, J. M. Sneider, and D. W. Trent.
1992. Genetic evidence that epizootic Venezuelan equine en-
cephalitis (VEE) viruses may have evolved from enzootic VEE
subtype I-D virus. Virology 191:569-580.
261. Kinney, R. M., K. R Tsuchiya, J. M. Sneider, and D. W. Trent.
VOL. 58, 1994
554 STRAUSS AND STRAUSS
1992. Molecular evidence for the origin of the widespread
Venezuelan equine encephalitis epizootic of 1969-1972. J. Gen.
Virol. 73:3301-3305.
262. Koblet, H., C. Kempf, U. Kohler, and A. Omar. 1985. Conforma-
tional changes at pH 6 on the cell surface of Semliki Forest
virus-infected Aedes albopictus cells. Virology 143:334-336.
263. Kohara, M., T. Omata, A. Kameda, B. L. Semler, H. Itoh, E.
Wimmer, and A. Nomoto. 1985. In vitro phenotypic markers of a
poliovirus recombinant constructed from infectious cDNA clone
of the neurovirulent Mahoney strain and the attenuated Sabin 1
strain. J. Virol. 53:786-792.
264. Kondor-Koch, C., B. Burke, and H. Garoff. 1983. Expression of
Semliki Forest virus proteins from cloned complementary
DNA. I. The fusion activity of the spike glycoprotein. J. Cell Biol.
97:644-651.
265. Kondor-Koch, C., H. Riedel, K Soderberg, and H. Garoff. 1982.
Expression of the structural proteins of Semliki Forest virus from
cloned cDNA microinjected into the nucleus of the baby hamster
kidney cells. Proc. Natl. Acad. Sci. USA 79:4525-4529.
266. Koonin, E. V. 1991. The phylogeny of RNA-dependent RNA
polymerases of positive-strand RNA viruses. J. Gen. Virol.
72:2197-2206.
267. Koonin, E. V., and V. V. Dolja. 1993. Evolution and taxonomy of
positive-strand RNA viruses: implications of comparative analy-
sis of amino acid sequences. Crit. Rev. Biochem. Mol. Biol.
28:375-430.
268. Kowal, K. J., and V. Stollar. 1981. Temperature-sensitive host-
dependent mutants of Sindbis virus. Virology 114:140-148.
269. Kuhn, R. J. 1994. Personal communication.
270. Kuhn, R. J., D. E. Griffin, H. G. M. Niesters, and J. H. Strauss.
Unpublished data.
271. Kuhn, R. J., D. E. Griffin, H. Zhang, H. G. M. Niesters, and J. H.
Strauss. 1992. Attenuation of Sindbis virus neurovirulence by
using defined mutations in nontranslated regions of the genome
RNA. J. Virol. 66:7121-7127.
272. Kuhn, R. J., Z. Hong, and J. H. Strauss. 1990. Mutagenesis of the
3' nontranslated region of Sindbis virus RNA. J. Virol. 64:1465-
1476.
273. Kuhn, R. J., H. G. M. Niesters, H. Zhang, and J. H. Strauss.
1991. Infectious RNA transcripts from Ross River virus cDNA
clones and the construction and characterization of defined
chimeras with Sindbis virus. Virology 182:430-441.
274. Kuisamanen, E., and J. Saraste. 1989. Low temperature-induced
transport blocks as tools to manipulate membrane traffic. Meth-
ods Cell Biol. 32:257-274.
275. Lanzrein, M., N. Kasermann, and C. Kempf. 1992. Changes in
membrane permeability during Semliki Forest virus induced cell
fusion. Biosci. Rep. 12:221-236.
276. Lanzrein, M., N. Kasermann, R. Weingart, and C. Kempf. 1993.
Early events of Semliki Forest virus-induced cell-cell fusion.
Virology 196:541-547.
277. Lanzrein, M., R. Weingart, and C. Kempf. 1993. pH-dependent
pore formation in Semliki Forest virus-infected Aedes albopictus
cells. Virology 193:296-302.
278. Laver, W. G., G. M. Air, R. G. Webster, and S. J. Smith-Gill.
1990. Epitopes on protein antigens: misconceptions and realities.
Cell 61:553-556.
279. Leathers, V., R. Tanguay, M. Kobayashi, and D. R. Gallie. 1993.
A phylogenetically conserved sequence within viral 3' untrans-
lated RNA pseudoknots regulates translation. Mol. Cell. Biol.
13:5331-5347.
280. Lee, H., and D. T. Brown. 1994. Mutations in an exposed domain
of Sindbis virus capsid protein result in the production of
noninfectious virions and morphological variants. Virology 202:
390-400.
281. Lehtovaara, P., H. Soderlund, S. Keranen, R. F. Pettersson, and
L. Kiiariainen. 1981. 18S defective interfering RNA of Semliki
Forest virus contains a triplicated linear repeat. Proc. Natl. Acad.
Sci. USA 78:5353-5357.
282. Lehtovaara, P., H. Soderlund, S. Keranen, R. F. Pettersson, and
L. Kiiariainen. 1982. Extreme ends of the genome are conserved
and rearranged in the defective interfering RNAs of Semliki
Forest virus. J. Mol. Biol. 156:731-748.
283. Lemm, J. A., R. K. Durbin, V. Stollar, and C. M. Rice. 1990.
Mutations which alter the level or structure of nsP4 can affect the
efficiency of Sindbis virus replication in a host-dependent man-
ner. J. Virol. 64:3001-3011.
284. Lemm, J. A., and C. M. Rice. 1993. Assembly of functional
Sindbis virus RNA replication complexes: requirement for coex-
pression of P123 and P34. J. Virol. 67:1905-1915.
285. Lemm, J. A., and C. M. Rice. 1993. Roles of nonstructural
polyproteins and cleavage products in regulating Sindbis virus
RNA replication and transcription. J. Virol. 67:1916-1926.
286. Lemm, J. A., T. Rumenapf, E. G. Strauss, J. H. Strauss, and
C. M. Rice. 1994. Polypeptide requirements for assembly of
functional Sindbis virus replication complexes: a model for the
temporal regulation of minus-strand and plus-strand RNA-syn-
thesis. EMBO J. 13:2925-2934.
287. Lerner, D. M., J. M. Deutsch, and G. F. Oster. 1993. How does a
virus bud? Biophys. J. 65:73-79.
288. Levine, B., and D. Griffin. 1993. Molecular analysis of neuroviru-
lent strains of Sindbis virus that evolve during persistent infection
of scid mice. J. Virol. 67:6872-6875.
289. Levine, B., and D. E. Griffin. 1992. Persistence of viral RNA in
mouse brains after recovery from acute alphavirus encephalitis. J.
Virol. 66:6429-6435.
290. Levine, B., H. M. Hardwick, B. D. Trapp, T. 0. Crawford, R. C.
Bollinger, and D. E. Griffin. 1991. Antibody-mediated clearance
of alphavirus infection from neurons. Science 254:856-860.
291. Levine, B., Q. Huang, J. T. Isaacs, J. C. Reed, D. E. Griffin, and
J. M. HardwicL 1993. Conversion of lytic to persistent alphavirus
infection by the bcl-2 cellular oncogene. Nature (London) 361:
739-742.
292. Levinson, R., J. H. Strauss, and E. G. Strauss. 1990. Determi-
nation of the complete nucleotide sequence of the genomic RNA
of O'Nyong-nyong virus and its use in the construction of
phylogenetic trees. Virology 175:110-123.
293. Levis, R., H. Huang, and S. Schlesinger. 1987. Engineered
defective interfering RNAs of Sindbis virus express bacterial
chloramphenicol acetyltransferase in avian cells. Proc. Natl.
Acad. Sci. USA 84:4811-4815.
294. Levis, R., S. Schlesinger, and H. V. Huang. 1990. The promoter
for Sindbis virus RNA-dependent subgenomic RNA transcrip-
tion. J. Virol. 64:1726-1733.
295. Levis, R., B. G. Weiss, M. Tsiang, H. Huang, and S. Schlesinger.
1986. Deletion mapping of Sindbis virus DI RNAs derived from
cDNAs defines the sequences essential for replication and pack-
aging. Cell 44:137-145.
296. Levy-Mintz, P., and M. Kielian. 1991. Mutagenesis of the puta-
tive fusion domain of the Semliki Forest virus spike protein. J.
Virol. 65:4292-4300.
297. Li, G., M. W. LaStarza, W. R. Hardy, J. H. Strauss, and C. M.
Rice. 1990. Phosphorylation of Sindbis vi-us nsP3 in vivo and in
vitro. Virology 179:416-427.
298. Li, G., B. M. Praigai, and C. M. Rice. 1991. Rescue of Sindbis
virus-specific RNA replication and transcription by using a
vaccinia virus recombinant. J. Virol. 65:6714-6723.
299. Li, G., and C. M. Rice. 1989. Mutagenesis of the in-frame opal
termination codon preceding nsP4 of Sindbis virus: studies of
translational readthrough and its effect on virus replication. J.
Virol. 63:1326-1337.
300. Li, G., and C. M. Rice. 1993. The signal for translational
readthrough of a UGA codon in Sindbis virus RNA involves a
single cytidine residue immediately downstream of the termina-
tion codon. J. Virol. 67:5062-5067.
301. LiUestrom, P., and H. Garoff. 1991. Internally located cleavable
signal sequences direct the formation of Semliki Forest virus
membrane proteins from a polyprotein precursor. J. Virol.
65:147-154.
302. Liljestrom, P., and H. Garof. 1991. A new generation of animal
cell expression vectors based on the Semliki Forest virus replicon.
Bio/Technology 9:1356-1361.
303. Liljestrom, P., S. Lusa, D. Huylebroeck, and H. Garoff. 1991. In
vitro mutagenesis of a full-length cDNA clone of Semliki Forest
virus: the small 6000-molecular-weight membrane protein mod-
ulates virus release. J. Virol. 65:4107-4113.
MICROBIOL. REV.
THE ALPHAVIRUSES 555
304. Lindqvist, B. H., J. DiSalvo, C. M. Rice, J. H. Strauss, and E. G.
Strauss. 1986. Sindbis virus mutant ts20 of complementation
groupE contains a lesion in glycoprotein E2. Virology 151:10-20.
305. Lindsay, M. D. A., R. J. Coelen, and J. S. Mackenzie. 1993.
Genetic heterogeneity among isolates of Ross River virus from
different geographical regions. J. Virol. 67:3576-3585.
306. Liu, N., and D. T. Brown. 1993. Transient translocation of the
cytoplasmic (endo) domain of a type I membrane glycoprotein
into cellular membranes. J. Cell Biol. 120:877-883.
307. Liu, N., and D. T. Brown. 1994. Phosphorylation and dephos-
phorylation events play critical roles in Sindbis virus maturation.
Virology 196:703-711.
308. Lobigs, M., and H. Garoff. 1990. Fusion function of the Semliki
Forest virus spike is activated by proteolytic cleavage of the
envelope glycoprotein precursor p62. J. Virol. 64:1233-1240.
309. Lobigs, M., Z. Hongxing, and H. Garoff. 1990. Function of
Semliki Forest virus E3 peptide in virus assembly: replacement of
E3 with an artificial signal peptide abolishes spike heterodimer-
ization and surface expression of El. J. Virol. 64:4346-4355.
309a.Lobigs, M., L. D. Marshall, R. C. Weir, and L. Dalgarno. 1986.
Genetic differentiation of Murray Valley encephalitis virus in
Australia and Papua New Guinea. Aust. J. Exp. Biol. Med. Sci.
64:571-585.
310. Lobigs, M., J. M. Wahlberg, and H. Garoff. 1990. Spike protein
oligomerization control of Semliki Forest virus fusion. J. Virol.
64:5214-5218.
310a.Lobigs, M., R. C. Weir, and L. Dalgarno. 1986. Genetic analysis
of Kunjin virus isolates using HaeIII and TaqI restriction digests
of single-stranded cDNA to virion RNA. Aust. J. Exp. Biol. Med.
Sci. 64:185-196.
311. London, S. D., A. L. Schmaljohn, J. D. Dalrymple, and C. M.
Rice. 1992. Infectious enveloped RNA virus RNA chimeras.
Proc. Natl. Acad. Sci. USA 89:207-211.
312. Lopez, S., J.-S. Yao, R. J. Kuhn, E. G. Strauss, and J. H. Strauss.
1994. Nucleocapsid-glycoprotein interactions required for alpha-
virus assembly. J. Virol. 68:1316-1323.
313. Lord, R. D., and C. H. Calisher. 1970. Further evidence of
southward transport of arboviruses by migratory birds. J. Epide-
miol. 92:73-78.
314. Ludwig, G. V., and J. F. Smith. 1994. Personal communication.
315. Luo, T., and D. T. Brown. 1993. Purification and characterization
of a Sindbis virus-induced peptide which stimulates its own
production and blocks virus RNA synthesis. Virology 194:44-49.
316. Luo, T., and D. T. Brown. 1994. A 55-kDa protein induced in
Aedes albopictus (mosquito) cells by antiviral protein. Virology
200:200-206.
317. Lusa, S., H. Garoff, and P. Liljestrom. 1991. Fate of the 6K
membrane protein of Semliki Forest virus during virus assembly.
Virology 185:843-846.
318. Lustig, S., A. Jackson, C. S. Hahn, D. E. Griflin, E. G. Strauss,
and J. H. Strauss. 1988. Molecular basis of Sindbis virus neuro-
virulence in mice. J. Virol. 62:2329-2336.
319. Maassen, J. A., and C. Terhorst. 1981. Identification of a
cell-surface protein involved in the binding site of Sindbis virus
on human lymphoblastic cell lines using a heterobifunctional
cross-linker. Eur. J. Biochem. 115:153-158.
320. Mabruk, M. J., A. M. Flack, G. M. Glasgow, J. M. Smyth, J. C.
Folan, J. G. Bannigan, M. A. O'Sullivan, B. J. Sheahan, and G. J.
Atkins. 1988. Teratogenicity of the Semliki Forest virus mutant
ts22 for the foetal mouse: induction of skeletal and skin defects.
J. Gen. Virol. 69:2755-2762.
321. Mabruk, M. J., G. M. Glasglow, A. M. Flack, J. C. Folan, J. G.
Bannigan, J. M. Smyth, M. A. O'Sullivan, B. J. Sheahan, and
G. J. Atkins. 1989. Effect of infection with the ts22 mutant of
Semliki Forest virus on development of the central nervous
system in the fetal mouse. J. Virol. 63:4027-4033.
322. Malinoski, F., and V. Stollar. 1980. Inhibition of Sindbis virus
replication in Aedes albopictus cells by virazole (ribavirin) and its
reversal by actinomycin: a correction. Virology 102:473-476.
323. Mann, E., J. Edwards, and D. T. Brown. 1983. Polycaryocyte
formation mediated by Sindbis virus glycoproteins. J. Virol.
45:1083-1089.
324. Marquardt, M. T., T. Phalen, and M. Kielian. 1993. Cholesterol
is required in the exit pathway of Semliki Forest virus. J. Cell
Biol. 123:57-65.
325. Marquardt, T., and A. Helenius. 1992. Misfolding and aggrega-
tion of newly synthesized proteins in the endoplasmic reticulum.
J. Cell Biol. 117:505-513.
326. Marsh, M. 1984. The entry of enveloped viruses into cells by
endocytosis. Biochem. J. 218:1-10.
327. Marsh, M., E. Bolzau, and A. Helenius. 1983. Penetration of
Semliki Forest virus from acidic prelysosomal vacuoles. Cell
32:931-940.
328. Marsh, M., and A. Helenius. 1980. Adsorptive endocytosis of
Semliki Forest virus. J. Mol. Biol. 142:439-454.
329. Marsh, M., and A. Helenius. 1989. Virus entry into animal cells.
Adv. Virus Res. 36:107-151.
330. Marsh, M., J. Wellsteed, H. Kern, E. Harms, and A. Helenius.
1982. Monensin inhibits Semliki Forest virus penetration into
baby hamster kidney (BHK-21) cells. Proc. Natl. Acad. Sci. USA
79:5297-5301.
331. Marshall,I. D., B.K. Brown, K. Keith, G. P. Gard, and E. Thibos.
1982. Variation in arbovirus infection rates in species of birds
sampled in a serological survey during an encephalitis epidemic
in the Murray Valley of south-eastern Australia, February 1974.
Aust. J. Exp. Biol. Med. Sci. 60:471-478.
332. Marshall,I. D., and J. A. R. Miles. 1984. Ross River virus and
epidemic polyarthritis. Curr. Top. Vector Res. 2:31-56.
333. Marshall,I. D., E. Thibos, and K. Clarke. 1982. Species compo-
sition of mosquitoes collected in the Murray Valley of south-
eastern Australia during an epidemic of arboviral encephalitis.
Aust. J. Exp. Biol. Med. Sci. 60:447-456.
334. Marshall,I. D., G. M. Woodroofe, and S. Hirsch. 1982. Viruses
recovered from mosquitoes and wildlife serum collected in the
Murray Valley of south-eastern Australia, February 1974, during
an epidemic of encephalitis. Aust. J. Exp. Biol. Med. Sci.
60:457-470.
335. Martin, E. M., and J. A. Sonnabend. 1967. Ribonucleic acid
polymerase catalyzing synthesis of double-stranded arbovirus
ribonucleic acid. J. Virol. 1:97-109.
336. Mathews, J. H., and J. T. Roehrig. 1982. Determination of the
protective epitopes on the glycoproteins of Venezuelan equine
encephalomyelitis virus by passive transfer of monoclonal anti-
bodies. J. Immunol. 129:2763-2767.
337. Mathiot, C. C., G. Grimaud, P. Garry, J. C. Bouquety, A. Mada,
A. M. Daguisy, and A. J. Georges. 1990. An outbreak of human
Semliki Forest virus infection in Central African Republic. Am. J.
Trop. Med. Hyg. 42:386-393.
338. Matlin, K. S. 1986. The sorting of proteins to the plasma
membrane in epithelial cells. J. Cell Biol. 103:2565-2568.
339. Matlin, K. S., and K. Simons. 1984. Sorting of apical plasma
membrane glycoprotein occurs before it reaches the cell surface
in cultured epithelial cells. J. Cell Biol. 99:2131-2139.
340. Mayne, J. T., J. R. Bell, E. G. Strauss, and J. H. Strauss. 1985.
Pattern of glycosylation of Sindbis virus envelope proteins syn-
thesized in hamster and chicken cells. Virology 142:121-133.
341. McDowell, W., P. A. Romero, R. Datema, and R. T. Schwarz.
1987. Glucose trimming and mannose trimming affect different
phases of the maturation of Sindbis virus in infected BHK cells.
Virology 161:37-44.
342. Meek, A. D. J., S. G. Faragher, R. C. Weir, and L. Dalgarno. 1989.
Genetic and phenotypic studies on Ross River virus variants of
enhanced virulence selected during mouse passage. Virology
172:399-407.
343. Mehta, S., S. Pathak, and H. E. Webb. 1990. Induction of
membrane proliferation in mouse CNS by gold sodium thioma-
late with reference to increased virulence of the avirulent Semliki
Forest virus. Biosci. Rep. 10:271-279.
344. Melancon, P., and H. Garoff. 1986. Reinitiation of translocation
in the Semliki Forest virus structural polyprotein: identification
of the signal for the El glycoprotein. EMBO J. 5:1551-1560.
345. Melancon, P., and H. Garoff. 1987. Processing of the Semliki
Forest virus structural polyprotein: role of the capsid protease. J.
Virol. 61:1301-1309.
346. Mellman, I., and K. Simons. 1992. The Golgi complex: in vitro
veritas? Cell 68:829-840.
VOL. 58, 1994
556 STRAUSS AND STRAUSS
347. Mendoza, Q. P., J. Stanley, and D. E. Griffin. 1988. Monoclonal
antibodies to the El and E2 glycoproteins of Sindbis virus:
definition of epitopes and efficiency of protection from fatal
encephalitis. J. Gen. Virol. 70:3015-3022.
348. Metsikko, K., and H. Garoff. 1990. Oligomers of the cytoplasmic
domain of the p62/E2 membrane protein of Semliki Forest virus
bind to the nucleocapsid in vitro. J. Virol. 64:4678-4683.
349. Meyer, W. J., S. Gidwitz, V. K. Ayers, R. J. Schoepp, and R. E.
Johnston. 1992. Conformational alteration of Sindbis virion
glycoproteins induced by heat, reducing agents, or low pH. J.
Virol. 66:3504-3513.
350. Mi, S., R. Durbin, H. V. Huang, C. M. Rice, and V. Stollar. 1989.
Association of the Sindbis virus RNA methytransferase activity
with the nonstructural protein nsPl. Virology 170:385-391.
351. Mi, S., and V. Stollar. 1990. Both amino acid changes in nsPl of
Sindbis virusLM2l contribute to and are required for efficient
expression of the mutant phenotype. Virology 178:429-434.
352. Mi, S., and V. Stollar. 1991. Expression of Sindbis virus nsPl
methyltransferase activity in Escherichia coli. Virology 184:423-
427.
353. Michel, M. R., M. Elgizoli, Y. Dai, R. Jakob, H. Koblet, and A.-P.
Arrigo. 1990. Karyophilic properties of Semliki Forest virus
nucleocapsid protein. J. Virol. 64:5123-5131.
354. Michel, M. R., and P. J. Gomatos. 1973. Semliki Forest virus-
specific RNAs synthesized in vitro by enzyme from infected BHK
cells. J. Virol. 11:900-914.
355. Migliaccio, G., M. C. Pascale, A. Leone, and S. Bonatti. 1989.
Biosynthesis, membrane translocation, and surface expression of
Sindbis virus El glycoprotein. Exp. Cell Res. 185:203-216.
356. Miller, M. L., and D. T. Brown. 1991. Alphavirus infection in
cultured tissue cells. Adv. Dis. Vector Res. 8:107-142.
357. Miller, M. L., and D. T. Brown. 1993. The distribution of Sindbis
virus proteins in mosquito cells as determined by immunofluo-
rescence and immunoelectron microscopy. J. Gen. Virol. 74:293-
298.
358. Mokhtarian, F., D. Grob, and D. E. Griffin. 1989. Role of the
immune response in Sindbis virus-induced paralysis of SJL/J
mice. J. Immunol. 143:633-637.
359. Mokhtarian, F., and P. Swoveland. 1987. Predisposition to EAE
induction in resistant mice by prior infection with Semliki Forest
virus. J. Immunol. 138:3264-3268.
360. Monroe, S. S., J.-H. Ou, C. M. Rice, S. Schlesinger, E. G. Strauss,
and J. H. Strauss. 1982. Sequence analysis of cDNAs derived
from the RNA of Sindbis virions and of defective interfering
particles. J. Virol. 41:153-162.
361. Monroe, S. S., and S. Schlesinger. 1983. RNAs from two inde-
pendently isolated defective interfering particles of Sindbis virus
contain a cellular tRNA sequence at their 5' ends. Proc. Natl.
Acad. Sci. USA 80:3279-3283.
362. Monroe, S. S., and S. Schlesinger. 1984. Common and distinct
regions of defective-interfering RNAs of Sindbis virus. J. Virol.
49:865-872.
363. Morrison, T., and A. Portner. 1991. Structure, function, and
intracellular processing of the glycoproteins of Paramyxoviridae,
p. 347-382. In D. W. Kingsbuiy (ed.), The paramyxoviruses.
Plenum Publishing Corp., New York.
364. Mudge, P. R., R. S. H. Lim, B. Moore, and A. J. Radford. 1980.
Epidemic polyarthritis in South Australia 1979-1980. Med. J.
Aust. 2:626-627.
365. Mulvey, M., and D. T. Brown. 1994. Formation and rearrange-
ment of disulfide bonds during maturation of the Sindbis virus El
glycoprotein. J. Virol. 68:805-812.
366. Naim, H. Y., and H. Koblet. 1990. The cleavage of p62, the
precursor of E2 and E3, is an early and continuous event in
Semliki Forest virus-infected Aedes albopictus cells. Arch. Virol.
110:221-237.
367. Nakhasi, H. L., X.-Q. Cao, T. A. Rouault, and T.-Y. Liu. 1991.
Specific binding of host cell proteins to the 3'-terminal stem-loop
structure of rubella virus negative-strand RNA. J. Virol. 65:5961-
5967.
368. Nakhasi, H. L., T. A. Rouault, D. J. Haile, T.-Y. Liu, and R. D.
Klausner. 1990. Specific high-affinity binding of host cell proteins
to the 3' region of rubella virus RNA. New Biol. 2:255-264.
369. Newton, S. E., and L. Dalgarno. 1983. Antiviral activity released
from Aedes albopictus cells persistently infected with Semliki
Forest virus. J. Virol. 47:652-655.
370. Niesters, H. G. M., and J. H. Strauss. 1990. Defined mutations in
the 5' nontranslated sequence of Sindbis virus RNA. J. Virol.
64:4162-4168.
371. Niesters, H. G. M., and J. H. Strauss. 1990. Mutagenesis of the
conserved 51 nucleotide region of Sindbis virus. J. Virol. 64:
1639-1647.
372. Niklasson, B. 1988. Sindbis and Sindbis-like viruses, p. 167-176.
In T. P. Monath (ed.), The arboviruses: epidemiology and
ecology. CRC Press, Inc., Boca Raton, Fla.
373. Niklasson, B., A. Aspmark, J. W. LeDuc, T. P. Gargan, W. A.
Ennis, R. B. Tesh, and J. A. J. Main. 1984. Association of a
Sindbis-like virus with Ockelbo disease in Sweden. Am. J. Trop.
Med. Hyg. 33:1212-1217.
374. Nitsch, L., D. Tramontano, and F.-S. Ambesi-Impiombato. 1985.
Morphological and functional polarity of an epithelial thyroid
cell line. Eur. J. Cell Biol. 38:57-66.
375. Nuss, D. L., H. 0. Oppermann, and G. Koch. 1975. Selective
blockage of initiation of host protein synthesis in RNA virus
infected cells. Proc. Natl. Acad. Sci. USA 72:1258-1262.
376. Oldstone, M. B. A., A. Tishon, F. Dutko, S. I. T. Kennedy, J. J.
Holland, and P. W. Lampert. 1980. Does the major histocompat-
ibility complex serve as a specific receptor for Semliki Forest
virus? J. Virol. 34:256-265.
377. Olivo, P. D., I. Frolov, and S. Schlesinger. 1994. A cell line that
expresses a reporter gene in response to infection by Sindbis
virus: a prototype for detection of positive strand RNA viruses.
Virology 198:381-384.
378. Olmsted, R A., R. S. Baric, B. A. Sawyer, and R. E. Johnston.
1984. Sindbis virus mutants selected for rapid growth in cell
culture display attenuated virulence in animals. Science 225:424-
427.
379. Olmsted, R. A., W. J. Meyer, and R. E. Johnston. 1986. Charac-
terization of Sindbis virus epitopes important for penetration in
cell culture and pathogenesis in animals. Virology 148:245-254.
380. Olson, K., and D. W. Trent. 1985. Genetic and antigenic varia-
tions among geographical isolates of Sindbis virus. J. Gen. Virol.
66:797-810.
381. Omar, A., and H. Koblet. 1988. Semliki Forest virus particles
containing only the El envelope glycoprotein are infectious and
can induce cell-cell fusion. Virology 166:17-23.
382. Omar, A., and H. Koblet. 1989. The use of sulfite to study the
mechanism of membrane fusion induced by El of Semliki Forest
virus. Virology 168:177-179.
383. Orci, L., M. Ravazzola, M.-J. Storch, R. G. W. Anderson, J.-D.
Vassalli, and A. Perrelet. 1987. Proteolytic maturation of insulin
is a post-Golgi event which occurs in acidifying clathrin-coated
secretory vesicles. Cell 49:865-868.
384. Ou, J.-H., C. M. Rice, L. Dalgarno, E. G. Strauss, and J. H.
Strauss. 1982. Sequence studies of several alphavirus genomic
RNAs in the region containing the start of the subgenomic RNA.
Proc. Natl. Acad. Sci. USA 79:5235-5239.
385. Ou, J.-H., E. G. Strauss, and J. H. Strauss. 1981. Comparative
studies of the 3'-terminal sequences of several alphavirus RNAs.
Virology 109:281-289.
386. Ou, J.-H., E. G. Strauss, and J. H. Strauss. 1983. The 5'-terminal
sequences of the genomic RNAs of several alphaviruses. J. Mol.
Biol. 168:1-15.
387. Ou, J.-H., D. W. Trent, and J. H. Strauss. 1982. The 3-non-
coding regions of alphavirus RNAs contain repeating sequences.
J. Mol. Biol. 156:719-730.
388. Pardigon, N. 1994. Unpublished data.
389. Pardigon, N., E. Lenches, and J. H. Strauss. 1993. Multiple
binding sites for cellular proteins in the 3' end of Sindbis
alphavirus minus sense RNA. J. Virol. 67:5003-5011.
390. Pardigon, N., and J. H. Strauss. 1992. Cellular proteins bind to
the 3' end of Sindbis virus minus strand RNA. J. Virol. 66:1007-
1015.
391. Paredes, A. M., D. T. Brown, R. B. Rothnagel, W. Chiu, R. J.
Schoepp, R. E. Johnston, and B. V. V. Prasad. 1993. Three-
dimensional structure of a membrane-containing virus. Proc.
MICROBIOL. REV.
THE ALPHAVIRUSES 557
Natl. Acad. Sci. USA 90:9095-9099.
392. Paredes, A. M., M. Simon, and D. T. Brown. 1993. The mass of
the Sindbis virus nucleocapsid suggests it has T=4 icosahedral
symmetry. Virology 187:324-332.
393. Parry, N., G. Fox, D. Rowlands, F. Brown, E. Fry, R. Acharya, D.
Logan, and D. Stuart. 1990. Structural and serological evidence
for a novel mechanism of antigenic variation in foot-and-mouth
disease virus. Nature (London) 347:569-572.
394. Pavan, A., E. Covelli, M. C. Pascale, G. Lucania, S. Bonatti, P.
Pinto da Silva, and M. R. Torrisi. 1992. Dynamics of transmem-
brane proteins during Sindbis virus budding. J. Cell Sci. 102:149-
155.
395. Pavan, A., L. V. Lotti, M. R. Torrisi, G. Migliaccio, and S.
Bonatti. 1987. Regional distribution of Sindbis virus glycopro-
teins on the plasma membrane of infected baby hamster kidney
cells. Exp. Cell Res. 168:53-62.
396. Pence, D. F., N. L. Davis, and R. E. Johnston. 1990. Antigenic and
genetic characterization of Sindbis virus monoclonal antibody
escape mutants which define a pathogenesis domain on glyco-
protein E2. Virology 175:41-49.
397. Peranen, J. 1991. Localization and phosphorylation of Semliki
Forest virus non-structural protein nsP3 expressed in COS cells
from a cloned cDNA. J. Gen. Virol. 72:195-199.
398. Peranen, J., M. Rikkonen, P. Lilestrom, and L. Kiiariainen. 1990.
Nuclear localization of the Semliki Forest virus-specific nonstruc-
tural protein nsP2. J. Virol. 64:1888-1896.
399. Peranen, J., K. Takkinen, N. Kalkkinen, and L. Kaariainen.
1988. Semliki Forest virus-specific non-structural protein nsP3 is
a phosphoprotein. J. Gen. Virol. 69:2165-2178.
400. Perez, L., R. Guinea, and L. Carrasco. 1991. Synthesis of Semliki
Forest virus RNA requires continuous lipid synthesis. Virology
183:74-82.
401. Perez, L., A. Irurzun, and L. Carrasco. 1993. Activation of
phospholipase activity during Semliki Forest virus infection.
Virology 194:28-36.
402. Peters, C. J., and J. M. Dalrymple. 1990. Alphaviruses, p.
713-761. In B. N. Fields, and D. M. Knipe (ed.), Virology. Raven
Press, New York.
403. Pettersson, R. F. 1981. 5'-terminal nucleotide sequence of Sem-
liki Forest virus 18S defective-interfering RNA is heterogeneous
and different from the genomic 42S RNA. Proc. Natl. Acad. Sci.
USA 78:115.
404. Phalen, T., and M. Kielian. 1991. Cholesterol is required for
infection by Semliki Forest virus. J. Cell Biol. 112:615-623.
405. Phillips, D. A., J. R. Murray, J. G. Asakov, and M. A. Wiemers.
1990. Clinical and subclinical Barmah Forest virus infection in
Queensland. Med. J. Aust. 152:463-466.
406. Polo, J. M., N. L. Davis, C. M. Rice, H. V. Huang, and R. E.
Johnston. 1988. Molecular analysis of Sindbis virus pathogenesis
in neonatal mice by using virus recombinants constructed in vitro.
J. Virol. 62:2124-2133.
407. Polo, J. M., and R. E. Johnston. 1990. Attenuating mutations in
glycoproteins El and E2 of Sindbis virus produce a highly
attenuated strain when combined in vitro. J. Virol. 64:4438-4444.
408. Polo, J. M., and R. E. Johnston. 1991. Mutational analysis of a
virulence locus in the E2 glycoprotein gene of Sindbis virus. J.
Virol. 65:6358-6361.
409. Porterfield, J. S. 1980. Antigenic characteristics and classification
of togaviridae, p. 13-46. In R. W. Schlesinger (ed.), The togavi-
ruses: biology, structure, replication. Academic Press, Inc., New
York.
410. Presley, J. F., and D. T. Brown. 1989. The proteolytic cleavage of
PE2 to envelope glycoprotein E2 is not strictly required for the
maturation of Sindbis virus. J. Virol. 63:1975-1980.
411. Raju, R., and H. V. Huang. 1991. Analysis of Sindbis virus
promoter recognition in vivo, using novel vectors with two
subgenomic mRNA promoters. J. Virol. 65:2501-2510.
412. Ranki, M., and L. Kiiariainen. 1979. Solubilized RNA replication
complex from Semliki Forest virus-infected cells. Virology 98:
298-307.
413. Rao, C. N., V. Castronovo, C. M. Schmitt, U. M. Wewer, A. P.
Claysmith, L. A. Liotta, and M. E. Sobel. 1989. Evidence for a
precursor of the high-affinity metastasis-associated murine lami-
nin receptor. Biochemistry 28:7476-7486.
414. Rennels, M. B. 1984. Arthropod-borne virus infections of the
central nervous system. Neurol. Clin. 2:241-254.
415. Rentier-Delrue, F., and N. A. Young. 1980. Genomic divergence
among Sindbis virus strains. Virology 106:59-70.
416. Rice, C. M., J. R. Bell, M. W. Hunkapiller, E. G. Strauss, and
J. H. Strauss. 1982. Isolation and characterization of the hydro-
phobic COOH-terminal domains of the Sindbis virus glycopro-
teins. J. Mol. Biol. 154:355-378.
417. Rice, C. M., C. A. Franke, J. H. Strauss, and D. E. Hruby. 1985.
Expression of Sindbis virus structural proteins via recombinant
vaccinia virus: synthesis, processing and incorporation into ma-
ture Sindbis virions. J. Virol. 56:227-239.
418. Rice, C. M., R. Levis, J. H. Strauss, and H. V. Huang. 1987.
Production of infectious RNA transcripts from Sindbis virus
cDNA clones: mapping of lethal mutations, rescue of a temper-
ature sensitive marker, and in vitro mutagenesis to generate
defined mutants. J. Virol. 61:3809-3819.
419. Rice, C. M., and J. H. Strauss. 1981. Nucleotide sequence of the
26S mRNA of Sindbis virus and deduced sequence of the
encoded virus structural proteins. Proc. Natl. Acad. Sci. USA
78:2062-2066.
420. Rice, C. M., and J. H. Strauss. 1982. Association of Sindbis virion
glycoproteins and their precursors. J. Mol. Biol. 154:325-348.
421. Rico-Hesse, R., J. T. Roehrig, D. W. Trent, and R. W. Dickerman.
1988. Genetic variation of Venezuelan equine encephalitis virus
strains of the ID variety in Columbia. Am. Soc. Trop. Med. Hyg.
38:195-204.
422. Riedel, B., and D. T. Brown. 1979. Novel antiviral activity found
in the media of Sindbis virus-persistently infected mosquito
(Aedes albopictus) cell cultures. J. Virol. 29:51-60.
423. Riedel, H. 1985. Different membrane anchors allow the Semliki
Forest virus spike subunit E2 to reach the cell surface. J. Virol.
54:224-228.
424. Rikkonen, M., J. Peranen, and L. Kaariainen. 1992. Nuclear and
nucleolar targeting signals of Semliki Forest virus nonstructural
protein nsP2. Virology 189:462-473.
425. Robbins, A. R., S. S. Peng, and J. L. Marshall. 1983. Mutant
Chinese hamster ovary cells pleiotropically defective in receptor-
mediated endocytosis. J. Cell Biol. 96:1064-1071.
426. Roehrig, J. T. 1986. The use of monoclonal antibodies in studies
of the structural proteins of togaviruses and flaviviruses, p.
251-278. In S. Schlesinger and M. J. Schlesinger (ed.), The
Togaviridae and Flaviviridae. Plenum Publishing Corp., New
York.
427. Roehrig, J. T., J. W. Day, and R. M. Kinney. 1982. Antigenic
analysis of the surface glycoproteins of a Venezuelan equine
encephalomyelitis virus (TC-83) using monoclonal antibodies.
Virology 118:269-278.
428. Roehrig, J. T., D. Gorski, and M. J. Schlesinger. 1982. Properties
of monoclonal antibodies directed against the glycoproteins of
Sindbis virus. J. Gen. Virol. 59:421-425.
429. Roehrig, J. T., A. R. Hunt, G. J. Chang, B. Sheik, R. A. Bolin, T. F.
Tsai, and D. W. Trent. 1990. Identification of monoclonal antibodies
capable of differentiating antigenic varieties of Eastern equine
encephalitis viruses. Am. J. Trop. Med. Hyg. 42:394-398.
430. Roehrig, J. T., A. R. Hunt, R. M. Kinney, and J. H. Mathews.
1988. In vitro mechanisms of monoclonal antibody neutralization
of alphaviruses. Virology 165:66-73.
431. Roehrig, J. T., and J. H. Mathews. 1985. The neutralization site
on the E2 glycoprotein of Venezuelan equine encephalomyelitis
virus is composed of multiple conformationally-stable epitopes.
Virology 142:347-356.
432. Roman, L. M., and H. Garoff. 1986. Alteration of the cytoplasmic
domain of the membrane-spanning glycoprotein p62 of Semliki
Forest virus does not affect its polar distribution in established
lines of Madin-Darby canine kidney cells. J. Cell Biol. 103:2607-
2618.
433. Rozanov, M. N., E. V. Koonin, and A. E. Gorbalenya. 1992.
Conservation of the putative methyltransferase domain: a hall-
mark of the 'Sindbis-like' supergroup of positive strand RNA
viruses. J. Gen. Virol. 73:2129-2134.
434. Rumenapf, T. 1993. Unpublished data.
VOL. 58, 1994
558 STRAUSS AND STRAUSS
435. Rumenapf, T., D. T. Brown, E. G. Strauss, and J. H. Strauss.
Unpublished data.
436. Rumenapf, T., E. G. Strauss, and J. H. Strauss. 1994. The
subgenomic mRNA of Aura alphavirus is packaged into virions.
J. Virol. 68:56-62.
437. Russell, D. L., J. M. Dalrymple, and R. E. Johnston. 1989. Sindbis
virus mutations which coordinately affect glycoprotein process-
ing, penetration and virulence in mice. J. Virol. 63:1619-1629.
438. Ryser, H. J.-P., R. Mandel, and F. Ghani. 1991. Cell surface
sulfhydryls are required for the cytotoxicity of diphtheria toxin
but not of ricin in Chinese hamster ovary cells. J. Biol. Chem.
266:18439-18442.
439. Saborio, J. L., S. S. Pong, and G. Koch. 1974. Selective and
reversible inhibition of initiation of protein synthesis in mamma-
lian cells. J. Mol. Biol. 85:195-211.
440. Salminen, A., J. M. Wahlberg, M. Lobigs, P. Liljestrom, and H.
Garoff. 1992. Membrane fusion process of Semliki Forest virus II:
cleavage-dependent reorganization of the spike protein complex
controls virus entry. J. Cell Biol. 116:349-357.
441. Sanders, B. G., K. M. Wan, K. Kline, R. F. Garry, and H. R. Bose.
1980. Chicken fetal antigens: role as cell surface receptors for
Sindbis virus hemagglutinin. Virology 106:183-186.
442. Saraste, J., and K. Hedman. 1983. Intracellular vesicles involved
in the transport of Semliki Forest virus membrane proteins to the
cell surface. EMBO J. 2:2001-2006.
443. Saraste, J., and E. Kaismanen. 1984. Pre-Golgi and post-Golgi
vacuoles operate in the transport of Semliki Forest virus mem-
brane glycoproteins to the cell surface. Cell 38:535-549.
444. Saraste, J., C.-H. von Bonsdorff, K. Hashimoto, L. Kiaariainen,
and S. Keranen. 1980. Semliki Forest virus mutant with temper-
ature-sensitive transport defect of envelope proteins. Virology
100:229-245.
445. Sarver, N., and V. Stollar. 1977. Sindbis virus-induced cytopathic
effect in clones ofAedes albopictus (Singh) cells. Virology 80:390-
400.
446. Sawicki, D. L., D. B. Barkhimer, S. G. Sawicki, C. M. Rice, and
S. Schlesinger. 1990. Temperature sensitive shut-off of alphavirus
minus strand RNA synthesis maps to a nonstructural protein,
nsP4. Virology 174:43-52.
447. Sawicki, D. L., and S. G. Sawicki. 1980. Short-lived minus-strand
polymerase for Semliki Forest virus. J. Virol. 34:108-118.
448. Sawicki, D. L., and S. G. Sawicki. 1985. Functional analysis of the
A complementation group mutants of Sindbis HR virus. Virology
144:20-34.
449. Sawicki, D. L., and S. G. Sawicki. 1993. A second nonstructural
protein functions in the regulation of alphavirus negative-strand
RNA synthesis. J. Virol. 67:3605-3610.
450. Sawicki, D. L., S. G. Sawicki, S. Keranen, and L. Kiarialinen.
1981. Specific Sindbis virus coded function for minus-strand
RNA synthesis. J. Virol. 39:348-358.
451. Sawicki, S. G., and D. L. Sawicki. 1986. The effect of loss of
regulation of minus-strand RNA synthesis on Sindbis virus
replication. Virology 151:339-349.
452. Sawicki, S. G., and D. L. Sawicki. 1986. The effect of overpro-
duction of nonstructural proteins on alphavirus plus-strand and
minus-strand RNA synthesis. Virology 152:507-512.
453. Sawicki, S. G., D. L. Sawicki, L. Kiiariainen, and S. Keranen.
1981. A Sindbis virus mutant temperature-sensitive in the regu-
lation of minus-strand RNA synthesis. Virology 115:161-172.
454. Scharer, C. G., H. Y. Naim, and H. Koblet. 1993. Palmitoylation
of Semliki Forest virus glycoproteins in insect cells (C6/36) occurs
in an early compartment and is coupled to the cleavage of the
precursor p62. Arch. Virol. 132:237-254.
455. Scheidel, L. M., R. K. Durbin, and V. Stollar. 1987. Sindbis virus
mutants resistant to mycophenolic acid and ribavirin. Virology
158:1-7.
456. Scheidel, L. M., R K. Durbin, and V. Stollar. 1989. SVLM21, a
Sindbis virus mutant resistant to methionine deprivation, encodes
an altered methyltransferase. Virology 173:408-414.
457. Scheule, R K. 1987. Fusion of Sindbis virus with model mem-
branes containing phosphatidylethanolamine: implications for
protein-induced membrane fusion. Biochim. Biophys. Acta 899:
185-195.
458. Schlegel, A., A. Omar, P. Jentsch, A. Morell, and C. Kempf. 1991.
Semliki Forest virus envelope proteins function as proton chan-
nels. Biosci. Rep. 11:243-255.
459. Schlesinger, M., and S. Schlesinger. 1986. Formation and assem-
bly of alphavirus glycoproteins, p. 121-148. In S. Schlesinger and
M. J. Schlesinger (ed.), The Togaviridae and Flaviviridae. Ple-
num Publishing Corp., New York.
460. Schlesinger, M. J. 1989. Inhibition of Sindbis virus assembly by
peptides that mimic the cytoplasmic domain of the virus glyco-
protein, p. 73-76. In H.-G. Krausslich, S. Oroszlan, and E.
Wimmer (ed.), Viral proteinases as targets for chemotherapy.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
461. Schlesinger, M. J., and D. Cahill. 1989. Verapamil and chlor-
promazine inhibit the budding of Sindbis and vesicular stomatitis
viruses from infected chicken embryo fibroblasts. Virology 168:
187-190.
462. Schlesinger, M. J., S. D. London, and C. Ryan. 1993. An in-frame
insertion into the Sindbis virus 6K gene leads to defective
proteolytic processing of the virus glycoproteins, a trans-domi-
nant negative inhibition of normal virus formation, and interfer-
ence in virus shutoff of host-cell protein synthesis. Virology
193:424-432.
463. Schlesinger, S. 1993. Personal communication.
464. Schlesinger, S., A. H. Koyama, C. Malfer, S. L. Gee, and M. J.
Schlesinger. 1985. The effects of inhibitors of glucosidase I on the
formation of Sindbis virus. Virus Res. 2:139-149.
465. Schlesinger, S., R Levis, B. G. Weiss, M. Tsiang, and H. Huang.
1987. Replication and packaging sequences in defective interfer-
ing RNAs of Sindbis virus. UCLA Symp. Mol. Cell. Biol. New
Ser. 54:241-250.
466. Schlesinger, S., and M. J. Schlesinger (ed.). 1986. The Togaviri-
dae and Flaviviridae. Plenum Publishing Corp., New York.
467. Schlesinger, S., and B. G. Weiss. 1986. Defective RNAs of
alphaviruses, p. 149-166. In S. Schlesinger and M. J. Schlesinger
(ed.), The Togaviridae and Flaviviridae. Plenum Publishing
Corp., New York.
468. Schmaljohn, A. L. Unpublished results.
469. Schmaljohn, A. L., E. D. Johnson, J. M. Dalrymple, and G. A.
Cole. 1982. Nonneutralizing monoclonal antibodies can prevent
lethal alphavirus encephalitis. Nature (London) 297:70-72.
470. Schmaljohn, A. L., K. M. Kokubun, and G. A. Cole. 1983.
Protective monoclonal antibodies define maturational and pH-
dependent antigenic changes in Sindbis virus El glycoprotein.
Virology 130:144-154.
471. Schmid, S., R Fuchs, M. Kielian, A. Helenius, and I. Meliman.
1989. Acidification of endosome subpopulations in wild-type
Chinese hamster ovary cells and temperature-sensitive acidifica-
tion-defective mutants. J. Cell Biol. 108:1291-1300.
472. Schmid, S. L., R. Fuchs, P. Male, and I. Mellman. 1988. Two
distinct subpopulations of endosomes involved in membrane
recycling and transport to lysosomes. Cell 52:73-83.
473. Schmidt, M., M. F. G. Schmidt, and R Rott. 1988. Chemical
identification of cysteine as palmitoylation site in a transmem-
brane protein (Semliki Forest virus El). J. Biol. Chem. 263:
18635-18639.
474. Schmidt, M. F. G. 1982. Acylation of viral spike glycoproteins, a
feature of envelope RNA viruses. Virology 116:327-338.
475. Schmidt, M. F. G., M. Bracha, and M. J. Schlesinger. 1979.
Evidence for covalent attachment of fatty acids to Sindbis virus
glycoproteins. Proc. Natl. Acad. Sci. USA 76:1687-1691.
476. Schmidt, M. F. G., and M. J. Schlesinger. 1980. Relation of fatty
acid attachment to the translation and maturation of vesicular
stomatitis and Sindbis virus membrane glycoproteins. J. Biol.
Chem. 255:3334-3339.
477. Schoepp, R. J., and R. E. Johnston. 1993. Directed mutagenesis
of a Sindbis virus pathogenesis site. Virology 193:149-159.
478. Schoepp, R J., and R. E. Johnston. 1993. Sindbis virus patho-
genesis: phenotypic reversion of an attenuated strain to virulence
by second-site intragenic suppressor mutations. J. Gen. Virol.
74:1691-1695.
479. Scott, T. W., and S. C. Weaver. 1989. Eastern equine encephalo-
myelitis virus: epidemiology and evolution of mosquito transmis-
sion. Adv. Virus Res. 37:277-328.
MICROBIOL. REV.
THE ALPHAVIRUSES 559
480. Sefton, B. M. 1977. Immediate glycosylation of Sindbis virus
membrane proteins. Cell 10:659-668.
481. Shah, K. V., H. N. Johnson, T. R. Rao, P.K. Rajagopalan, and
B. S. Lamba. 1960. Isolation of five strains of Sindbis virus in
India. Ind. J. Med. Res. 48:300-308.
482. Shenk, T. E., K. A. Koshelnyk, and V. Stollar. 1974. Tempera-
ture-sensitive virus from Aedes albopictus cells chronically in-
fected with Sindbis virus. J. Virol. 13:439-447.
483. Sherman, L. A., and D. E. Griffin. 1990. Pathogenesis of enceph-
alitis induced in newborn mice by virulent and avirulent strains of
Sindbis virus. J. Virol. 64:2041-2046.
484. Shirako, Y. 1994. Unpublished data.
485. Shirako, Y., B. Niklasson, J. M. Dalrymple, E. G. Strauss, and
J. H. Strauss. 1991. Structure of the Ockelbo virus genome and
its relationship to other Sindbis viruses. Virology 182:753-764.
486. Shirako,Y., and J. H. Strauss. 1990. Cleavage between nsPl and
nsP2 initiates the processing pathway of Sindbis virus nonstruc-
tural polyprotein P123. Virology 177:54-64.
487. Shirako, Y., and J. H. Strauss. 1994. Regulation of Sindbis virus
RNA replication: uncleaved P123 and nsP4 function in minus
strand RNA synthesis whereas cleaved products from P123 are
required for efficient plus strand RNA synthesis. J. Virol. 68:
1874-1885.
488. Shope, R. E. 1980. Medical significance of togaviruses: An
overview of diseases caused by togaviruses in man and in
domestic and wild vertebrate animals, p. 47-82. In R. W.
Schlesinger (ed.), The togaviruses: biology, structure, replication.
Academic Press, Inc., New York.
488a.Simizu, B. 1984. Inhibition of host cell macromolecular synthesis
following togavirus infection, p. 465-499. In H. Fraenkel-Conrat
and R. R. Wagner (ed.), Comprehensive virology, vol. 19.
Plenum Publishing Corp., New York.
489. Simmons, D. T., and J. H. Strauss. 1974. Translation of Sindbis
virus 26S RNA and 49S RNA in lysates of rabbit reticulocytes. J.
Mol. Biol. 86:397-409.
490. Singh, I., and A. Helenius. 1992. Nucleocapsid uncoating during
entry of enveloped RNA viruses into cells. Semin. Virol. 3:511-
518.
491. Singh, I., and A. Helenius. 1992. Role of ribosomes in Semliki
Forest virus nucleocapsid uncoating. J. Virol. 66:7049-7058.
492. Smeekens, S. P. 1993. Processing of protein precursors by a novel
family of subtilisin-related mammalian endoproteases. Bio/Tech-
nology 11:182-186.
493. Smeekens, S. P., A. G. Montag, G. Thomas, C. Albiges-Rizo, R.
Carroll, M. Benig, L. A. Phillips, S. Martin, S. Ohagi, P.
Gardner, H. H. Swift, and D. F. Steiner. 1992. Proinsulin
processing by the subtilisin-related proprotein convertases furin,
PC2, and PC3. Proc. Natl. Acad. Sci. USA 89:8822-8826.
494. Smith, A. L., and G. H. Tignor. 1980. Host cell receptors for two
strains of Sindbis virus. Arch. Virol. 66:11-26.
495. Smith, D. B., and S. C. Inglis. 1987. The mutation rate and
variability of eukaryotic viruses: an analytical review. J. Gen.
Virol. 68:2729-2740.
496. Sneider, J. M., R. M. Kinney, K. R. Tsuchiya, and D. W. Trent.
1993. Molecular evidence that epizootic Venezuelan equine
encephalitis (VEE) I-AB viruses are not evolutionary derivatives
of enzootic VEE subtype I-E or II viruses. J. Gen. Virol.
74:519-523.
497. Soderlund, H., L. Kiiariainen, C.-H. V. Bonsdorff, and P. Weck-
stein. 1972. Properties of Semliki Forest virus nucleocapsid II: an
irreversible contraction by acid pH. Virology 47:753-760.
498. Sreevalsan, T., and F. H. Yin. 1969. Sindbis virus induced viral
ribonucleic acid polymerase. J. Virol. 3:599-604.
499. Stamm, D. D., and R. J. Newman. 1963. Evidence of southward
transport of arboviruses from the U.S. by migratory birds. An.
Microbiol. 11:123-133.
500. Stanley, J., S. J. Cooper, and D. E. Griffin. 1985. Alphavirus
neurovirulence: monoclonal antibodies discriminating wild-type
from neuroadapted Sindbis virus. J. Virol. 56:110-119.
501. Stanley, J., S. J. Cooper, and D. E. Griffin. 1986. Monoclonal
antibody cure and prophylaxis of lethal Sindbis virus encephalitis
in mice. J. Virol. 58:107-115.
502. Stec, D. S., A. Waddell, C. S. Schmaljohn, G. A. Cole, and A. L.
Schmaljohn. 1986. Antibody-selected variation and reversion in
Sindbis virus neutralization epitopes. J. Virol. 57:715-720.
503. Stegmann, T., J. M. Delfino, F. M. Richards, and A. Helenius.
1991. The HA2 subunit of influenza hemagglutinin inserts into
the target membrane prior to fusion. J. Biol. Chem. 266:18404-
18410.
504. Stegmann, T., R. W. Doms, and A. Helenius. 1989. Protein-
mediated membrane fusion. Annu. Rev. Biophys. Biophys.
Chem. 18:187-211.
505. Stegmann, T., P. Schoen, R. Bron, J. Wey, I. Bartoldus, A. Ortiz,
J.-L. Nieva, and J. Wilschut. 1993. Evaluation of viral membrane
fusion assays: comparison of the octadecylrhodamine dequench-
ing assay with the pyrene excimer assay. Biochemistry 32:11330-
11337.
506. Steiner, D. F., S. P. Smeekens, S. Ohag, and S. J. Chan. 1992. The
new enzymology of precursor processing endoproteases. J. Biol.
Chem. 267:23435-23438.
507. Steinhauer, D. A., E. Domingo, and J. J. Holland. 1992. Lack of
evidence for proofreading mechanisms associated with an RNA
virus polymerase. Gene 122:281-288.
508. Steinhauer, D. A., and J. J. Holland. 1987. Rapid evolution of
RNA viruses. Annu. Revs. Microbiol. 41:409-433.
509. Stollar, V. 1987. Approaches to the study of vector specificity for
arboviruses-model systems using cultured mosquito cells. Adv.
Virus Res. 33:327-365.
510. Strauss, E. G. 1978. Mutants of Sindbis virus. III. Host polypep-
tides present in purified HR and tslO3 virus particles. J. Virol.
28:466-474.
511. Strauss, E. G., C. R. Birdwell, E. M. Lenches, S. E. Staples, and
J. H. Strauss. 1977. Mutants of Sindbis virus. II. Characterization
of a maturation-defective mutant, ts 103. Virology 82:122-149.
512. Strauss, E. G., R. J. de Groot, R. Levinson, and J. H. Strauss.
1992. Identification of the active site residues in the nsP2
proteinase of Sindbis virus. Virology 191:932-940.
513. Strauss, E. G., E. M. Lenches, and M. A. Stamreich-Martin.
1980. Growth and release of several alphaviruses in chick and
BHK cells. J. Gen. Virol. 49:297-307.
514. Strauss, E. G., E. M. Lenches, and J. H. Strauss. 1976. Mutants
of Sindbis virus. I. Isolation and partial characterization of 89
new temperature-sensitive mutants. Virology 74:154-168.
515. Strauss, E. G., R. Levinson, C. M. Rice, J. M. Dalrymple, and
J. H. Strauss. 1988. Nonstructural proteins nsP3 and nsP4 of
Ross River and O'Nyong-nyong viruses: sequence and compari-
son with those of other alphaviruses. Virology 164:265-274.
516. Strauss, E. G., C. M. Rice, and J. H. Strauss. 1983. Sequence
coding for the alphavirus nonstructural proteins is interrupted by
an opal termination codon. Proc. Natl. Acad. Sci. USA 80:5271-
5275.
517. Strauss, E. G., C. M. Rice, and J. H. Strauss. 1984. Complete
nucleotide sequence of the genomic RNA of Sindbis virus.
Virology 133:92-110.
518. Strauss, E. G., A. L. Schmaljohn, D. E. Griffin, and J. H. Strauss.
1987. Structure-function relationships in the glycoproteins of
alphaviruses. UCLA Symp. Mol. Cell. Biol. New Ser. 54:365-378.
519. Strauss, E. G., A. L. Schmaljohn, D. S. Stec, and J. H. Strauss.
1990. Mapping of Sindbis virus neutralization epitopes, p. 305-
308. In M. A. Brinton and F. X. Heinz (ed.), New aspects of
positive-strand RNA viruses. American Society for Microbiology,
Washington, D.C.
520. Strauss, E. G., D. S. Stec, A. L. Schmaljohn, and J. H. Strauss.
1991. Identification of antigenically important domains in the
glycoproteins of Sindbis virus by analysis of antibody escape
variants. J. Virol. 65:4654-4664.
521. Strauss, E. G., and J. H. Strauss. 1980. Mutants of alphaviruses:
genetics and physiology, p. 393-426. In R. W. Schlesinger (ed.),
The togaviruses: biology, structure, replication. Academic Press,
Inc., New York.
522. Strauss, E. G., and J. H. Strauss. 1983. Replication strategies of
the single stranded RNA viruses of eukaryotes. Curr. Top.
Microbiol. Immunol. 105:1-98.
523. Strauss, E. G., and J. H. Strauss. 1985. Assembly of enveloped
animal viruses, p. 205-234. In S. Casjens (ed.), Virus structure
and assembly. Jones and Bartlett Publishers, Boston.
VOL. 58, 1994
560 STRAUSS AND STRAUSS
524. Strauss, E. G., and J. H. Strauss. 1986. Structure and replication
of the alphavirus genome, p. 35-90. In S. Schlesinger and M. J.
Schlesinger (ed.), The Togaviridae and Flaviviridae. Plenum
Publishing Corp., New York.
525. Strauss, E. G., J. H. Strauss, and A. J. Levine. 1991. Viral
evolution, p. 167-190. In B. N. Fields and D. M. Knipe (ed.),
Fundamental virology. Raven Press, New York.
526. Strauss, J. H. (ed.). 1990. Viral Proteinases. Semin. Virol.
1:307-384.
527. Strauss, J. H. 1993. Recombination in the evolution of RNA
viruses, p. 241-251. In S. S. Morse (ed.), Emerging viruses.
Oxford University Press, New York.
528. Strauss, J. H., B. W. Burge, and J. E. Darnell. 1969. Sindbis virus
infection of chick and hamster cells: synthesis of virus-specific
proteins. Virology 37:367-376.
529. Strauss, J. H., and E. G. Strauss. 1976. Togaviruses, p. 111-166.
In D. P. Nayak (ed.), The molecular biology of animal viruses.
Marcel Dekker, Inc., New York.
530. Strauss, J. H., and E. G. Strauss. 1988. Evolution of RNA
viruses. Annu. Rev. Microbiol. 42:657-683.
531. Strauss, J. H., and E. G. Strauss. 1990. Alphavirus proteinases.
Semin. Virol. 1:347-356.
532. Strauss, J. H., E. G. Strauss, C. S. Hahn, Y. S. Hahn, R. Galler,
W. R. Hardy, and C. M. Rice. 1987. Replication of alphaviruses
and flaviviruses: proteolytic processing of polyproteins. UCLA
Symp. Mol. Cell. Biol. New Ser. 54:209-225.
533. Stubbs, M. J., A. Miller, P. J. H. Sizer, J. R Stephenson, and A. J.
Crooks. 1991. X-ray solution scattering of Sindbis virus: changes
in conformation induced at low pH. J. Mol. Biol. 221:39-42.
534. Subak-Sharpe, I., H. Dyson, and J. Fazakerley. 1993. In vivo
depletion of CD8+ T cells prevents lesions of demyelination in
Semliki Forest virus infection. J. Virol. 67:7269-7633.
535. Suomalainen, M., and H. Garoff. 1992. Alphavirus spike-nucleo-
capsid interaction and network antibodies. J. Virol. 66:5106-
5109.
536. Suomalainen, M., P. LiUestrom, and H. Garoff. 1992. Spike
protein-nucleocapsid interactions drive the budding of alphavi-
ruses. J. Virol. 66:4737-4747.
537. Symington, J., and M. J. Schlesinger. 1975. Isolation of a Sindbis
virus variant by passage on mouse plasmacytoma cells. J. Virol.
15:1037-1041.
538. Symington, J., and M. J. Schlesinger. 1978. Characterization of a
Sindbis virus variant with altered host range. Arch. Virol. 58:127-
136.
539. Tahara, S. M., E. Darzynkiewicz, J. Stepinski, I. Ekiel, Y. Lin,
C. S. Hahn, J. H. Strauss, T. Sujiwade, and D. Haber. 1990.
Effects of hypermethylated and aberrant 5' caps on translation of
,-globin and Sindbis virus 26S mRNAs. UCLA Symp. Mol. Cell.
Biol. New Ser. 128:67-82.
540. Takkinen, K. 1986. Complete nucleotide sequence of the non-
structural protein genes of Semliki Forest virus. Nucleic Acids
Res. 14:5667-5682.
541. Takkinen, K., J. Peranen, and L. Kiaarifiinen. 1991. Proteolytic
processing of Semliki Forest virus-specific non-structural
polyprotein. J. Gen. Virol. 72:1627-1633.
542. Takkinen, K., J. Peranen, S. Keranen, H. Soderlund, and L.
Kiaariainen. 1990. The Semliki Forest virus-specific nonstructural
protein nsP4 is an autoproteinase. Eur. J. Biochem. 189:33-38.
543. Tatem, J., and V. Stollar. 1989. Effect of Sindbis virus infection
on induction of heat shock proteins in Aedes albopictus cells. J.
Virol. 63:992-996.
544. Theilmann, D., B. T. Eaton, and A. E. Downe. 1984. Properties of
Sindbis virus variants from infected Culex tarsalis mosquitoes. J.
Gen. Virol. 65:945-953.
545. Tobias, J. W., T. E. Shrader, G. Rocap, and A. Varshavsky. 1991.
The N-end rule in bacteria. Science 254:1374-1377.
546. Tong, L., G. Wengler, and M. G. Rossmann. 1993. Refined
structure of Sindbis virus core protein and comparison with other
chymotrypsin-like serine proteinase structures. J. Mol. Biol.
230:228-247.
547. Tooze, J., M. Hollinshead, R Frank, and B. Burke. 1987. An
antibody specific for an endoproteolytic cleavage site provides
evidence that pro-opiomelanocortin is packaged into secretory
granules in AtT20 cells before its cleavage. J. Cell Biol. 105:155-
162.
548. Torrisi, M. R, and S. Bonatti. 1985. Immunocytochemical study
of the partition and distribution of Sindbis virus glycoproteins in
freeze-fractured membranes of infected baby hamster kidney
cells. J. Cell Biol. 101:300-306.
549. Trent, D. W., and J. A. Grant. 1980. A comparison of New World
alphaviruses in the Western equine encephalitis virus complex by
immunochemical and oligonucleotide fingerprint techniques. J.
Gen. Virol. 47:261-282.
550. Tsiang, M., S. S. Monroe, and S. Schlesinger. 1985. Studies of
defective interfering RNAs of Sindbis virus with and without
tRNAAsP sequences at their 5' termini. J. Virol. 54:38-44.
551. Tsiang, M., B. G. Weiss, and S. Schlesinger. 1988. Effects of
5'-terminal modifications on the biological activity of defective
interfering RNAs of Sindbis virus. J. Virol. 62:47-53.
552. Tucker, P. C., and D. E. Grilfin. 1991. Mechanism of altered
Sindbis virus neurovirulence associated with a single-amino-acid
change in the E2 glycoprotein. J. Virol. 65:1551-1557.
553. Tucker, P. C., E. G. Strauss, R. J. Kuhn, J. H. Strauss, and D. E.
Griffin. 1993. Viral determinants of age-dependent virulence of
Sindbis virus for mice. J. Virol. 67:4605-4610.
553a.Tuomi, K., L. Kiariainen, and H. Soderlund. 1975. Quantitation
of Semliki Forest virus RNAs in infected cells using 32P equilib-
rium labeling. Nucleic Acids Res. 2:555-565.
554. Turell, M. J. 1988. Horizontal and vertical transmission of viruses
by insect and tick vectors, p. 127-152. In T. P. Monath (ed.), The
arboviruses: epidemiology and ecology. CRC Press, Inc., Boca
Raton, Fla.
555. Ubol, S., and D. E. Griffin. 1991. Identification of a putative
alphavirus receptor on mouse neural cells. J. Virol. 65:6913-6921.
556. Ubol, S., P. C. Tucker, D. E. Griffin, and J. M. Hardwick
Neurovirulent strains of alphavirus induce apoptosis in bcl-2-
expressing cells: role of a single amino change in the E2
glycoprotein. Proc. Natl. Acad. Sci. USA, in press.
557. Ulmanen, I., H. Soderlund, and L Kfiariainen. 1976. Semliki
Forest virus capsid protein associates with the 60S ribosomal
subunit in infected cells. J. Virol. 20:203-210.
558. Ulmanen, I., H. Soderlund, and L. Kaariainen. 1979. Role of
protein synthesis in the assembly of Semliki Forest virus nucleo-
capsid. Virology 99:265-276.
559. Ulug, E. T., and H. R. Bose. 1985. Effect of tunicamycin on the
development of the cytopathic effect in Sindbis virus-infected
cells. Virology 143:546-557.
560. Ulug, E. T., R. F. Garry, and H. R Bose. 1989. The role of
monovalent cation transport in Sindbis virus maturation and
release. Virology 172:42-50.
561. Ulug, E. T., R F. Garry, M. R F. Waite, and H. R. Bose. 1984.
Alterations in monovalent cation transport in Sindbis virus-
infected chick cells. Virology 132:118-130.
562. van Duin, L. P., M. Kasperaitis, C. Ameling, and H. 0. Voor-
man. 1986. Additional methylation at the N(2)-position of the
cap of 26S Semliki Forest virus late mRNA and initiation of
translation. Virus Res. 5:61-66.
563. Van Steeg, H., M. Kasperaitis, H. 0. Voorma, and R Benne.
1984. Infection of neuroblastoma cells by Semliki Forest virus:
the interference of viral capsid protein with the binding of host
messenger RNAs into initiation complexes is the cause of the
shut-off of host protein synthesis. Eur. J. Biochem. 138:473-478.
564. van Steeg, H., A. Thomas, S. Verbeek, M. Kasperaitis, H. 0.
Voorma, and R Benne. 1981. Shutoff of neuroblastoma cell
protein synthesis by Semliki Forest virus: loss of ability of crude
initiation factors to recognize early Semliki Forest virus and host
mRNAs. J. Virol. 38:728-736.
565. Varshavsky, A. 1992. The N-end rule. Cell 69:725-735.
566. Vaux, D. J., A. Helenius, and I. Meliman. 1988. Spike-nucleocap-
sid interaction in Semliki Forest virus reconstructed using net-
work antibodies. Nature (London) 336:36-42.
567. Venien-Bryan, C., and S. D. Fuller. 1994. The organization of the
spike complex of Semliki Forest virus. J. Mol. Biol. 236:572-583.
568. Vogel, R H., S. W. Provencher, C. H. von Bonsdorff, M. Adrian,
and J. Dubochet. 1986. Envelope structure of Semliki Forest
virus reconstructed from cryoelectron micrographs. Nature (Lon-
MICROBIOL. REV.
THE ALPHAVIRUSES 561
don) 320:533-535.
569. Volchkov, V. E., V. A. Volchkova, and S. V. Netesov. 1991.
Complete nucleotide sequence of the Eastern equine encepha-
lomyelitis virus genome. Mol. Genet. Mikrobiol. Virusol. 5:8-15.
570. von Bonsdorff, C.-H., and S. C. Harrison. 1975. Sindbis virus
glycoproteins form a regular icosahedral surface lattice. J. Virol.
16:141-145.
571. von Bonsdorff, C.-H., and S. C. Harrison. 1978. Hexagonal
glycoprotein arrays from Sindbis virus membranes. J. Virol.
28:578-583.
572. Vrati, S., S. G. Faragher, R. C. Weir, and L. Dalgarno. 1986. Ross
River virus mutant with a deletion in the E2 gene: properties of
the virion, virus-specific macromolecule synthesis, and attenua-
tion of virulence for mice. Virology 151:222-232.
573. Vrati, S., C. A. Fernon, L. Dalgarno, and R. C. Weir. 1988.
Location of a major antigenic site involved in Ross River virus
neutralization. Virology 162:346-353.
574. Wahlberg, J. M., W. A. M. Boere, and H. Garoff. 1989. The
heterodimeric association between the membrane proteins of
Semliki Forest virus changes its sensitivity to low pH during virus
maturation. J. Virol. 63:4991-4997.
575. Wahlberg, J. M., R. Bron, J. Wilschut, and H. Garoff. 1992.
Membrane fusion of Semliki Forest virus involves homotrimers
of the fusion protein. J. Virol. 66:7309-7318.
576. Wahlberg, J. M., and H. Garoff. 1992. Membrane fusion process
of Semliki Forest virusI: low pH-induced rearrangement in spike
glycoprotein quaternary structure precedes virus penetration into
cells. J. Cell Biol. 116:339-348.
577. Waite, M. R. F., D. T. Brown, and E. R. Pfefferkorn. 1972.
Inhibition of Sindbis virus release by media of low ionic strength:
an electron microscope study. J. Virol. 10:537-544.
578. Waite, M. R. F., and E. R. Pfefferkorn. 1970. Inhibition of Sindbis
virus production by media of low ionic strength: intracellular
events and requirements for reversal. J. Virol. 5:60-71.
579. Walton, T. E., and M. A. Grayson. 1989. Venezuelan equine
encephalomyelitis, p. 203-231. In T. P. Monath (ed.), The
arboviruses: epidemiology and ecology. CRC Press, Inc., Boca
Raton, Fla.
580. Wang, K-S.,R. J. Kuhn, E. G. Strauss, S. Ou, and J. H. Strauss.
1992. High-affinity laminin receptor is a receptor for Sindbis virus
in mammalian cells. J. Virol. 66:4992-5001.
581. Wang, K.-S., R. J. Kuhn, and H. Zhang. 1992. Unpublished data.
582. Wang, K.-S., A. L. Schmaljohn, R. J. Kuhn, and J. H. Strauss.
1991. Antiidiotypic antibodies as probes for the Sindbis virus
receptor. Virology 181:694-702.
583. Wang, K.-S., and J. H. Strauss. 1991. Use of a Xgtll expression
library to localize a neutralizing antibody-binding site in glycop-
rotein E2 of Sindbis virus. J. Virol. 65:7037-7040.
584. Wang, Y.-F., S. G. Sawicki, and D. L. Sawicki. 1991. Sindbis virus
nsPl functions in negative-strand RNA synthesis. J. Virol. 65:
985-988.
585. Watson, D. G., J. M. Moehring, and T. J. Moehring. 1991. A
mutant CHO-Kl strain with resistance to Pseudomonas exotoxin
A and alphaviruses fails to cleave Sindbis virus glycoprotein PE2.
J. Virol. 65:2332-2339.
586. Weaver, S. C. Evolution of alphaviruses. In C. H. Calisher, A. J.
Gibbs, and F. Garcia-Arenals (ed.), Molecular basis of viral
evolution, in press. Cambridge University Press, Cambridge.
587. Weaver, S. C. 1994. Personal communication.
588. Weaver, S. C., L. A. Bellew, L. Gousset, P. M. Repik, T. W. Scott,
and J. J. Holland. 1993. Diversity within natural populations of
Eastern equine encephalomyelitis virus. Virology 195:700-709.
589. Weaver, S. C., L. A. Bellew, and R. Rico-Hesse. 1992. Phyloge-
netic analysis of alphaviruses in the Venezuelan equine enceph-
alitis complex and identification of epizootic viruses. Virology
191:282-290.
590. Weaver, S. C., A. Hagenbaugh, L. A. Bellew, and C. H. Calisher.
1992. Genetic characterization of an antigenic subtype of Eastern
equine encephalomyelitis virus. Arch. Virol. 127:305-314.
591. Weaver, S. C., A. Hagenbaugh, L. A. Bellew, L. Gousset, V.
Mallampalli, J. J. Holland, and T. W. Scott. 1994. Evolution of
alphaviruses in the Eastern equine encephalomyelitis complex. J.
Virol. 68:158-169.
592. Weaver, S. C., A. Hagenbaugh, L. A. Bellew, S. V. Netesov, V. E.
Volchkov, G.-J. J. Chang, D.K. Clarke, L. Gousset, T. W. Scott,
D. W. Trent, and J. J. Holland. 1993. A comparison of the
nucleotide sequences of Eastern and Western equine encepha-
lomyleitis viruses with those of other alphaviruses and related
RNA viruses. Virology 197:375-390.
593. Weaver, S. C., L. H. Lorenz, and T. W. Scott. 1992. Pathologic
changes in the midgut of Culex tarsalis following infection with
Western equine encephalomyelitis virus. Am. J. Trop. Med. Hyg.
47:691-701.
594. Weaver, S. C.,R Rico-Hesse, and T. W. Scott. 1992. Genetic
diversity and slow rates of evolution in New World alphaviruses.
Curr. Top. Microbiol. Immunol. 176:99-117.
595. Weaver, S. C., T. W. Scott, L. H. Lorenz, K. Lerdthusnee, and
W. S. Romoser. 1988. Togavirus-associated pathologic changes in
the midgut of a natural mosquito vector. J. Virol. 62:2083-2090.
596. Weaver, S. C., T. W. Scott, L. H. Lorenz, and P. M. Repik. 1991.
Detection of Eastern equine encephalomyelitis virus deposition
in Culiseta melanura following ingestion of radiolabeled virus in
blood meals. Am. J. Trop. Med. Hyg. 44:250-259.
597. Weaver, S. C., T. W. Scott, and R. Rico-Hesse. 1991. Molecular
evolution of Eastern equine encephalomyelitis virus in North
America. Virology 182:774-784.
598. Weir,R. C., and R. J. Kuhn. 1993. Unpublished data.
599. Weiss, B., H. Nitschko,I. Ghattas, R. Wright, and S. Schlesinger.
1989. Evidence for specificity in the encapsidation of Sindbis
RNAs. J. Virol. 63:5310-5318.
600. Weiss, B., and S. Schlesinger. 1981. Defective-interfering parti-
cles of Sindbis virus do not interfere with the homologous virus
obtained from persistently infected BHK cells but do interfere
with Semliki Forest virus. J. Virol. 37:840.
601. Weiss, B. G., and S. Schlesinger. 1991. Recombination between
Sindbis virus RNAs. J. Virol. 65:4017-4025.
602. Wellink, J., and A. van Kammen. 1988. Proteases involved in the
processing of viral polyproteins. Arch. Virol. 98:1-26.
603. Wen, D., and M. J. Schlesinger. 1986. Regulated expression of
Sindbis and vesicular stomatitis virus glycoproteins in Saccharo-
myces cerevisiae. Proc. Natl. Acad. Sci. USA 83:3639-3643.
604. Wengler, G. 1980. Effects of alphaviruses on host cell macromo-
lecular synthesis, p. 459-472. In R. W. Schlesinger (ed.), The
togaviruses: biology, structure, replication. Academic Press, Inc.,
New York.
605. Wengler, G. 1987. The mode of assembly of alphavirus cores
implies a mechanism for the disassembly of the cores in the early
stages of infection. Arch. Virol. 94:1-14.
606. Wengler, G., U. Boege, G. Wengler, H. Bischoff, and K Wahn.
1982. The core protein of the alphavirus Sindbis virus assembles
into core-like nucleoproteins with the viral genome RNA and
with other single-stranded nucleic acids in vitro. Virology 118:
401-410.
607. Wengler, G., and G. Wengler. 1975. Studies on the synthesis of
viral RNA-polymerase-template complexes in BHK 21 cells
infected with Semliki Forest virus. Virology 66:322-326.
608. Wengler, G., and G. Wengler. 1984. Identification of a transfer of
viral core protein to cellular ribosomes during the early stages of
alphavirus infection. Virology 134:435.
609. Wengler, G., G. Wengler, U. Boege, and K. Wahn. 1984. Estab-
lishment and analysis of a system which allows assembly and
disassembly of alphavirus core-like particles under physiological
condition in vitro. Virology 132:401-412.
610. Wengler, G., G. Wengler, and H. J. Gross. 1979. Replicative form
of Semliki Forest virus RNA contains an unpaired guanosine.
Nature (London) 282:754-756.
611. Wengler, G., G. Wengler, and H. J. Gross. 1982. Terminal
sequences of Sindbis virus-specific nucleic acids: identity in
molecules synthesized in vertebrate and insect cells and charac-
teristic properties of the replicative form RNA. Virology 123:
273-283.
612. Wengler, G., D. Wurkner, and G. Wengler. 1992. Identification of
a sequence element in the alphavirus core protein which medi-
ates interaction of cores with ribosomes and the disassembly of
cores. Virology 191:880-888.
613. Wewer, U. M., L. A. Liotta, M. Jaye, G. A. Ricca, W. A. Drohan,
VOL. 58, 1994
562 STRAUSS AND STRAUSS
A. P. Claysmith, C. N. Rao, P. Wirth, J. Coligan, R Albrechtsen,
M. Mudry, and M. E. Sobel. 1986. Altered levels of laminin
receptor mRNA in various human carcinoma cells that have
different abilities to bind laminin. Proc. Natl. Acad. Sci. USA
83:7137-7141.
614. Wewer, U. M., G. Taraboletti, M. E. Sobel, R Albrechtsen, and
L. A. Liotta. 1987. Role of laminin receptor in tumor cell
migration. Cancer Res. 47:5691-5698.
615. White, J., and A. Helenius. 1980. pH-dependent fusion between
the Semliki Forest virus membrane and liposomes. Proc. Natl.
Acad. Sci. USA 77:3273-3277.
616. White, J., J. Kartenbeck, and A. Helenius. 1980. Fusion of
Semliki Forest virus with the plasma membrane can be induced
by low pH. J. Cell Biol. 87:264-272.
617. White, J., K. Matlin, and A. Helenius. 1981. Cell fusion by
Semliki Forest, influenza and vesicular stomatitis virus. J. Cell
Biol. 89:674-679.
618. White, J. M. 1990. Viral and cellular membrane fusion proteins.
Annu. Rev. Physiol. 52:675-697.
619. Willems, W. R., G. Kaluza, C. B. Boschek, H. Barrier, H. Hager,
H. J. Schutz, and H. Feistner. 1979. Semliki Forest virus: cause of
a fatal case of human encephalitis. Science 203:1127-1129.
620. Wright, H. T., A. W. Marston, and D. J. Goldstein. 1984. A
functional role for cysteine disulfides in the transmembrane
transport of diphtheria toxin. J. Biol. Chem. 259:1649-1654.
621. Wust, C. J., R. Crombie, and A. Brown. 1987. Passive protection
across subgroups of alphaviruses by hyperimmune non-cross-
neutralizing anti-Sindbis serum. Proc. Soc. Exp. Biol. Med.
184:56-63.
622. Wust, C. J., J. A. W. Nicholas, D. Fredin, D. C. Dodd, R. J.
Brideau, M. E. Levely, and A. Brown. 1989. Monoclonal antibod-
ies that cross-react with the El glycoprotein of different alphavi-
rus serogroups: characterization including passive protection in
vivo. Virus Res. 13:101-112.
623. Xiong, C., R. Levis, P. Shen, S. Schlesinger, C. M. Rice, and H. V.
Huang. 1989. Sindbis virus: an efficient, broad host range vector
for gene expression in animal cells. Science 243:1188-1191.
624. Yoshimasa, Y., S. Seino, J. Whittaker, T. Kakehi, A. Kosaki, H.
Kuzuya, H. Imura, G. I. Bell, and D. F. Steiner. 1988. Insulin-
resistant diabetes due to a point mutation that prevents insulin
proreceptor processing. Science 240:784-787.
625. Zavadova, Z., J. Zavada, and R. Weiss. 1977. Unilateral pheno-
typic mixing of envelope antigens between togaviruses and vesic-
ular stomatitis virus or avian RNA tumor virus. J. Gen. Virol.
37:557-567.
626. Zhao, H., and H. Garoff. 1992. Role of cell surface spikes in
alphavirus budding. J. Virol. 66:7089-7095.
627. Ziemiecki, A., and H. Garoff. 1978. Subunit composition of the
membrane glycoprotein complex of Semliki Forest virus. J. Mol.
Biol. 122:259-269.
628. Ziemiecki, A., H. Garoff, and K. Simons. 1980. Formation of the
Semliki Forest virus membrane glycoprotein complexes in the
infected cell. J. Gen. Virol. 50:111-123.
629. Zurzolo, C., C. Polistina, M. Saini, R. Gentile, L. Aloj, G.
Migliaccio, S. Bonatti, and L. Nitsch. 1992. Opposite polarity of
virus budding and of viral envelope glycoprotein distribution in
epithelial cells derived from different tissues. J. Cell Biol. 117:
551-564.
MICROBIOL. REV.
